0001437749-17-005629.txt : 20170330 0001437749-17-005629.hdr.sgml : 20170330 20170330161654 ACCESSION NUMBER: 0001437749-17-005629 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 92 CONFORMED PERIOD OF REPORT: 20161231 FILED AS OF DATE: 20170330 DATE AS OF CHANGE: 20170330 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LIQTECH INTERNATIONAL INC CENTRAL INDEX KEY: 0001307579 STANDARD INDUSTRIAL CLASSIFICATION: MISC INDUSTRIAL & COMMERCIAL MACHINERY & EQUIPMENT [3590] IRS NUMBER: 201431677 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36210 FILM NUMBER: 17725878 BUSINESS ADDRESS: STREET 1: INDUSTRIPARKEN 22C CITY: BALLERUP STATE: G7 ZIP: DK-2750 BUSINESS PHONE: 01145 2390 4545 MAIL ADDRESS: STREET 1: INDUSTRIPARKEN 22C CITY: BALLERUP STATE: G7 ZIP: DK-2750 FORMER COMPANY: FORMER CONFORMED NAME: Blue Moose Media Inc DATE OF NAME CHANGE: 20041101 10-K 1 liqt20161231_10k.htm FORM 10-K liqt20161231_10k.htm

 UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2016

 

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-53769

 

LiqTech International, Inc.

(Exact name of registrant as specified in its charter)

 

Nevada

 

20-1431677

(State or other jurisdiction of incorporation or organization)

 

(I.R.S. Employer Identification No.)

  

 

  

Industriparken 22C, DK 2750 Ballerup, Denmark

 

  

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: +4544986000

 

Securities registered pursuant to Section 12(b) of the Act: Common Stock, $0.001 par value

 

Securities registered pursuant to Section 12(g) of the Act: None

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.    Yes ☐   No   ☒

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.    Yes ☐   No   ☒

 

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   ☒     No   ☐

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    Yes   ☒     No   ☐

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K.   ☒

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

Accelerated filer

Non-accelerated filer 

(Do not check if a smaller reporting company)

Smaller reporting company

 

 Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act).    Yes ☐   No   ☒

 

On June 30, 2016, the aggregate market value of the common stock outstanding and held by non-affiliates (as defined in Rule 405 under the Securities Act of 1933) of the registrant based on the closing price of the registrant’s common stock of $0.60 per share on June 30, 2016 was $14,711,188. As of March 23, 2017, there were 36,835,514 shares of common stock, $0.001 par value per share, outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

None.

  

 

 

 

Table of Contents

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

 

TABLE OF CONTENTS

 

  

  

  

Page

PART I

  

  

  

Item 1

Business

1

 

Item 1A

Risk Factors

9

  

Item 1B

Unresolved Staff Comments

17

  

Item 2

Properties

18

  

Item 3

Legal Proceedings

18

  

Item 4

Mine Safety Disclosures

18

PART II

  

  

  

Item 5

Market for the Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

18

  

Item 6

Selected Financial Data

19

  

Item 7

Management’s Discussion and Analysis of Financial Condition and Results of Operations

19

  

Item 7A

Quantitative and Qualitative Disclosures About Market Risk

30

  

Item 8

Financial Statements and Supplementary Data

30

  

Item 9

Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

30

  

Item 9A

Controls and Procedures

30

  

Item 9B

Other Information

31

PART III

  

  

  

Item 10

Directors, Executive Officers and Corporate Governance

31

  

Item 11

Executive Compensation

35

  

Item 12

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

39

  

Item 13

Certain Relationships and Related Transactions, and Director Independence

40

  

Item 14

Principal Accountant Fees and Services

41

PART IV

  

  

  

Item 15

Exhibits and Financial Statement Schedules

41

  

Signatures

  

46

  

i

 

 

PART I

 

Item 1.        Business

 

Overview

We are a clean technology company that provides state-of-the-art technologies for gas and liquid purification by manufacturing ceramic silicon carbide filters. For more than a decade, we have developed and manufactured products of re-crystallized silicon carbide. We specialize in two business areas: ceramic membranes for liquid filtration and diesel particulate filters (DPFs) for the control of soot exhaust particles from diesel engines. We are phasing out the fabrication of kiln furniture for the refractory industry. Using nanotechnology, we develop proprietary products using patented silicon carbide technology. Our products are based on unique silicon carbide membranes which facilitate new applications and improve existing technologies. We market our products from our offices in the United States and Denmark, and through local representatives. The products are shipped directly to customers from our production facilities in the United States and Denmark.

 

The terms “LiqTech”, “we”, “our”, “us”, the “Company” or any derivative thereof, as used herein refer to LiqTech International, Inc., a Nevada corporation, together with its direct and indirect wholly owned subsidiaries, including LiqTech USA, Inc., a Delaware corporation (“LiqTech USA”), which owns all of the outstanding equity interest in LiqTech International A/S, a Danish limited company, organized under the Danish Act on Limited Companies of the Kingdom of Denmark (“LiqTech Int. DK”), together with its direct wholly owned subsidiary LiqTech Systems A/S, a Danish limited company, organized under the Danish Act on Limited Companies of the Kingdom of Denmark (formerly known as Provital, “LiqTech Systems”) and LiqTech NA, Inc., a Delaware corporation (“LiqTech Delaware”). Collectively, LiqTech USA, LiqTech Int. DK, LiqTech Systems and LiqTech Delaware are referred to herein as our “Subsidiaries”.  

 

We conduct operations in the Kingdom of Denmark and the United States. Our Danish operations are located in the Copenhagen area and LiqTech Systems are located in Hobro in Jutland, Denmark, and our U.S. operations are conducted by LiqTech Delaware located in White Bear Lake, Minnesota.

 

Our Products

 

We manufacture and sell ceramic membranes and systems for the filtration of liquid and diesel particulate filters for the control of soot exhaust particles from diesel engines. 

   

Ceramic Silicon Carbide Membranes for Liquid Filtration

   

  Under the “LiqTech”, “Cometas” and “Provital” brand names, we manufacture and sell ceramic silicon carbide membranes and systems for liquid filtration using our patented silicon carbide technology (sometimes also referred to herein as our “SiC Filters”) that currently focus on hydrocarbon production-derived contaminated water, which we refer to herein as “produced water”, removal of heavy metals in mining and energy applications, pre-filtration for reverse osmosis in drinking water and industrial applications. Our SiC Filters have been used in the following applications by our clients:

   

 

Produced water: Our membranes can be used for the filtration of "produced" water – a byproduct from oil and gas production. The amount of produced water varies between 0.1 to ten times the amount of oil produced. We have performed testing with many of the major international private and public oil and gas companies. We have been awarded a contract by one of the major international oil and gas companies to provide and service produced water filters on one of its offshore platforms. Two additional commercial installations have been commissioned with the LiqTech membranes.

 

 

 

 

Pre-filtration of reverse osmosis drinking water: Prior to passing through reverse osmosis membranes to produce drinking or industrial water from sea or surface water, the sea or surface water must be pre-filtered. We have performed successful tests for the pre-filtration of sea and surface water for this purpose with numerous clients, including Synertech in Serbia, a supplier of drinking water, Arteron in Malaysia, a company producing compact drinking water solutions, and Hoimyung Corp in South Korea, a supplier of industrial waste water systems and pretreatment for reverse osmosis. 

 

 

 

 

Industrial applications: We have delivered complete water treatment systems for targeted applications, such as removal of a variety of substances such as heavy metals (energy providers in Denmark and Germany), scrubber wastewater from marine installations (Yara Marine Technologies), and mining wastewater for a European mining company.

 

1

 

 

 

Producing clean drinking water: The potential for the use of LiqTech SiC Filters in drinking water production is diverse and the benefits are numerous. Some examples include: ground water – removal of precipitated salts such as iron and manganese; surface water – removal of organic suspended solids and humic acid; and sea water – pre-filtration before reverse osmosis. We have entered into a cooperation agreement with a leading pump producer Grundfos to market a newly developed water treatment unit for ground water.

 

 

 

 

Pool and spa water: We have supplied several medium to very large public pool installations in Europe.

 

Our products are based on the following silicon carbide membrane technologies:

 

 

CoMem is a unique patented membrane technology that utilizes a cross-flow structure to handle high concentrations of suspended solids found in produced water from the oil and chemical industry, wastewater from industrial processes and manure filtration; and

 

 

 

 

Aqua Solution integrates a dead-end structural design with cutting-edge membrane technology in a solution specifically designed for applications in pre-treatment for reverse osmosis, wastewater treatment and pool and spa filtration.

 

 Our SiC Filters are manufactured with a silicon carbide ceramic membrane based on a patented technology, and we are not aware of any other company that makes both the substrate (honeycomb) and the membrane (the part which accomplishes the filtering) solely from silicon carbide.

    

The advantages of our SiC Filters compared to other pre-filtration systems for reverse osmosis are:

 

 

Our SiC Filters offer the same water flow as commonly used sand filters which take up to 400 times more space and have pore sizes at least three times bigger than our SiC Filters, and reduce the number of membrane elements and pressure vessels;

 

 

 

 

With our SiC Filters, high flow capacities are achieved at very low pressures, which reduces energy costs;

 

 

 

 

Our SiC Filters reduce water consumption for sand filter backwash; and

 

 

 

 

Our SiC Filters eliminate consumption/maintenance of cartridges.

 

Our SiC Filters offer consistent removal of oil and suspended solids at high throughput rates regardless of feed conditions. The membranes are ideal for treatment of produced water for discharge, re-injection, pre-reverse osmosis ("RO") as well as polymer flooded streams. We offer on shore and off shore solutions and have extensive experience with produced water streams from fracking, gas condensate, and oil emulsions. We believe our SiC Filters are the best alternative to micro-flotation and walnut shell filters due to their cost savings, reduced installation cost and robustness with reduced downtime. Our chemically inert plug-and-play filter designs are extremely hard and durable materials with high flux (flow) to increase membrane life and reduce downtime for cleaning. SiC Filters are stronger, harder, longer lasting, more temperature resistant, and recover faster than conventional ceramic and polymeric membranes.

 

Our flat sheet membranes (“FSM”) offer low energy consumption, maximum permeation, innovative rack design, and high flux. These membranes are used in drinking water, pre-RO, and industrial wastewater reuse. The FSM carrier and the selective layer are also made of silicon carbide, which gives the product some unique advantages such as high flux, total chemical resistance (pH 0-14), long life, and the lowest fouling tendency of any polymeric and ceramic membrane material. Our tubular membranes offer robust and high yielding membrane solutions for produced water from the Oil & Gas market, and industrial wastewater to remove suspended solids as well as oil droplets and oil-emulsions from solutions. Our dynamic high flux membrane disks are designed for removal of high suspended solids. The filtration format is outside-in, with internal permeation channels that facilitate removal of the solids. The cross-flow effect is generated through the rotation of the discs at high velocities which enables flow cleaning of the filter membrane surface. This principle offers energy savings above 80% compared to conventional cross flow.

 

The strategic acquisition of Provital in July 2014 (now LiqTech Systems) is consistent with our long-term growth strategy and strengthens our position in the integrated filtration technologies market. LiqTech Systems was one of the first in the world to develop filtration solutions based on ceramic membranes whose products result in more efficient, longer lasting systems that save water and demand less maintenance for large public pools and wastewater. The filtration systems are equipped with LiqTech Systems' own Intelligent Control System, which allows for local and/or remote control, monitoring and management of every aspect of the system. The system is easy to use and gives the user full control. The control system logs all necessary data and sends daily e-mails/SMS with all the information to a designated operator if required. We believe that LiqTech Systems solves many of the problems present in today's pool industry, including excess water consumption, energy, chemical usage, space and maintenance, and improves cost efficiency. The acquisition of LiqTech Systems has allowed LiqTech Systems to become a fully integrated, one-stop shop for plug and play filtration systems. We believe LiqTech will significantly accelerate the time to market for our SiC Filters and provide us with immediate credibility in the liquid filtration industry, particularly with our SiC Filters. By acquiring LiqTech Systems, we have gained validation in the industry by directly expanding our customer base to include existing reputable customers from LiqTech Systems. We plan to continue the research and development, and marketing efforts of LiqTech Systems' UVC Hybrid Mercury/LED lighting systems for use in large marine and recreational pools.

 

2

 

 

We believe tightening government regulation and increasing industry awareness about the need for high quality injection water will contribute to the implementation of membrane technology, since conventional technologies will not be able to meet these demands. 

 

For the years ended December 31, 2016 and 2015, we received grants from governmental entities of $157,804 and $797,008, respectively.

 

For the years ended December 31, 2016 and December 31, 2015, our sales of liquid filters, services and systems were $7,731,079 and $10,347,010, respectively, and accounted for 56% and 65% of our total sales, respectively. 

 

Diesel Particulate Filters (DPFs)

 

We offer diesel particulate filters for exhaust emission control solutions to the verified retrofit and the original equipment manufacturer (OEM) market through our direct sales force. DPF sales are generally made to distributors specializing in sales to end users. We use a proprietary “nano washcoat” to provide catalytic coating for anything from diesel particulate filters to catalytic converters. We have developed a robust silicon carbide diesel particulate filter that is especially useful for vehicles that produce a high soot load, and, if properly maintained, should last as long as the vehicle’s engine. Our DPFs are ideal for off-road vehicles because of their strength, chemical non-reactive nature, temperature resilience and thermal conductivity. Our DPF products are sold worldwide under the LiqTech brand name. 

 

Our SiC Filters can handle higher soot loads than filters that do not use a silicon carbide membrane, which makes them ideal for situations in which engines infrequently reach high enough temperatures to burn off soot. Examples include:

 

 

Garbage trucks;

 

 

 

 

Port vehicles;

 

 

 

 

Diesel pickup trucks not carrying a full load;

 

 

 

 

Off-road construction vehicles that idle for long periods of time; and

 

 

 

 

Intra-city vehicles that do not reach highway speeds.

  

For the years ended December 31, 2016 and 2015, our sales of DPFs were $5,820,793 and $5,081,304, respectively, and accounted for 42% and 32% of our total sales, respectively.

 

Kiln Furniture

 

Kiln furniture refers to all items used in a kiln to support ceramics that create additional space to maximize the number of items for each firing. Our high-quality SiC kiln furniture is thinner (allowing more items to be added for each firing), withstands higher heat, lasts longer and reduces the firing time (reducing energy costs) as compared to cordierite, mullite and oxide bonded kiln furniture.

 

Although we have produced kiln furniture as a means to maximize the efficiency of our manufacturing process and not as one of our primary products, we intend to phase out this commercial product over time.

 

For the years ended December 31, 2016 and December 31, 2015, our kiln furniture revenues were $354,522 and $384,273, respectively, and accounted for 2% and 2% of our total sales, respectively.

 

Our Competitive Strengths

 

We believe the following strengths position us to increase our revenue and profitability:

 

 

Advantages of Silicon Carbide Membranes: Our diesel exhaust and liquid filtration products utilize silicon carbide membranes which have certain qualities that we believe make our products more desirable than those of our competitors. Unlike filtration products that use aluminum oxide, silicon carbide membranes are chemically inert and temperature resistant. Furthermore, silicon carbide membranes exhibit a high degree of hydrophilicity (tendency of a surface to become wet or to absorb water) which results in unique flux (low energy consumption). Silicon carbide is also highly durable, with hardness second to diamonds, making it conducive in a variety of industrial settings. As a result, we believe that such superior properties make our products desirable in both exhaust emissions control products and liquid filtration products.

 

3

 

 

 

Complete systems fabrication: LiqTech provides full fabrication and integration of our membranes into complete systems made from corrosive resistant materials and components. We strive to provide full in-house engineering capabilities in process design, 3D modelling and controls. The entire specification, engineering, fabrication and commission process is driven by our professional staff of highly dedicated engineers and craftsman. We believe that suppling our customers with turnkey solutions built around our silicon carbide membranes is unique in this market. LiqTech is more than a membrane supplier - we see ourselves as a full provider of complete water treatment systems.

  

 

Broad Application of LiqTech Membranes: Our membranes can and have been applied in a variety of applications, including the processing of industrial waste water, produced water and pretreatment of drinking water, prefilters for reverse osmosis, oil emulsion separation, bacteria removal for aquaculture, commercial pool treatment solutions and separating metals from liquids used in industrial processes.

 

 

Marketing and Manufacturing in Key Markets and Expanding to Other Market: We have production and sales capacity in North America and Europe. We also sell our products through offices and agents in several key countries such as China, Spain, UK, Korea, France, Italy and Brazil, and we have established customer relations in more than 25 countries.

 

 

 

 

Strong and Experienced Management Team: Our management team has significant experience in the clean technology and filtration industries, driving growth through development of new applications and technologies and cultivating relationships with customers.

 

Our Strategy 

 

Our strategy is to create stockholder value by leveraging our competitive and strengths and focusing on the opportunities in the end-markets we serve. Key features of our strategy include:

 

 

Enter New Geographic Markets and Expand Existing Markets. We plan to continue to manufacture and sell our products out of Denmark and the United States. We intend to continue to develop our organization in Denmark and the United States. We intend to work with agents and partners to access appropriate markets.

 

 

Continue to Strengthen Position in DPF Market. We believe that we have a strong position in the retrofit market for diesel particulate filter (DPF) systems. We intend to continue our efforts to maintain our strength in this area. Furthermore, we intend to leverage our experience in the OEM market and expand our presence in the OEM market with new products relating to diesel particulate filter systems. Furthermore, LiqTech and Kailong have signed a Letter of Intent to establish a joint venture for production of SiC Filters in China.

 

 

Continue to Develop and Improve Technologies and Open New End Markets. We intend to continuously develop our ceramic membranes and improve the filtration efficiency for our filtration products. Through continuous development, we intend to find new uses for our products and plan to expand into any new markets that we believe would be appropriate for our Company. One of our key strategies is to develop our membrane applications together with our customers including, for example, the development of the next generation of diesel particulate filters with asymmetric design for the OEM market.

 

 

Continue Our Focus on Selling and on Development New Standard Units. We will continue our focus on selling systems based on our unique SIC Filters. We will also combine the ceramic membranes with other technologies to be able to offer our customers a complete solution. We will continue our focus to develop smaller standard systems, like our ground water treatment unit and our residential swimming pool units. These units will be sold through a network of agents and partnerships.

 

Our Industry 

 

Overview

 

We primarily serve two industries - the diesel particle filter (DPF) market and the liquid filtration system market. Our goal is to position ourselves to expand on and leverage our products and technology and to take advantage of the favorable industry trends that we anticipate.

 

4

 

 

Liquid Filtration Market

 

Water is essential to life on earth, and clean water shortages are expected to affect two-thirds of the human population by 2025 (Worldwildlife). One-third of the human population is living today with clean water shortcomings and this is expected to increase to two-thirds of the population by 2025 due to the growing population (United Nations). According to the World Health Organization, approximately 1.6 million children die every year due to unsafe water and the lack of basic sanitation. Due to the growing need for pure water for drinking and industrial purposes, the market for membrane filtration is growing rapidly, with more and larger plants being commissioned all over the world.

 

We also see a general trend worldwide for increasing demand for higher quality re-injection water in connection with unconventional oil and gas production. In addition, we see tightening discharge legislations, increasing water cuts (more water produced per barrel oil) and the introduction of Enhanced Oil Recovery (“EOR”) techniques. The tightening of produced water specifications is a problem for conventional technologies. However, our SiC Filters have been shown to solve these challenges and we believe represent favorable market trends for our business.

 

LiqTech offers packaged systems consisting of ceramic SiC and conventional RO membranes for industrial and municipal customers. We anticipate that global demand will increase for robust and OPEX attractive products such as ours that are well suited for mobile and modular systems. Reverse osmosis membranes are increasingly being used for the production of drinking water (desalination of sea water or brackish water), for demineralized water in industrial processes (boiler feed water, microelectronics production), as well as in food processing and pharmaceutical production (Lux Research). In addition, many laboratories rely on pure water, for which demineralization is an essential step. LiqTech is differentiating by the superior SiC membrane technology and being able to produce more of the water treatment package in-house. According to an industry report (Lux Research), the aggregate water volume treated by membranes is expected to grow from 29 billion cubic meters in 2009 to 82 billion cubic meters in 2020.

 

The market for marine installations is developing fast with new regulations for Sulphur and ballast water emissions. An estimated +10,000 ships will install a water treatment system over the coming five years. The sales of ballast water cleaning systems may reach as much as $3.1 billion by 2023, up from $467 million in 2013 (Frost and Sullivan).

 

Diesel Particulate Filter (DPF) Market

 

  The increase in global regulation of diesel particles is expected to drive growth in the DPF market. We expect areas of the United States to begin introducing DPF filters. In Europe, cities in Germany are setting requirements for off-road machinery requirements for DPF filters. According to an industry publication, the global market for new DPF filters manufactured by OEMs is expected to increase from approximately 1.7 million units in 2010 to over 9 million units in 2020. Diesel emissions consist of several toxic gasses and particles: particulate matter (soot), carbon monoxide and hydrocarbons. Soot has been linked to a variety of health problems in humans. Abt Associates, for the Clean Air Task Force, estimates that approximately 21,000 people in the U.S. die prematurely each year from breathing diesel soot, 3,000 of those from lung cancer. Another 27,000 heart attacks, 14,500 hospitalizations and 2.4 million lost work days a year are attributable to diesel particulate matter exposures. In 2010, the Organization for Economic Co-operation and Development (OECD) estimated that diesel transport represented 50% of the total ambient air pollution in OECD countries, which equates to over $785 billion in health damages. The Abt Associates report, using EPA science advisory board methodology, estimated that the monetary value of the health damages from diesel-related particulate matter in the U.S. was approximately $139 billion (in 1999 dollars). Reducing diesel emissions will have both health benefits and social benefits to society, along with reduced costs.

 

  In response to these health impacts, governments have been implementing legislation to regulate emissions from diesel engines. California implemented the Diesel Risk Reduction Plan, which required the curtailment of diesel particle emissions by 25% by 2010 and a further 15% by 2020. New York City has implemented binding directives for the retrofitting of buses, garbage trucks and construction machines. In the European Union, Directive EC 715/2007 of June 20, 2007 defined particle count limits for certain cars and light utility vehicles. Also, in Europe, low emission zones have been implemented locally, creating a patchwork of regulation. The increase in global regulation of diesel particles is expected to drive growth in the DPF market. According to an industry publication, the global market for new DPF filters manufactured by OEMs is expected to increase from approximately 1.7 million units in 2010 to over 9 million units in 2020. 

 

The Asian markets have shown economic growth and an improved standard of living which has led to increased sales of vehicles in the Asia-Oceania region. At the same time, the pollution in major cities has reached high PM levels. As a result, we believe that the Chinese government could introduce additional regulations, including new emissions standards faster than previously anticipated. We also believe the high pollution levels will result in an increase in the need for retrofitting existing vehicles.

 

5

 

 

Manufacturing

 

We currently manufacture our products in facilities located in Ballerup, Denmark and White Bear Lake, Minnesota and assemble our systems in LiqTech Systems, located in Hobro in Jutland, Denmark. We have plans to expand our production capacity in both Denmark and Minnesota, primarily through additional investment in equipment relating to our liquid filtration products, when this becomes necessary.

 

Raw Materials

 

The main raw materials that we use in our manufacturing processes are silicon carbide, steel, plastic, platinum and palladium. We purchase these commodities from various sources generally based upon availability and price. There is a limited supply of silicon carbide available to us. As other industries develop products utilizing silicon carbide, we may not be able to obtain adequate supplies of silicon carbide required for the manufacture of our existing and planned future water filtration products. Any increased demand for silicon carbide, platinum or palladium could increase the price we must pay to obtain it and could adversely affect our profitability. However, our management believes that we could obtain satisfactory substitutes for these materials should they become unavailable.

 

Sales, Marketing and Distribution 

 

Our products are sold primarily to large industrial customers that use our products for gas and liquid filtration. Since the start of the Company the automotive industry has been a focus for us and our single largest market. In 2014, we acquired LiqTech Systems (formerly known as Provital), a Danish systems manufacturing company, which has strengthened our focus on the liquid filtration business. This business is now our largest products group focusing on applications within the pool, drinking water, water reclamation, oil and gas, heavy metal removal and aquaculture markets.

 

  For the year ended December 31, 2016, our four largest customers accounted for approximately 33%, 25%, 5% and 4%, respectively, of our net sales (approximately 67% in total). For the year ended December 31, 2015, our four largest customers accounted for approximately 24%, 15%, 11% and 6%, respectively, of our net sales (approximately 56% in total). If we are unable to diversify our customer base, our future results will be heavily dependent on these customers. Our dependence on a limited number of customers means that the loss of a major customer or any reduction in orders by a major customer would materially reduce our net sales and adversely affect our results of operations.

 

 We expect that sales to relatively few customers will continue to account for a significant percentage of our net sales for the foreseeable future. However, these customers or our other customers may not use our products at current levels in the future, if at all. We have no firm, long-term volume commitments from any of our major customers and we generally enter into individual purchase orders with our customers, in certain cases under master agreements that govern the terms and conditions of the relationship. We have experienced cancellations of orders and fluctuations in order levels from period-to-period and expect that we will continue to experience such cancellations and fluctuations in the future. Customer purchase orders may be cancelled and order volume levels can be changed, cancelled or delayed with limited or no penalties. We may not be able to replace cancelled, delayed or reduced purchase orders with new orders. If any one of our four largest customers reduces their demand for our products, it will likely have a material adverse effect on our operations. Furthermore, a significant portion of our accounts receivable is concentrated with these major customers, some of whom have limited working capital resources who may not be able to meet their financial obligations to us.

  

   We plan to actively market our existing products to new customers as we increase our production capacity. As of March 23, 2017, we had nine (9) full time salesmen or distribution agents. We promote our products through direct contact to potential customers and by meeting potential customers in trade fairs and exhibitions.

 

In certain instances, our products are delivered to the end customer through systems integrators. These systems integrators use our filtration products in larger filtration systems, which eventually are installed in products used by the end customer. Due to the regulation surrounding the reasons why many of the end customers use filtration systems, the systems integrators often are required by such end customers to receive approval of their systems, including the components used in such systems, which requires the use of significant time and money. As a result, we believe that certain of the systems integrators that use our products will not replace our filters with competitive products unless there is good reason.

 

Intellectual Property

 

Our success depends in part upon our ability to obtain, maintain and protect intellectual property rights that cover our silicon carbide product forms, applications and/or manufacturing processes and specifications and the technology or know-how that enable these product forms, applications, processes and specifications, and to avoid and defend against claims that we infringe upon the intellectual property rights of others and to prevent the unauthorized use of our intellectual property. Silicon carbide is a well-known material which was developed over 100 years ago and thus, extensive research, development and publication on this material exists, making it difficult to obtain intellectual property rights to key elements of silicon carbide technology. Accordingly, at least some of the technology used in the manufacture of our re-crystallized silicon carbide products is not protected by patents. Where we consider it appropriate, we seek to protect our proprietary rights by filing United States and foreign patent applications related to technology, inventions and improvements that we consider patentable and important to the development and conduct of our business. We also rely on trade secrets, trademarks, licensing agreements, confidentiality and nondisclosure agreements, business partnerships and continuing technological innovation to safeguard our intellectual property rights and develop and maintain our competitive advantage.

 

6

 

 

As of March 23, 2017, we had one issued United States patent that we co-own with a third party, two issued Danish patents, three issued foreign patents (in Germany, China and South Korea) that we co-own with a third party and one pending European patent application which we co-own with a third party. The United States patent that we co-own is generally effective for 20 years from the filing date of the earliest U.S. or international application to which it claims priority. The scope and duration of each of our foreign patents varies in accordance with local law. On July 7, 2014, we obtained a new Danish patent application related to the silicon carbide membrane technology in Denmark. Our patent strategy is generally uncertain and involves complex legal and factual questions. Our ability to maintain and solidify our proprietary technology may depend in part upon our success in obtaining patent rights and enforcing those rights once granted or licensed. We do not know whether any of our pending patent applications will result in the issuance of any patents. Our issued patents and those that may be issued in the future may be challenged, invalidated, rendered unenforceable or circumvented, which could limit our ability to prevent competitors from marketing similar or related products, or shorten the term of patent protection that we may have for our products, processes and enabling technologies. In addition, the rights granted under any issued patents may not provide us with competitive advantages against competitors with similar technology. Furthermore, our competitors may independently develop similar technologies, duplicate technology developed by us or otherwise possess intellectual property rights that could limit our ability to manufacture our products and operate our business. 

 

We also rely on trade secret protection for our confidential and proprietary information. Trade secrets, however, can be difficult to protect. We may not be able to maintain our technology or know-how as trade secrets, and competitors may develop or acquire equally valuable or more valuable technology or know-how related to the manufacture of comparable silicon carbide products. We also seek to protect our confidential and proprietary information, in part, by requiring all employees, consultants and business partners to execute confidentiality and/or nondisclosure agreements upon the commencement of any employment, consulting arrangement or engagement with us. These agreements generally require that all confidential and proprietary information developed by the employee, consultant or business partner, or made known to the employee, consultant or business partner by us, during the course of the relationship with us, be kept confidential and not disclosed to third parties. These agreements may be breached and may not provide adequate remedies in the event of breach. To the extent that our employees, consultants or business partners use intellectual property owned by others in their work for and/or with us, disputes could arise as to the rights in related or resulting technologies, know-how or inventions. Moreover, while we also require customers and vendors to execute agreements containing confidentiality and/or nondisclosure provisions, we may not have obtained such agreements from all of our customers and vendors. In addition, our trade secrets may otherwise become known or be independently discovered by competitors, customers or vendors. Such customers or vendors may also be subject to laws and regulations that require them to disclose information that we would otherwise seek to keep confidential.

  

We also believe that having distinctive names may be an important factor in marketing our products, and therefore use trademarks to brand some of our products. As of March 23, 2017, we had one trademark registration in the United States (LiqTech NA) and four trademark registrations in the European Union (AQUA SOLUTION, CoMem, CDPX and FUTURE FILTRATION).

 

Government Regulation

 

We do not believe that we are subject to any special governmental regulations affecting our products in the countries in which we have operations, except that in Minnesota, we are required to comply with the Minnesota Air Pollution standards related to the use of our incinerators located in our Minnesota facilities. We are subject to numerous health and safety laws and regulations. In the United States, these laws and regulations include the Federal Occupation Safety and Health Act and comparable state legislation. We are also subject to similar requirements in other countries in which we have extensive operations, including Denmark, where we are subject to various regulations. These regulations are frequently changing, and it is impossible to predict the effect of such laws and regulations on us in the future. We actively seek to maintain a safe, healthy and environmentally friendly workplace for all of our employees and those who work with us.

 

Environmental Matters

 

We are subject to a broad range of federal, state, local and foreign environmental laws and regulations which govern, among other things, air emissions, wastewater discharges and the handling, storage, disposal and release of waste and hazardous substances. It is our policy to comply with applicable environmental requirements at all of our facilities. We are also subject to laws such as the Comprehensive Environmental Response, Compensation and Liability Act, that may impose liability retroactively and without fault for releases or threatened releases of hazardous substances at on-site or off-site locations. We are subject to similar requirements in Denmark and other European countries. From time to time, we have identified environmental compliance issues at our facilities. To date, compliance with environmental matters has not had a material effect upon the Company’s capital expenditures or competitive position.

 

7

 

 

We believe that, due to the constant focus on the environment and clean air and clean water standards throughout the world, a requirement in the future to adhere to new and more stringent regulations both in the U.S. and abroad is possible as governmental agencies seek to improve standards required for certification of products intended to promote clean air and water. In the event our products fail to meet these ever-changing standards, some or all of our products may become obsolete, which could have an adverse effect on our business, operating results, financial condition and long-term prospects.

 

The nature of our manufacturing operations exposes us to potential claims and liability for environmental damage, personal injury, loss of life and damage to, or destruction of, property. Our manufacturing operations are subject to numerous laws and regulations that govern environmental protection and human health and safety. These laws and regulations have changed frequently in the past and it is reasonable to expect additional and more stringent changes in the future. Our manufacturing operations may not comply with future laws and regulations, and we may be required to make significant unanticipated capital and operating expenditures to bring our operations within compliance with such regulations. If we fail to comply with applicable environmental laws and regulations, manufacturing guidelines, and workplace safety requirements, governmental authorities may seek to impose fines and penalties on us or to revoke or deny the issuance or renewal of operating permits, and private parties may seek damages from us. Under such circumstances, we could be required to curtail or cease operations, conduct site remediation or other corrective action, or pay substantial damage claims for which may not have sufficient or any insurance coverage for claims. 

 

Research and Development

 

As of March 23, 2017, we had ten (10) full-time employees spending a majority of their working hours on research and development. For the years ended December 31, 2016 and 2015, we spent $626,147 and $707,844, respectively, on Company-sponsored research and development.

 

In 2014, we started the development of a UV LED technology for disinfection of organics in primarily commercial pool and drinking water applications. UV is a known disinfection method, but current technology with mercury lamps has its limitations. With LED technology, it is possible to have instant on/off and thereby apply the correct amount of UV rays for maximum bacteria kill increasing the overall system efficiency. Further, the lifetime of the LED lamps are much higher than mercury lamps and disposal cost at end of life lower and more environmentally friendly. In systems design LED technology provides more flexibility than traditional lamps, which are fixed in length, size and output. We believe that our UV LED development efforts will disrupt the current technology space.

 

Competition 

 

Our products compete with other filters that are made using both ceramic and plastic membranes. Most of our competitors are large industrial companies. However, we believe our patented technology allows us to produce high quality, low cost products that give us an advantage over many of our competitors, many of which have greater financial, technological, manufacturing and personnel resources. We intend to continue to devote resources to improving our products in order to maintain our existing customers and to add new customers.

 

Employees

 

As of March 23, 2017, we had 69 employees, 66 of whom were full-time employees. We had 59 employees at our operations in Denmark, including 10 in research and development, 9 in sales and engineering and 2 in executive management. We also had 10 employees in the United States sales, accounting and production.

 

Certain labor employees in Denmark are represented by workers’ councils that have collective bargaining agreements. With the exception of said Denmark employees, no other employees are members of a labor union or are represented by workers’ councils that have collective bargaining agreements. We believe that our relations with our employees are good.

 

Corporate Information

 

We filed our Articles of Incorporation on July 1, 2004 and are incorporated under the laws of the State of Nevada. Our principal executive offices are located at Industriparken 22C, 2750 Ballerup, Denmark, and our telephone number is +4544986000. We maintain an Internet website at www.liqtech.com. The information contained in, or accessible from, our website is not a part of this report. 

 

8

 

 

Item 1A.   Risk Factors

 

RISKS RELATED TO OUR BUSINESS 

 

We may be unable to continue as a going concern based on our historical performance, which has included net losses and an accumulated deficit. We may continue to generate losses and be required to reduce or curtail our operations.

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern.  As discussed in Note 2 to the financial statements, the Company has limited cash and incurred significant recent losses. These factors raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regards to these matters are also described in Note 2.  

 

We have historically incurred operating losses and may continue to do so in the future. There can be no assurance that our efforts to execute our business plan will be successful. We must develop new customer relationships and substantially increase our revenues. Our net loss for the year ended December 31, 2016 was $16,418,634 and our net loss for the year ended December 31, 2015 was $2,209,857. As of December 31, 2016 and 2015, we have an accumulated deficit of $24,011,343 and $7,592,709, respectively.  

 

We will need additional funds to sustain our business.  In the event that such funds are not received by April 15, 2017, the Company will need to raise funds through public or private sales of equity or debt securities. Financing may not be available on acceptable terms, or at all, and our failure to raise capital when needed could materially adversely impact our financial condition and results of operations. Additional equity financing may be dilutive to holders of our common stock, and debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate our business. In the event that the Company is unable to raise funds, there is substantial doubt about the ability of the Company to continue as a going concern, and the Company may be required to reduce or curtail its operations.

 

Our acquisition of LiqTech Systems included the acquisition of goodwill, which is subject to a periodic impairment analysis, and a significant impairment determination in any future period could have an adverse effect on our results of operations even without a significant loss of revenue or increase in cash expenses attributable to such period.

 

Our acquisition of LiqTech Systems included approximately $9.4 million of goodwill. We are required to evaluate this goodwill for impairment based on the fair value of LiqTech Systems at least once a year. This estimated fair value could change if LiqTech Systems is unable to achieve operating results at the levels that have been forecasted, the market valuation of LiqTech Systems decreases based on transactions involving similar companies, or there is a permanent, negative change in the market demand for the services offered by LiqTech Systems. These changes could result in an impairment of the existing goodwill balance that could require a material non-cash charge to our results of operations. The Company recorded an impairment charge of $7,343,208 and $0 on goodwill, during the year ended December 31, 2016 and 2015 respectively, as managements estimated fair value of the reporting unit did not exceeded the carrying value during 2016 fourth quarter testing.

 

Historically, we have been dependent on a few major customers for a significant portion of our Company's revenue. Our revenue could decline if we are unable to maintain or develop relationships with additional customers and our results of operations could be adversely affected if any one of these customers is unable to meet their financial obligations to us.

 

During the year ended December 31, 2016, we had four customers who accounted for approximately 33%, 25%, 5% and 4%, respectively, of our net sales (approximately 67% in total). For the year ended December 31, 2015, our four largest customers accounted for approximately 24%, 15%, 11% and 6%, respectively, of our net sales (approximately 56% in total). If we are unable to diversify our customer base, our future results will be heavily dependent on these customers. Our dependence on a limited number of customers means that the loss of a major customer or any reduction in orders by a major customer would materially reduce our net sales and adversely affect our results of operations. We expect that sales to relatively few customers will continue to account for a significant percentage of our net sales for the foreseeable future. However, these customers or our other customers may not use our products at current levels in the future, if at all. We have no firm, long-term volume commitments from any of our major customers (other than Kailong for producing DPFs) and we generally enter into individual purchase orders with our customers, in certain cases under master agreements that govern the terms and conditions of the relationship. We have experienced cancellations of orders and fluctuations in order levels from period-to-period and expect that we will continue to experience such cancellations and fluctuations in the future. Customer purchase orders may be cancelled and order volume levels can be changed, cancelled or delayed with limited or no penalties. We may not be able to replace cancelled, delayed or reduced purchase orders with new orders. If any one of these customers reduces their demand for our products, it will likely have a material adverse effect on our operations.

  

Furthermore, a significant portion of our accounts receivable is concentrated with these four major customers, some of whom have limited working capital resources who may not be able to meet their financial obligations to us. The failure of any such customers to pay amounts owed to us in a timely fashion or at all could have an adverse effect on our results of operations. The Company is also exposed to credit risk on its accounts receivable, and this risk is heightened during periods when economic conditions worsen. The Company's outstanding receivables are not covered by collateral or credit insurance. The Company's exposure to credit and collectability risk on its receivables may also be higher in certain international markets and its ability to mitigate such risks may be limited. While the Company has procedures to monitor and limit exposure to credit risk on its receivables as well as long-term prepayments, there can be no assurance such procedures will effectively limit its credit risk and avoid losses.

 

Our success will depend, to a large degree, on the expertise and experience of the members of our management team, the loss of whom could have a materially adverse effect on our business.

 

Our success is, to a large degree, dependent upon the expertise and experience of the management team and its ability to attract and retain quality personnel. The loss of the services of one or more of such personnel could have a material adverse effect on our business. Our business may be adversely affected if we are unable to continue to attract and retain such personnel.

  

We will need to add qualified additional personnel as we expand our business, and we may not be able to employ such persons, which could affect our ability to expand and have a materially adverse effect on our business.

 

In order to expand our product offerings and customer base, we will need to hire additional qualified personnel. We may not be able to locate such persons, and even if we locate them, we may not have the funds to employ them, which could have a materially adverse effect on our business.

 

9

 

 

Future growth of our business depends in part, on the general availability of funding for emissions control programs, as well as enforcement of existing emissions-related environmental regulations and further tightening of emission standards worldwide, both of which are beyond our control and the lack of which could negatively affect our future growth.

 

Future growth of our business depends in part on the general availability of funding for emissions control programs, which can be affected by economic as well as political reasons which are beyond our control. For example, in light of the budget crisis in California, funding was not available for a state-funded emissions control project and its start date was pushed back. Funding for these types of emissions control projects drives the demand for our diesel particulate filters. If such funding is not available, it can negatively affect our future growth prospects. In addition to funding, we also expect that our future business growth will be driven, in part, by the enforcement of existing emissions-related environmental regulations and tightening of emissions standards worldwide, which regulations and standards are frequently contested in litigation. For example, the Alliance for California Business filed suit against the California Air Resources Board in an effort to cease the California Air Resources Board’s mandate that a DPF be retrofitted on certain older diesel trucks. If existing regulations and emissions standards do not continue to become stricter, are loosened or are not enforced by governmental authorities due to commercial and business pressure or otherwise, it could have a material adverse effect on our business, operating results, financial condition and long-term prospects.

  

If we are unable to manage our expected growth, our business may be materially and adversely affected.

 

We have expanded, and expect to continue to expand, our operations. The growth of our business could place significant strain on our management and operational and financial resources. To manage our future growth, we could be required to improve existing or implement new operational or financial systems, procedures and controls or expand, train and manage a growing employee base. Our failure to accomplish any of these tasks could materially and adversely affect our business.

  

We face constant changes in governmental standards by which our products are evaluated, and if we cannot meet any such changes, some of our products could become obsolete, which could have a materially adverse effect on our business.

 

We believe that, due to the constant focus on the environment and clean air and clean water standards throughout the world, a requirement in the future to adhere to new and more stringent regulations both in the U.S. and abroad is possible as governmental agencies seek to improve standards required for certification of products intended to promote clean air and water. In the event our products fail to meet these ever-changing standards, some or all of our products may become obsolete, which could have an adverse effect on our business, operating results, financial condition and long-term prospects.

  

10

 

 

Our inability to protect our intellectual property rights could negatively affect our business and results of operations.

 

Our ability to compete effectively depends in part upon developing, maintaining and/or protecting intellectual property rights relevant to our re-crystallized silicon carbide product forms, applications and manufacturing processes. We rely principally on a combination of patent protection, trade secret laws, confidentiality and non-disclosure agreements and trusted business relationships to establish, maintain and protect the intellectual property rights relevant to our business. These measures, however, may not be adequate in every given case to permit us to gain or keep any competitive advantage, particularly in those countries where the laws do not protect our proprietary rights as fully as in the United States. In particular, because silicon carbide is a well-known material (developed over 100 years ago), and there has been extensive research, development and publication related to this material and its wide range of applications, obtaining intellectual property rights to key elements of silicon carbide technology can be challenging. Accordingly, at least some of the technology employed in our manufacture of re-crystallized silicon carbide products is not protected by patents.

 

Where we consider it appropriate, we seek patent protection in the United States and other countries on technologies used in, or relating to, our re-crystallized silicon carbide product forms, applications and manufacturing processes. The issuance of a patent is not conclusive as to its scope, validity and enforceability. Thus, any patent or patent application which may issue into a patent held by us could be challenged, invalidated or held unenforceable in litigation or proceedings before the U.S. Patent and Trademark Office and/or other patent tribunals, or circumvented by others. No consistent policy regarding the breadth of patent claims has emerged to date in the United States and the landscape could become more uncertain in view of future rule changes by the United States Patent and Trademark Office, the introduction of patent reform legislation and decisions in patent law cases by United States federal courts. The patent landscape outside the United States is even less predictable. As a result, the validity and enforceability of patents cannot be predicted with certainty. In addition, we may fail to apply for patents on important technologies or product candidates in a timely fashion, if at all, and our existing and future patents may not be sufficiently broad to prevent others from practicing our technologies or from developing competing products or technologies, especially given the long history of silicon carbide development. 

 

As of March 23, 2017, we had one issued United States patent that we co-own with a third party, two issued Danish patents, three issued foreign patents (in Germany, China and South Korea) that we co-own with a third party and one pending European patent application which we co-own with a third party. The United States patent that we co-own is generally effective for 20 years from the filing date of the earliest U.S. or international application to which it claims priority. The scope and duration of each of our foreign patents varies in accordance with local law. On July 7, 2014, we obtained a new Danish patent application related to the silicon carbide membrane technology in Denmark. Our patent strategy is generally uncertain and involves complex legal and factual questions. Our ability to maintain and solidify our proprietary technology may depend in part upon our success in obtaining patent rights and enforcing those rights once granted or licensed. We do not know whether any of our pending patent applications will result in the issuance of any patents. Our issued patents and those that may be issued in the future may be challenged, invalidated, rendered unenforceable or circumvented, which could limit our ability to prevent competitors from marketing similar or related products, or shorten the term of patent protection that we may have for our products, processes and enabling technologies. In addition, the rights granted under any issued patents may not provide us with competitive advantages against competitors with similar technology. Furthermore, our competitors may independently develop similar technologies, duplicate technology developed by us or otherwise possess intellectual property rights that could limit our ability to manufacture our products and operate our business. 

 

We also rely on trade secret protection for our confidential and proprietary information. Trade secrets, however, can be difficult to protect. We may not be able to maintain our technology or know-how as trade secrets, and competitors may develop or acquire equally valuable or more valuable technology or know-how related to the manufacture of comparable silicon carbide products. We also seek to protect our confidential and proprietary information, in part, by requiring all employees, consultants and business partners to execute confidentiality and/or nondisclosure agreements upon the commencement of any employment, consulting arrangement or engagement with us. These agreements generally require that all confidential and proprietary information developed by the employee, consultant or business partner, or made known to the employee, consultant or business partner by us, during the course of the relationship with us, be kept confidential and not disclosed to third parties. These agreements may be breached and may not provide adequate remedies in the event of breach. To the extent that our employees, consultants or business partners use intellectual property owned by others in their work for and/or with us, disputes could arise as to the rights in related or resulting technologies, know-how or inventions. Moreover, while we also require customers and vendors to execute agreements containing confidentiality and/or nondisclosure provisions, we may not have obtained such agreements from all of our customers and vendors. In addition, our trade secrets may otherwise become known or be independently discovered by competitors, customers or vendors. Such customers or vendors may also be subject to laws and regulations that require them to disclose information that we would otherwise seek to keep confidential.

  

We also believe that having distinctive names may be an important factor in marketing our products, and therefore use trademarks to brand some of our products. As of March 23, 2017, we had one trademark registration in the United States (LiqTech NA) and four trademark registrations in the European Union (AQUA SOLUTION, CoMem, CDPX and FUTURE FILTRATION).

 

Moreover, others may independently develop and obtain patents covering technologies that are similar or superior to the product forms, applications or manufacturing processes that we employ. If that happens, we may need to obtain licenses for these technologies and may not be able to obtain licenses on reasonable terms, if at all, which could limit our ability to manufacture our future products and operate our business. In addition, third parties could practice our intellectual property rights in territories where we do not have intellectual property protection. Such third parties may then try to import products made using our intellectual property rights into the United States or other countries, which could have a materially adverse effect on our business.

  

Our contracts with third parties could negatively affect our intellectual property rights.

 

To further our product development efforts, we continue to work closely with customers, the Danish government and other third parties to research and develop advancements in silicon carbide product forms, applications, manufacturing processes and related products and technologies. We have entered into agreements with private third parties and have been awarded a research and development contract with the Danish government to independently and jointly research, design and develop new devices and systems that incorporate our silicon carbide technologies. We expect to enter into similar private agreements and be awarded similar government contracts in the future. In some instances, the research and development activities that we conduct under these contracts may produce intellectual property to which we may not have ownership or exclusive rights and will be unable to protect or monetize. Furthermore, there could be disputes between us and a private third party as to the ownership rights to any inventions that we develop in collaboration with such third party. Any such dispute may cause us to incur substantial costs and could place a significant strain on our financial resources, divert the attention of management from our core business or harm our reputation. 

 

11

 

 

We rely on trade secrets to protect our technology, and our failure to obtain or maintain trade secret protection could adversely affect our competitive business position.

 

We rely in part on trade secret protection to protect confidential and proprietary information relating to our technology, particularly where we do not believe patent protection is appropriate or obtainable. We continue to develop and refine the manufacturing processes used to produce our re-crystallized silicon carbide products and believe that we have already developed, and will continue to develop, significant know-how related to these processes. Trade secrets however can be difficult to protect. We may not be able to maintain the secrecy of our know-how, and competitors may develop or acquire equally or more valuable know-how related to the manufacture of comparable silicon carbide products. Our strategy for scale-up of commercial production will continue to require us to share confidential and proprietary information with third parties. While we take reasonable efforts to protect our trade secrets, our employees, consultants, contractors or scientific and other advisors, or those of our business partners, may intentionally or inadvertently disclose our confidential and proprietary information to competitors. Any enforcement of claims by us that a third party has obtained and is using our trade secrets is expensive, time consuming and uncertain. In addition, foreign courts are sometimes less willing than United States courts to protect trade secrets.

 

We also require all employees, consultants and business partners to execute confidentiality and/or nondisclosure agreements upon the commencement of employment, consulting arrangement or other engagement with us, which agreements generally require that all confidential and proprietary information developed by such employee, consultant or business partner, or made known to such employee, consultant or business partner by us during the course of the relationship with us, be kept confidential and not disclosed to third parties. These agreements generally provide, with respect to employees, that inventions conceived by an individual in the course of rendering services to us will be our exclusive property. Nevertheless, these agreements may not be honored and our confidential and proprietary information may be disclosed, or these agreements may be unenforceable or difficult to enforce. We also require customers and vendors to execute agreements containing confidentiality and/or nondisclosure provisions. However, we may not have obtained such agreements from all of our customers and vendors. Some of our customers may also be subject to laws and regulations that require them to disclose information that we would otherwise seek to keep confidential. Our confidential and proprietary information may be otherwise disclosed without our authorization. For example, third parties might reverse engineer our manufacturing processes, independently develop substantially equivalent confidential and proprietary information or otherwise gain access to our trade secrets. Failure to maintain trade secret protection could enable others to produce competing products and adversely affect our competitive business position.

   

We could become subject to intellectual property litigation that could be costly, limit or cancel our intellectual property rights, divert time and efforts away from business operations, require us to pay damages and/or otherwise have an adverse material impact on our business.

 

The success of our business is highly dependent on protecting our intellectual property rights. Unauthorized parties may attempt to copy or otherwise obtain and use our products and/or enabling technology. Policing the unauthorized use of our intellectual property rights is difficult and expensive, as is enforcing these rights against unauthorized use by others. Identifying unauthorized use of our intellectual property rights is difficult because we may be unable to monitor the processes and/or materials being employed by other parties. The steps we have taken may not prevent unauthorized use of our intellectual property rights, particularly in foreign countries where enforcement of intellectual property rights may be more difficult than in the United States.

 

Our continued commercial success will also depend in part upon not infringing the patents or violating the intellectual property rights of third parties. We are aware of patents and patent applications generally relating to aspects of our technologies filed by, and issued to, third parties. Nevertheless, we cannot determine with certainty whether such patents or patent applications of other parties may materially affect our ability to conduct our business. There may be existing patents of which we are unaware that we may inadvertently infringe, resulting in claims against us or our customers. In the event that the manufacture, use and/or sale of our products or processes is challenged, or if our product forms or processes conflict with the patent rights of others, third parties could bring legal actions against us in the United States, Europe or other countries, claiming damages and seeking to enjoin the manufacturing and/or marketing of our products. Additionally, it is not possible to predict with certainty what patent claims may issue from any relevant third-party pending patent applications. Third parties may be able to obtain patents with claims relating to our product forms, applications and/or manufacturing processes which they could attempt to assert against us.

 

In either case, litigation may be necessary to enforce, protect or defend our intellectual property rights or to determine the validity and scope of the intellectual property rights of others. Any litigation could be unsuccessful, cause us to incur substantial costs, divert resources and the efforts of our personnel away from daily operations, harm our reputation and/or result in the impairment of our intellectual property rights. In some cases, litigation may be threatened or brought by a patent holding company or other adverse patent owner who has no relevant product revenues and against which our patents may provide little or no deterrence. If we are found to infringe any patents, we could be required to (1) pay substantial monetary damages, including lost profits, reasonable royalties and/or treble damages if an infringement is found to be willful and/or (2) totally discontinue or substantially modify any products or processes that are found to be in violation of another party’s intellectual property rights. If our competitors are able to use our technology without payment to us, our ability to compete effectively could be harmed.

 

12

 

 

We face competition and technological advances by competitors, which could adversely affect the sales of our products.

 

The growth of our Company depends in part on maintaining and growing the sales of our current products in our markets, but also in developing new products and technologies. There is significant competition among companies that provide solutions for pollutant emissions from diesel engines and water purification solutions. Several companies market products that compete directly with our products. Other companies offer products that potential customers may consider to be acceptable alternatives to our products and services, including products that are verified by the Environmental Protection Agency or other environmental authorities. We face direct competition from companies with greater financial, technological, manufacturing and personnel resources. Newly developed products could be more effective and cost efficient than our current or future products.

 

Failure to obtain adequate supplies of raw materials or failure to obtain raw materials at affordable prices could negatively affect our ability to supply products to our customers and negatively affect our profit margins.

 

We use silicon carbide, steel, plastic, platinum and palladium in the manufacture of our products. As other industries develop products utilizing silicon carbide, we may not be able to obtain adequate supplies of silicon carbide required for the manufacture of our existing and planned future water filtration products which would prevent us from supplying products to our customers and materially affect our business. Furthermore, any increased demand for silicon carbide, steel, plastic, platinum or palladium could increase the price we must pay to obtain it and could adversely affect our profitability, which would have an adverse effect on our financial results.

 

We rely on sub-contractors to meet current demand for our products and we may need to obtain additional manufacturing capacity in order to increase production of our existing products or to produce our proposed new products, the failure to do so could have a materially adverse effect on our operations.

 

We may not have sufficient internal manufacturing capacity to meet the current demand for our products, and we may need to rely on subcontractors to enable us to meet this demand. Since we may rely on our subcontractors for a significant amount of our production capacity, the loss of the services of our subcontractors would have a material adverse effect on our business. Our plans for the growth of our business rely upon increasing sales of our existing products and systems and developing and marketing new products. We do not have adequate internal manufacturing facilities to substantially increase production of our products and obtaining additional manufacturing capacity in-house will require substantial capital expenditures. We may not be able to locate such additional facilities, and, if located, we may not have the capital resources to obtain or construct them, which could have a materially adverse effect on our operations.

 

Our results may fluctuate due to certain regulatory, marketing and competitive factors over which we have little or no control.

 

The factors listed below, some of which we cannot control, may cause our revenue and results of operations to fluctuate significantly:

 

 

Actions taken by regulatory bodies relating to the verification, registration or health effects of our products;

 

 

The extent to which existing and newly developed products obtain market acceptance;

 

 

The timing and size of customer purchases;

 

 

Customer concerns about the stability of our business, which could cause them to seek alternatives to our solutions and products; and

 

 

Increases in raw material costs.

 

Any significant fluctuations in our revenue or results of operations could negatively impact investor confidence and shares of our common stock may trade at prices significantly below the price you paid to acquire them. Furthermore, declines in the price of our common stock may adversely affect our ability to conduct future offerings or to recruit and retain key employees, including our managing directors and other key professional employees.

 

13

 

 

 Foreign currency fluctuations could adversely impact financial performance.

 

Our reporting currency is the United States dollar. Because of our activities in Denmark, the European Continent and other countries, we are exposed to fluctuations in foreign currency rates. We may manage the risk to such exposure by entering into foreign currency futures and option contracts, however we can make no assurance that such actions will be sufficient to offset a materially adverse effect on our operations in the future. 

 

We may be adversely affected by global and regional economic conditions and legislative, regulatory and political developments.

 

We sell our products around the world, and we expect to continue to derive a substantial portion of sales from outside the U.S. The uncertain macroeconomic environment in the U.S. and other countries around the globe from which we derive significant sales may adversely affect our results and could have a negative impact on demand for our products. Customers or suppliers may experience cash flow problems and as a result, may modify, delay or cancel plans to purchase our products, and suppliers may significantly and quickly increase their prices or reduce their output. Additionally, if customers are not successful in generating sufficient revenue or are precluded from securing financing, they may not be able to pay, or may delay payment of, amounts owed to us. Any inability of current and/or potential customers to purchase our products and/or to pay us for our products may adversely affect our sales, earnings and cash flow. Sales and earnings could also be affected by our ability to manage the risks and uncertainties associated with the application of local legal requirements or the enforceability of laws and contractual obligations, trade protection measures, changes in tax laws, regional political instability, war, terrorist activities, severe or prolonged adverse weather conditions and natural disasters as well as health epidemics or pandemics.

 

Any liability for environmental harm or damages resulting from technical faults or failures of our products could be substantial and could materially adversely affect our business and results of operations.

 

Customers rely upon our products to meet emissions control standards imposed upon them by the government. Failure of our products to meet such standards could expose us to claims from customers. Our products are also integrated into goods used by consumers, and therefore a malfunction or the inadequate design of our products could result in product liability claims. Any liability for environmental harm or damages resulting from technical faults or failures could be substantial and could materially adversely affect our business and results of operations. In addition, a well-publicized actual or perceived problem could adversely affect the market’s perception of our products, which would materially impact our financial condition and operating results.

 

We could become liable for damages resulting from our manufacturing activities, which could have a materially adverse effect on our business or cause us to cease operations.

 

The nature of our manufacturing operations exposes us to potential claims and liability for environmental damage, personal injury, loss of life and damage to, or destruction of, property. Our manufacturing operations are subject to numerous laws and regulations that govern environmental protection and human health and safety. These laws and regulations have changed frequently in the past and it is reasonable to expect additional and more stringent changes in the future. Our manufacturing operations may not comply with future laws and regulations, and we may be required to make significant unanticipated capital and operating expenditures to bring our operations within compliance with such regulations. If we fail to comply with applicable environmental laws and regulations, manufacturing guidelines, and workplace safety requirements, governmental authorities may seek to impose fines and penalties on us or to revoke or deny the issuance or renewal of operating permits, and private parties may seek damages from us. Under such circumstances, we could be required to curtail or cease operations, conduct site remediation or other corrective action, or pay substantial damage claims for which may not have sufficient or any insurance coverage for claims.

  

A significant portion of our assets and the majority of our officers and directors are located outside of the United States, and therefore it may be difficult for an investor to enforce within the United States any judgments obtained against us or such officers and directors.

 

A significant portion of our assets are located outside of the United States. In addition, the majority of our officers and directors are nationals and/or residents of countries other than the United States, and all or a substantial portion of such persons’ assets are located outside the United States. As a result, it may be difficult for an investor to affect service of process or enforce within the United States any judgments obtained against us or such officers or directors, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state thereof. In addition, there is uncertainty as to whether the courts of other jurisdictions would recognize or enforce judgments of United States courts obtained against us or our directors and officers predicated upon the civil liability provisions of the securities laws of the United States or any state thereof, or be competent to hear original actions brought in other jurisdictions against us, or such officers and directors predicated upon the securities laws of the United States or any state thereof.

 

14

 

 

We will continue to incur significant costs as a result of operating as a public company, and our management may be required to devote substantial time to compliance initiatives which ultimately could have a materially adverse effect on our financial condition and results of operations.   

 

As a public company, we expect to continue to incur significant legal, accounting and other expenses. In addition, the Sarbanes-Oxley Act, as well as rules subsequently implemented by the SEC, have imposed various requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls as well as mandating certain corporate governance practices. Our management and other personnel will continue to devote a substantial amount of time and financial resources to these compliance initiatives.

 

If we fail to staff our accounting and finance function adequately, or maintain internal control systems adequate to meet the demands that are placed upon us as a public company, we may be unable to report our financial results accurately or in a timely manner and our business and stock price may suffer. The costs of being a public company, as well as diversion of management’s time and attention, may have a material adverse effect on our future business, financial condition and results of operations.

  

The JOBS Act allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies, which means that our financial statements may not be comparable to companies that comply with public company effective dates, which could make our common stock less attractive to investors.

 

We have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(1) of the JOBS Act, which allows us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates.

 

RISKS RELATED TO OUR COMMON STOCK

 

Approximately 18.5% of our common stock is beneficially owned by our officers and directors, who have the ability to substantially influence the election of directors and other matters submitted to stockholders.

 

As of March 23, 2017, 6,825,567 shares, or approximately 18.5% of our common stock, inclusive of shares issuable upon the exercise of immediately exercisable options and warrants, were beneficially owned by our officers and directors, including 1,358,261 shares, or 3.7%, of our common stock beneficially owned by Sune Mathiesen, our Chief Executive Officer and 3,188,541 shares, or 8.7%, of our common stock beneficially owned by Aldo Petersen, our Chairman of the Board. As a result, certain officers and, directors, in particular Sune Mathiesen, and Aldo Petersen, are expected to continue to have the ability to significantly influence the election of our Board of Directors and the outcome of all other issues submitted to our stockholders. The interests of these principal stockholders may not always coincide with our interests or the interests of other stockholders, and they may act in a manner that advances their best interests and not necessarily those of other stockholders. One consequence to this substantial influence or control is that it may be difficult for investors to remove our management. This could also deter unsolicited takeovers, including transactions in which stockholders might otherwise receive a premium for their shares over then current market prices. 

 

Future equity financings or convertible debt would dilute your ownership and could adversely affect your common stock ownership rights in comparison with those of other security holders.

 

Our board of directors has the power to issue additional shares of common or preferred stock without stockholder approval. In general, stockholders do not have preemptive rights to any common stock issued by us in the future. Therefore, stockholders may experience additional dilution of their equity investment if we issue additional shares of common stock in the future, including shares issuable under equity incentive plans, or if we issue securities that are convertible into shares of our common stock. 

 

If additional funds are raised through the issuance of equity or convertible debt securities, the percentage of ownership of our existing stockholders will be reduced, and such newly issued securities may have rights, preferences or privileges senior to those of existing stockholders. If we issue additional common stock or securities convertible into common stock, such issuance will reduce the proportionate ownership and voting power of each other stockholder. In addition, such stock issuances might result in a reduction of the book value of our common stock, which could make our stock unattractive to existing stockholders.

  

15

 

 

Provisions in our articles of incorporation and bylaws could discourage a change in control, or an acquisition of us by a third party, even if the acquisition would be favorable to you, thereby adversely affecting existing stockholders.

 

Our articles of incorporation and bylaws contain provisions that may have the effect of making more difficult or delaying attempts by others to obtain control of our Company, even when these attempts may be in the best interests of stockholders. For example, our articles of incorporation authorize our Board of Directors, without stockholder approval, to issue one or more series of preferred stock, which could have voting and conversion rights that adversely affect or dilute the voting power of the holders of common stock. These provisions and others that could be adopted in the future could deter unsolicited takeovers or delay or prevent changes in our control or management, including transactions in which stockholders might otherwise receive a premium for their shares over then current market prices. These provisions may also limit the ability of stockholders to approve transactions that they may deem to be in their best interests.

 

There is limited trading volume of our common stock, which could make it difficult for you to liquidate an investment in our common stock in a timely manner.

 

Since December 2, 2013, our common stock has been traded on NYSE MKT under the symbol LIQT. Because there is limited volume of our common stock, investors may not be able to liquidate their investments when they desire to do so.

 

In addition, if we fail to meet the criteria set forth in SEC and NYSE MKT rules and regulations, various requirements would be imposed by law on broker-dealers who sell our securities to persons other than established customers and accredited investors. Consequently, such regulations may deter broker-dealers from recommending or selling our common stock, which may further affect its liquidity.

 

If securities analysts do not publish research or reports about our business or if they downgrade us or our sector, the price of our common stock could decline.

 

The trading market for our common stock will depend in part on research and reports that industry or financial analysts publish about us or our business. We do not control these analysts. Furthermore, if one or more of the analysts who cover us downgrades us or the industry in which we operate or the stock of any of our competitors, the price of our common stock will probably decline. If one or more of these analysts ceases coverage altogether, we could lose visibility, which could also lead to a decline in the price of the common stock. 

 

The Company is considered a “smaller reporting company” and is exempt from certain disclosure requirements, which could make our common stock less attractive to potential investors.

 

Rule 12b-2 of the Exchange Act defines a “smaller reporting company” as an issuer that is not an investment company, an asset-backed issuer, or a majority-owned subsidiary of a parent that is not a smaller reporting company and that:

 

 

 

Had a public float of less than $75 million as of the last business day of its most recently completed second fiscal quarter, computed by multiplying the aggregate worldwide number of shares of its voting and non-voting common equity held by non-affiliates by the price at which the common equity was last sold, or the average of the bid and asked prices of common equity, in the principal market for the common equity; or

 

 

In the case of an initial registration statement under the Securities Act or Exchange Act for shares of its common equity, had a public float of less than $75 million as of a date within 30 days of the date of the filing of the registration statement, computed by multiplying the aggregate worldwide number of such shares held by non-affiliates before the registration plus, in the case of a Securities Act registration statement, the number of such shares included in the registration statement by the estimated public offering price of the shares; or

 

 

In the case of an issuer whose public float as calculated under paragraph (1) or (2) of this definition was zero, had annual revenues of less than $50 million during the most recently completed fiscal year for which audited financial statements are available.

 

As a “smaller reporting company” we are not required and may not include a Compensation Discussion and Analysis section in our proxy statements; we provide only 3 years of business development information; provide fewer years of selected financial data; and have other “scaled” disclosure requirements that are less comprehensive than issuers that are not “smaller reporting companies” which could make our stock less attractive to potential investors, which could make it more difficult for you to sell your shares.

 

16

 

 

The market price and trading volume of our common stock may be volatile, which may adversely affect its market price.

 

The market price of our common stock could be subject to significant fluctuations due to factors such as:

 

 

actual or anticipated fluctuations in our financial condition or results of operations;

 

 

the success or failure of our operating strategies and our perceived prospects; realization of any of the risks described in this section; failure to be covered by securities analysts or failure to meet the expectations of securities analysts;

 

 

a decline in the stock prices of peer companies; and

 

 

a discount in the trading multiple of our common stock relative to that of common stock of certain of our peer companies due to perceived risks associated with our smaller size.

 

As a result, shares of our common stock may trade at prices significantly below the price you paid to acquire them. Furthermore, declines in the price of our common stock may adversely affect our ability to conduct future offerings or to recruit and retain key employees, including our managing directors and other key professional employees.

 

We have no current plan to pay dividends on our common stock, and investors may lose the entire amount of their investment.

 

We have no current plans to pay dividends on our common stock. Therefore, investors will not receive any funds absent a sale of their shares. We cannot assure investors of a positive return on their investment when they sell their shares nor can we assure that investors will not lose the entire amount of their investment.

 

Item 1B.    Unresolved Staff Comments

 

None.

 

17

 

 

Item 2.        Properties

 

Our corporate headquarters are located at Industriparken 22C, 2750 Ballerup, Denmark. We lease approximately 55,000 square feet at our Ballerup location, of which approximately 10,000 square feet is used for office space and 45,000 square feet is used for production. The lease will expire on August 31, 2018. Our U.S. operations are located at 1800 - 1808 Buerkle Road White Bear Lake, Minnesota 55110 where we lease approximately an aggregate of 25,700 square feet, of which 6,000 square feet is used for office space and 19,700 square feet is used for production. The lease will expire on March 1, 2021. Our LiqTech Systems operations are located at Benshøj Industrivej 24, 9500 Hobro, Denmark. We lease approximately 20,699 square feet at our Hobro location, of which approximately 3,550 square feet is used for office space and 17,149 square feet is used for production. The lease will expire on May 31, 2018. Until June 30, 2017, our LiqTech Systems operations has leased an additional 6,060 square feet in Hobro, at Bornholmsvej 3C, Denmark, of which all is planned to be used for production and assembling.

 

Item 3.        Legal Proceedings

 

From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business. Except as set forth below, as of December 31, 2016, we were not a party to any legal proceeding that we believe would have a material adverse effect on our business, financial condition or operating results.

 

 On September 9, 2014, Mr. Raffaele Bruno Tronchetti Provera (“Plaintiff”), the 60% owner of LiqTech Italy s.r.l. (the “Venture”), sued LiqTech International A/S, the 40% owner of the Venture (“Defendant”), for 750,000 Euros before the Court of Como, Italy alleging, among other things, that certain products provided by Defendant to the Venture were defective.  As of March 23, 2017, the case is in the preliminary stages where the court has appointed an expert in order to verify the quality of the products in order to determine whether there is sufficient evidence to proceed.  An evaluation of the outcome will only be possible after the results of the court appointment expert are known. This outcome of the court appointment expert is expected to be reported in second quarter of 2017. Defendant believes that the claims are without merit and intends to vigorously defend any litigation.

 

Item 4.        Mine Safety Disclosures.

 

Not applicable. 

 

Item 5.        Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

 

Our common stock is currently quoted on NYSE MKT under the symbol LIQT. The following table sets forth the high and low bid prices for the common stock for the periods indicated:

 

2017

 

High

 

 

Low

 

1st Quarter (through March 23, 2017) 

 

$

0.67

 

 

$

0.42

 

 

 

 

 

2016

 

High

 

 

Low

 

4th Quarter

 

$

0.83

 

 

$

0.59

 

3rd Quarter

 

 

0.97

 

 

 

0.64

 

2nd Quarter

 

 

0.85

 

 

 

0.58

 

1st Quarter

 

 

1.01

 

 

 

0.69

 

 

 

2015

 

High

 

 

 

Low

 

 

4th Quarter

 

$

1.47

 

 

$

0.89

 

3rd Quarter

 

 

1.14

 

 

 

0.70

 

2nd Quarter

 

 

0.94

 

 

 

0.66

 

1st Quarter

 

 

1.17

 

 

 

0.67

 

 

2014

 

High

 

 

Low

 

4th Quarter

 

$

1.70

 

 

$

1.00

 

3rd Quarter

 

 

2.08

 

 

 

1.38

 

2nd Quarter

 

 

2.49

 

 

 

1.60

 

1st Quarter

 

 

2.55

 

 

 

1.82

 

 

  

The above table is based on a report provided by the NYSE MKT. These quotations reflect inter-dealer prices, without retail mark-up, markdown or commissions, and may not necessarily represent actual transactions. 

 

18

 

 

Based upon information supplied to us by our transfer agent as of March 20, 2017, we had approximately 43 stockholders of record.

 

We have not declared or paid any dividends and do not intend to declare or pay dividends on our common stock in the foreseeable future. Instead, we generally intend to invest any future earnings in our business. Subject to Nevada law, our Board of Directors will determine the payment of future dividends on our common stock, if any, and the amount of any dividends in light of:

 

 

any contractual restrictions limiting our ability to pay dividends that may be applicable at such time;

     
 

our earnings and cash flow;

     
 

our capital requirements;

     
 

our financial condition; and

     
 

other factors our Board of Directors deems relevant.

 

Item 6.        Selected Financial Data

 

We are not required to provide selected financial data disclosures because we are a smaller reporting company.

 

Item 7.        Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Forward Looking Statements

 

Certain statements made in this Annual Report on Form 10-K are “forward-looking statements” regarding the plans and objectives of management for future operations and market trends and expectations. Such statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The forward-looking statements included herein are based on current expectations that involve numerous risks and uncertainties. Our plans and objectives are based, in part, on assumptions involving the continued expansion of our business. Assumptions relating to the foregoing involve judgments with respect to, among other things, future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond our control.  Although we believe that our assumptions underlying the forward-looking statements are reasonable, any of the assumptions could prove inaccurate and, therefore, there can be no assurance that the forward-looking statements included in this report will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as a representation by us or any other person that our objectives and plans will be achieved. We undertake no obligation to revise or update publicly any forward-looking statements for any reason.   

 

Overview

 

We are a Nevada corporation, formerly named Blue Moose Media, Inc. In October, 2011, we changed our name to LiqTech International, Inc. For more than a decade we have developed and provided state-of-the-art technologies for gas and liquid purification using ceramic silicon carbide filters, particularly highly specialized filters for the control of soot exhaust particles from diesel engines and for liquid filtration. Using nanotechnology, LiqTech develops products using proprietary silicon carbide technology. LiqTech's products are based on unique silicon carbide membranes which facilitate new applications and improve existing technologies. In particular, LiqTech Systems A/S (www.provital.dk), the Company's subsidiary, has developed a new standard of water filtration technology to meet the ever increasing demand for higher water quality. By incorporating LiqTech's SiC liquid membrane technology with its longstanding systems design experience and capabilities it offers solutions to the most difficult water pollution problem.

 

19

 

 

Acquisition of LiqTech Systems

 

On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the "Shares") of Provital Solutions A/S, a Danish company (now known as LiqTech Systems) from Masu A/S, a Danish company ("MASU") controlled by Sune Mathiesen. In consideration for the Shares, MASU received cash consideration in the sum of DKK12,600,000, that is, approximately $2,300,000 (at July 28, 2014), and 4,044,782 shares of the Company's common stock (the "Payment Shares"). Two-thirds (2/3) of the Payment Shares were held in escrow and subject to achievement of certain milestones. The milestones were not achieved and such Payment Shares were forfeited and returned to treasury on December 31, 2016.

 

2016 Developments

  

 On February 22, 2016, we announced that we received an approximately $2.0 million order for a groundwater treatment plant. The order is from the company Synertech for a project in Serbia. LiqTech will deliver engineering and key components for precipitation of arsenic, boron, iron and manganese and a complete Ultra Filtration system based on the Company´s SiC membranes. The order was delivered in the second quarter of 2016.

 

On March 3, 2016, we announced that we received a $150,000 order from a new customer in the municipal pool market in France. The order was received by LiqTech´s distributor Lea Technology Group and was the first pool related system order from a French customer.

 

 On May 4, 2016, we announced that we had received a $2.0 million follow-on order for the Ground Water Treatment Plant in Serbia that was announced by the Company in February 2016. The total value of the project was $4.0 million and the order was delivered partly in the third quarter of 2016 and the last part is expected to delivered in the second quarter of 2017.

 

20

 

 

 On July 21, 2016, we announced that we had entered into a strategic relationship with one of the leading Chinese companies for diesel particulate filters (DPFs), Kailong High Technology Co. Ltd., to provide Kailong with advanced silicon carbide material for DPF filters. The framework agreement was valued at $2.2 million with the first order of $0.375 million delivered in September 2016.

 

 On August 25, 2016, we announced that we had entered into a letter of intent to establish a diesel particulate filter company in China, The agreement includes a technology transfer fee of $1.5 million, which is payable upon achievement of certain milestones, and a royalty of $2.25 per liter of DPFs. Kailong believes the market potential for high quality emission control systems is significant in China and together with LiqTech could scale to a capacity of 2 million liters in silicon carbide DPFs to serve the Chinese and international market. The New China 6 standard for diesel vehicle emissions will likely put China on the forefront of emission standards in the world creating the need for better DPFs in China.

 

 On September 7, 2016, we announced that we had entered into a Letter of Intent (LOI) to supply a $1.8 million filtration system for a 100,000 tons per year bioethanol plant to be located in Harbin, Heilongjiang, China. The LOI is subject to execution of definitive documents and financing of the project from a Chinese Investment bank. The filtration system is based on the Company´s ceramic membranes and its newly developed RO systems.

 

On September 27, 2016, we announced that the Company had received an order for silicon carbide diesel particulate filters from Kailong High Technology ("Kailong") for $2,360,000 as part of the framework agreement made between the parties.

 

 On October 6, 2016, we announced that due to regulatory issues it had not been possible for Kailong High Technology to meet the September 30, 2016 deadline for an investment in LiqTech. The parties have therefor agreed to amend the agreement, so that the joint venture is increasing the payment for the technology of producing Silicon Carbide Filters. LiqTech would be paid 2 million USD up-front for the technology and a royalty of USD 2.25 per liter of filters sold in the joint venture in 2018 - 2020.

 

On October 25, 2016, we announced that our products have been certified according to NSF61 for drinking water products.

 

On November 10, 2016, we announced that we and Hunan Yonker Water Co., Ltd. ("Yonker") had signed an equity joint venture agreement to set up a joint venture company in China relating to filtration systems based on LiqTech's Silicon Carbide Membrane technology used in water and wastewater treatment for industrial municipal facilities. In addition, Hunan Yonker Investment Group Co. Ltd and LiqTech entered into an agreement pursuant to which Hunan Yonker Investment Group Co. Ltd agreed to purchase 4,000,000 shares of common stock of LiqTech at $1.00 per share. The closing of the purchase of the shares is subject to receipt of all US and China government approvals. On March 1, 2017, we announced that due to regulatory issues it has not been feasible for Hunan Yonker Investment Group (Yonker) to complete the agreed investment in LiqTech before the deadline of February 28, 2017. Therefore, the parties have amended the Investment Agreement and the deadline for completion of the $4 million investment in LiqTech has been extended to April 15, 2017.

 

On December 13, 2016, we announced that we had received a $350,000 order for the Company´s water treatment systems for flue gas condensate. The order was received from DuPont and will be installed at their facility in Grindsted, Denmark.

 

On December 19, 2016, we announced that we had received a $260,000 order for the Company´s water treatment systems for flue gas condensate. The order was received from Tjæreborg Industri A/S, a Danish company who specializes in the development and manufacturing of equipment for power plants. The system will be installed at Hobro Varmeværk, Denmark.

 

2017 Developments

 

On January 5, 2017, we announced that we and Grundfos Biobooster A/S (Grundfos) have signed a framework agreement for the delivery of silicon carbide ceramic discs. The agreement has a value of minimum $450,000 and an initial term of 2 years. The ceramic discs will be used in Grundfos´s Ultra Filtration systems for water re-use.

 

On January 17, 2017, we announced that we had received a $120,000 order for the Company´s water treatment systems for flue gas condensate. The order was received from Tjæreborg Industri A/S, a Danish company who specializes in the development and manufacturing of equipment for power plants. The system will be installed at Uldum Varmeværk, Denmark in 2017.

 

21

 

 

On March 1, 2017, we announced that due to regulatory issues it has not been feasible for Hunan Yonker Investment Group (Yonker) to complete the agreed investment in LiqTech before the deadline of February 28, 2017. Therefore, the parties have amended the Investment Agreement and the deadline for completion of the USD 4 million investment in LiqTech has been extended to April 15, 2017.

 

Results of Operations

 

Results of Operations for the Year Ended December 31, 2016 Compared to the Year Ended December 31, 2015 

 

The following table sets forth our revenues, expenses and net income for the year ended December 31, 2016 and 2015.

  

                                   

Period to Period Change

 
   

2016

   

As a % of

Sales

   

2015

   

As a %

of Sales

      $    

Percent %

 

Net Sales

    13,906,394       100 %     15,812,587       100 %     (1,906,193 )     (12.1 )

Cost of Goods Sold

    12,473,965       89.7       12,598,163       79.7       (124,198 )     (1.0 )

Gross Profit

    1,432,429       10.3       3,214,424       20.3       (1,781,995 )     (54.4 )
                                                 

Operating Expenses

                                               

Selling expenses

    2,164,780       15.6       2,721,781       17.2       (557,001 )     (20.5 )

General and administrative expenses

    3,997,304       28.7       2,814,747       17.8       1,182,557       42.0  

Non-cash compensation expenses

    435,794       3.1       369,531       2.3       66,263       17.9  

Research and development expenses

    626,147       4.5       707,844       4.5       (81,697 )     (11.5 )

Impairment of goodwill

    7,343,208       52.8       -       -       7,343,208       -  

Total Operating Expenses

    14,567,233       104.8       6,613,903       41.8       7,953,330       120.3  
                                                 

Loss from Operating

    (13,134,804 )     (94.5 )     (3,399,479 )     (21.5 )     (9,735,325 )     286.4  
                                                 

Other Income (Expense)

                                               

Interest and other income

    968       0.0       98,171       0.6       (97,203 )     (99.0 )

Interest (Expense)

    (38,945 )     (0.3 )     (51,232 )     (0.3 )     12,287       (24.0 )

Gain (Loss) on investments

    (16,621 )     (0.1 )     7,253       0.0       (23,874 )     (329.2 )

Gain (Loss) on currency transactions

    (9,555 )     (0.1 )     459,279       2.9       (468,834 )     (102.1 )

Total Other Income (Expense)

    (64,153 )     (0.5 )     513,471       3.2       (577,624 )     (112.5 )
                                                 

Loss Before Income Taxes

    (13,198,957 )     (94.9 )     (2,886,008 )     (18.3 )     (10,312,949 )     357.3  

Income Taxes Expense (Benefit)

    3,219,677       23.2       (697,786 )     (4.4 )     3,917,463       (561.4 )
                                                 

Net Loss

    (16,418,634 )     (118.1 )     (2,188,222 )     (13.8 )     (14,230,412 )     650.3  

Less net income attributable to the non-controlled interest in subsidiaries

    -       -       21,635       0.1       (21,635 )     (100.0 )

Net Loss attributable to LiqTech

    (16,418,634 )     (118.1 )     (2,209,857 )     (14.0 )     (14,208,777 )     643.0  

 

 

Revenues

 

Net sales for the year ended December 31, 2016 were $13,906,394 compared to $15,812,587 for the same period in 2015, representing a decrease of $1,906,193, or 12%. The decrease in sales consist of an increase in sales of DPFs of $739,488, a decrease in sales of liquid filters of $2,615,931 and a decrease in sales of kiln furniture $29,751 respectively. The increase in demand for our DPFs is mainly due to an increase in market activity in China compared to the same period last year. The decrease in demand for our liquid filters and systems is due to a delay in certain business opportunities compared to the same period last year where various projects were realized. The decrease in demand for our kiln furniture is due to our decision to not focus on this product line anymore.

 

22

 

 

Gross Profit

 

 Gross profit for the year ended December 31, 2016 was $1,432,429 compared to $3,214,424 for same period in 2015, representing a decrease of $1,781,995, or 55%. The decrease in gross profit was due to a lower sales activity for the year ended December 31, 2016 compared to the same period in 2015 and an increase in the reserve for obsolete inventory. Included in the gross profit is depreciation of $1,378,277 and $1,437,787 for the years ended December 31, 2016 and 2015, respectively.

 

Expenses

 

 Total operating expenses for the year ended December 31, 2016 were $14,567,233, representing an increase of $7,953,330, or 120%, compared to $6,613,903 for the same period in 2015. This increase in operating expenses is attributable to an increase in impairment charge of goodwill of $7,343,208, an increase in general and administrative expenses of $1,182,557 or 42% and an increase in non-cash compensation expenses of $66,263 or 18%, and this is partially offset by a decrease in selling and marketing expenses of $557,001 or 21% and a decrease in research and development expenses of $81,697 or 12% compared to the same period in 2015. 

 

Selling expenses for the year ended December 31, 2016 were $2,164,780 compared to $2,721,781 for the same period in 2015, representing a decrease of $557,001 or 21%. This decrease is attributable to a cost reduction in selling expenses in general. Furthermore, the increase of USD against EURO and DKK of approximately 3% from period to period has had a decreasing effect on our expenses in 2016, because a significant amount of our expenses is in EURO and DKK.

 

General and administrative expenses for the year ended December 31, 2016 were $3,997,304 compared to $2,814,747 for the same period in 2015, representing an increase of $1,182,557, or 42%. This increase is attributable to a cost reduction in general and administrative cost offset by an increase in the provision for bad debt of $1,437,949.

 

Non-cash compensation expenses for the year ended December 31, 2016 were $435,794 compared to $369,531 for the same period in 2015, representing an increase of $66,263 or 18%. This increase is attributable to increased non-cash compensation expense for options, shares and warrants for services performed granted to directors, employees and management. 

 

The following is a summary of our non-cash compensation:

 

 

 

2016

 

 

2015

 

Compensation upon vesting of stock options granted to employees

 

$

307,493

 

 

$

154,745

 

Compensation for vesting of restricted stock awards issued to the board of directors

 

 

77,667

 

 

 

204,500

 

Value of warrants issued for services

 

 

50,634

 

 

 

10,286

 

Total

 

$

435,794

 

 

$

369,531

 

 

Research and development expenses for the year ended December 31, 2016 were $626,147 compared to $707,844 for the same period in 2015, representing a decrease of $81,697, or 12%. This decrease is attributable to decreased research and development expenditures for the period ended December 31, 2016 compared to the same period in 2015.

 

Impairment of goodwill for the year ended December 31, 2016 was $7,343,208 compared to $0 for the same period in 2015, representing an increase of $7,343,208. The Company recorded an impairment charge on goodwill, during the year ended December 31, 2016, as managements estimated fair value of the reporting unit did not exceeded the carrying value during 2016 fourth quarter testing.

  

Net Loss

 

Net loss attributable to the Company for the year ended December 31, 2016 was a loss of $16,418,634 compared to a loss of $2,209,857 for the comparable period in 2015, representing an increase of $14,208,777.

 

This decrease was primarily attributable to a decrease of $1,781,995 in our gross profit, an increase in operating expenses of $7,953,330, and a decrease in total other income of $577,624. The largest contributor to the increase in operating expenses was the impairment write down of $7,343,208.

  

23

 

 

Results of Operations for the Year Ended December 31, 2015 Compared to the Year Ended December 31, 2014 

 

The following table sets forth our revenues, expenses and net income for the year ended December 31, 2015 and 2014.

  

                                   

Period to period change

 
   

2015

   

As a % of

Sales

   

2014

   

As a % of

Sales

         

Percent %

 

Net Sales

    15,812,587       100

%

    14,561,192       100

%

    1,251,395       8.6  

Cost of Goods Sold

    12,598,163       79.7       12,463,949       85.6       134,214       1.1  

Gross Profit

    3,214,424       20.3       2,097,243       14.4       1,117,181       53.3  
                                                 

Operating Expenses

                                               

Selling and Marketing

    2,721,781       17.2       3,360,566       23.1       (638,785

)

    (19.0

)

General and Administrative

    2,814,747       17.8       3,019,094       20.7       (204,347

)

    (6.8

)

Non-cash compensation

    369,531       2.3       573,029       3.9       (203,498

)

    (35.5

)

Research and Development

    707,844       4.5       336,066       2.3       371,778       110.6  

Total Operating Expenses

    6,613,903       41.8       7,288,755       50.1       (674,852

)

    (9.3

)

                                                 

Loss from Operating

    (3,399,479

)

    (21.5

)

    (5,191,512

)

    (35.7

)

    1,792,033       (34.5

)

                                                 
Other Income (Expense)                                                

Interest and Other Income

    98,171       0.6       10,511       0.1       87,660       834.0  

Interest (Expense)

    (51,232

)

    (0.3

)

    (53,379

)

    (0.4

)

    2,147       (4.0

)

Gain (Loss) on Investments

    7,253       0.0       (815

)

    (0.0

)

    8,068       (989.9

)

Gain on Currency Transactions

    459,279       2.9       450,147       3.1       9,132       2.0  
                                                 

Total Other Income

    513,471       3.2       406,464       2.8       107,007       26.3  
                                                 

Loss Before Income Taxes

    (2,886,008

)

    (18.3

)

    (4,785,048

)

    (32.9

)

    1,899,040       (39.7

)

Income Taxes Benefit

    (697,786

)

    (4.4

)

    (1,702,551

)

    (11.7

)

    1,004,765       (59.0

)

                                                 

Net Loss

    (2,188,222

)

    (13.8

)

    (3,082,497

)

    (21.2

)

    894,275       (29.0

)

Less net income attributable to the non-controlled interest in subsidiaries

    21,635       0.1       (16,429

)

    (0.1

)

    38,064       (231.7

)

                                                 

 

Net Loss attributable to LiqTech

    (2,209,857

)

    (14.0

)

    (3,066,068

)

    (21.1

)

    856,211       (27.9

)

 

 

Revenues

 

Net sales for the year ended December 31, 2015 were $15,812,587 compared to $14,561,192 for the same period in 2014, representing an increase of $1,251,395, or 8.6%. The increase in sales consist of a decrease in sales of DPFs of $1,539,321, an increase in sales of liquid filters of $2,814,482 and a decrease in sales of kiln furniture $23,766, respectively. The decrease in demand for our DPFs is mainly due to a lack of new low emissions zone activity in both Europe and United States. The increase in demand for our liquid filters and systems is due to an increase in worldwide sales of those products and the acquisition of LiqTech Systems A/S. The decrease in demand for our kiln furniture is due to our decision to not focus on this product line anymore.

 

Gross Profit

 

Gross profit for the year ended December 31, 2015 was $3,214,424 compared to $2,097,243 for same period in 2014, representing an increase of $1,117,181, or 53.3%. The increase in gross profit was due to an increase in sales for the year ended December 31, 2015 compared to the same period in 2014 combined with the acquisition of LiqTech Systems higher margin sales and a continuing focus on lowering our production costs. Included in the gross profit is depreciation of $1,437,787 and $1,630,531 for the years ended December 31, 2015 and 2014, respectively.

 

Expenses

 

 Total operating expenses for the year ended December 31, 2015 were $6,613,903, representing a decrease of $674,852, or 9.3%, compared to $7,288,755 for the same period in 2014. This decrease in operating expenses is attributable to a decrease in selling and marketing expenses of $638,785 or 19.0%, a decrease in general and administrative expenses of $204,347 or 6.8% and, a decrease in non-cash compensation expenses of $203,498 or 35.5%, is partially offset an increase in research and development expenses of $371,778 or 110.6% compared to the same period in 2014. 

 

  Selling expenses for the year ended December 31, 2015 were $2,721,781 compared to $3,360,566 for the same period in 2014, representing a decrease of $638,785 or 19.0%. This decrease is attributable to a cost reduction in selling expenses in general. Furthermore, the increase of USD against EURO and DKK of approximately 20% from period to period has had a decreasing effect on our expenses, because a significant amount of our expenses is in EURO and DKK. This decrease was partially offset by the inclusion of LiqTech Systems in the selling expenses for all the period ending December 31, 2015. LiqTech Systems was part of the consolidated numbers from the date of acquisition on July 29, 2014.

  

24

 

 

General and administrative expenses for the year ended December 31, 2015 were $2,814,747 compared to $3,019,094 for the same period in 2014, representing a decrease of $204,347, or 6.8%. This decrease is attributable to an increase in general and administrative expenses in general due to the acquisition of LiqTech Systems offset by the increase of USD against EURO and DKK of approximately 20% from period to period as discussed above in selling expenses resulted in reduced general and administrative expenses for 2015.

 

Non-cash compensation expenses for the year ended December 31, 2015 were $369,531 compared to $573,029 for the same period in 2014, representing a decrease of $203,498 or 35.5%. This decrease is primarily attributable to decreased non-cash compensation expense for restricted stocks and warrants for services performed granted to directors and consultants offset by stock compensation expense for options granted to employees.

 

The following is a summary of our non-cash compensation:

 

 

 

2015

 

 

2014

 

Compensation upon vesting of stock options granted to employees

 

$

154,745

 

 

$

34,295

 

Compensation for vesting of restricted stock awards issued to the board of directors

 

 

204,500

 

 

 

479,334

 

Value of warrants issued for services

 

 

10,286

 

 

 

59,400

 

Total

 

$

369,531

 

 

$

573,029

 

 

 Research and development expenses for the year ended December 31, 2015 were $707,844 compared to $336,066 for the same period in 2014, representing an increase of $371,778, or 110.6%. This increase is attributable to increased research and development expenditures for the period ended December 31, 2015 compared to the same period in 2014 due to investing in new products, and the inclusion of LiqTech Systems for the entire period ending December 31, 2015. LiqTech Systems was included in the consolidated numbers from the date of acquisition on July 29, 2014. 

 

Net Loss

 

Net loss attributable to the Company for the year ended December 31, 2015 was a loss of $2,209,857 compared to a loss of $3,066,068 for the comparable period in 2014, representing an improvement of $856,211. This increase was primarily attributable to an increase of $1,117,181 in our gross profit, a decrease in operating expenses of $674,852, an increase in total other income of $107,007 and an decrease in income tax benefit of $1,004,765. The largest contributor to the decrease in operating expenses was a decrease in selling expenses of $638,785 or 19.0%.

 

Liquidity and Capital Resources

 

 The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has limited cash and incurred significant recent losses raising substantial doubt about the ability of the Company to continue as a going concern. As earlier announced the Company has entered into an Investment Agreement with Hunan Yonker Investment Group for an USD 4 million investment in LiqTech no later than April 15, 2017. In the event that such funds are not received by April 15, 2017, the Company will need to raise funds by the issuance of debt or equity. There can be no assurance that the Company will be able to raise funds on terms that are favorable to the Company or at all. In the event that the Company is unable to raise funds, the Company will be required to reduce or curtail operations.

 

We have historically satisfied our capital and liquidity requirements through offerings of equity instruments, internally generated cash from operations and our available lines of credit. At the filing date, the Company did not have any available lines of credit with any lender. At December 31, 2016, we had cash and restricted cash of $1,208,650 and working capital of $3,497,577 and at December 31, 2015, we had cash and restricted cash of $1,663,417 and working capital of $7,642,313. At December 31, 2016, our working capital decreased by $4,144,736, compared to December 31, 2015. Total current assets were $8,506,321 and $12,983,004 at December 31, 2016 and at December 31, 2015, respectively, and total current liabilities were $5,008,744 and $5,340,690 at December 31, 2016 and at December 31, 2015, respectively.

 

LiqTech Systems had previously a DKK 2,000,000 (approximately $300,000 at September 30, 2015) standby line of credit with a bank, subject to certain borrowing base limitations. Outstanding borrowings are due on demand. Interest is calculated based on a variable interest rate and is payable quarterly. The line was cancelled June 12, 2015. 

 

25

 

 

In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we previously had a guarantee credit line of DKK 94,620 (approximately $13,416 at December 31, 2016) with a bank, subject to certain base limitations. As of December 31, 2016, we had DKK 94,620 (approximately $13,416) in working guarantee against the line. This line of credit is guaranteed by Vækstfonden (the Danish state's investments fund) and is secured by certain assets of LiqTech Systems such as receivables, inventory and equipment.

 

In general, lines of credit in Denmark are due on demand. Our line of credit with the bank was cancelled June 12, 2015.

 

  We will need additional funds to sustain our business. We may raise such funds from time to time through public or private sales of equity or debt securities. Financing may not be available on acceptable terms, or at all, and our failure to raise capital when needed could materially adversely impact our financial condition and results of operations. Additional equity financing may be dilutive to holders of our common stock, and debt financing, if available, may involve significant cash payment obligations and covenants that restrict our ability to operate our business. In the event that the Company is unable to raise funds, there is substantial doubt about the ability of the Company to continue as a going concern.

 

Cash Flows

 

Year Ended December 31, 2016 Compared to Year Ended December 31, 2015

 

 Cash provided (used) by operating activities is net income (losses) adjusted for certain non-cash items and changes in assets and liabilities. Cash provided by operating activities for the year ended December 31, 2016 was $415,794, representing an increase of $2,506,758 compared to cash used by operating activities of $2,090,964 for the year ended December 31, 2015. The $2,506,758 increase in cash provided by operating activities for the year ended December 31, 2016 was mainly due to decreases in accounts receivable of $841,918, a decrease in accrued expenses of $1,018,643 and a decrease in long term contracts of $1,807,658 offset by an increase in inventory of $547,934 and a decrease in accounts payable of $1,192,386.

 

The decreases in accounts receivable, the decrease in accrued expenses, the decrease in long term contracts, the increase in inventory and the decrease in accounts payable were all due to normal variations in the ordinary course of business.

 

Cash used in investing activities was $373,740 for the year ended December 31, 2016, as compared to cash used in investing activities of $592,656 for the year ended December 31, 2015. Cash used in investing activities decreased of $218,916 for the year ended December 31, 2016, compared to the year ended December 31, 2015. This decrease was primarily due to the period over period decrease of $202,538 in the purchase of property and equipment.

 

Cash used by financing activities was $202,619 for the year ended December 31, 2016, as compared to cash provided by financing activities of 223,072 for the year ended December 31, 2015. This decrease in cash used by financing activities for the year ended December 31, 2016, compared to 2015, was mainly due to a decrease in payments proceeds on capital lease obligations offset by payments on loans payable.

  

Year Ended December 31, 2015 Compared to Year Ended December 31, 2014

 

Cash provided (used) by operating activities is net income (losses) adjusted for certain non-cash items and changes in assets and liabilities. Cash used by operating activities for the year ended December 31, 2015 was $2,090,964, representing a decrease of $3,642,710 compared to cash used by operating activities of $5,733,674 for the year ended December 31, 2014. The $3,642,710 decrease in cash used by operating activities for the year ended December 31, 2015 was mainly due to decreases in accounts receivable of $1,280,537 and long term contracts of $1,171,325 offset by increases of $1,118,143 in accounts payable and $24,671 in accrued expenses and the improvement in the net loss, after taking into account the assets and liabilities acquired in the acquisition of LiqTech Systems.

 

The increase in accounts payable, and the increase in accrued expenses were all due to normal variations in the ordinary course of business.

 

Cash used in investing activities was $592,656 for the year ended December 31, 2015, as compared to cash used in investing activities of $2,331,116 for the year ended December 31, 2014. Cash used in investing activities decreased of $1,738,460 for the year ended December 31, 2015, compared to the year ended December 31, 2014. This decrease was primarily due to the $1,874,684 net cash used to purchase LiqTech Systems in 2014 offset by a period over period increase of $119,846 in the purchase of property and equipment.

 

26

 

 

Cash used by financing activities was $223,072 for the year ended December 31, 2015, as compared to cash provided by financing activities of $10,451,991 for the year ended December 31, 2014. This change of $10,675,163 in cash provided by financing activities in 2015, compared to 2014, was primarily due to the public offering of 8,000,000 shares at a price to public of $1.50 per share in 2014.

 

Off Balance Sheet Arrangements

 

As of December 31, 2016, we had no off-balance sheet arrangements other than normal operating leases. We are not aware of any material transactions which are not disclosed in our consolidated financial statements.

 

Operating Leases -- The Company leases office and production facilities under operating lease agreements expiring in March 2021, August 2018, May 2018, and June 2017. In some of these lease agreements, the Company has the right to extend.

 

The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of one year as of December 31, 2016 are as follows:

   

Year ending December 31,

 

Lease Payments

 

2017

 

 

559,058

 

2018

 

 

457,735

 

2019

   

179,094

 

Thereafter

 

 

395,898

 

Total Minimum Lease Payments

 

$

1,591,785

 

 

Significant Accounting Policies and Critical Accounting Estimates

 

The methods, estimates, and judgments that we use in applying our accounting policies have a significant impact on the results that we report in our consolidated financial statements. Some of our accounting policies require us to make difficult and subjective judgments, often as a result of the need to make estimates regarding matters that are inherently uncertain. Our most critical accounting estimates include:

 

 

the assessment of collectability of accounts receivable, which impacts operating expenses when and if we record bad debt or adjust the allowance for doubtful accounts;

 

the assessment of recoverability of long-lived assets, which impacts gross margin or operating expenses when and if we record asset impairments or accelerate their depreciation;

 

the recognition and measurement of current and deferred income taxes (including the measurement of uncertain tax positions), which impact our provision for taxes;

 

the valuation of inventory, which impacts gross margin; and

 

the recognition and measurement of loss contingencies, which impact gross margin or operating expenses when we recognize a loss contingency, revise the estimate for a loss contingency, or record an asset impairment.

 

We discuss these policies further below, as well as the estimates and judgments involved. 

 

Accounts Receivable / Long Term Receivable / Allowance for Doubtful Accounts / Bad Debt

 

We assess the collectability of accounts receivable and long term receivable on an ongoing basis and establish an allowance for doubtful accounts when collection is no longer reasonably assured. In establishing the allowance, factors we consider include known troubled accounts, historical experience, age, and other currently available evidence.

    

The roll forward of the allowance for doubtful accounts for the year ended December 31, 2016 and December 31, 2015 was as follows:

 

 

 

2016

 

 

2015

 

Allowance for doubtful accounts at the beginning of the period

 

$

1,087,871

 

 

$

1,654,290

 

Bad debt expense

 

 

1,437,949

 

 

 

80,729

 

Amount of receivables written off

 

 

(252,792

)

 

 

(398,083

)

Effect of currency translation

 

 

(144,576

)

 

 

(249,065

)

Allowance for doubtful accounts at the end of the period

 

$

2,128,452

 

 

$

1,087,871

 

 

27

 

 

Goodwill and Definite-life intangible assets

 

The Company accounts for Goodwill and definite-life intangible assets in accordance with provisions of the Statement of Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Intangibles, Goodwill and Other. Goodwill and intangible assets acquired in a purchase business combination and determined to have an indefinite useful life are not amortized, but instead are tested for impairment at least annually in accordance with the provisions of Topic 350. Impairment losses arising from this impairment test, if any, are included in operating expenses in the period of impairment. Topic 350 requires that definite intangible assets with estimable useful lives be amortized over their respective estimated useful lives, and reviewed for impairment in accordance with Topic 360, criteria for recognition of an impairment of Long-Lived Assets.

 

Goodwill

 

Goodwill is evaluated for impairment annually in the fourth quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. The Company recorded an impairment charge of $7,343,208 and $0 on goodwill, during the year ended December 31, 2016 and 2015, as management's estimated fair value of the reporting unit did not exceeded the carrying value during 2016 fourth quarter testing.

 

Long-Lived Assets

 

We assess the impairment of long-lived assets when events or changes in circumstances indicate that the carrying value of the assets or the asset grouping may not be recoverable. Factors that we consider in deciding when to perform an impairment review include significant under-performance of a business or product line in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in our use of the assets. We measure the recoverability of assets that will continue to be used in our operations by comparing the carrying value of the asset grouping to our estimate of the related total future undiscounted net cash flows. If an asset grouping’s carrying value is not recoverable through the related undiscounted cash flows, the asset grouping is considered to be impaired. The impairment is measured by comparing the difference between the asset grouping’s carrying value and its fair value. Long-lived assets such as goodwill, intangible assets, and property, plant and equipment are considered non-financial assets, and are recorded at fair value only if an impairment charge is recognized.

 

Impairments of long-lived assets are determined for groups of assets related to the lowest level of identifiable independent cash flows. Due to our asset usage model and the interchangeable nature of our ceramic filter manufacturing capacity, we must make subjective judgments in determining the independent cash flows that can be related to specific asset groupings. In addition, as we make manufacturing process conversions and other factory planning decisions, we must make subjective judgments regarding the remaining useful lives of assets, primarily process-specific filter manufacturing tools and building improvements. If we determine that the useful lives of assets are shorter than we had originally estimated, we accelerate the rate of depreciation over the assets’ new, shorter useful lives. During the years ended December 31, 2016 and 2015, no impairment charge of long-lived assets has been recorded. 

 

Revenue Recognition and Sales Incentives

 

The Company's accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements” (SAB 101), FASB ASC 605 Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collections of resulting receivable is reasonably assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.

 

The Company has received various grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each grant multiplied by the grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process. 

 

Project costs of the grants include all direct material and labor costs and those indirect costs related to the project. Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.

 

28

 

 

In Denmark, Value Added Tax (“VAT”) of 25% of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.

 

Income Taxes

 

We must make estimates and judgments in determining the provision for taxes for financial statement purposes. These estimates and judgments occur in the calculation of tax credits, benefits, and deductions, and in the calculation of certain tax assets and liabilities that arise from differences in the timing of recognition of revenue and expense for tax and financial statement purposes. Significant changes in these estimates may result in an increase or decrease to our tax provision in a subsequent period.

 

We must assess the likelihood that we will be able to recover our deferred tax assets. If recovery is not likely, we must increase our provision for taxes by recording a valuation allowance against the deferred tax assets that we estimate will not ultimately be recoverable. We believe that we will ultimately recover the deferred tax assets recorded on our consolidated balance sheets. However, should there be a change in our ability to recover our deferred tax assets, our tax provision would increase in the period in which we determined that the recovery was not likely. Recovery of a portion of our deferred tax assets is impacted by management's plans and methods of allocating research and development costs to the underlying reporting units.

 

The calculation of our tax liabilities involves uncertainties in the application of complex tax regulations in Denmark and the United States. When a tax position is determined uncertain, we recognize liabilities based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. If we determine that a tax position will more likely than not be sustained on audit, the second step requires us to estimate and measure the tax benefit as the largest amount that is more than 50% likely to be realized upon ultimate settlement. It is inherently difficult and subjective to estimate such amounts, as we have to determine the probability of various possible outcomes. If uncertainties arise we re-evaluate the tax positions on a quarterly basis. This evaluation is based on factors such as changes in facts or circumstances, changes in tax law, new audit activity, and effectively settled issues. Determining whether an uncertain tax position is effectively settled requires judgment. Such a change in recognition or measurement would result in the recognition of a tax benefit or an additional charge to the tax provision.

 

Inventory

 

The valuation of inventory requires us to estimate obsolete or excess inventory as well as inventory that is not of saleable quality. The determination of obsolete or excess inventory requires us to estimate the future demand for our products. The estimate of future demand is compared to work-in-process and finished goods inventory levels to determine the amount, if any, of obsolete or excess inventory. As of December 31, 2016, we had total furnace parts and supplies of 336,799, raw material of $1,216,098, work-in-process inventory of $ 2,499,242, total finished goods inventory of $ 2,544,081 and reserve for obsolescence of $1,421,345. The estimated future demand is included in the development of our short-term manufacturing plans to enable consistency between inventory valuation and build decisions. Product-specific facts and circumstances reviewed in the inventory valuation process include a review of the customer base, acceptance of the product by the customer and the various environmental authorities, competitor’s products, as well as an assessment of the selling price in relation to the product cost. If our demand forecast for specific products is greater than actual demand, and we fail to reduce manufacturing output accordingly, we could be required to write off inventory, which would negatively impact our gross margin.

 

In order to determine what costs can be included in the valuation of inventory, we must determine normal capacity at our manufacturing and assembly and test facilities, based on historical production, compared to total available capacity. If the factory production is below the established normal capacity level, a portion of our manufacturing overhead costs would not be included in the cost of inventory, and therefore would be recognized as cost of sales in that period, which would negatively impact our gross margin. We refer to these costs as excess capacity charges. Over the past two years we have experienced no excess capacity charges. 

  

Loss Contingencies

 

We are subject to various legal and administrative proceedings and asserted and potential claims, accruals related to product warranties and potential asset impairments (loss contingencies) that arise in the ordinary course of business. An estimated loss from such contingencies is recognized as a charge to income if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. Disclosure of a loss contingency is required if there is at least a reasonable possibility that a loss has been incurred. The outcomes of legal and administrative proceedings and claims, and the estimation of product warranties and asset impairments, are subject to significant uncertainty. Significant judgment is required in both the determination of probability and the determination as to whether a loss is reasonably estimable. With respect to estimating the losses associated with repairing and replacing parts in connection with product warranty, we make judgments with respect to customer claim rates. Current warranty estimates are immaterial for accrual or further disclosure. At least quarterly, we review the status of each significant matter, and we may revise our estimates. These revisions could have a material impact on our results of operations and financial position. 

 

29

 

 

Item 7A.     Quantitative and Qualitative Disclosures about Market Risk.

 

We are not required to provide quantitative and qualitative disclosures about market risk because we are a smaller reporting company.

 

Item 8.        Financial Statements and Supplementary Data.

 

Our financial statements are attached on the following “F” pages.

 

30

 

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

 

Index to Consolidated Financial Statements

 

  

Page

Reports of Independent Registered Public Accounting Firm

F-1

  

  

Consolidated Balance Sheets at December 31, 2016 and 2015

F-2

  

  

Consolidated Statements of Operations for the years ended December 31, 2016 and 2015

F-4

  

  

Consolidated Statement of Other Comprehensive Income for the years ended December 31, 2016 and 2015

F-5

  

  

Consolidated Statement of Stockholders’ Equity for the years ended December 31, 2016 and 2015

F-6

  

  

Consolidated Statement of Cash Flows for the years ended December 31, 2016 and 2015

F-7

  

  

Notes to the Consolidated Financial Statements

F-9

  

F-i

 

 

 

4397 SOUTH ALBRIGHT DRIVE,SALT LAKE CITY, UTAH 84124

(801) 277-2763 PHONE • (801) 277-6509 FAX

  

Board of Directors

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

Industriparken 22C, DK

2750 Ballerup, Denmark

 

We have audited the accompanying consolidated balance sheets of LiqTech International, Inc. and subsidiaries as of December 31, 2016 and 2015, and the related consolidated statements of operations, other comprehensive income, stockholders’ equity and cash flows for the years ended December 31, 2016 and 2015. These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these financial statements based on our audit.

 

We conducted our audit in accordance with standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, and audit of its internal controls over financial reporting for the year ended December 31, 2016 and 2015. Our audit included consideration of internal controls over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal controls over financial reporting for the year ended December 31, 2016 and 2015. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the consolidated financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall consolidated financial statement presentation. We believe that our audit provides a reasonable basis for our opinion.

 

 In our opinion, based on our audit, the consolidated financial statements audited by us present fairly, in all material respects, the financial position of LiqTech International, Inc. and subsidiaries as of December 31, 2016 and 2015 and the results of their operations and their cash flows for the years ended December 31, 2016, and 2015, in conformity with generally accepted accounting principles in the United States.

 

The accompanying consolidated financial statements have been prepared assuming the Company will continue as a going concern. As discussed in Note 2 to the financial statements, the Company has limited cash and incurred significant recent losses. These factors raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regards to these matters are also described in Note 2. The consolidated financial statements do not include any adjustments that might result from the outcome of these uncertainties.

 

 

/s/ Gregory & Associates, LLC.

March 30, 2017

Salt Lake City, Utah

 

F-1

 

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

   

As of

   

As of

 
   

December 31,

   

December 31,

 
   

2016

   

2015

 

Current Assets:

               

Cash

  $ 1,208,650     $ 1,370,591  

Restricted cash balances

    -       292,826  

Accounts receivable, net

    1,111,759       3,191,858  

Other receivables

    306,177       505,945  

Cost in excess of billing

    642,700       2,519,321  

Inventories

    5,174,874       4,916,671  

Prepaid expenses

    62,161       13,670  

Current deferred tax asset

    -       172,122  
                 

Total Current Assets

    8,506,321       12,983,004  
                 

Property and Equipment, net accumulated depreciation:

    2,633,558       3,538,694  
                 

Other Assets:

               
                 

Investments at costs

    5,282       21,838  

Long term deferred tax asset

    -       3,684,497  

Goodwill

    -       7,582,749  

Other intangible assets

    5,614       10,386  

Deposits

    261,553       252,378  
                 

Total Other Assets

    272,449       11,551,848  
                 

Total Assets

  $ 11,412,328     $ 28,073,546  

 

(Continued)

 

The accompanying notes are an integral part of these consolidated financial statements.

  

F-2

 

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

   

As of

   

As of

 
   

December 31,

   

December 31,

 
   

2016

   

2015

 

Current Liabilities:

               

Current portion of notes payable

  $ 15,034     $ -  

Current portion of capital lease obligations

    45,883       150,157  

Accounts payable

    2,262,688       3,455,085  

Accrued expenses

    2,385,586       1,441,840  

Billing in excess of cost

    106,375       175,338  

Accrued income taxes payable

    580       570  

Deferred revenue / customers deposits

    192,597       117,700  
                 

Total Current Liabilities

    5,008,743       5,340,690  
                 
                 

Long-term notes payable, less current portion

    39,895       -  

Long-term capital lease obligations, less current portion

    93,942       165,572  

Total Long-Term Liabilities:

    133,837       165,572  
                 

Total Liabilities

    5,142,580       5,506,262  
                 

Commitment and Contingencies See Note 11

    -       -  
                 

Stockholders' Equity:

               

Common stock; par value $0,001, 100,000,000 shares authorized, 36,835,514 and 39,532,035 shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively

    36,836       39,532  

Additional paid-in capital

    36,084,117       36,087,808  

Accumulated deficit

    (24,011,343

)

    (7,592,709

)

Deferred compensation

    (148,561

)

    (590,742

)

Other comprehensive income, net

    (5,691,301

)

    (5,376,605  
                 

Total Stockholders' Equity

    6,269,748       22,567,284  
                 

Total Liabilities and Stockholders' Equity

  $ 11,412,328     $ 28,073,546  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-3

 

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS

 

   

For the Years Ended

 
                 
   

December 31,

 
   

2016

   

2015

 

Net Sales

  $ 13,906,394     $ 15,812,587  
                 

Cost of Goods Sold

    12,473,965       12,598,163  
                 

Gross Profit

    1,432,429       3,214,424  
                 

Operating Expenses:

               

Selling expenses

    2,164,780       2,721,781  

General and administrative expenses

    3,997,304       2,814,747  

Non-cash compensation expenses

    435,794       369,531  

Research and development expenses

    626,147       707,844  

Impairment of goodwill

    7,343,208       -  
                 

Total Operating Expense

    14,567,233       6,613,903  
                 

Loss from Operations

    (13,134,804

)

    (3,399,479

)

                 

Other Income (Expense)

               

Interest and other Income

    968       98,171  

Interest expense

    (38,945

)

    (51,232

)

Gain (Loss) on investments

    (16,621

)

    7,253  

Gain (Loss) on currency transactions

    (9,555

)

    459,279  
                 

Total Other Income (Expense)

    (64,153 )     513,471  
                 

Loss Before Income Taxes

    (13,198,957

)

    (2,886,008

)

                 

Income Tax Expense (Benefit)

    3,219,677       (697,786

)

                 

Net Loss

    (16,418,634

)

    (2,188,222

)

                 

Less Net Loss Attributable To Non-Controlled Interests in Subsidiaries

    -       (21,635

)

                 

Net Loss Attributable To LiqTech

  $ (16,418,634

)

  $ (2,209,857

)

                 

Basic Loss Per Share

  $ (0.45

)

  $ (0.06

)

                 

Weighted Average Common Shares Outstanding

    36,835,514       36,790,420  
                 

Diluted Loss Per Share

  $ (0.45

)

  $ (0.06

)

                 

Weighted Average Common Shares Outstanding Assuming Dilution

    36,835,514       36,790,420  

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-4

 

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

 

 CONSOLIDATED STATEMENTS OF OTHER COMPREHENSIVE INCOME

  

   

For the Years Ended

 
   

December 31,

 
   

2016

   

2015

 
                 

Net Loss

    (16,418,634

)

    (2,188,222

)

                 

Currency Translation, Net of Taxes

    (314,696

)

    (2,540,688

)

                 

Other Comprehensive Loss

  $ (16,733,330

)

  $ (4,728,910

)

                 

Comprehensive Income (Loss) Attributable To Non-controlled Interest in Subsidiaries

    -       -  
                 

Comprehensive Loss Attributable To LiqTech International Inc.

  $ (16,733,330 )   $ (4,728,910

)

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-5

 

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

For the Years Ended December 31, 2016, 2015 and 2014

 

   

Common Stock

   

 

Additional

Paid-in

   

Retained

   

Other

Compre-

hensive

   

 

Deferred

Compen-

   

Non-

controlled

Interest in

 
   

Shares

   

Amount

   

Capital

   

Earnings

   

Income

   

sation

   

Subsidiaries

 

BALANCE, December 31, 2014

    39,404,782     $ 39,405     $ 35,632,410     $ (5,382,852

)

  $ (2,835,917

)

  $ (504,748

)

  $ 16,717  
                                                         

Common shares issued at $0.75 each for services provided and to be provided by the board of directors

    100,000       100       74,900                       (75,000

)

       
                                                         

Common shares issued at $0.74 each for services provided and to be provided by the board of directors

    27,253       27       20,140                       (20,167

)

       
                                                         

Deferred compensation on shares issued to the board of directors, employees and services

                    391,546                       (391,546

)

       
                                                         

Forfeiture of Stock Based Compensation

                    (31,188

)

                    31,188          
                                                         

Stock based compensation expenses recognized for the year ended December 31, 2015

                                            369,531          
                                                         

Currency translation, net

                                    (2,540,688

)

            (16,717

)

                                                         

Net Income for the year ended December 31, 2015

                            (2,209,857

)

                       
                                                         

BALANCE, December 31, 2015

    39,532,035     $ 39,532     $ 36,087,808     $ (7,592,709

)

  $ (5,376,605

)

  $ (590,742

)

  $ 0  
                                                         

Warrants issued for services

                    33,000                       (33,000 )        
                                                         

Forfeiture of Stock Based Compensation

                    (39,387

)

                    39,387          
                                                         

Stock based compensation expenses recognized for the year ended December 31, 2016

                                            435,794          
                                                         

Cancelation of common share held in escrow in connection with acquisition of LiqTech Systems AS

    (2,696,521 )     (2,696 )     2,696                                  

Currency translation, net

                                    (314,696

)

               
                                                         

Net Income for the year ended December 31, 2016

                            (16,418,634

)

                       
                                                         

BALANCE, December 31, 2016

    36,835,514     $ 36,836     $ 36,084,117     $ (24,011,343

)

  $ (5,691,301

)

  $ (148,561

)

  $ 0  

 

F-6

 

 

LiqTech International, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

Increase (Decrease) in Cash and Cash Equivalents

 

   

For the Years Ended

 
   

December 31,

 
   

2016

   

2015

 

Cash Flows from Operating Activities:

               

Net Loss

  $ (16,418,634 )   $ (2,188,222 )

Adjustments to reconcile net (loss) to net cash provided (used) by operations:

               

Depreciation and amortization

    1,378,277       1,444,109  

Non-cash compensation

    435,794       369,531  

Bad debt expense

    1,437,949       (80,729 )

Reserve for obsolete inventory

    802,966       174,143  

Change in deferred tax asset / liability

    3,856,619       (250,523 )

Impairment of goodwill

    7,343,208       -  

Loss on Investments

    16,556       -  

Changes in assets and liabilities:

               

(Increase) decrease in restricted cash

    292,826       (73,947 )

(Increase) decrease in accounts receivable

    841,918       (1,280,537 )

(Increase) decrease in inventory

    (1,147,934 )     (175,948 )

(Increase) decrease in prepaid expenses/deposits

    (57,666 )     49,012  

Increase (decrease) in accounts payable

    (1,192,386 )     1,118,143  

Increase (decrease) in accrued expenses

    1,018,643       (24,671 )

Increase (decrease) long-term contracts

    1,807,658       (1,171,325 )
                 

Total Adjustments

    16,834,428       97,258  
                 

Net Cash Provided (Used) by Operating Activities

    415,794       (2,090,964 )
                 

Cash Flows from Investing Activities:

               

Purchase of property and equipment

    (373,740 )     (576,278 )

Purchase of Long-term investments

    -       (16,378 )
                 

Net Cash Used by Investing Activities

    (373,740 )     (592,656 )
                 

Cash Flows from Financing Activities:

               

Payments on loans payable

    (26,714 )     -  

Net payments proceeds on capital lease obligation

    (175,905 )     (223,072 )
                 

Net Cash Used by Financing Activities

    (202,619 )     (223,072 )
                 

Loss on Currency Translation

    (1,376 )     (1,576,469 )
                 

Net Increase (Decrease) in Cash and Cash Equivalents

    (161,941 )     (4,483,161 )
                 

Cash and Cash Equivalents at Beginning of Period

    1,370,591       5,853,752  

Cash and Cash Equivalents at End of Period

  $ 1,208,650     $ 1,370,591  

 

The accompanying notes are an integral part of these consolidated financial statements. 

  

F-7

 

 

LIQTECH INTERNATIONAL, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

Increase (Decrease) in Cash and Cash Equivalents

 

   

For the Years Ended

December 31,

 
   

2016

   

2015

 

Supplemental Disclosures of Cash Flow Information:

 

Cash paid during the period for:

         

Interest

  $ 38,945     $ 51,232  

Income Taxes

  $ 590     $ 570  
                 

Supplemental Disclosures of Non-Cash Investing and Financing Activities:

               
                 

Compensation upon vesting of stock options granted to employees

  $ 307,493     $ 154,745  

Compensation for vesting of restricted stock awards issued to the board of directors

    77,667       204,500  

Value of warrants issued for services

    50,634       10,286  

Total

  $ 435,794     $ 369,531  

  

On December 31, 2016, the Company canceled 2,696,521 common shares two-thirds (2/3) of the previously issued common shares held in escrow issued in connection with the Company through its subsidiary, LiqTech Int. DK, acquisition of all of the issued and outstanding capital stock of LiqTech Systems A/S (formerly Provital Solutions A/S), as LiqTech Systems A/S failed to meet the 2014, 2015 and 2016 catchup gross revenue and EBITDA thresholds for release from escrow.

 

The Company purchased a $81,643 vehicle on a note payable.

 

The accompanying notes are an integral part of these consolidated financial statements.

 

F-8

 

 

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Business and Basis of Presentation

 

The consolidated financial statements include the accounts of LiqTech International, Inc. (“Parent”) and its subsidiaries. The terms "Company", “us", "we" and "our" as used in this report refer to Parent and its subsidiaries, which are set forth below. The Company engages in the development, design, production, marketing and sale of automated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America. Set forth below is a description of Parent and each of its subsidiaries:

 

LiqTech International, Inc., a Nevada corporation organized in July 2004, formerly known as Blue Moose Media, Inc.

 

LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in May 2011.

 

LiqTech International AS, a Danish corporation, incorporated on January 15, 2000 (“LiqTech Int. DK”), a 100% owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.

 

LiqTech NA, Inc. (“LiqTech NA”), incorporated in Delaware on July 1, 2005, a 100% owned subsidiary of LiqTech USA. LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.

 

LiqTech Asia (“LiqTech Asia”) a 60% owned subsidiary of LiqTech Int. DK, incorporated in South Korea on July 20, 2006, was a dormant subsidiary. The company was closed on March 6, 2015.

 

LiqTech Germany (“LiqTech Germany”) a 100% owned subsidiary of LiqTech Int. DK, incorporated in Germany on December 9, 2011, engages in marketing and sale of liquid filters in Germany. The Company is in the process of closing operations, which is expected to be completed during 2017.

 

LiqTech PTE Ltd, (“LiqTech Sing”) a 95% owned subsidiary of LiqTech Int. DK, incorporated in Singapore on January 19, 2012, engages in marketing and sale of liquid filters in Singapore and other countries in the area. The Company is in the process of closing operations, which is expected to be completed during 2017.

 

LiqTech Systems AS, a Danish Corporation ("LiqTech Systems") (Formerly Provital Solutions A/S) was incorporated on September 1, 2009 and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of LiqTech Systems from the date of acquisition on July 31, 2014.

   

Consolidation -- The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.

 

Functional Currency / Foreign currency translation -- The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar. The Functional Currency of LiqTech Int. DK and LiqTech Systems AS is the Danish Krone (“DKK”), the functional currency of LiqTech Germany is the Euro, the functional currency of LiqTech Singapore is the Singapore Dollar and the functional Currency of LiqTech Asia is South Korean Won. The Company’s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the years ended December 31, 2016 and 2015. Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders’ equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.

 

Cash, Cash Equivalents and Restricted Cash -- The Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents. The Company had no balances held in a financial institution in the United States in excess of federally insured amounts at December 31, 2016 and December 31, 2015. At December 31, 2016 and 2015, the Company had cash balances of $0 and $292,826 that are restricted to secure guarantees issued by the Company. The cash is restricted until the underlying guarantees are released. 

 

F-9

 

 

Accounts Receivable -- Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence. 

 

The roll forward of the allowance for doubtful accounts for the year ended December 31, 2016 and December 31, 2015 is as follows:

 

   

2016

   

2015

 

Allowance for doubtful accounts at the beginning of the period

  $ 1,087,871     $ 1,654,290  

Bad debt expense

    1,437,949       80,729  

Amount of receivables written off

    (252,792

)

    (398,083

)

Effect of currency translation

    (144,576

)

    (249,065

)

Allowance for doubtful accounts at the end of the period

  $ 2,128,452     $ 1,087,871  

  

Inventory -- Inventory is carried at the lower of cost or market, as determined on the first-in, first-out method.

 

Property and Equipment -- Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets, which range from three to ten years (See Note 5).

 

Long-Term Investments -- Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information may be more limited, may not be as timely as and may be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.

 

Intangible Assets -- Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (“FASB”) Accounting Standards Codification, (“ASC”) Topic 350, “Goodwill and Other Intangible Assets” and amortized the patents on a straight line basis over the estimated useful life of two to ten years. 

 

Goodwill -- Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.

 

Revenue Recognition and Sales Incentives -- The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. 101, “Revenue Recognition in Financial Statements” (SAB 101), FASB ASC 605 Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collections of resulting receivable is reasonably assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.

 

The Company has received long-term contracts for the installation of various water filtrations systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long-term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long-term contract or grant multiplied by the long-term contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.

 

F-10

 

 

Project costs of the long-term contracts and grants include all direct material and labor costs and those indirect costs related to the project. Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.

 

In Denmark, Value Added Tax (“VAT”) of 25% of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities. 

 

Advertising Cost -- Costs incurred in connection with advertising of the Company’s products is expensed as incurred. Such costs amounted to $14,504 and $34,442, for the years ended December 31, 2016 and 2015, respectively.

 

Research and Development Cost -- The Company expenses research and development costs for the development of new products as incurred. Included in operating expense for the years ended December 31, 2016 and 2015 were $626,147, and $707,844, respectively, of research and development costs.

 

Income Taxes -- The Company accounts for income taxes in accordance with FASB ASC Topic 740 Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.

 

Income (Loss) Per Share -- The Company calculates earnings (loss) per share in accordance with FASB ASC 260 Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options and warrants that have been granted but have not been exercised.

 

Stock Options and Awards -- The Companies have granted stock options to certain key employees. See Note 14. During the years presented in the accompanying consolidated financial statements, the Company has granted stock options and awards. The Company accounts for options in accordance with the provisions of FASB ASC Topic 718, Compensation – Stock Compensation. Non-cash compensation costs of $435,794 and $369,531 have been recognized for the vesting of options and stock awards granted to employees with an associated recognized tax benefit of $35,045 and $157,080 for the years ended December 31, 2016 and 2015, respectively.

 

Fair Value of Financial Instruments -- The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic 820. The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:

 

 

Level 1. Observable inputs such as quoted prices in active markets for identical assets or liabilities;

   

 

Level 2. Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and

 

 

Level 3. Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.

 

Unless otherwise disclosed, the fair value of the Company’s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.

  

Accounting Estimates -- The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets allowance for doubtful accounts receivable, cost in excess of billings, reserve for obsolete inventory, depreciation and impairment of property plant and equipment and impairment of goodwill and liabilities billings in excess of cost commitment and contingencies, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.

 

F-11

 

 

Recent Accounting Pronouncements -- In May 2014, the Financial Accounting Standards Board (FASB) issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On July 9 2015, the FASB agreed to delay the effective date by one year; accordingly, the new standard is effective for us beginning in the first quarter of 2018 and we expect to adopt it at that time. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method, nor have we determined the impact of the new standard on our consolidated financial statements.

 

In 2015, the FASB issued an amended standard requiring that we classify all deferred tax assets and liabilities as non-current on the balance sheet instead of separating deferred taxes into current and non-current. The amended standard is effective for us beginning in the first quarter of 2017; early adoption is permitted and we are evaluating whether we will early adopt. The amended standard may be adopted on either a prospective or retrospective basis. We do not expect that the adoption of this standard will have a significant impact on our financial position or results of operations.

 

In February 2016, the FASB issued changes to the accounting for leases that primarily affect presentation and disclosure requirements. The new standard will require the recognition of a right to use asset and underlying lease liability for operating leases with an initial life in excess of one year. This standard is effective for us beginning in the first quarter of 2019. We have not yet determined the impact of the new standard on our consolidated financial statements.

 

In August 2014, the FASB issued ASU 2014-15, Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern, that will require management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. In connection with each annual and interim period, management will assess if there is substantial doubt about an entity’s ability to continue as a going concern within one year after the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within one year after the issuance date. The new standard defines substantial doubt and provides example indicators. Disclosures will be required if conditions give rise to substantial doubt. However, management will need to assess if its plans will alleviate substantial doubt to determine the specific disclosures. This standard is effective for public entities for annual periods ending after December 15, 2016. Earlier application of this standard is permitted. This standard is not expected to have a material effect on the Company’s financial position, results of operations and cash flows.

 

In March 2016, the FASB issued ASU 2016-09, Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which changes how companies account for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled, allows an employer to repurchase more of an employee’s shares than previously allowed for tax withholding purposes without triggering liability accounting, allows a company to make a policy election to account for forfeitures as they occur, and eliminates the requirement that excess tax benefits be realized before companies can recognize them. The new guidance also requires excess tax benefits and tax shortfalls to be presented on the cash flow statement as an operating activity rather than as a financing activity, and clarifies that cash paid to a tax authority when shares are withheld to satisfy its statutory income tax withholding obligation are to be presented as a financing activity. The standard is effective for financial statements issued for fiscal years beginning after December 15, 2016, and interim periods within those fiscal years. Early adoption is permitted. This standard is not expected to have a material effect on the Company’s financial position, results of operations and cash flows.

 

Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company’s present or future financial statements. 

 

NOTE 2 - GOING CONCERN

 

The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has limited cash and incurred significant recent losses. These factors raise substantial doubt about the ability of the Company to continue as a going concern. There is no assurance that the Company will be successful in raising additional cash through the issuance of debt or equity instruments or return to achieving profitable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties. 

 

F-12

 

 

NOTE - RELATED PARTY TRANSACTIONS

  

During October and December of 2014, an officer of LiqTech NA provided $25,000 and $35,000 in non-interest bearing advances to the Company totaling $60,000. These advances have been included in accounts payable at December 31, and were repaid in January 2015.

 

During March 2015, an officer of LiqTech NA provided $25,000 in non-interest bearing advances to the Company. These advances were repaid in May 2015.

 

NOTE 4 - INVENTORY

 

Inventory consisted of the following at December 31, 2016 and December 31, 2015:

 

   

2016

   

2015

 

Furnace parts and supplies

  $ 336,799     $ 466,538  

Raw materials

    1,216,098       1,498,406  

Work in process

    2,499,242       1,770,070  

Finished goods and filtration systems

    2,544,080       1,788,161  

Reserve for obsolescence

    (1,421,345

)

    (606,504

)

Net Inventory

  $ 5,174,874     $ 4,916,671  

  

The inventory is held as collateral on a lines and credit and guarantees with financial institutions. See Note 9.

 

NOTE - PROPERTY AND EQUIPMENT

 

Property and equipment consisted of the following at December 31, 2016 and December 31, 2015:

 

   

Useful Life

   

2016

   

2015

 

Production equipment

   3 - 10     $ 10,370,462     $ 10,536,377  

Lab equipment

   3 - 10       76,658       143,783  

Computer equipment

   3 - 5       185,652       269,526  

Vehicles

   3 - 5       39,090       40,365  

Furniture and fixture

    5         146,453       141,502  

Leasehold improvements

    10         955,563       972,023  
                11,773,878       12,103,576  

Less Accumulated Depreciation

              (9,140,320 )     (8,564,882

)

Net Property and Equipment

            $ 2,633,558     $ 3,538,694  

 

Depreciation expense amounted to $1,373,505 and $1,437,787, for the year ended December 31, 2016 and 2015, respectively. The property and equipment is held as collateral on a lines of credit and guarantees with financial institutions. See Note 9.

 

 

NOTE 6 – INVESTMENTS AT COST

 

The following tables summarize Level 1, 2 and 3 financial assets and financial (liabilities) by their classification in the Statement of Financial Position:

 

As of December 31, 2016

 

Level 1

   

Level 2

   

Level 3

 
                         

Investments

    -       -       5,282  
                         

Total

    -       -       5,282  

    

As of December 31, 2015

 

Level 1

   

Level 2

   

Level 3

 
                         

Investments

    -       -       21,838  
                         

Total

    -       -       21,838  

 

At December 31, 2016, our total investments of $5,282 consisted of an investment of $5,282 in LEA Technology in France to strengthen our sales channels in the French market.

 

At December 31, 2015, our total investments of $21,838 consisted of an investment of $5,460 in LEA Technology in France to strengthen our sales channels in the French market and an investment of $16,378 in LiqTech Italy, a newly organized Italian Company, to strengthen our sales channels in the Italian market.

 

F-13

 

 

NOTE - DEFINITE-LIFE INTANGIBLE ASSETS

 

At December 31, 2016 and December 31, 2015, definite-life intangible assets, net of accumulated amortization, consisted of patents on the Company’s products of $5,614 and $10,386, respectively. The patents are recorded at cost and amortized over two to ten years. Amortization expense for the years ended December 31, 2016 and 2015 was $4,772 and $6,322, respectively. Expected future amortization expense for the years ended are as follows:

 

Year ending December 31,

 

Amortization

Expenses

 

2017

    2,699  

2018

    2,270  

2019

    645  

Thereafter

    -  
    $ 5,614  

 

   NOTE 8 - GOODWILL

 

The following is a summary of goodwill:

 

   

December 31,

2016

 
         

Goodwill at beginning of period

  $ 7,582,749  

Effect of currency translation

    (239,541

)

Impairment write down

    (7,343,208

)

Goodwill at end of period

  $ -  

 

Goodwill consists of:

 

December 31,

2016

 
         

LiqTech Systems A/S (Formerly Provital Solutions A/S)

  $ -  

  

Goodwill is evaluated for impairment annually in the fourth quarter of the Company’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill may not be recoverable. Triggering events that may indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. Key variables included in evaluating goodwill for impairment include the pipeline of proposed potential customer sales, budgeted reoccurring sales, risk free interest rate and risk premium rate and future budgeted operating results. The Company recorded an impairment charge of $7,343,208 and $0 on goodwill, during the year ended December 31, 2016 and 2015, as management's estimated fair value of the reporting unit did not exceeded the carrying value during 2016 fourth quarter testing. 

    

NOTE 9 - LINES OF CREDIT

 

In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a guarantee line of DKK 94,620 (approximately $13,416 at December 31, 2016) with a bank, subject to certain base limitations. As of December 31, 2016, we had DKK 94,620 (approximately $13,416) in working guarantee against the line. This line of credit is guaranteed by Vækstfonden (the Danish State's investments fund) and is secured by certain assets of LiqTech Systems such as receivables, inventory and equipment. The Company has no other available lines of credit.

 

NOTE 10 - LEASES

 

Operating Leases -- The Company leases office and production facilities under operating lease agreements expiring in March 2021, August 2018, May 2018, and June 2017. In some of these lease agreements, the Company has the right to extend.

 

F-14

 

 

The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of one year as of December 31, 2016 are as follows:

 

Year ending December 31,

 

Lease

Payments

 

2017

    559,058  

2018

    457,735  

2019

    179,094  

Thereafter

    395,898  

Total Minimum Lease Payments

  $ 1,591,785  

 

Lease expense charged to operations was $645,817 and $697,736, for the year ended December 31, 2016, and 2015.

 

Capital Leases -- The Company leases equipment on various variable rate capital leases currently calling for monthly payments of approximately $9,319, $591 and $532 expiring through July 2018. Included in property and equipment, at December 31, 2016 and December 31, 2015, the Company had recorded equipment on capital lease at $1,240,358 and $1,302,005, respectively, with related accumulated depreciation of $1,126,550 and $1,033,062, respectively. 

 

During the years ended December 31, 2016 and 2015, depreciation expense for equipment on capital lease amounted to $130,025, and $141,050, respectively, and has been included in depreciation expense. During the years ended December 31, 2016 and 2015, interest expense on a capital lease obligation amounted to $16,758 and $26,840, respectively.

 

Future minimum capital lease payments are as follows for the years ended December 31:

 

Year ending December 31,

 

Lease

Payments

 

2017

  $ 121,636  

2018

    23,720  

Thereafter

    -  

Total minimum lease payments

    145,356  

Less amount representing interest

    (5,531

)

Present value of minimum lease payments

    139,825  

Less Current Portion

    (45,883

)

    $ 93,942  

  

NOTE 11 - AGREEMENTS, COMMITMENTS AND CONTINGENCIES

 

401(K) Profit Sharing Plan -- LiqTech NA has a 401(k) profit sharing plan and trust covering certain eligible employees. The amount LiqTech NA contributes is discretionary. For the year ending December 31, 2016 and 2015, matching contributions were expensed and totaled $11,347 and $14,610, respectively.

 

Contingencies -- From time to time, we may be involved in litigation relating to claims arising out of our operations in the normal course of business.

 

On September 9, 2014, Mr. Raffaele Bruno Tronchetti Provera (“Plaintiff”), the 60% owner of LiqTech Italy s.r.l. (the “Venture”), sued LiqTech International A/S, the 40% owner of the Venture (“Defendant”), 750,000 Euros before the Court of Como, Italy alleging, among other things, that certain products provided by Defendant to the Venture were defective.  As of March 23, 2017, the case is in the preliminary stages where the court has appointed an expert in order to verify the quality of the products in order to determine whether there is sufficient evidence to proceed.  An evaluation of the outcome will only be possible after the results of the court appointment expert are known. This outcome of the court appointment expert is expected to be reported in second quarter of 2017. Defendant believes that the claims are without merit and intends to vigorously defend any litigation.

 

In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a guarantee line of DKK 94,620 (approximately $13,416 at December 31, 2016) with a bank, subject to certain base limitations. As of December 31, 2016, we had DKK 94,620 (approximately $13,416) in working guarantee against the line. At December 31, 2016, the Company had a cash balance of $292,826 that is restricted to secure work issued by the Company that is not part of the above line of credit.

 

 

F-15

 

 

NOTE 12 - INCOME TAXES

 

The Company accounts for income taxes in accordance with FASB ASC Topic 740, Accounting for Income Taxes; which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carry forwards. The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company’s future earnings, and other future events, the effects of which cannot be determined. In accordance with prevailing accounting guidance, the Company is required to recognize and disclose any income tax uncertainties. The guidance provides a two-step approach to recognizing and measuring tax benefits and liabilities when realization of the tax position is uncertain. The first step is to determine whether the tax position meets the more-likely-than-not condition for recognition and the second step is to determine the amount to be recognized based on the cumulative probability that exceeds 50%, Actual results could differ from these estimates.

 

As of December 31, 2016, the Company had net operating loss carryovers of approximately $11,128,000 for U.S. Federal purposes expiring through 2036; approximately $6,486,000 for Danish tax purposes, which do not expire; approximately $437,000 for German tax purposes, which do not expire and approximately $571,000 for Singapore tax purposes which do not expire. 

 

As of December 31, 2016 and 2015, the Company established a valuation allowance of $3,542,000 and $0 for the tax components of LiqTech International Inc and Liqtech NA, $1,095,000 and $0 for the tax components of LiqTech International AS and LiqTech Systems AS, $122,000 and $118,000 for the tax component of LiqTech Germany and $97,000 and $109,000 for the tax component of LiqTech Singapore as management could not determine that it was more than likely not that sufficient income could be generated by these components to realize the resulting net operating loss carry forwards and other deferred tax assets of these components.  The change in the valuation allowance for the year ended December 31, 2016 was $3,542,000, $1,095,000, $4,000 and $12,000 for the US, Danish, German and Singapore components. The change in the valuation allowance for the year ended December 31, 2015 was $0, $0, $118,000 and $109,000 for the US, Danish, German and Singapore components.

 

The Company is not relying on the reversal of deferred tax liabilities to realize the deferred tax assets. The same variable used by the Company in evaluating goodwill for impairment were used in assessing the realization of deferred tax assets (See Note 8).

 

The Company further considered the following positive and negative evidence:

 

Positive Evidence

 

1) The Company had profitable 2015 third and fourth quarter results. The Company noted a significant increase in proposed sales pipeline from December 31, 2014 to 2015.

 

2) The Company executed in June 2015 a Diesel Particular Filtration supplier contract in China.

 

3) For Danish tax purposes the Company is able to obtain tax refunds for research and development expenditures

 

Negative Evidence 

 

1) The Company has noted a longer than anticipated sales cycle from proposals to signing filtration systems order.

 

2) The Company has a net loss from operations for the year ended December 31, 2016 and 2015.

 

3) The Company has experienced a decrease in liquid filter sales.

 

4) The Company has experienced delays in requested shipment date of large DPF sales orders and collection of receivables from large water treatment systems.

 

The temporary differences, tax credits and carry forwards gave rise to the following deferred tax asset (liabilities) at December 31, 2016 and December 31, 2015:  

 

 

   

2016

   

2015

 

Vacation accrual

  $ 5,450     $ 3,933  

Allowance for doubtful Accounts

    1,202       14,089  

Reserve for obsolete inventory

    200,118       154,100  

Valuation Allowance

    (206,770

)

       

Net current tax assets

  $ -     $ 172,122  
                 

Business tax credit carryover

    30,935       30,935  

Deferred compensation

    8,500       -  

Net operating loss carryover

    4,906,974       4,333,820  

Excess of book over tax depreciation

    (296,227

)

    (452,088

)

Valuation Allowance

    (4,650,182

)

    (228,170

)

Long term deferred tax asset

  $ -     $ 3,684,497  

  

F-16

 

 

A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company’s effective rate is as follows for the years ended December 31, 2016 and 2015: 

 

   

2016

   

2015

 

Computed tax at expected statutory rate

  $ (4,487,649

)

  $ (991,139

)

State and local income taxes, net of federal benefits

    (3,721

)

    (20,476

)

Non-deductible expenses

    4,242       5,291  

Non-US income taxed at different rates

    1,325,180       47,837  

Non-deductible deferred compensation

    148,170       140,175  

Effect of changes in tax rates

    (21,489 )     (31,748

)

Non-deductible impairment of goodwill

    1,615,506       -  

Non-deductible loss of subsidiaries

    -       50,579  

Valuation Allowance

    4,739,806       109,842  

Other items

    (100,368

)

    (8,147

)

Income tax expense (benefit)

  $ 3,219,677     $ (697,786

)

 

 

The components of income tax expense (benefit) from continuing operations for the years ended December 31, 2016 and 2015 consisted of the following:

 

   

2016

   

2015

 

Current income tax expense:

               

Danish

  $ (329,816

)

  $ (266,107

)

Federal

    -       -  

State

    580       570  

Current tax (benefit)

  $ (329,236

)

  $ (265,537

)

                 
                 

Book in excess of tax depreciation

  $ (158,684

)

  $ (136,572

)

Business tax credit carryover

    -       (5,226

)

Net operating loss carryover

    (1,000,650

)

    (517,153

)

Allowance for doubtful accounts

    12,705       156,036  

Valuation Allowance

    4,756,013       -  

Accrued Vacation

    (1,517

)

    1,143  

Deferred Compensation

    (8,500

)

    171,615  

Reserve for obsolete inventory

    (50,452

)

    (102,092

)

Deferred tax expense (benefit)

  $ 3,548,913     $ (432,249

)

Total tax expense (benefit)

  $ 3,219,677     $ (697,786

)

 

Deferred income tax expense / (benefit) results primarily from the reversal of temporary timing differences between tax and financial statement income. 

  

The Company files Danish and U.S. federal and Minnesota state income tax returns. LiqTech International AS is generally no longer subject to tax examinations for years prior to 2010 for their Danish tax returns. LiqTech NA is generally no longer subject to tax examinations for years prior to 2012 for U.S. federal and U.S. states tax returns. 

 

NOTE 13 - EARNINGS PER SHARE

 

The following data shows the amounts used in computing earnings per share and the effect on income and the weighted average number of shares of potential dilutive common stock for the year ended December 31, 2016 and 2015:

 

   

For the Year Ended December 31

 
   

2016

   

2015

 

Net Loss attributable to LiqTech International Inc.

  $ (16,418,634

)

  $ (2,209,857

)

Weighted average number of common shares used in basic earnings per share

    36,835,514       36,790,420  

Effect of dilutive securities, stock options and warrants

    -       -  

Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share

    36,835,514       36,790,420  

 

F-17

 

 

For the year ended December 31, 2016, Parent had 868,000 options outstanding to purchase common stock of Parent at $0.74 to $1.90 per share and Parent had 825,575 warrants outstanding to purchase common stock of Parent at $0.81 to $4.06 per share, which were not included in the loss per share computation because their effect would be anti-dilutive.

 

For the year ended December 31, 2015, Parent had 1,071,000 options outstanding to purchase common stock of Parent at $0.74 to $1.90 per share and Parent had 7,225,575 warrants outstanding to purchase common stock of Parent at $1.00 to $4.06 per share, which were not included in the loss per share computation because their effect would be anti-dilutive. The basic and diluted weighted average shares was restated to reflect the cancelation of 2,696,521 shares held in escrow. See Note 14.

 

NOTE 14 - STOCKHOLDERS' EQUITY

 

Common Stock -- Parent has 100,000,000 authorized shares of common stock, $0.001 par value. As of December 31, 2016 and 2015, respectively, there were 36,835,514 and 39,532,035 common shares issued and outstanding.      

 

Voting -- Holders of Parent common stock are entitled to one vote for each share held of record on each matter submitted to a vote of stockholders, including the election of directors, and do not have any right to cumulate votes in the election of directors. 

 

Dividends -- Subject to the rights and preferences of the holders of any series of preferred stock which may at the time be outstanding, holders of Parent common stock are entitled to receive ratably such dividends as our Board of Directors from time to time may declare out of funds legally available.  

 

Liquidation Rights -- In the event of any liquidation, dissolution or winding-up of affairs of Parent, after payment of all of our debts and liabilities and subject to the rights and preferences of the holders of any outstanding shares of any series of our preferred stock, the holders of Parent common stock will be entitled to share ratably in the distribution of any of our remaining assets.  

  

Other Matters -- Holders of Parent common stock have no conversion, preemptive or other subscription rights, and there are no redemption rights or sinking fund provisions with respect to the common stock. All of the issued and outstanding shares of common stock on the date of this report are validly issued, fully paid and non-assessable.

 

Preferred Stock -- Our Board of Directors has the authority to issue Parent preferred stock in one or more classes or series and to fix the designations, powers, preferences and rights, the qualifications, limitations or restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series, without further vote or action by the stockholders. The issuance of Parent preferred stock may have the effect of delaying, deferring or preventing a change in control of us without further action by the stockholders and may adversely affect the voting and other rights of the holders of common stock.

 

Common Stock Cancelation 

 

On December 31, 2016, the Company canceled 2,696,521 common shares two-thirds (2/3) of the previously issued common shares held in escrow issued in connection with the Company through its subsidiary, LiqTech Int. DK, acquisition of all of the issued and outstanding capital stock of Provital Solutions A/S, as Provital Solutions A/S failed to meet the 2014, 2015 and 2016 catchup gross revenue and EBITDA thresholds for release from escrow.

 

Common Stock Issuance

 

On August 14, 2015, the Company issued an additional 27,253 shares of restricted stock valued at $20,167 for services provided and to be provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which 27,253 shares vested on January 1, 2016.

 

On April 13, 2015, the Company issued an additional 100,000 shares of restricted stock valued at $75,000 for services provided and to be provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which 33,333 shares vested on January 1, 2016, 33,333 shares will vest on January 1, 2017 and 33,334 shares will vest on January 1, 2018.

 

During the third quarter 2014, the Company issued 47,500 shares of common stock in connection with the exercise of 47,500 stock options with an exercise price of $1.50 each.

 

On the July 29, 2014, the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Shares”) of LiqTech Systems and as part of the consideration for the LiqTech Systems Shares, the Company issued 4,044,782 of Parent’s common shares. 

 

F-18

 

 

On July 28, 2014, Parent completed a registered public offering of its common stock. As part of the closing, Parent issued 8,000,000 shares of common stock at a per share price of $1.50 and generated net proceeds of $10,736,278 net of offering costs of $1,263,722.  

 

During 2014, the Company issued an additional 100,000 shares of restricted stock valued at $158,000 for services provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which 33,333 shares vested on December 31, 2014, 33,333 shares will vest on December 31, 2015 and 33,334 shares will vest on December 31, 2016.  

 

As of December 31, 2016 and 2015, the Company has recorded non-cash compensation expense of $77,667 and $204,500 relating to the awards, respectively.   

 

Common Stock Purchase Warrants

 

A summary of the status of the warrants outstanding at December 31, 2016 is presented below:

 

       

Warrants Outstanding

   

Warrants Exercisable

 

Exercise Prices

   

Number

Outstanding

   

Weighted

Average

Remaining

Contractual Life

(years)

   

Weighted

Average

Exercise

Price

   

Number

Exercisable

   

Weighted

Average

Exercise

Price

 
$ 0.81       100,000       1.00     $ 0.81       100,000     $ 0.81  
$ 1.00       200,000       1.00     $ 1.00       133,333     $ 1.00  
$ 1.65       400,000       2.57     $ 1.65       400,000     $ 1.65  
$ 4.06       125,575       0.18     $ 4.06       125,575     $ 4.06  

Total

      825,575       1.64     $ 1.76       758,908     $ 1.82  

    

At December 30, 2016, the Company had 66,667 non-vested warrants. We have recorded non-cash compensation expense of $50,634 for the year ended December 31, 2016 related to the warrants issued.

 

The exercise price of the warrants and the number of shares underlying the warrants are subject to adjustment for stock dividends, subdivisions of the outstanding shares of common stock and combinations of the outstanding shares of common stock. For so long as the warrants remain outstanding, we are required to keep reserved from our authorized and unissued shares of common stock a sufficient number of shares to provide for the issuance of the shares underlying the warrants.

 

On February 15, 2016, the Company issued to a consultant a warrant to purchase 100,000 shares at an exercise price of $0.81 per share. The warrants are exercisable immediately and will remain exercisable until December 31, 2017.

 

On June 4, 2015, the Company issued to Wolfe Axelrod Weinberger Associates, LLC a warrant to purchase 200,000 shares at an exercise price of $1.00 per share. The warrants vested 1/3 upon issuance, 1/3 on June 4, 2016, 1/3 will vest on June 2017, and will remain exercisable until December 31, 2017. 

 

Stock Options  

 

In August 2011, Parent’s Board of Directors adopted a Stock Option Plan (the “Plan”). Under the terms and conditions of the Plan, the Board of Directors is empowered to grant stock options to employees, officers, and directors of the Company. At December 31, 2016, 868,000 options were granted and outstanding under the Plan. 

 

The Company recognizes compensation costs for stock option awards to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average assumptions used to estimate the fair values of the stock options granted using the Black-Scholes option-pricing model are as follows:

 

   

LiqTech

International, Inc.

 

Expected term (in years)

   5 - 10  

Volatility

   74.65% to 76.87%  

Risk free interest rate

   1.38% - 2.24%  

Dividend yield

    0%    

 

F-19

 

 

The Company recognized stock based compensation expense related to the options of $307,493 and $154,745 for the years ended December 31, 2016 and 2015, respectively. At December 31, 2016, the Company had approximately $105,927 of unrecognized compensation cost related to non-vested options expected to be recognized through December 31, 2018.

 

A summary of the status of the options outstanding under the Company’s stock option plans at December 31, 2015 is presented below: 

 

       

Options Outstanding

   

Options Exercisable

 

Exercise

Prices

   

Number

Outstanding

   

Weighted

Average

Remaining

Contractual

Life (years)

   

Weighted

Average

Exercise

Price

   

Number

Exercisable

   

Weighted

Average

Exercise

Price

 
$ 0.74       400,000       3.62     $ 0.74       133,334     $ 0.74  
$ 0.75       100,000       3.29     $ 0.75       33,333     $ 0.75  
$ 1.01       130,000       8.97     $ 1.01       130,000     $ 1.01  
$ 1.90       238,000       0.08     $ 1.90       238,000     $ 1.90  

Total

      868,000       3.41     $ 1,10       534,667     $ 3.32  

 

A summary of the status of the options at December 31, 2016, and changes during the period is presented below:

 

   

December 31, 2016

 
   

Shares

   

Weighted

Average

Exercise

Price

   

Average

Remaining

Life

   

Weighted

Average

Intrinsic

Value

 
                                 

Outstanding at beginning of period

    1,071,000     $ 1.19       3.93     $ -  

Granted

    -       -       -       -  

Exercised

    -       -       -       -  

Forfeited

    (203,000

)

    1.59       -       -  

Expired

    -       -       -       -  

Outstanding at end of period

    868,000     $ 1.10       3.41     $ 0  

Vested and expected to vest

    868,000     $ 1.10       3.41     $ 0  

Exercisable end of period

    534,667     $ 1.32       3.32     $ 0  

 

At December 31, 2016, the Company had 333,333 non-vested options with a weighted average exercise price of $0.74 and with a weighted average grant date fair value of $0.46, resulting in unrecognized compensation expense of $105,927, which is expected to be expensed over a weighted-average period of 1.2 years.

 

The total intrinsic value of options at December 31, 2016 was $0. Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at December 31, 2016 (for outstanding options), less the applicable exercise price. 

 

NOTE 15 - SIGNIFICANT CUSTOMERS / CONCENTRATION

 

For the year ended December 31, 2016, our four largest customers accounted for approximately 33%, 25%, 5% and 4%, respectively, of our net sales (approximately 67% in total). For the year ended December 31, 2015, our four largest customers accounted for approximately 24%, 15%, 11% and 6%, respectively, of our net sales (approximately 56% in total).

 

The Company sells products throughout the world; sales by geographical region are as follows for the year ended December 31, 2016 and 2015:

 

   

For the Year Ended December 31

 
   

2016

   

2015

 

United States and Canada

  $ 689,766     $ 1,521,718  

Australia

    387,807       382,883  

South America

    115,675       2,400,000  

Asia

    1,105,272       1,139,090  

Europe

    11,607,874       10,368,896  
    $ 13,906,394     $ 15,812,587  

  

F-20

 

 

  

The Company’s sales by product line are as follows for the year ended December 31, 2016 and 2015:

 

   

For the Year Ended

December 31

 
   

2016

   

2015

 

Ceramic diesel particulate

  $ 5,820,793     $ 5,081,304  

Liquid filters

    7,731,079       10,347,010  

Kiln furniture

    354,522       384,273  
    $ 13,906,394     $ 15,812,587  

 

As of December 31, 2016, approximately 85% and 15% of the Company’s assets were located in Denmark and the United States, respectively. As of December 31, 2015, approximately 89% and 11% of the Company’s assets were located in Denmark and the United States, respectively

 

NOTE 16 - SUBSEQUENT EVENT

 

The Company had 238,000 options and 125,575 warrants expire unexercised during the first quarter of 2017.

 

The Company’s management reviewed material events through March 30, 2017. 

 

F-21

 

 

Item 9.     Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 

None

 

Item 9A.      Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Our management, with the participation of both of our chief executive officer and chief financial officer, carried out an evaluation of the effectiveness of our “disclosure controls and procedures” (as defined in the Exchange Act Rules 13a-15(e) and 15-d-15(e)) as of the end of the period covered by this report (the “Evaluation Date”). Based upon that evaluation, both our chief executive officer and chief financial officer concluded that as of the Evaluation Date, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms and (ii) is accumulated and communicated to our management, including our chief executive officer and our chief financial officer, as appropriate to allow timely decisions regarding required disclosure.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal controls over financial reporting that occurred during the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. 

 

Management’s Report on International Control Over Financial Reporting

 

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. The Company’s internal control over financial reporting includes those policies and procedures that:

 

 

pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the Company;

 

 

provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the Company are being made only in accordance with authorizations of management and directors of the Company; and

 

 

provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Because of inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even internal controls determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. The effectiveness of our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the possibility of human error, and the risk of fraud. The projection of any evaluation of effectiveness to future periods is subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with policies may deteriorate. Because of these limitations, there can be no assurance that any system of internal control over financial reporting will be successful in preventing all errors or fraud or in making all material information known in a timely manner to the appropriate levels of management.

 

Management assessed the effectiveness of the Company’s internal control over financial reporting as of December 31, 2016. In making this assessment, management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control - Integrated Framework.

 

Based on its assessment and those criteria, our principal executive officer and principal financial officer concluded that the Company’s internal control over financial reporting as of December 31, 2016 was effective.

 

This annual report does not include an attestation report of the Company’s registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to an exemption by the SEC which permits the Company to provide only management’s report in this report. 

 

30

 

 

Item 9B.     Other Information

 

 None

  

Item 10.      Directors, Executive Officers and Corporate Governance

 

Set forth below is information concerning our directors and senior executive officers as of March 23, 2017.

 

Name

  

Age

  

Titles

Aldo Petersen

  

55

  

Chairman of the Board

Sune Mathiesen

  

42

  

Chief Executive Officer (Principal Executive Officer), Director

Soren Degn

  

47

  

Chief Financial Officer (Principal Financial and Accounting Officer)

Paul Burgon

  

46

  

Director

Mark Vernon

  

64

  

Director

Michael S. Barish

  

76

  

Director

Rengarajan Ramesh

  

56

  

Director

 

According to our bylaws, the number of directors at any one time may not be less than one or more than seven. The maximum number of directors at any one time may be increased by a vote of a majority of the directors then serving.

  

Our charter provides for the annual election of directors. At each annual meeting of stockholders, our directors will be elected for a one-year term and serve until their respective successors have been elected and qualified. It is anticipated that the Board of Directors will meet at least quarterly.

 

Executive officers are appointed by and serve at the pleasure of the Board of Directors. A brief biography of each director and executive officer follows:

 

Aldo Petersen. Aldo Petersen has been Chairman of the Board of LiqTech since August 2011. He has been the Chief Executive Officer of APE Invest A/S, a private Danish investment company, since 1996. Until 2006, Mr. Petersen was also the Chief Executive Officer of EuroTrust (formerly known as Telepartner), a former NASDAQ-listed company that he founded in 1986. Prior to EuroTrust, he started and sold one of Denmark’s first hedge funds, Dansk Formue Invest. Mr. Petersen was a major investor in Greentech, a renewable energy company that builds wind farms in Denmark, Germany, Poland and Italy. He is a private investor in wind farms in Germany and France, and was also a major investor in Football Club Copenhagen (listed on the Copenhagen Stock Exchange). Mr. Petersen has a B.A. degree in Economics from Copenhagen Business School.

 

Sune Mathiesen. Mr. Mathiesen was appointed as Chief Executive Officer and a Director of LiqTech International on July 29 2014. Mr. Mathiesen has served as Chief Executive Officer and as a Director of Masu A/S, a Danish company since February 2013. He has served as CEO and Director of the Board of Provital Solutions A/S since March 2012. Before that he served as Country Manager of Broen Lab Group since August 2010 and before that as Country Manager of GPA Flowsystem since February 2000. Mr. Mathiesen has a solid background in executive management, sales and turn-arounds. Mr. Mathiesen has been working hands-on with technical products within the valves and fittings industry for the past 16 years. He has a degree in commercial science from Via College in Randers, Denmark.

 

Soren Degn. Mr. Degn has served as Chief Financial Officer of LiqTech International, Inc. since August 2011. From 2008 until 2011, he was the Chief Financial Officer of Guava, a publicly listed internet advertising company. From 2007 to 2008, Mr. Degn served as Chief Financial Officer of Advance Renewable Energy Ltd. From 2001 to 2006, he was the Chief Financial Officer of EuroTrust (a NASDAQ/AIM listed company, formerly known as Telepartner). From 1996 to 2001, he was the financial controller at Kampsax (a consulting company). From 1989 to 1996, he worked at KPMG in Denmark. Mr. Degn has a B.A. degree in Business Administration and an M.B.A. from Copenhagen Business School.

 

Paul Burgon. Mr. Burgon has served as a Director of LiqTech since September 2011. Mr. Burgon has led corporate mergers and acquisitions for most of his career, leading and completing over 60 transactions worth over $2 billion. Mr. Burgon has been the Vice President of Business Development and then the Senior Vice President of Mergers & Acquisitions for Steel Partners Holdings since 2012. Mr. Burgon was the interim Chief Financial Officer of SWK Holdings Corporation (OTCBB: SWKH) from 2010 to 2012. Mr. Burgon served as a Principal and CFO of NightWatch Capital Advisors, LLC from 2005 to 2012. Mr. Burgon was a Manager and then Director of Corporate Development for Danaher Corporation from 1998 to 2005. Mr. Burgon led corporate development at Fluke Corporation from 1997 to 1998 and worked at Coopers and Lybrand from 1994 to 1997. Mr. Burgon holds a B.S.BA. degree (cum laude) in Finance and International Business and an International Executive M.B.A. degree from the McDonough School of Business at Georgetown University.

 

31

 

 

Mark Vernon. Mr. Vernon has served as a Director of LiqTech International, Inc. since February 26, 2013. Mr. Vernon currently serves as a Director of Senior plc, a UK-based aerospace and industrial engineering business, following his appointment in May 2011. Mr. Vernon has had a distinguished career in the industrial engineering industry, with wide international business experience. In January 2014, Mr. Vernon retired as Chief Executive Officer and Director of Spirax-Sarco Engineering plc (London Stock Exchange: SPX),a designer and supplier of industrial steam systems and peristaltic pumping, after serving on the Spirax Board since 2006. He also served previously as Group Vice-president of Flowserve’s Flow Control Business Unit, Group Vice-president of Durco International and President of Valtek International. Mr. Vernon earned a BSc degree (magna cum laude) from Weber State University.

  

Michael S. Barish. Mr. Barish was appointed to serve as Director effective as of May 19, 2014. Mr. Barish has over 40 years’ experience in the investment industry, having worked as a security analyst, portfolio manager, and investment advisor. Since 2009, Mr. Barish has actively pursued personal investments in both public and private companies. Furthermore, he has served on the Board of Directors of AeroGrow International Inc. and Zero E Technologies, LLC since 2010. Previously, he served on the Board of Directors of Guaranty National Insurance Company, a publicly held property and casualty company. Mr. Barish co-founded Lazarus Investment Partners LLLP in 2003, a private investment partnership for which he served as portfolio manager until July 2009. In 1973, Mr. Barish founded Cambiar Investors, an investment advisory firm for which he served as President and Chief Investment Officer until 2001. Mr. Barish was a member of the New York Society of Security Analysts and received the designation as Chartered Financial Analyst. He received his BBA in Accounting & Finance from the University of Michigan.

 

Dr. Rengarajan Ramesh. Dr. Ramesh was appointed to serve as Director effective as of April 14, 2015. Dr. Ramesh consulted for Wasserstein & Co. in 2009 and joined them as a partner in 2010. He currently serves on the board of RWL Water as well as on the Innovation Business Development Advisory Board for United Technologies Corporation. He is a member of the investment committee for Sustainable Water for Food, at US AID, was a Board member of Imagine H2O, and is the Chairman of its Scientific Advisory Board. Most recently he served on the board of High Pressure Equipment Company a portfolio company of Wasserstein & Co. Mr. Ramesh served as a member of the International Advisory Board to The Ministry of Environment and Water for the Government of Singapore from 2006 to 2009 and on the Executive Board of the National Center for Food Protection and Defense from 2006-2009. From 2003 to 2009, he held several senior management roles at GE Water & Process Technologies, including four years as Chief Technology Officer during which time Dr. Ramesh played a key role in the development and implementation of the strategy that led to the creation of GE's $2.5 billion global water platform, managing engineering and technology organizations of over 700 engineers and scientists. Prior to serving at GE, Dr. Ramesh worked with A. Schulman Inc., a global, specialty chemicals manufacturer, for over 20 years. Dr. Ramesh received his M.S. and Ph.D. in Chemical Engineering from the University of Akron and was awarded the distinguished alumni award in 2005. Dr. Ramesh has four issued patents.

 

Director Expertise

 

The following is a brief description of the specific experience and qualifications, attributes or skills of each director that led to the conclusion that such person should serve as a director of the Company.

 

Mr. Petersen’s knowledge regarding our history and operations provides a critical link between management and the Board, enabling the Board to provide its oversight function with the benefit of management’s perspective of the business.

 

Mr. Burgon’s hands-on experience in public company corporate governance and corporate finance provides the Board with a unique perspective on corporate governance matters and corporate finance matters. Given his financial experience, Mr. Burgon has been determined by our Board to be an Audit Committee Financial Expert. 

 

Mr. Vernon’s extensive global experience in the industrial engineering industry, particularly in North and South America, provides the Board with valuable insight in the markets the Company serves, as well as proven management and Board expertise.

 

Mr. Barish’s experience in the investment industry, spanning over forty (40) years, includes successes as a security analyst, portfolio manager, investment advisor, public company board member, and founder of investment management firms. Mr. Barish is also a Chartered Financial Analyst. Given such experience and expertise, Mr. Barish provides the Board with a unique perspective on financial matters. Further, the Board has determined that he qualifies as an Audit Committee Financial Expert.

 

Mr. Mathiesen’s prior experience at leading businesses as the Chief Executive Officer and Chairman of companies in the technical products space distinguish him as an integral part of the Company’s management team. He is uniquely qualified to provide a perspective on matters involving the continued growth and development of the Company.

 

32

 

 

Mr. Ramesh’s significant experience in technology, products, industry dynamics and business development in the water industry are valuable to the Board as it seeks to implement and maintain growth strategies that will enable the Company to succeed.

 

Family Relationships

 

None of our Directors or executive officers is related by blood, marriage or adoption.

  

Director Independence

 

Our Board of Directors has determined that Messrs. Burgon, Vernon, Barish and Ramesh are independent as that term is defined in the listing standards of the NYSE. In making these determinations, our Board of Directors has concluded that none of our independent directors has an employment, business, family or other relationship, which, in the opinion of our Board of Directors, would interfere with the exercise of independent judgment in carrying out the responsibilities of a director. Our other director, Mr. Petersen, is not considered independent under these rules because Mr. Petersen has influence as a significant stockholder. Mr. Mathiesen is not considered independent under these rules because Mr. Mathiesen has influence as a significant stockholder and as the Chief Executive Officer of the Company. We expect that our independent directors will meet in executive session (without the participation of executive officers or other non-independent directors) at least two times each year.

 

Director Attendance at Board and Stockholder Meetings

 

The board of directors met formally two times and informally eight times during 2016. During 2016, each director attended at least 75% of the meetings of the board and the committees upon which he or she serves.

 

We do not have a policy regarding director attendance at our annual meetings of stockholders. Directors Aldo Petersen and Sune Mathiesen both attended our annual meeting of stockholders held on November 8, 2016.

 

Committees of our Board of Directors

 

Committee Composition

 

Our Board of Directors has an Audit Committee, a Compensation Committee, and a Governance Committee. The following table sets forth the current membership of each of these committees: 

 

Audit Committee

 

Compensation Committee

 

Governance Committee

Paul Burgon*

 

Mark Vernon *

 

Mark Vernon *

Mark Vernon

 

Paul Burgon

 

Paul Burgon

Michael Barish

 

Michael Barish

 

Michael Barish

 

 

  

 

  

* Chairman of the committee

 

  

 

  

 

Audit Committee

 

Our Audit Committee consists of Paul Burgon (Chair), Mark Vernon and Michael Barish each of whom is an independent director as defined in the NYSE rules and SEC rules. Based upon past employment experience in finance and other business experience requiring accounting knowledge and financial sophistication, our Board of Directors has determined that Mr. Burgon is an “Audit Committee Financial Expert” as defined in Item 407(d)(5) of Regulation S-K, and that each member of our Audit Committee is able to read and understand fundamental financial statements. We have implemented a written charter for our Audit Committee that provides that our Audit Committee is responsible for:

 

 

appointing, compensating, retaining, overseeing and terminating our independent auditors and pre-approving all audit and non-audit services permitted to be performed by the independent auditors;

 

 

discussing with management and the independent auditors our annual audited financial statements, our internal control over financial reporting, and related matters;

 

 

reviewing and approving any related party transactions;

 

 

meeting separately, periodically, with management, the internal auditors and the independent auditors;

 

 

annually reviewing and reassessing the adequacy of our Audit Committee charter;

 

33

 

 

 

such other matters that are specifically delegated to our Audit Committee by our Board of Directors from time to time; and

 

 

reporting regularly to the Board of Directors.

 

During the fiscal year ended December 31, 2016, the Audit Committee met four times.

 

Compensation Committee

 

Our Compensation Committee consists of Mark Vernon (Chair), Paul Burgon and Michael Barish, each of whom is an independent director as defined in the NYSE rules, a “non-employee director” under Rule 16b-3 promulgated under the Exchange Act, and an “outside director” for purposes of Section 162(m) of the Code. We have implemented a written charter for our Compensation Committee that provides that our Compensation Committee is responsible for:

 

 

reviewing and making recommendations to our Board Directors regarding our compensation policies and forms of compensation provided to our directors and officers;

 

 

 

 

reviewing and making recommendations to our Board of Directors regarding bonuses for our officers and other employees;

 

 

 

 

reviewing and making recommendations to our Board of Directors regarding stock-based compensation for our directors and officers;

 

 

 

 

administering our stock option plans in accordance with the terms thereof; and

     
 

such other matters that are specifically delegated to the Compensation Committee by our Board of Directors after the business combination from time to time.

 

During the fiscal year ended December 31, 2016, the Compensation Committee met two times.  

 

Governance Committee

 

Our Governance Committee consists of Mark Vernon (Chair), Paul Burgon and Michael Barish. Mr. Vernon is an independent director as defined in the NYSE rules. We have implemented a written charter for our Governance Committee that provides that our Governance Committee is responsible for:

 

 

overseeing the process by which individuals may be nominated to our Board of Directors;

     
 

identifying potential directors and making recommendations as to the size, functions and composition of our Board of Directors and its committees;

 

 

 

 

considering nominees proposed by our stockholders;

     
 

establishing and periodically assessing the criteria for the selection of potential directors;

     
 

making recommendations to the Board of Directors on new candidates for Board membership; and

     
 

overseeing corporate governance matters.

  

In making nominations, the Governance Committee intends to submit candidates who have high personal and professional integrity, who have demonstrated exceptional ability and judgment and who are effective, in conjunction with the other nominees to the Board of Directors, in collectively serving the long-term interests of the stockholders. In evaluating nominees, the Governance Committee intends to take into consideration attributes such as leadership, independence, interpersonal skills, financial acumen, business experiences, industry knowledge, and diversity of viewpoints.

 

During the fiscal year ended December 31, 2016, the Governance Committee met three times.

 

34

 

 

Legal Proceedings Involving Officers and Directors

 

To the knowledge of the Company after reasonable inquiry, no current director or executive officer of the Company during the past ten years, has (i) been convicted in a criminal proceeding (excluding traffic violations or other minor offenses), (ii) been a party to any judicial or administrative proceeding (except for any matters that were dismissed without sanction or settlement) that resulted in a judgment, decree or final order enjoining the person from future violations of, or prohibiting activities subject to, U.S. federal or state securities laws, or a finding of any violation of U.S. federal or state securities laws, (iii) filed a petition under federal bankruptcy laws or any state insolvency laws or has had a receiver appointed for the person’s property or (iv) been subject to any judgment, decree or final order enjoining, suspending or otherwise limiting for more than 60 days, the person from engaging in any type of business practice, acting as a futures commission merchant, introducing broker, commodity trading advisor, commodity pool operator, floor broker, leverage transaction merchant, any other person regulated by the Commodity Futures Trading Commission, or an associated person of any of the foregoing, or as an investment adviser, underwriter, broker or dealer in securities, or as an affiliated person, director or employee of any investment company, bank, savings and loan association or insurance company, or engaging in or continuing any conduct or practice in connection with such activity or engaging in any activity in connection with the purchase or sale of any security or commodity or in connection with any violation of Federal or State securities laws or Federal commodities laws, (v) been found by a court of competent jurisdiction in a civil action or by the Commission to have violated any Federal or State securities law, and the judgment in such civil action or finding by the Commission has not been subsequently reversed, suspended, or vacated, (vi) been found by a court of competent jurisdiction in a civil action or by the Commodity Futures Trading Commission to have violated any Federal commodities law, and the judgment in such civil action or finding by the Commodity Futures Trading Commission has not been subsequently reversed, suspended or vacated, (vii) been the subject of, or a party to, any Federal or State judicial or administrative order, judgment, decree, or finding, not subsequently reversed, suspended or vacated, relating to an alleged violation of: (a) any Federal or State securities or commodities law or regulation, (b) any law or regulation respecting financial institutions or insurance companies including, but not limited to, a temporary or permanent injunction, order of disgorgement or restitution, civil money penalty or temporary or permanent cease-and-desist order, or removal or prohibition order, or (c) any law or regulation prohibiting mail or wire fraud or fraud in connection with any business entity, or (viii) been the subject of, or a party to, any sanction or order, not subsequently reversed, suspended or vacated, of any self-regulatory organization (as defined in Section 3(a)(26) of the Exchange Act (15 U.S.C. 78c(a)(26)), any registered entity (as defined in Section 1(a)(29) of the Commodity Exchange Act (7 U.S.C. 1(a)(29)), or any equivalent exchange, association, entity or organization that has disciplinary authority over its members or persons associated with a member.

 

Code of Ethics

 

 We adopted a code of conduct and ethics on January 1, 2012. The code of ethics has been posted on the Company’s website.

 

Section 16(a) Beneficial Ownership Reporting Compliance

 

Section 16(a) of the Exchange Act requires a company’s officers and directors, and persons who own more than ten percent (10%) of a registered class of a company’s equity securities, to file reports of ownership and changes in ownership with the SEC. Officers, directors, and greater than ten percent (10%) stockholders are required by SEC regulations to furnish the Company with copies of all Section 16(a) forms they file. 

  

To our knowledge, based solely on a review of the copies of such reports furnished to us, we believe that all reports under Section 16(a) required to be filed by its officers and directors and greater than ten percent (10%) beneficial owners were timely filed.

  

Item 11.    Executive Compensation

 

Summary Compensation Table

 

The following table sets forth certain information with respect to compensation for the years ended December 31, 2016 and 2015 earned by or paid to our chief executive officer and our two most highly compensated executive officers, other than our chief executive officer, in 2016 whose total compensation exceeded $100,000 (the “named executive officers”).

 

Summary Compensation Table

 

Name and Principal Position

Year

 

Salary

($)

(1)

   

Bonus

($)

   

Stock Awards

($)

   

Option Awards

($) (2)

   

Nonequity

Incentive Plan

Compensation

   

Nonqualified

Deferred

Compensation

Earnings

   

Other

   

Total

 

Sune Mathiesen, Chief Executive Officer (3)

                                                                 
 

2016

  $ 216,099                     $ -       -       -     $ 21,268 (5)   $ 237,267  
 

2015

    220,992                       -       -       -       22,962       243,954  
 

2014

    266,951                       -       -       -       11,123       278,074  
                                                                   

Soren Degn, Chief Financial Officer (4)

                                                                 
 

2016

    216,146                       -       -       -       17,440 (5)     233,586  
 

2015

    169,801       -       -       96,968       -       -       16,691       283,460  
 

2014

    229,813       -       -       -       -       -       18,331       248,144  
                                                                   

Johnny Marcher, Chief Technical Officer (6)

                                                               
 

2016

    128,845                       -       -               12,775 (5)     141,620  
 

2015

    115,258       -       -       31,700       -       -       7,204       154,162  
 

2014

    121,885       -       -       -       -       -       5,125       127,010  

 

35

 

 

(1)

Total salaries for Messrs. Mathiesen, Marcher and Degn for 2014 are reported on an as-converted basis from Danish Krone (DKK) to U.S. dollars ($) based on the currency exchange rate of $1.00 = DKK 5.6190, as of December 31, 2014. Total salaries for Messrs. Mathiesen, Marcher and Degn for 2015 are reported on an as-converted basis from Danish Krone (DKK) to U.S. dollars ($) based on the currency exchange rate of $1.00 = DKK 6.8300, as of December 31, 2015. Total salaries for Messrs. Mathiesen, Marcher and Degn for 2016 are reported on an as-converted basis from Danish Krone (DKK) to U.S. dollars ($) based on the currency exchange rate of $1.00 = DKK 7.0528, as of December 31, 2015. We do not make any representation that the Danish Krone amounts could have been, or could be, converted into U.S. dollars at such rate on December 31, 2014, December 31, 2015 or December 31, 2016, or at any other rate.

 

 

 (2)

These amounts represent the aggregate grant date fair value for stock awards granted in fiscal year 2015, computed in accordance with FASB ASC Topic 718. See notes to consolidated financial statements contained elsewhere in this report for further information on the assumptions used to value stock options. On December 22, 2015, Mr. Degn was granted stock options to purchase 130,000 shares of common stock, at $1.01 per share. The options vested immediately. All of these options will expire on December 21, 2025. On August 14, 2015, Mr. Marcher was granted stock options to purchase 75,000 shares of common stock, at $0.74 per share. The vesting schedule of such options is as follows: one-third of the options vest on August 13, 2016, one third of such options vest on August 13, 2017 and one third of such options vest on August 13, 2018. All of these options will expire on August 13, 2020.

 

(3)

Mr. Mathiesen became our Chief Executive Officer in August 2014. Pursuant to his employment agreement, Mr. Mathiesen is entitled to an annual base salary of approximately $212,681 based on the currency exchange rate of $1.00 = DKK 7.0528, as of December 31, 2016.

 

(4)

Mr. Degn became our Chief Financial Officer in August 2011. Pursuant to his employment agreement, Mr. Degn is entitled to an annual base salary of approximately $174,399 based on the currency exchange rate of $1.00 = DKK 7.0528, as of December 31, 2016.

 

 

(5)

Pursuant to Mr. Mathiesen’s employment agreement, Mr. Matiesen’s received $21,268 of contributions from the Company to his individual retirement account in 2016. Pursuant to Mr. Degn’s employment agreement, Mr. Degn received $17,440, $16,691 and $18,331 of contributions from the Company to his individual retirement account in 2016, 2015 and 2014. Pursuant to Mr. Marcher’s employment agreement, Mr. Marcher received 12,775, $7,204 and $5,125 of contributions from the Company to his individual retirement account in 2016, 2015 and 2014, respectively.

 

(6)

On September 1, 2015, Mr. Marcher executed an employment agreement with LiqTech International A/S (Denmark) to serve as Chief Technology Officer and on the same date, Mr. Marcher’s employment agreement (as amended) to serve as Chief Operating Officer of LiqTech International, Inc. and, Liqtech Int. DK, and Director of LiqTech Delaware was terminated. Pursuant to his employment agreement, Mr. Marcher is entitled to an annual base salary of approximately $129,310 based on the currency exchange rate of $1.00 = DKK 7.0528, as of December 31, 2016.

  

 Employment Arrangements 

 

During the year ended December 31, 2016, we had employment agreements with Messrs. Mathiesen, Degn, Marcher and Petersen. A description of each agreement is set forth below.

 

Mathiesen Agreement

 

Effective July 30, 2014 the Company’s Board of Directors appointed Mr. Sune Mathiesen to serve as Chief Executive Officer of the Company and as a Director of the Company. Mr. Mathiesen was also engaged to serve as a Director of LiqTech Int. DK pursuant to a Director Contract, dated July 15, 2014, by and between Mr. Mathiesen and LiqTech Int. DK (the “Mathiesen Agreement”). Pursuant to the terms of the Mathiesen Agreement, in consideration for his services, Mr. Mathiesen shall receive an annual base salary initially set at DKK 1,500,000 (or approximately $245,042 based on the currency exchange rate of $1 = DKK 6.1214 as of December 31, 2014). Further, he shall receive a yearly bonus of 5% of the average gross profit for LiqTech Int. DK and LiqTech Systems A/S for any sales (revenue) ≥130,000,000 DKK per year (the gross margin is fixed at 40% without depreciations). For example, the calculation will be as follows, if the revenue for LiqTech Int. DK and LiqTech Systems should be DKK 200,000,000 in a year and the gross profit DKK 80,000,000 (40%) the bonus would be the following: 80,000,000 minus 130,000,000 * 0.4 = 52,000,000 DKK = 28,000,000 * 0.05 = DKK 1,400,000. Mr. Mathiesen is entitled to five weeks of vacation, home internet service, a LiqTech Int. DK mobile phone, a LiqTech Int. DK laptop and reimbursement of LiqTech Int. DK-related travel expenses. LiqTech Int. DK may terminate the Mathiesen Agreement upon not less than twelve months prior notice and Mr. Mathiesen may terminate the Mathiesen Agreement with twelve months prior notice to the end of the month. The Mathiesen Agreement was irredeemable from both parties until December 31, 2016. The full details of the Mathiesen Agreement are set forth and incorporated by reference to Exhibit No. 10.24 to this Annual Report on Form 10-K. 

 

36

 

 

Degn Agreement

 

Effective December 21, 2015, LiqTech International, Inc. entered into an Amended and Restated Employment Agreement with Søren Degn, the Company’s Chief Financial Officer (“CFO”). Mr. Degn has served as the Company’s CFO since his appointment on August 24, 2011. The Agreement supersedes and replaces all other agreements between the Company and Mr. Degn regarding the terms of his engagement by the Company as its CFO. In consideration for Mr. Degn’s service to the Company, Mr. Degn is entitled to receive a base salary initially set at DKK 1,230,000 per year USD equivalent, with eligibility to receive up to 60% of his base salary in the sole discretion of the Board, a one-time signing bonus in the amount of $40,000, and options to purchase 130,000 shares of common stock of the Company pursuant to the Company’s equity incentive plan. The Agreement also sets forth the other terms of the standard Company benefits that Mr. Degn will be eligible for as an employee. The Agreement shall last until the second anniversary of the Effective Date (as defined in the agreement) and will renew automatically for successive one year terms unless a notice of non-renewal is given by either party, or unless Mr. Degn’s employment is otherwise terminated prior to the expiration of any term. The amended and restated employment agreement is referenced as Exhibit No. 10.28 to this Annual Report on Form 10-K.

 

Marcher Appointment

 

On November 1, 2013, Johnny Marcher was appointed to serve as Chief Operating Officer (“COO”) of LiqTech International, Inc. and LiqTech Int. DK. Mr. Marcher was also engaged to serve as a Director of LiqTech Int. DK and as a Director of LiqTech Delaware pursuant to an amendment to his previous contract, by and between Mr. Marcher and LiqTech Int. DK. In consideration for such services, Mr. Marcher received an annual base salary initially set at DKK 720,000 (or approximately $117,620 based on the currency exchange rate of $1 = DKK 6.1214 as of December 31, 2014). In addition, Mr. Marcher was entitled to five weeks’ vacation, a Company mobile phone, a Company laptop and reimbursement of Company-related travel expenses. On September 1, 2015, Mr. Marcher executed an employment agreement with LiqTech International A/S (Denmark) to serve as Chief Technology Officer and on the same date, Mr. Marcher’s employment agreement (as amended) to serve as COO of LiqTech International, Inc. and Liqtech Int. DK, and Director of LiqTech Delaware was terminated. In consideration for such services, Mr. Marcher received an annual base salary initially set at DKK 900,000 (or approximately $127,609 based on the currency exchange rate of $1 = DKK 7.0528 as of December 31, 2016).

 

Petersen Agreement

 

Effective January 1, 2014, LiqTech International, Inc. and Aldo Petersen entered into a Services Agreement (the “Petersen Agreement”) whereby Mr. Petersen shall provide on-going services to us which shall include, without limitation, participation at road shows, general investor relations services, general work as Chairman of the Board and other services which are mutually agreeable by both parties on an ad hoc basis (collectively, the “Services”) in consideration for annual payments equal to DKK1,235,000 (or approximately $201,751 based on the currency exchange rate of $1 = DKK 6.1214 as of December 31, 2014), payable as follows: (a) DKK205,833.34 representing payment for the Services for the months of January and February, 2014; and (b) DKK102,916.67 on the final business day of each month beginning on March 31, 2014 through the end of the term of this Agreement (i.e. December 31, 2014). Except for the above-mentioned amounts, no amounts, bonus amounts or otherwise, shall be due and payable by us to Mr. Petersen in connection with the Services. We shall, at our sole cost and expense, provide Mr. Peterson with a laptop computer and a mobile telephone, including communication costs. Such items shall be utilized by Mr. Peterson in furtherance of Mr. Peterson’s duties and obligations under the Petersen Agreement. The Petersen Agreement shall continue for an initial period of one year and thereafter, shall be renewed automatically for subsequent one year terms unless otherwise agreed to in writing by both parties or unless otherwise terminated in accordance with the terms of the Petersen Agreement. We may terminate the Petersen Agreement at any time by providing twelve months prior written notice of termination to Mr. Petersen, effective as of the date of delivery of said notice. The Petersen Agreement is referenced as Exhibit No. 10.23 to this Annual Report on Form 10-K.

 

37

 

 

Outstanding Equity Awards at Last Fiscal Year End

 

The following table sets forth all outstanding equity awards held by our named executive officers as of December 31, 2016.

 

   

Option Awards

   

Stock Awards

 

Name

 

Number of

Securities

Underlying

Unexercised

Exercisable

(#)

   

Number of

Securities

Underlying

Unexercised

Unexercisable (#)

   

Equity

Incentive

Plan

Awards:

No. of

Securities

Underlying

Unexercised

Unearned

Options

(1)

   

Option

Exercise

Price

   

Option

Expiration

Date

   

Number

of Shares

or Units

of Stock

That Have

Not Vested

   

Market

Value of

Shares

or Units

of Stock

That

Have Not

Vested

   

Equity

Incentive

Plan

Awards:

Number of

Unearned

Shares,

Units, or

Other

Rights That

Have Not

Vested

   

Equity

Incentive

Plan Awards:

Market or

Payout

Value of

Unearned

Shares,

Units, or

Other Rights

That Have

Not Vested

 

Sune Mathiesen, CEO

    -       -       -     $ -       -       -       -       -       -  
                                                                         

Soren Degn, CFO

    -       -       -     $ -       -       -       -       -       -  
                                                                         

Johnny Marcher, CTO LiqTech Int. DK

    -       -       -     $ -       -       -       -       -       -  

 

 

(1)

Each option has an exercise price equal to the fair market value of our common stock at the time of grant as reported on the NYSE Mkt on the date of grant.

 

 

(2)

See footnote 2 to the Summary Compensation Table for the grant date and vesting schedule of each option reflected above.

 

Compensation of Directors

 

For 2016 each non-executive director was entitled to $25,000 for services on the Board of Directors; the Audit Committee Chairman was paid an additional fee of $10,000 per year, the Compensation Committee Chairman was paid an additional fee of $6,000 per year; and each qualifying non-executive director would receive an automatic annual stock grant on January 2 of each year in the amount of $30,000 commencing the first year after full vesting of their initial 100,000 share stock grant that vest over a three year period.

 

The following table provides information regarding compensation that was earned or paid to the individuals who served as non-employee directors during the year ended December 31, 2016. Except as set forth in the table, during 2016, directors did not earn nor receive cash compensation or compensation in the form of stock awards, option awards or any other form. 

 

Name

 

Fees

earned or

paid in cash

(1)($)

   

Stock

Awards

(2)($)

   

Option

awards

(2)

   

Non-equity

incentive plan

compensation

   

Non-qualified

deferred

compensation

earnings

   

All other

compensation (3)

   

Total

 

Aldo Petersen

    -       -       -       -       -       172,910     $ 172,910  

Paul Burgon

    35,000       30,000       -       -       -       -     $ 65,000  

Mark Vernon

    31,000       30,000       -       -       -       -     $ 61,000  

Mike Barish

    25,000       -       -       -       -       -     $ 25,000  

Rengarajan Ramesh

    25,000       -       -       -       -       -     $ 25,000  

  

38

 

 

(1)

Our independent directors are entitled to cash compensation of $25,000 per year, the chairman of our Audit Committee is entitled to $35,000 per year and the chairman of our Compensation Committee is entitled to $31,000.

 

 

(2)

These amounts represent the aggregate grant date fair value for stock awards granted in 2015, computed in accordance with FASB ASC Topic 718. As such, these amounts do not correspond to the compensation actually realized by each director for the period.

 

 

 

The Company issued 48,875 shares of restricted stock valued at $30,000 for services provided and to be provided by Mr. Burgon. Mr. Burgon shall provide general work as member of the Board of Directors and other services, which are mutually agreeable by both parties on an ad hoc basis. 

 

The Company issued 48,875 shares of restricted stock valued at $30,000 for services provided and to be provided by Mr. Vernon. Mr. Vernon shall provide general work as member of the Board of Directors and other services, which are mutually agreeable by both parties on an ad hoc basis. 

 

 

(3)

Mr. Petersen has entered into a Services Agreement whereby Mr. Petersen shall provide on-going services to us including participation at road shows, general investor relations services, general work as Chairman of the Board of Directors and other services, which are mutually agreeable by both parties on an ad hoc basis. See “Certain Relationships and Related Transactions” for a description of the Services Agreement.

 

Item 12.    Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

 

The following table sets forth, as of March 18, 2016, certain information regarding the beneficial ownership of our common stock, the only class of capital stock we have currently outstanding, of (i) each director and “named executive officers”  (as defined in the section titled “Executive Compensation — Summary Compensation Table”) individually, (ii) our chief financial officer, (iii) all directors and executive officers as a group, and (iv) each person known to us who is known to be the beneficial owner of more than 5% of our common stock. In accordance with the rules of the SEC, “beneficial ownership” includes voting or investment power with respect to securities. To our knowledge, except as indicated in the footnotes to this table and pursuant to applicable community property laws, the persons named in the table have sole voting and investment power with respect to all shares of common stock beneficially owned by them. 

 

Name of Beneficial Owner(1)

 

Shares of

Common Stock

Beneficially

Owned (2)

   

Percentage of

Common Stock

Beneficially

Owned (3)

 

Directors and NEOs

               

Sune Mathiesen(4)

    1,358,261       3.7

%

Mike Barish

    1,402,336       3.8  

Aldo Petersen

    3,188,541       8.7  

Soren Degn(5)

    298,000       *  

Mark Vernon

    243,033       *  

Paul Burgon

    235,396       *  

Rengarajan Ramesh

    66,666       *  

All executive officers and directors as a group (7 persons)(6)

    6,792,233       18.5

%

5% Shareholders:

               

Clear Harbor Asset Management, LLC

    2,103,026       5.7

%

Norman H. Pessin (7)

    3,812,569       10.4

%

Sandra F. Pessin (7)

    3,812,569       10.4

%

Brian Pessin (7)

    3,812,569       10.4

%

 

*

Less than one percent.

   

(1)

Unless otherwise indicated, the address for each person listed above is: c/o LiqTech International A/S, Industriparken 22C 12, DK-2750 Ballerup, Denmark.

 

(2)

Under the rules and regulations of the SEC, beneficial ownership includes (i) shares actually owned, (ii) shares underlying options and warrants that are currently exercisable and (iii) shares underlying options and warrants that are exercisable within 60 days of March 23, 2017. All shares beneficially owned by a particular person under clauses (ii) and (iii) of the previous sentence are deemed to be outstanding for the purpose of computing the percentage ownership of that person but are not deemed outstanding for the purpose of computing the percentage ownership of any other person.

 

39

 

 

(3)

Based on 36,835,514 shares issued and outstanding as of March 23, 2017.

 

(4)

All of these shares are owned by Masu A/S, a Danish entity. Mr. Mathiesen controls the voting and disposition of the shares owned by Masu A/S

 

(5)

Includes 118,000 shares and 50,000 shares owned by LD Consulting ApS (former SHD Invest ApS) and LHD Invest ApS, respectively, each of which is a Danish entity. The voting and disposition of the shares owned by LD Consulting ApS and LHD Invest ApS are controlled by Mr. Degn. Includes 130,000 shares underlie a 10-year option immediately exercisable at an exercise price of $1.01 per share with expiration date December 11, 2025.

 

(6)

Includes 130,000 shares underlie a 10-year option immediately exercisable at an exercise price of $1.01 per share.

 

(7)

Includes 1,302,006 shares owned by Norman H. Pessin, 1,510,869 shares owned by Sandra F. Pessin and 999,694 shares owned by Brian Pessin.

 

We know of no arrangements, including pledges, by or among any of the forgoing persons, the operation of which could result in a change of control of us. 

  

Item 13.   Certain Relationships and Related Transactions, and Director Independence

 

Transactions with Related Persons

 

The following discussion relates to types of transactions involving our company and any of our executive officers, directors, director nominees or five percent stockholders, each of whom we refer to as a "related party." For purposes of this discussion, a "related-party transaction" is a transaction, arrangement or relationship:

 

     in which we participate;

 

     that involves an amount in excess of the lesser of $120,000; and

 

     in which a related party has a direct or indirect material interest.

 

From January 1, 2015 through the date of this Annual Report on Form 10-K, there have been no related-party transactions, except for the executive officer and director compensation arrangements described in the section "Executive Compensation" and as described below.

 

Effective January 1, 2014, LiqTech International, Inc. and Mr. Petersen entered into a Services Agreement whereby Mr. Petersen shall provide on-going services to us which shall include, without limitation, participation at road shows, general investor relations services, general work as Chairman of the Board and other services which are mutually agreeable by both parties on an ad hoc basis (collectively, the “Services”) in consideration for annual payments equal to DKK1,235,000, payable as follows:  (a) DKK205,833.34 representing payment for the Services for the months of January and February, 2014; and (b) DKK102,916.67 on the final business day of each month beginning on March 31, 2014 through the end of the term of this Agreement (i.e. December 31, 2014).  Except for the above-mentioned amounts, no amounts, bonus amounts or otherwise, shall be due and payable by us to Mr. Petersen in connection with the Services. We shall, at our sole cost and expense, provide Mr. Petersen with a laptop computer and a mobile telephone, including communication costs. Mr. Petersen shall utilize such items in furtherance of Mr. Petersen’s duties and obligations under the Services Agreement. The Services Agreement shall continue for an initial period of one (1) year and thereafter, shall be renewed automatically for subsequent one (1) year terms unless otherwise agreed to in writing by both parties or unless otherwise terminated in accordance with the terms of the Services Agreement.  We may terminate the Services Agreement at any time by providing twelve (12) months prior written notice of termination to Mr. Petersen, effective as of the date of delivery of said notice. The agreement is ongoing as of the date of filing.

 

During March 2015, an officer of LiqTech NA provided $25,000 in non-interest bearing advances to the Company. These advances were repaid in May 2015.

  

Policies and Procedures for Related Party Transactions

 

Any request for us to enter into a transaction with an executive officer, director, principal stockholder, or any of such persons’ immediate family members or affiliates, in which the amount involved exceeds $120,000 must first be presented to our audit committee for review, consideration and approval. All of our directors, executive officers and employees will be required to report to our audit committee any such related party transaction. In approving or rejecting the proposed agreement, our audit committee will consider the relevant facts and circumstances available and deemed relevant to the audit committee, including, but not limited to, the risks, costs and benefits to us, the terms of the transaction, the availability of other sources for comparable services or products, and, if applicable, the impact on a director’s independence. Our audit committee will approve only those agreements that, in light of known circumstances, are in, or are not inconsistent with, our best interests, as our audit committee determines in the good faith exercise of its discretion.

 

40

 

 

Item 14.   Principal Accountant Fees and Services

 

Audit and Audit-Related Fees

 

The aggregate fees billed or expected to be billed by our independent auditors for the audit of our annual consolidated financial statements for the year ended December 31, 2016, and 2015 and for the review of our quarterly financial statements. During 2016 and 2015 audit fees were $151,689 and $162,277. Our auditors did not provide any tax compliance, planning services. or audit related services for the Company. Our auditors did not provide any other services than those described above. 

 

Audit Committee Pre-approval

 

The policy of the Audit Committee is to pre-approve all audit and non-audit services provided by the independent accountants. These services may include audit services, audit-related services, tax fees, and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of services. The Audit Committee has delegated pre-approval authority to certain committee members when expedition of services is necessary. The independent accountants and management are required to periodically report to the full Audit Committee regarding the extent of services provided by the independent accountants in accordance with this pre-approval delegation, and the fees for the services performed to date. The Audit Committee approved all of the services described above in this Item 14 in advance during the fiscal year ended December 31, 2016. 

  

Item 15.    Exhibits and Financial Statement Schedules

 

(a)        Financial Statements and Schedules

 

The financial statements are set forth under Item 8 of this Annual Report. The following financial statement schedule for the years ended December 31, 2016 and December 31, 2015 is included in this Annual Report on Form 10-K:

 

a.         Valuation and Qualifying Accounts for the years ended December 31, 2016 and December 31, 2015.

 

   

Balance

Beginning

of Year

   

Charges to

Costs and

Expenses

   

Deductions

(1)

   

Balance

End of

Year

 

Year Ended December 31, 2016

                               

Allowance for inventory obsolescence

  $ 606,504     $ 824,958     $ (10,117

)

  $ 1,421,345  

Allowance for doubtful accounts

    1,087,871       1,437,949       (397,368

)

    2,128,452  

Totals

  $ 1,694,375     $ 2,262,907     $ (407,485

)

  $ 3,549,797  

 

   

Balance

Beginning

of Year

   

Charges to

Costs and

Expenses

   

Deductions

(1)

   

Balance

End of

Year

 

Year Ended December 31, 2015

                               

Allowance for inventory obsolescence

  $ 449,098     $ 174,143     $ (16,737

)

  $ 606,504  

Allowance for doubtful accounts

    1,654,290       (80,729

)

    (485,690

)

    1,087,871  

Totals

  $ 2,103,388     $ 93,414     $ (502,427

)

  $ 1,694,375  

  

   

2016

   

2015

 

Allowance for doubtful accounts at the beginning of the period

  $ 1,087,871     $ 1,654,290  

Bad debt expense

    1,437,949       80,729  

Amount of receivables written off

    (252,792

)

    (398,083

)

Effect of currency translation

    (144,576

)

    (249,065

)

Allowance for doubtful accounts at the end of the period

  $ 2,128,452     $ 1,087,871  

 

(1) Includes write-offs, the impact of foreign currency exchange rates and the effect of the acquisition of LiqTech Systems A/S. 

 

Schedules other than that listed above are omitted because the conditions requiring their filing do not exist or because the required information is provided in the Consolidated Financial Statements, including the Notes thereto. Financial statement schedules have been omitted since they are either not required, not applicable, or the information is otherwise included.

 

41

 

 

(b)           Exhibits

 

Exhibit No.

  

Description

  

Location

1.1

  

Placement Agency Agreement, dated March 2, 2012, by and between LiqTech International, Inc. and Sunrise Securities Corp.

  

Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on March 8, 2012

  

  

  

  

  

2.1

  

Agreement and Plan of Merger dated as of August 23, 2011 by and among Blue Moose Media, Inc., LiqTech USA, Inc. and BMD Sub

  

Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K/A as filed with the SEC on October 11, 2011

  

  

  

  

  

3.1

  

Articles of Incorporation

  

Incorporated by reference to Exhibit 3(i) to the Company’s Registration Statement on Form 10 (SEC Accession No. 0001078782-09-001287) as filed with the SEC on August 19, 2009

 

 

 

 

 

3.2

  

Certificate of Amendment to the Articles of Incorporation

  

Incorporated by reference to Exhibit A to the Company’s Information Statement on Schedule 14C as filed with the SEC on September 20, 2011

 

 

 

 

 

3.3

  

Bylaws

  

Incorporated by reference to Exhibit 3(ii) to the Company’s Registration Statement on Form 10 (SEC Accession No. 0001078782-09-001287) as filed with the SEC on August 19, 2009

  

  

  

  

  

4.1

  

Form of Common Stock Certificate

  

Incorporated by reference to Exhibit 4.1 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

  

  

  

  

  

4.2

  

Form of Warrant issued to Investors in the Private Placement

  

Incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K as filed with the SEC on August 25, 2011

         

4.3

  

Form of Warrant issued to Sunrise Securities Corp.

  

Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K as filed with the SEC on March 8, 2012

  

  

  

  

  

10.1

  

Form of Securities Purchase Agreement by and between LiqTech USA, Inc. and each of the investors in the Private Placement

  

Incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K as filed with the SEC on August 25, 2011

 

 

 

 

 

10.2

  

Employment Agreement dated July 29, 2011 between LiqTech A/S and Lasse Andreasson

  

Incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K/A as filed with the SEC on October 11, 2011 (translated in English)

  

  

  

  

  

10.3

  

Employment Agreement dated November 16, 2005 between LiqTech NA, Inc. and Donald S. Debelak

  

Incorporated by reference to Exhibit 10.3 to the Company’s Current Report on Form 8-K/A as filed with the SEC on October 11, 2011

  

  

  

  

  

10.4

  

Addendum to Employment Agreement, dated December 15, 2011, between LiqTech NA, Inc. and Donald S. Debelak

  

Incorporated by reference to Exhibit 10.4 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

 

42

 

 

10.5

  

Employment Agreement, dated July 29, 2011, between LiqTech International Inc. and Soren Degn (translated in English)

  

Incorporated by reference to Exhibit 10.5 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

  

  

  

  

  

10.6

  

Lease Agreements for 1800 - 1810 Buerkle Road, White Bear Lake, Minnesota 55110

  

Incorporated by reference to Exhibit 10.4 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011

  

  

  

  

  

10.7

  

Lease Agreement for 1800 - 1816 Buerkle Road, White Bear Lake, Minnesota 55110

  

Incorporated by reference to Exhibit 10.7 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

         

10.8

  

Lease Agreement for Grusbakken 12, DK-2820 Gentofte Denmark

  

Incorporated by reference to Exhibit 10.5 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)

  

  

  

  

  

10.9

  

Lease Agreement for Industriparken 22C, 2750 Ballerup, Denmark

  

Incorporated by reference to Exhibit 10.6 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)

  

  

  

  

  

10.10

  

DKK 6,000,000 Line of Credit Agreement, between LiqTech A/S and Sydbank A/S

  

Incorporated by reference to Exhibit 10.7 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)

  

  

  

  

  

10.11

  

DKK 3,000,000 Line of Credit Agreement, between LiqTech A/S and Sydbank A/S

  

Incorporated by reference to Exhibit 10.8 to the Company’s Current Report on Form 8-K/A as filed with the SEC on November 15, 2011 (translated in English)

  

  

  

  

  

10.12

  

Note Payable Agreement between LiqTech A/S and Sydbank A/S, for the principal amount of $475,000 USD

  

Incorporated by reference to Exhibit 10.9 to the Company’s Quarterly Report on Form 10-Q as filed with the SEC on November 15, 2011 (translated in English)

         

10.13

  

Form of Guarantee in respect of obligations of LiqTech A/S (translated in English)

  

Incorporated by reference to Exhibit 10.13 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

 

 

 

 

 

10.14

 

Form of Guarantee in respect of obligations of LiqTech International A/S (translated in English)

 

Incorporated by reference to Exhibit 10.14 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

         

10.15

  

Form of Guarantee in respect of obligations of LiqTech NA, Inc. (translated in English)

  

Incorporated by reference to Exhibit 10.15 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

  

  

  

  

  

10.16

  

Form of Promissory Note payable to certain related parties

  

Incorporated by reference to Exhibit 10.16 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

  

  

  

  

  

10.17

  

Business Mortgage of LiqTech A/S (translated in English)

  

Incorporated by reference to Exhibit 10.17 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

  

  

  

  

  

10.18

  

Business Mortgage of LiqTech International A/S (translated in English)

  

Incorporated by reference to Exhibit 10.18 to the Company’s Form 10-K as filed with the SEC on March 29, 2012

 

43

 

 

10.19

 

Bonus and Services Agreement, dated October 31, 2012, by and between the Company and Aldo Petersen

 

Incorporated by reference to Exhibit 10.19 to the Company’s Quarterly Report on Form 10-Q as filed with the SEC on November 14, 2012

 

 

 

 

 

10.20 

 

Agreement, dated March 25, 2013, by and among LiqTech International, Inc., LiqTech Denmark International and Mr. Lasse Andreassen.

 

Incorporated by reference to Exhibit 10.20 to the Company’s Form 10-K as filed with the SEC on March 27, 2013

 

 

 

 

 

10.21

  

Director Conract, dated March 27, 2013, by and between Mr. Finn Helmer and LiqTech Denmark International

 

Incorporated by reference to Exhibit 10.21 to the Company's Quarterly Report on Form 10-Q as filed with the SEC on May 15, 2013

  

  

 

  

  

10.22

 

Director Agreement, dated November 1, 2013, by and between LiqTech International A/S and Mr. Marcher

 

Incorporated by reference to Exhibit 10.22 to the Company's Annual Report on Form 10-K as filed with the SEC on March 27, 2014

 

 

 

 

 

10.23

 

Services Agreement, dated effective January 1, 2014, by and between LiqTech International, Inc. and Aldo Petersen

 

Incorporated by reference to Exhibit 10.23 to the Company's Annual Report on Form 10-K as filed with the SEC on March 27, 2014

         

10.24

 

Director Contract, dated July 29, 2014, by and between LiqTech International A/S and Sune Mathiesen

 

Incorporated by reference to Exhibit 10.2 to the Company's Current Report on Form 8-K as filed with the SEC on August 1, 2014

 

 

 

 

 

10.25

 

Securities Purchase Agreement, dated July 15, 2014 by and among LiqTech International A/S, a Danish company, LiqTech Systems  A/S, a Danish company and Masu A/S, a Danish company

 

Incorporated by reference to the Company’s Form 8-K as filed with the SEC on July 16, 2014

 

 

 

 

 

10.26

 

Form of Purchase Agreement (Craig-Hallum Capital Group LLC)

 

Incorporated by reference to the Company’s Form 8-K as filed with the SEC on July 23, 2014

 

 

 

 

 

10.27

 

Form of Underwriter’s Warrant (Craig-Hallum Capital Group LLC)

 

Incorporated by reference to the Company’s Form 8-K as filed with the SEC on July 23, 2014

 

 

 

 

 

10.28

 

Amended and Restated Employment Agreement, dated December 21, 2015 by and between LiqTech International, Inc. and Søren Degn

 

Incorporated by reference to the Company's Form 8-K as filed with the SEC on December 23, 2015

 

 

 

 

 

10.29   Contract for Yonker-Liqtech Equity Joint Venture by and between LiqTech International, Inc., and Hunan Yonker Water Co., Ltd., dated November 8, 2016   Incorporated by reference to the Company's Form 8-K as filed with the SEC on November 14, 2016
         
10.30   Agreement for the Purchase of Common Stock in LiqTech International, Inc., by and between Hunan Yonker Investment Group Co., Ltd, dated November 8, 2016   Incorporated by reference to the Company's Form 8-K as filed with the SEC on November 14, 2016
         
10.31   Amendment to the Letter of Intent between Liqtech International, Inc. and Kailong High Technology, Co., Ltd.   Incorporated by reference to the Company's Form 8-K as filed with the SEC on October 6, 2016
         
10.32  

Binding Letter of Intent between LiqTech International, Inc. and Kailong High Technology Co., Ltd.

  Incorporated by reference to the Company's Form 8-K as filed with the SEC on August 26, 2016

 

44

 

 

21

  

List of Subsidiaries

  

Filed herewith

  

  

  

  

  

31.1

  

Certifications of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  

Filed herewith

  

  

  

  

  

31.2

  

Certifications of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

  

Filed herewith

  

  

  

  

  

32.1

  

Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act Of 2002

  

Furnished herewith

  

  

  

  

  

32.2

  

Certification Pursuant To 18 U.S.C. Section 1350, As Adopted Pursuant To Section 906 of the Sarbanes-Oxley Act Of 2002

  

Furnished herewith

 

 

 

101. INS

  

XBRL Instance Document

  

Provided herewith

  

  

  

  

  

101. CAL

  

XBRL Taxonomy Extension Calculation Link base Document

  

Provided herewith

  

  

  

  

  

101. DEF

  

XBRL Taxonomy Extension Definition Link base Document

  

Provided herewith

  

  

  

  

  

101. LAB

  

XBRL Taxonomy Label Link base Document

  

Provided herewith

  

  

  

  

  

101. PRE

  

XBRL Extension Presentation Link base Document

  

Provided herewith

  

  

  

  

  

101. SCH

  

XBRL Taxonomy Extension Scheme Document

  

Provided herewith

 

45

 

 

SIGNATURES

 

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  

LIQTECH INTERNATIONAL, INC.

Date: March 30, 2017

  

  

  

By:

/s/ Sune Mathiesen

  

  

Sune Mathiesen 

Chief Executive Officer, Principal

Executive Officer and Director

 

In accordance with the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated on the dates indicated.

 

Signatures

  

Title

  

Date

  

  

  

  

  

/s/ Sune Mathiesen

  

Chief Executive Officer, Principal Executive Officer and Director

  

March 30, 2017

Sune Mathiesen 

  

 

  

  

 

 

 

 

 

  

  

  

  

  

/s/ Aldo Petersen

  

Chairman of the Board of Directors

  

March 30, 2017

Aldo Petersen

  

 

  

  

 

 

 

 

 

  

  

  

  

  

/s/ Soren Degn

  

Chief Financial Officer, Principal Financial and Accounting Officer

 

March 30, 2017

Soren Degn

  

 

  

  

 

 

 

 

 

  

  

  

  

  

/s/ Paul Burgon

  

Director

  

March 30, 2017

Paul Burgon

  

 

  

  

 

 

 

 

 

 

 

 

 

 

/s/ Mike Barish

  

Director

  

March 30, 2017

Mike Barish

  

 

  

  

 

 

 

 

 

 

 

 

 

 

/s/ Mark Vernon

  

Director

  

March 30, 2017

Mark Vernon

  

 

  

  

         
         
/s/ Rengarajan Ramesh   Director   March 30, 2017
Rengarajan Ramesh        

 

 

46

EX-21 2 ex21.htm EXHIBIT 21 ex21.htm

 

Exhibit 21

  

Subsidiaries

 

1) LiqTech USA, Inc., a Delaware corporation;

 

2) Liqtech A/S, a Danish limited company, organized under the Danish Act on Limited Companies of the Kingdom of Denmark;

 

3) LiqTech International A/S, a Danish limited company, organized under the Danish Act on Limited Companies of the Kingdom of Denmark;

 

4) Liqtech NA, Inc., a Delaware corporation; and

 

5) LiqTech Systems A/S, a Danish company

 

EX-31.1 3 ex31-1.htm EXHIBIT 31.1 ex31-1.htm

 

Exhibit 31.1

 

 

OFFICER’S CERTIFICATE

PURSUANT TO SECTION 302

 

I, Sune Mathiesen, certify that:

 

1.          I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2016 of Liqtech International, Inc.;

 

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.          I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)          Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)          Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.          The registrant’s other certifying officer (s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)          Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: March 30, 2017

By:

Sune Mathiesen  

 

Name:

Sune Mathiesen

 

Title:

Chief Executive Officer and Principal

Executive Officer

 

EX-31.2 4 ex31-2.htm EXHIBIT 31.2 ex31-2.htm

 

Exhibit 31.2

  

OFFICER’S CERTIFICATE

PURSUANT TO SECTION 302

 

I, Soren Degn, certify that:

 

1.          I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2016 of Liqtech International, Inc.;

 

2.          Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.          Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.          I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)          Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)          Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)          Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)          Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.          The registrant’s other certifying officer (s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)          All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

(b)         Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: March 30, 2017

By:

/s/ Soren Degn

 

Name:

Soren Degn

 

Title:

Chief Financial Officer and Principal

Financial and Accounting Officer

 

EX-32.1 5 ex32-1.htm EXHIBIT 32.1 ex32-1.htm

 

Exhibit 32.1

  

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Annual Report of Liqtech International, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2016 as filed with the U.S. Securities and Exchange Commission on the date hereof (the “ Report ”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1.          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: March 30, 2017

By:

/s/ Sune Mathiesen

 

Name:

Sune Mathiesen

 

Title:

Chief Executive Officer and Principal

Executive Officer

  

 

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its staff upon request.

 

EX-32.2 6 ex32-2.htm EXHIBIT 32.2 ex32-2.htm

 

Exhibit 32.2

  

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Annual Report of Liqtech International, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2016 as filed with the U.S. Securities and Exchange Commission on the date hereof (the “ Report ”), the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

1.          The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

 

2.          The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: March 30, 2017

By:

/s/ Soren Degn 

 

Name:

Soren Degn

 

Title:

Chief Financial Officer and Principal

Financial and Accounting Officer

  

 

A signed original of this written statement required by Section 906, or other document authentications, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the U.S. Securities and Exchange Commission or its staff upon request.

EX-101.INS 7 liqt-20161231.xml XBRL INSTANCE DOCUMENT false --12-31 FY 2016 2016-12-31 10-K 0001307579 36835514 Yes Smaller Reporting Company 14711188 LIQTECH INTERNATIONAL INC No No liqt 2696521 2696521 -2696521 -2696 2696 100000 133333 400000 125575 758908 0.81 1 1.65 4.06 1.82 125575 0.81 1 1.65 4.06 1.76 0.333 0.333 0.333 P1Y P1Y P2Y208D P65D P1Y233D -1517 1143 -5226 -8500 171615 4756013 12705 156036 -50452 -102092 -1000650 -517153 435794 369531 4 4 1 1 0.6 1 0.95 0.74 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Beginning</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">of Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Charges to</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Costs and</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expenses</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Deductions</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">(1)</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">End of</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">December 31, 2016</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for inventory obsolescence</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,504</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">824,958</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,117</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,421,345</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,437,949</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(397,368</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,128,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Totals</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,694,375</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,262,907</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(407,485</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,549,797</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Beginning</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">of Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Charges to</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Costs and</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expenses</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Deductions</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">(1)</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">End of</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">2015</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for inventory obsolescence</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">449,098</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">174,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(16,737</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,504</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,654,290</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(80,729</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(485,690</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Totals</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,103,388</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">93,414</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(502,427</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,694,375</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 0.25 2262688 3455085 1111759 3191858 580 570 2385586 1441840 9140320 8564882 -5691301 -5376605 36084117 36087808 391546 -391546 369531 435794 16834428 97258 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Advertising Cost</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Costs incurred in connection with advertising of the Company&#x2019;s products is expensed as incurred. Such costs amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,504</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$34,442,</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div></div></div></div></div> 14504 34442 435794 369531 77667 204500 50634 307493 154745 435794 369531 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the beginning of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,654,290</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Bad debt expense</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,437,949</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,729</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amount of receivables written off</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(252,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(398,083</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of currency translation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(144,576</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(249,065</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the end of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,128,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 1087871 1654290 2128452 252792 398083 -144576 -249065 4772 6322 868000 825575 1071000 7225575 11412328 28073546 8506321 12983004 0 0 5282 0 0 21838 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Business and Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The consolidated financial statements include the accounts of LiqTech International, Inc. (&#x201c;Parent&#x201d;) and its subsidiaries.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;The terms &quot;Company&quot;, &#x201c;us&quot;, &quot;we&quot; and &quot;our&quot; as used in this report refer to Parent and its subsidiaries, which are set forth below.&nbsp;The Company engages in the development, design, production, marketing and sale of automated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America.&nbsp;Set forth below is a description of Parent and each of its subsidiaries:</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech International, Inc., a Nevada corporation organized in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2004,</div> formerly known as Blue Moose Media, Inc.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011.</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech International AS, a Danish corporation, incorporated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2000</div> (&#x201c;LiqTech Int. DK&#x201d;), a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech NA, Inc. (&#x201c;LiqTech NA&#x201d;), incorporated in Delaware on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005,</div> a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> owned subsidiary of LiqTech USA. LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech Asia (&#x201c;LiqTech Asia&#x201d;) a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60%</div> owned subsidiary of LiqTech Int. DK, incorporated in South Korea on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006,</div> was a dormant subsidiary. The company was closed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech Germany (&#x201c;LiqTech Germany&#x201d;) a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> owned subsidiary of LiqTech Int. DK, incorporated in Germany on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> engages in marketing and sale of liquid filters in Germany. The Company is in the process of closing operations, which is expected to be completed during <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech PTE Ltd, (&#x201c;LiqTech Sing&#x201d;) a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">95%</div> owned subsidiary of LiqTech Int. DK, incorporated in Singapore on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> engages in marketing and sale of liquid filters in Singapore and other countries in the area. The Company is in the process of closing operations, which is expected to be completed during <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech Systems AS, a Danish Corporation (&quot;LiqTech Systems&quot;) (Formerly Provital Solutions A/S) was incorporated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of LiqTech Systems from the date of acquisition on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014.</div></div></div></div></div> 106375 175338 45883 150157 93942 165572 1240358 1302005 145356 121636 23720 0 5531 139825 1126550 1033062 1208650 1370591 5853752 -161941 -4483161 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Cash, Cash Equivalents and Restricted Cash</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company considers all highly liquid debt instruments purchased with a maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. The Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> balances held in a financial institution in the United States in excess of federally insured amounts at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company had cash balances of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$292,826</div> that are restricted to secure guarantees issued by the Company. The cash is restricted until the underlying guarantees are released.&nbsp;</div></div></div></div></div> 0 0 0.81 4.06 1 4.06 0.81 1 0.81 1 1.65 4.06 100000 200000 100000 200000 400000 125575 825575 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11</div>&nbsp;</div><div style="display: inline; font-weight: bold;">-&nbsp;AGREEMENTS, COMMITMENTS AND CONTINGENCIES</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">401(K)</div> Profit Sharing Plan</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;--&nbsp;LiqTech NA has a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">401(k)</div> profit sharing plan and trust covering certain eligible employees. The amount LiqTech NA contributes is discretionary. For the year ending <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> matching contributions were expensed and totaled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,347</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,610,</div> respectively.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Contingencies --</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> From time to time, we <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be involved in litigation relating to claims arising out of our operations in the normal course of business. </div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> Mr. Raffaele Bruno Tronchetti Provera (&#x201c;Plaintiff&#x201d;), the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60%</div> owner of LiqTech Italy s.r.l. (the &#x201c;Venture&#x201d;), sued LiqTech International A/S, the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40%</div> owner of the Venture (&#x201c;Defendant&#x201d;), <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">750,000</div> Euros before the Court of Como, Italy alleging, among other things, that certain products provided by Defendant to the Venture were defective.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp; As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> the case is in the preliminary stages where the court has appointed an expert in order to verify the quality of the products in order to determine whether there is sufficient evidence to proceed.&nbsp; An evaluation of the outcome will only be possible after the results of the court appointment expert are known.&nbsp;This outcome of the court appointment expert is expected to be reported in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> Defendant believes that the claims are without merit and intends to vigorously defend&nbsp;any litigation.</div></div> <div style=" margin: 0pt 7.5pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman,Times,serif; font-size: 10pt;">In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a guarantee line of DKK <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94,620</div> (approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$13,416</div> at <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016)</div> with a bank, subject to certain base limitations. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we&nbsp;had&nbsp;DKK <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94,620</div> (approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$13,416)</div>&nbsp;in working guarantee against the line.&nbsp;At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had a cash balance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$292,826</div> that is restricted to secure work issued by the Company that is not part of the above line of credit</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">.</div></div></div> 0.001 0.001 100000000 100000000 36835514 39532035 36835514 39532035 36836 39532 -16733330 -4728910 -16733330 -4728910 0.33 0.25 0.05 0.04 0.67 0.24 0.15 0.11 0.06 0.56 0.85 0.15 0.89 0.11 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Consolidation</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.</div></div></div></div></div> 12473965 12598163 642700 2519321 0 0 -329816 -266107 -329236 -265537 580 570 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div> </div><div style="display: inline; font-weight: bold;">- LINES OF CREDIT</div></div></div> <div style=" margin: 0pt; text-align: justify; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a guarantee line of DKK <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94,620</div> (approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$13,416</div> at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016)</div> with a bank, subject to certain base limitations. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> we&nbsp;had&nbsp;DKK <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">94,620</div> (approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$13,416)</div>&nbsp;in working guarantee against the line.&nbsp;This line of credit is guaranteed by V&aelig;kstfonden (the Danish State's investments fund) and is secured by certain assets of LiqTech Systems such as receivables, inventory and equipment. The Company has no other available lines of credit.</div></div></div> 9319 591 532 148561 590742 3548913 -432249 192597 117700 200118 154100 172122 3684497 4906974 4333820 11128000 6486000 437000 571000 30935 30935 8500 5450 3933 1202 14089 3542000 0 1095000 0 122000 118000 97000 109000 206770 4650182 228170 296227 452088 11347 14610 261553 252378 1373505 1437787 130025 141050 1378277 1444109 -0.45 -0.06 -0.45 -0.06 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Income (Loss) Per Share</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company calculates earnings (loss) per share in accordance with FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div> Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options and warrants that have been granted but have not been exercised.</div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13</div>&nbsp;</div><div style="display: inline; font-weight: bold;">-&nbsp;EARNINGS PER SHARE</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following data shows the amounts used in computing earnings per share and the effect on income and the weighted average number of shares of potential dilutive common stock for the year ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For the Year Ended </div><div style="display: inline; font-weight: bold;">December 31</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net Loss attributable to LiqTech International Inc.</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(16,418,634</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,209,857</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average number of common shares used in basic earnings per share</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,835,514</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,790,420</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of dilutive securities, stock options and warrants</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,835,514</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,790,420</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">For the year ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> Parent had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div> options outstanding to purchase common stock of Parent at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.74</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.90</div> per share and Parent had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">825,575</div>&nbsp;warrants outstanding to purchase common stock of Parent at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.81</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.06</div> per share, which were not included in the loss per share computation because their effect would be anti-dilutive.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> Parent had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,071,000</div> options outstanding to purchase common stock of Parent at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.74</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.90</div> per share and Parent had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,225,575</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;warrants outstanding to purchase common stock of Parent at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4.06</div> per share, which were not included in the loss per share computation because their effect would be anti-dilutive. The basic and diluted weighted average shares was restated to reflect the cancelation of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,696,521</div> shares held in escrow. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.</div> </div></div></div> -1376 -1576469 P1Y73D 105927 105927 35045 157080 0.6 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 55%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">As of <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">December 31, 2016</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 1</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 2</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 3</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Investments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,282</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,282</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div><div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 55%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">As of December 31, 201<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">5</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 1</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 2</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 3</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Investments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,838</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,838</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Fair Value of Financial Instruments</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">820.</div> The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px;"> <tr style="vertical-align: top;"> <td style="width: 9pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x25cf;</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Observable inputs such as quoted prices in active markets for identical assets or<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;liabilities;</div></div> </td> </tr> </table> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px;"> <tr style="vertical-align: top;"> <td style="width: 9pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x25cf;</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</div> </td> </tr> </table> <div style=" margin: 0pt;">&nbsp;</div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px;"> <tr style="vertical-align: top;"> <td style="width: 9pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x25cf;</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div> Unobservable inputs in which there is little or no market data, which require the<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;reporting entity to develop its own assumptions.</div></div> </td> </tr> </table> <div style=" margin: 0pt 7.7pt 0pt 42.9pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Unless otherwise disclosed, the fair value of the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.</div></div></div></div></div> P2Y P10Y P2Y P10Y 2699 645 2270 5614 -9555 459279 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Functional Currency / Foreign currency translation<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;--&nbsp;</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar.&nbsp;The Functional Currency of LiqTech Int. DK and LiqTech Systems AS is the Danish Krone (&#x201c;DKK&#x201d;), the functional currency of LiqTech Germany is the Euro, the functional currency of LiqTech Singapore is the Singapore Dollar and the functional Currency of LiqTech Asia is South Korean Won.&nbsp;The Company&#x2019;s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders&#x2019; equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.</div></div></div></div></div> -16621 7253 3997304 2814747 7582749 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Goodwill</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> -- Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recoverable. Triggering events that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.</div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Intangible Assets</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (&#x201c;FASB&#x201d;) Accounting Standards Codification, (&#x201c;ASC&#x201d;) Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,</div> &#x201c;Goodwill and Other Intangible Assets&#x201d; and amortized the patents on a straight line basis over the estimated useful life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years.&nbsp;</div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> </div><div style="display: inline; font-weight: bold;">- GOODWILL</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following is a summary of goodwill:</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill at beginning of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,582,749</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of currency translation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(239,541</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Impairment write down</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,343,208</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill at end of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill consists of:</div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">LiqTech Systems A/S (Formerly Provital Solutions A/S)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Goodwill is evaluated for impairment annually in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter of the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recoverable. Triggering events that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. Key variables included in evaluating goodwill for impairment include the pipeline of proposed potential customer sales, budgeted reoccurring sales, risk free interest rate and risk premium rate and future budgeted operating results. The Company recorded an impairment charge of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$7,343,208</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> on goodwill, during the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> as management's estimated fair value of the reporting unit did not exceeded the carrying value during <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter testing.&nbsp;</div></div></div> -239541 7343208 0 1432429 3214424 94620 13416 -13198957 -2886008 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12</div>&nbsp;</div><div style="display: inline; font-weight: bold;">-&nbsp;INCOME TAXES</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company accounts for income taxes in accordance with FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740,</div> Accounting for Income Taxes; which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carry forwards. The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s future earnings, and other future events, the effects of which cannot be determined. In accordance with prevailing accounting guidance, the Company is required to recognize and disclose any income tax uncertainties.&nbsp;The guidance provides a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>-step approach to recognizing and measuring tax benefits and liabilities when realization of the tax position is uncertain.&nbsp;The <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> step is to determine whether the tax position meets the more-likely-than-not condition for recognition and the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">second</div> step is to determine the amount to be recognized based on the cumulative probability that exceeds <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50%,</div> Actual results could differ from these estimates.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">As of <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had net operating loss carryovers of approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$11,128,000</div> for U.S. Federal purposes expiring through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2036;</div> approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6,486,000</div>&nbsp;for Danish tax purposes, which do not expire; approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$437,000</div> for German tax purposes, which do not expire and approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$571,000</div> for Singapore tax purposes which do not expire.&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 40pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company established a valuation allowance of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,542,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> for the tax components of LiqTech International Inc and Liqtech NA, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,095,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> for the tax components of LiqTech International AS and LiqTech Systems AS, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$122,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$118,000</div> for the tax component of&nbsp;LiqTech Germany and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$97,000</div>&nbsp;and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$109,000</div>&nbsp;for the tax component of LiqTech Singapore as management could not determine that it was more than likely not that sufficient income could be generated by these components to realize the resulting net operating loss carry forwards and other deferred tax assets of these components. &nbsp;The change in the valuation allowance for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$3,542,000,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,095,000,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$12,000</div> for the US, Danish, German and Singapore components. The change in the valuation allowance for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$118,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$109,000</div> for the US, Danish, German and Singapore components. </div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company is not relying on the reversal of deferred tax liabilities to realize the deferred tax assets. The same variable used by the Company in evaluating goodwill for impairment were used in assessing the realization of deferred tax assets (See Note <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8).</div> </div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company further considered the following positive and negative evidence:</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">Positive Evidence</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">) The Company had profitable <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">fourth</div> quarter results. The Company noted a significant increase in proposed sales pipeline from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> </div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">) The Company executed in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> a Diesel Particular Filtration supplier contract in China. </div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">) For Danish tax purposes the Company is able to obtain tax refunds for research and development expenditures</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; text-decoration: underline;">Negative Evidence<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1)</div> The Company has noted a longer than anticipated sales cycle from proposals to signing filtration systems order.</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2)</div> The Company has a net loss from operations for the year ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> </div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3)</div> The Company has experienced a decrease in l<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">iquid filter sales.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4)</div> The Company has experienced delays in requested shipment date of large DPF sales orders and collection of receivables from large water treatment systems.</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The temporary differences, tax credits and carry forwards gave rise to the following deferred tax asset (liabilities) at <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div><div style="display: inline; font-weight: bold;"> &nbsp;</div></div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-right: 5%;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 68%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vacation accrual</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,933</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful Accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,202</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,089</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Reserve for obsolete inventory</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200,118</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154,100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(206,770</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current tax assets</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">172,122</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Business tax credit carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,935</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,935</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred compensation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net operating loss carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,906,974</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,333,820</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Excess of book over tax depreciation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(296,227</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(452,088</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,650,182</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(228,170</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Long term deferred tax asset</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,684,497</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s effective rate is as follows&nbsp;for the years ended&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div>&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Computed tax at expected statutory rate</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,487,649</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(991,139</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">State and local income taxes, net of federal benefits</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,721</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(20,476</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible expenses</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,242</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,291</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-US income taxed at different rates</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,325,180</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47,837</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible deferred compensation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">148,170</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,175</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of changes in tax rates</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(21,489</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(31,748</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible impairment of goodwill</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,615,506</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible loss of subsidiaries</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,579</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,739,806</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">109,842</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other items</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(100,368</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,147</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,219,677</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(697,786</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The components of income tax expense (benefit) from continuing operations for the years ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> consisted of the following:</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current income tax expense:</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Danish</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(329,816</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(266,107</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Federal</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">State</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">580</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">570</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current tax (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(329,236</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(265,537</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Book in excess of tax depreciation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(158,684</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(136,572</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Business tax credit carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,226</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net operating loss carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,000,650</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(517,153</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,705</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">156,036</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,756,013</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accrued Vacation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,517</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred Compensation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">171,615</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Reserve for obsolete inventory</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(50,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(102,092</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax expense (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,548,913</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(432,249</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total tax expense (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,219,677</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(697,786</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> </table> </div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Deferred income tax expense / (benefit) results primarily from the reversal of temporary timing differences between tax and financial statement income.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company files Danish and U.S. federal and<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;Minnesota state income tax returns. LiqTech International AS is generally no longer subject to tax examinations for years prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2010</div> for their Danish tax returns. LiqTech NA is generally no longer subject to tax examinations for years prior to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012</div> for U.S. federal and U.S. states tax returns.&nbsp;</div></div></div> 3219677 -697786 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Income Taxes</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company accounts for income taxes in accordance with FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.</div></div></div></div></div> 4739806 109842 -21489 -31748 -50579 1325180 47837 -4487649 -991139 4242 5291 -158684 -136572 1615506 148170 140175 -100368 -8147 -3721 -20476 590 570 -1192386 1118143 1018643 -24671 -3856619 250523 1147934 175948 1807658 -1171325 57666 -49012 -841918 1280537 -292826 73947 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7</div>&nbsp;</div><div style="display: inline; font-weight: bold;">-&nbsp;DEFINITE-LIFE INTANGIBLE ASSETS</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">At <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> definite-life intangible assets, net of accumulated amortization, consisted of patents on the Company&#x2019;s products of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,614</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,386,</div> respectively. The patents are recorded at cost and amortized over <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years. Amortization expense for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$4,772</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$6,322,</div> respectively. Expected future amortization expense for the years ended are as follows:</div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 84%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year ending December 31,</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expenses</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2017</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,699</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2018</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2019</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">645</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">-</div></div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,614</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div></div> 5614 10386 968 98171 38945 51232 16758 26840 38945 51232 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4</div> </div><div style="display: inline; font-weight: bold;">- INVENTORY</div></div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Inventory consisted of the following at <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Furnace parts and supplies</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">336,799</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">466,538</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Raw materials</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,216,098</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,498,406</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Work in process</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,499,242</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,770,070</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finished goods and filtration systems</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,544,080</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,788,161</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Reserve for obsolescence</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,421,345</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(606,504</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net Inventory</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,174,874</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,916,671</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The inventory is held as collateral on a lines and credit and guarantees with financial institutions. See Note <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.</div></div></div></div> 2544080 1788161 5174874 4916671 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Inventory</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Inventory is carried at the lower of cost or market, as determined on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-in, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-out method.</div></div></div></div></div> 1216098 1498406 1421345 606504 2499242 1770070 802966 174143 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Long-Term Investments</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be more limited, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be as timely as and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.</div></div></div></div></div> 0 0 5282 0 0 21838 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6</div> </div><div style="display: inline; font-weight: bold;">&#x2013; INVESTMENTS AT COST</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The following tables summarize Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div> financial assets and financial (liabilities) by their classification in the Statement of Financial Position:</div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 55%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">As of <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">December 31, 2016</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 1</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 2</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 3</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Investments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,282</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,282</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;</div></div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 55%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">As of December 31, 201<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">5</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 1</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 2</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level 3</div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Investments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,838</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">21,838</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">At <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> our total investments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,282</div> consisted of an investment of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,282</div> in LEA Technology in France to strengthen our sales channels in the French market.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> our total investments of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$21,838</div> consisted of an investment of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$5,460</div> in LEA Technology in France to strengthen our sales channels in the French market and an investment of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$16,378</div> in LiqTech Italy, a newly organized Italian Company, to strengthen our sales channels in the Italian market.</div></div> 645817 697736 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></div><div style="display: inline; font-weight: bold;">&nbsp;-&nbsp;LEASES</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Operating Leases</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div> The Company leases office and production facilities under operating lease agreements expiring in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2021,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div> In some of these lease agreements, the Company has the right to extend.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year as of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> are as follows:</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year ending December 31,</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Lease</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Payments</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2017</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">559,058</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2018</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">457,735</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2019</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">179,094</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">395,898</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total Minimum Lease Payments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,591,785</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Lease expense charged to operations was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$645,817</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$697,736,</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Capital Leases</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company leases equipment on various variable rate capital leases currently calling for monthly payments of&nbsp;approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$9,319,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$591</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$532</div> expiring through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div> Included in property and equipment, at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company had recorded equipment on capital lease at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,240,358</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,302,005,</div> respectively, with related accumulated depreciation of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,126,550</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,033,062,</div> respectively.&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15pt 0pt 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">During the years ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> depreciation expense for equipment on capital lease amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$130,025,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$141,050,</div> respectively, and has been included in depreciation expense. During the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> interest expense on a capital lease obligation amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$16,758</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$26,840,</div> respectively.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Future minimum capital lease payments are as follows for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31:</div></div> <div style=" margin: 0pt; text-align: center; text-indent: 24.2pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year ending December 31,</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Lease</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Payments</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2017</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">121,636</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2018</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,720</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">-</div></div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total minimum lease payments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,356</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less amount representing interest</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,531</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Present value of minimum lease payments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">139,825</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less Current Portion</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,883</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">93,942</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div></div> 5142580 5506262 11412328 28073546 5008743 5340690 133837 165572 94620 13416 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Accounts Receivable</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company&#x2019;s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence.&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The roll forward of the allowance for doubtful accounts for the year ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> is as follows:</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the beginning of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,654,290</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Bad debt expense</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,437,949</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,729</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amount of receivables written off</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(252,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(398,083</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of currency translation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(144,576</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(249,065</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the end of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,128,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div></div></div></div> 39895 750000 0.4 -202619 -223072 -373740 -592656 415794 -2090964 -2209857 -16418634 -16418634 -2209857 21635 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Financial Accounting Standards Board (FASB) issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB agreed to delay the effective date by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year; accordingly, the new standard is effective for us beginning in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and we expect to adopt it at that time. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method, nor have we determined the impact of the new standard on our consolidated financial statements.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued an amended standard requiring that we classify all deferred tax assets and liabilities as non-current on the balance sheet instead of separating deferred taxes into current and non-current. The amended standard is effective for us beginning in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017;</div> early adoption is permitted and we are evaluating whether we will early adopt. The amended standard <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be adopted on either a prospective or retrospective basis. We do not expect that the adoption of this standard will have a significant impact on our financial position or results of operations.</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued changes to the accounting for leases that primarily affect presentation and disclosure requirements. The new standard will require the recognition of a right to use asset and underlying lease liability for operating leases with an initial life in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. This standard is effective for us beginning in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> We have not yet determined the impact of the new standard on our consolidated financial statements.</div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> Disclosure of Uncertainties About an Entity<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s Ability to Continue as a Going Concern, that will require management to assess an entity&#x2019;s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. In connection with each annual and interim period, management will assess if there is substantial doubt about an entity&#x2019;s ability to continue as a going concern within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year after the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year after the issuance date. The new standard defines substantial doubt and provides example indicators. Disclosures will be required if conditions give rise to substantial doubt. However, management will need to assess if its plans will alleviate substantial doubt to determine the specific disclosures. This standard is effective for public entities for annual periods ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Earlier application of this standard is permitted. This standard is not expected to have a material effect on the Company&#x2019;s financial position, results of operations and cash flows.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which changes how companies account for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled, allows an employer to repurchase more of an employee<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s shares than previously allowed for tax withholding purposes without triggering liability accounting, allows a company to make a policy election to account for forfeitures as they occur, and eliminates the requirement that excess tax benefits be realized before companies can recognize them. The new guidance also requires excess tax benefits and tax shortfalls to be presented on the cash flow statement as an operating activity rather than as a financing activity, and clarifies that cash paid to a tax authority when shares are withheld to satisfy its statutory income tax withholding obligation are to be presented as a financing activity. The standard is effective for financial statements issued for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods within those fiscal years. Early adoption is permitted. This standard is not expected to have a material effect on the Company&#x2019;s financial position, results of operations and cash flows.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s present or future financial statements.&nbsp;</div></div></div></div></div> 81643 -64153 513471 15034 14567233 6613903 -13134804 -3399479 1591785 559058 179094 457735 395898 272449 11551848 -2540688 -16717 -314696 -314696 -2540688 336799 466538 5282 5282 21838 5460 16378 306177 505945 1263722 16378 373740 576278 62161 13670 10736278 -16418634 -2188222 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div>&nbsp;</div><div style="display: inline; font-weight: bold;">-&nbsp;PROPERTY AND EQUIPMENT</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Property and equipment consisted of the following at <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="3" style="width: 44%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Useful Life</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Production equipment</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,370,462</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,536,377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Lab equipment</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,658</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">143,783</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Computer equipment</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">185,652</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269,526</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vehicles</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,090</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,365</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Furniture and fixture</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">146,453</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141,502</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Leasehold improvements</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">955,563</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">972,023</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,773,878</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,103,576</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Less Accumulated Depreciation</div> </td> <td style="width: 1%;">&nbsp;</td> <td style="width: 4%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,140,320</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,564,882</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net Property and Equipment</div> </td> <td style="width: 1%;">&nbsp;</td> <td style="width: 4%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,633,558</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,538,694</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15.2pt 0pt 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Depreciation expense amounted to $<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,373,505</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,437,787,</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively. The property and equipment is held as collateral on a lines of credit and guarantees with financial institutions. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9.</div></div></div></div> 10370462 10536377 76658 143783 185652 269526 39090 40365 146453 141502 955563 972023 11773878 12103576 2633558 3538694 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Property and Equipment</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets, which range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years (See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5).</div></div></div></div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="3" style="width: 44%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Useful Life</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Production equipment</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,370,462</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,536,377</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Lab equipment</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76,658</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">143,783</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Computer equipment</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">185,652</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">269,526</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vehicles</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;3</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,090</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">40,365</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Furniture and fixture</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">146,453</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">141,502</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Leasehold improvements</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">955,563</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">972,023</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 4%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,773,878</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,103,576</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Less Accumulated Depreciation</div> </td> <td style="width: 1%;">&nbsp;</td> <td style="width: 4%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(9,140,320</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,564,882</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 56%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net Property and Equipment</div> </td> <td style="width: 1%;">&nbsp;</td> <td style="width: 4%;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 4%; text-align: right;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,633,558</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,538,694</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> P3Y P10Y P3Y P10Y P3Y P10Y P3Y P5Y P3Y P5Y P5Y P10Y 1437949 80729 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For the Year Ended</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Ceramic diesel particulate</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,820,793</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,081,304</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Liquid filters</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,731,079</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,347,010</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Kiln furniture</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">354,522</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">384,273</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,906,394</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,812,587</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 25000 35000 60000 25000 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3</div>&nbsp;</div><div style="display: inline; font-weight: bold;">-&nbsp;RELATED PARTY TRANSACTIONS</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> October</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> an officer of LiqTech NA provided <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$25,000</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$35,000</div> in non-interest bearing advances to the Company totaling <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$60,000.</div> These advances have been included in accounts payable at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> and were repaid in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> an officer of LiqTech NA provided <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$25,000</div> in non-interest bearing advances to the Company. These advances were repaid in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div> 175905 223072 26714 626147 707844 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Research and Development Cost</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company expenses research and development costs for the development of new products as incurred. Included in operating expense for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$626,147,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$707,844,</div> respectively, of research and development costs.</div></div></div></div></div> 0 292826 292826 -24011343 -7592709 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Revenue Recognition and Sales Incentives</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">101,</div> &#x201c;Revenue Recognition in Financial Statements&#x201d; (SAB <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">101),</div> FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div> Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collections of resulting receivable is reasonably assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company has received long-term contracts for the installation of various water filtrations systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long-term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long-term contract or grant multiplied by the long-term contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Project costs of the long-term contracts and grants include<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;all&nbsp;direct material and labor costs and those indirect costs related to the&nbsp;project.&nbsp;Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In Denmark, Value Added Tax (&#x201c;VAT&#x201d;) of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div></div></div></div> 689766 1521718 387807 382883 115675 2400000 1105272 1139090 11607874 10368896 13906394 15812587 5820793 5081304 7731079 10347010 354522 384273 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">2016</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current income tax expense:</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Danish</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(329,816</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(266,107</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Federal</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">State</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">580</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">570</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Current tax (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(329,236</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(265,537</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 12%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Book in excess of tax depreciation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(158,684</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(136,572</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Business tax credit carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,226</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net operating loss carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,000,650</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(517,153</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">12,705</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">156,036</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,756,013</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Accrued Vacation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,517</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred Compensation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">171,615</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Reserve for obsolete inventory</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(50,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(102,092</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred tax expense (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,548,913</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(432,249</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total tax expense (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,219,677</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(697,786</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-right: 5%;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 68%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vacation accrual</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,450</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,933</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful Accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,202</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,089</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Reserve for obsolete inventory</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200,118</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">154,100</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(206,770</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net current tax assets</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">172,122</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Business tax credit carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,935</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,935</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deferred compensation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,500</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net operating loss carryover</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,906,974</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,333,820</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Excess of book over tax depreciation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(296,227</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(452,088</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,650,182</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(228,170</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Long term deferred tax asset</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,684,497</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Computed tax at expected statutory rate</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(4,487,649</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(991,139</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">State and local income taxes, net of federal benefits</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(3,721</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(20,476</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible expenses</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,242</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,291</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-US income taxed at different rates</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,325,180</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47,837</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible deferred compensation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">148,170</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">140,175</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of changes in tax rates</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(21,489</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(31,748</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible impairment of goodwill</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,615,506</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Non-deductible loss of subsidiaries</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">50,579</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Valuation Allowance</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,739,806</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">109,842</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Other items</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(100,368</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(8,147</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Income tax expense (benefit)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,219,677</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(697,786</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year ending December 31,</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Lease</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Payments</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2017</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">121,636</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2018</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">23,720</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">-</div></div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total minimum lease payments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">145,356</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less amount representing interest</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(5,531</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Present value of minimum lease payments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">139,825</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Less Current Portion</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(45,883</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">93,942</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year ending December 31,</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Lease</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Payments</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2017</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">559,058</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2018</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">457,735</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2019</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">179,094</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">395,898</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total Minimum Lease Payments</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,591,785</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill at beginning of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,582,749</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of currency translation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(239,541</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Impairment write down</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(7,343,208</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill at end of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 85%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Goodwill consists of:</div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31,</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> <td>&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">LiqTech Systems A/S (Formerly Provital Solutions A/S)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Furnace parts and supplies</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">336,799</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">466,538</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Raw materials</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,216,098</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,498,406</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Work in process</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,499,242</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,770,070</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Finished goods and filtration systems</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,544,080</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,788,161</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Reserve for obsolescence</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1,421,345</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(606,504</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net Inventory</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,174,874</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,916,671</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For the Year Ended December 31</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">United States and Canada</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">689,766</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,521,718</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Australia</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">387,807</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">382,883</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">South America</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115,675</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,400,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Asia</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,105,272</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,139,090</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Europe</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,607,874</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,368,896</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,906,394</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,812,587</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 13%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="10" style="width: 21474836.47%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Outstanding</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="width: 114111%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Exercisable</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Prices</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Life (years)</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercisable</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.74</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.62</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.74</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">133,334</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.74</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.75</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.29</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.75</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,333</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.75</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">130,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.97</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">130,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.01</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.90</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238,000</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.08</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.90</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238,000</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.90</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.41</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,10</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,667</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.32</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="3" style="width: 55%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">LiqTech</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">International, Inc.</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expected term (in years)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;5</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Volatility</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;74.65%</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">to</div></td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76.87%</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Risk free interest rate</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;1.38%</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.24%</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dividend yield</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0%</div></td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="10" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Warrants Outstanding</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Warrants Exercisable</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise Prices</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual Life</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">(years)</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average </div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercisable</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">133,333</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.65</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.57</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.65</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.65</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.06</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">125,575</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.18</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.06</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">125,575</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.06</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">825,575</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.64</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.76</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">758,908</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.82</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The financial statements are set forth under Item<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8</div> of this Annual Report. The following financial statement schedule for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> is included in this Annual Report on Form <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div>-K:</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">a.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Valuation and Qualifying Accounts for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div></div> <div style=" margin: 0pt; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Beginning</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">of Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Charges to</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Costs and</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expenses</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Deductions</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">(1)</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">End of</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">December 31, 2016</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for inventory obsolescence</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,504</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">824,958</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(10,117</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,421,345</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,437,949</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(397,368</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,128,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Totals</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,694,375</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,262,907</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(407,485</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3,549,797</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Beginning</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">of Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Charges to</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Costs and</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expenses</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Deductions</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">(1)</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Balance</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">End of</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Year</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 48%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Year Ended December 31, <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">2015</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for inventory obsolescence</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">449,098</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">174,143</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(16,737</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">606,504</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Allowance for doubtful accounts</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,654,290</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(80,729</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(485,690</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 18pt;">Totals</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,103,388</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">93,414</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(502,427</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,694,375</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 74%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 74%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the beginning of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,654,290</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 74%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Bad debt expense</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,437,949</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,729</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 74%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amount of receivables written off</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(252,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(398,083</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 74%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of currency translation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(144,576</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(249,065</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 74%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the end of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,128,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 10%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(1)</div> Includes write-offs, the impact of foreign currency exchange rates and the effect of the acquisition of LiqTech Systems A/S.&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.5pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Schedules other than that listed above are omitted because the conditions requiring their filing do not exist or because the required information is provided in the Consolidated Financial Statements, including the Notes thereto. Financial statement schedules have been omitted since they are either not required, not applicable, or the information is otherwise included.</div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For the Year Ended </div><div style="display: inline; font-weight: bold;">December 31</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Net Loss attributable to LiqTech International Inc.</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(16,418,634</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2,209,857</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average number of common shares used in basic earnings per share</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,835,514</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,790,420</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of dilutive securities, stock options and warrants</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,835,514</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,790,420</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 84%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: thin; border-bottom-style: solid;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="display: inline; font-weight: bold;">Year ending December 31,</div></div> </td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Amortization</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Expenses</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2017</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,699</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2018</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,270</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">2019</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">645</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Thereafter</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-weight: bold;">-</div></div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,614</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15</div>&nbsp;</div><div style="display: inline; font-weight: bold;">-&nbsp;SIGNIFICANT CUSTOMERS / CONCENTRATION</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> largest customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4%,</div> respectively, of our net sales (approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">67</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">% in total). For the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> our <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">four</div> largest customers accounted for approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">24%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6%,</div> respectively, of our net sales (approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">56%</div> in total).</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company sells products<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;throughout the world; sales by geographical region are as follows for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For the Year Ended December 31</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">United States and Canada</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">689,766</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,521,718</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Australia</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">387,807</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">382,883</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">South America</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">115,675</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,400,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Asia</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,105,272</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,139,090</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Europe</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11,607,874</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,368,896</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,906,394</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,812,587</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s sales by product line are as follows for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015:</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">For the Year Ended</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December 31</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Ceramic diesel particulate</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,820,793</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5,081,304</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Liquid filters</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">7,731,079</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10,347,010</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Kiln furniture</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">354,522</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">384,273</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,906,394</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,812,587</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">85%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15%</div> of the Company&#x2019;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">s assets were located in Denmark and the United States, respectively.&nbsp;As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">89%</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">11%</div> of the Company&#x2019;s assets were located in Denmark and the United States, respectively</div></div></div> 2164780 2721781 435794 369531 307493 154745 77667 204500 50634 10286 27253 33333 33333 33334 33333 33333 33334 66667 0 0.7465 0.7687 0.0138 0.0224 534667 1.32 238000 203000 868000 0 868000 1071000 868000 0.74 1.90 0.74 1.90 1.19 1.10 0 <div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="margin: 0pt; text-indent: 0px; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="14" style="width: 21474836.47%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">3</div><div style="display: inline; font-weight: bold;">1</div><div style="display: inline; font-weight: bold;">, 2016</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Life</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 2%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Intrinsic</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Value</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 32%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 2%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at beginning of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,071,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.19</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.93</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(203,000</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.59</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expired</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at end of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.10</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.41</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested and expected to vest</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.10</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.41</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable end of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,667</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.32</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.32</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table></div> 868000 1.10 1.50 1.59 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Stock Options and Awards</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Companies have granted stock options to certain key employees. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.</div> During the years presented in the accompanying consolidated financial statements, the Company has granted stock options and awards. The Company accounts for options in accordance with the provisions of FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,</div> Compensation &#x2013; Stock Compensation. Non-cash compensation costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$435,794</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$369,531</div> have been recognized for the vesting of options and stock awards granted to employees with an associated recognized tax benefit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$35,045</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$157,080</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div></div></div></div></div> 133334 33333 130000 238000 534667 400000 100000 130000 238000 868000 0.74 0.75 1.01 1.90 1.50 P5Y P10Y 0 P3Y116D 333333 0.46 P3Y339D P3Y149D P3Y149D 0.74 0.75 1.01 1.90 3.32 0.74 0.75 1.01 1.90 110 P3Y226D P3Y105D P8Y354D P29D P3Y149D 39404782 39532035 36835514 0.75 0.74 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1</div> - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Business and Basis of Presentation</div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The consolidated financial statements include the accounts of LiqTech International, Inc. (&#x201c;Parent&#x201d;) and its subsidiaries.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;The terms &quot;Company&quot;, &#x201c;us&quot;, &quot;we&quot; and &quot;our&quot; as used in this report refer to Parent and its subsidiaries, which are set forth below.&nbsp;The Company engages in the development, design, production, marketing and sale of automated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America.&nbsp;Set forth below is a description of Parent and each of its subsidiaries:</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech International, Inc., a Nevada corporation organized in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2004,</div> formerly known as Blue Moose Media, Inc.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011.</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech International AS, a Danish corporation, incorporated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2000</div> (&#x201c;LiqTech Int. DK&#x201d;), a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech NA, Inc. (&#x201c;LiqTech NA&#x201d;), incorporated in Delaware on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2005,</div> a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> owned subsidiary of LiqTech USA. LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech Asia (&#x201c;LiqTech Asia&#x201d;) a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">60%</div> owned subsidiary of LiqTech Int. DK, incorporated in South Korea on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">20,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2006,</div> was a dormant subsidiary. The company was closed on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech Germany (&#x201c;LiqTech Germany&#x201d;) a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100%</div> owned subsidiary of LiqTech Int. DK, incorporated in Germany on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> engages in marketing and sale of liquid filters in Germany. The Company is in the process of closing operations, which is expected to be completed during <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech PTE Ltd, (&#x201c;LiqTech Sing&#x201d;) a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">95%</div> owned subsidiary of LiqTech Int. DK, incorporated in Singapore on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">19,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2012,</div> engages in marketing and sale of liquid filters in Singapore and other countries in the area. The Company is in the process of closing operations, which is expected to be completed during <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">LiqTech Systems AS, a Danish Corporation (&quot;LiqTech Systems&quot;) (Formerly Provital Solutions A/S) was incorporated on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> September</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2009</div> and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of LiqTech Systems from the date of acquisition on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Consolidation</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Functional Currency / Foreign currency translation<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;--&nbsp;</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar.&nbsp;The Functional Currency of LiqTech Int. DK and LiqTech Systems AS is the Danish Krone (&#x201c;DKK&#x201d;), the functional currency of LiqTech Germany is the Euro, the functional currency of LiqTech Singapore is the Singapore Dollar and the functional Currency of LiqTech Asia is South Korean Won.&nbsp;The Company&#x2019;s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders&#x2019; equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Cash, Cash Equivalents and Restricted Cash</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company considers all highly liquid debt instruments purchased with a maturity of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> months or less to be cash equivalents. The Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">no</div></div> balances held in a financial institution in the United States in excess of federally insured amounts at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015.</div> At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company had cash balances of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$292,826</div> that are restricted to secure guarantees issued by the Company. The cash is restricted until the underlying guarantees are released.&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Accounts Receivable</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company&#x2019;s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence.&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The roll forward of the allowance for doubtful accounts for the year ended <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> is as follows:</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">6</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">5</div></div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 70%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the beginning of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,654,290</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Bad debt expense</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,437,949</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">80,729</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Amount of receivables written off</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(252,792</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(398,083</div></td> <td nowrap="nowrap" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Effect of currency translation</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(144,576</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(249,065</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Allowance for doubtful accounts at the end of the period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,128,452</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 12%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,087,871</div></td> <td nowrap="nowrap" style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Inventory</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Inventory is carried at the lower of cost or market, as determined on the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-in, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div>-out method.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Property and Equipment</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets, which range from <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years (See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">5).</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Long-Term Investments</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be more limited, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be as timely as and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Intangible Assets</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (&#x201c;FASB&#x201d;) Accounting Standards Codification, (&#x201c;ASC&#x201d;) Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">350,</div> &#x201c;Goodwill and Other Intangible Assets&#x201d; and amortized the patents on a straight line basis over the estimated useful life of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div> to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">ten</div> years.&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Goodwill</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> -- Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> not be recoverable. Triggering events that <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Revenue Recognition and Sales Incentives</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No. <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">101,</div> &#x201c;Revenue Recognition in Financial Statements&#x201d; (SAB <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">101),</div> FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">605</div> Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collections of resulting receivable is reasonably assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company has received long-term contracts for the installation of various water filtrations systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long-term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long-term contract or grant multiplied by the long-term contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Project costs of the long-term contracts and grants include<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;all&nbsp;direct material and labor costs and those indirect costs related to the&nbsp;project.&nbsp;Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In Denmark, Value Added Tax (&#x201c;VAT&#x201d;) of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">25%</div> of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Advertising Cost</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;Costs incurred in connection with advertising of the Company&#x2019;s products is expensed as incurred. Such costs amounted to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$14,504</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$34,442,</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Research and Development Cost</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company expenses research and development costs for the development of new products as incurred. Included in operating expense for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$626,147,</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$707,844,</div> respectively, of research and development costs.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Income Taxes</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company accounts for income taxes in accordance with FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">740</div> Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Income (Loss) Per Share</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company calculates earnings (loss) per share in accordance with FASB ASC <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">260</div> Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options and warrants that have been granted but have not been exercised.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Stock Options and Awards</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Companies have granted stock options to certain key employees. See Note <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14.</div> During the years presented in the accompanying consolidated financial statements, the Company has granted stock options and awards. The Company accounts for options in accordance with the provisions of FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">718,</div> Compensation &#x2013; Stock Compensation. Non-cash compensation costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$435,794</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$369,531</div> have been recognized for the vesting of options and stock awards granted to employees with an associated recognized tax benefit of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$35,045</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$157,080</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Fair Value of Financial Instruments</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">820.</div> The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">three</div>-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px;"> <tr style="vertical-align: top;"> <td style="width: 9pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x25cf;</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.</div> Observable inputs such as quoted prices in active markets for identical assets or<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;liabilities;</div></div> </td> </tr> </table> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;</div></div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px;"> <tr style="vertical-align: top;"> <td style="width: 9pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x25cf;</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.</div> Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and</div> </td> </tr> </table> <div style=" margin: 0pt;">&nbsp;</div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px;"> <tr style="vertical-align: top;"> <td style="width: 9pt;">&nbsp;</td> <td style="width: 18pt;"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x25cf;</div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">Level <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.</div> Unobservable inputs in which there is little or no market data, which require the<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;reporting entity to develop its own assumptions.</div></div> </td> </tr> </table> <div style=" margin: 0pt 7.7pt 0pt 42.9pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Unless otherwise disclosed, the fair value of the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 52.8pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Accounting Estimates</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets allowance for doubtful accounts receivable, cost in excess of billings, reserve for obsolete inventory, depreciation and impairment of property plant and equipment and impairment of goodwill and liabilities billings in excess of cost commitment and contingencies, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Recent Accounting Pronouncements</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> May</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Financial Accounting Standards Board (FASB) issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">9</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB agreed to delay the effective date by <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year; accordingly, the new standard is effective for us beginning in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018</div> and we expect to adopt it at that time. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method, nor have we determined the impact of the new standard on our consolidated financial statements.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the FASB issued an amended standard requiring that we classify all deferred tax assets and liabilities as non-current on the balance sheet instead of separating deferred taxes into current and non-current. The amended standard is effective for us beginning in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017;</div> early adoption is permitted and we are evaluating whether we will early adopt. The amended standard <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> be adopted on either a prospective or retrospective basis. We do not expect that the adoption of this standard will have a significant impact on our financial position or results of operations.</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued changes to the accounting for leases that primarily affect presentation and disclosure requirements. The new standard will require the recognition of a right to use asset and underlying lease liability for operating leases with an initial life in excess of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year. This standard is effective for us beginning in the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2019.</div> We have not yet determined the impact of the new standard on our consolidated financial statements.</div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> Disclosure of Uncertainties About an Entity<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s Ability to Continue as a Going Concern, that will require management to assess an entity&#x2019;s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. In connection with each annual and interim period, management will assess if there is substantial doubt about an entity&#x2019;s ability to continue as a going concern within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year after the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> year after the issuance date. The new standard defines substantial doubt and provides example indicators. Disclosures will be required if conditions give rise to substantial doubt. However, management will need to assess if its plans will alleviate substantial doubt to determine the specific disclosures. This standard is effective for public entities for annual periods ending after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> Earlier application of this standard is permitted. This standard is not expected to have a material effect on the Company&#x2019;s financial position, results of operations and cash flows.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the FASB issued ASU <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">09,</div> Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which changes how companies account for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled, allows an employer to repurchase more of an employee<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s shares than previously allowed for tax withholding purposes without triggering liability accounting, allows a company to make a policy election to account for forfeitures as they occur, and eliminates the requirement that excess tax benefits be realized before companies can recognize them. The new guidance also requires excess tax benefits and tax shortfalls to be presented on the cash flow statement as an operating activity rather than as a financing activity, and clarifies that cash paid to a tax authority when shares are withheld to satisfy its statutory income tax withholding obligation are to be presented as a financing activity. The standard is effective for financial statements issued for fiscal years beginning after <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and interim periods within those fiscal years. Early adoption is permitted. This standard is not expected to have a material effect on the Company&#x2019;s financial position, results of operations and cash flows.</div></div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s present or future financial statements.&nbsp;</div></div></div> 4044782 47500 8000000 100000 27253 27253 100000 100000 47500 100 74900 -75000 27 20140 -20167 33000 -33000 20167 75000 158000 -31188 31188 -39387 39387 39405 35632410 -5382852 -2835917 -504748 16717 39532 36087808 -7592709 -5376605 -590742 0 36836 36084117 -24011343 -5691301 -148561 0 6269748 22567284 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE </div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14</div> </div><div style="display: inline; font-weight: bold;">- STOCKHOLDERS' EQUITY</div></div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Common Stock --</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> Parent has <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000,000</div> authorized shares of common stock, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.001</div> par value. As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively, there were <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">36,835,514</div></div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">39,532,035</div></div> common shares issued and outstanding.<div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;"> &nbsp;&nbsp;</div></div> &nbsp;&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Voting</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> --</div> Holders of Parent common stock are entitled to <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> vote for each share held of record on each matter submitted to a vote of stockholders, including the election of directors, and do not have any right to cumulate votes in the election of directors.&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Dividends</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> --</div> Subject to the rights and preferences of the holders of any series of preferred stock which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> at the time be outstanding, holders of Parent common stock are entitled to receive ratably such dividends as our Board of Directors from time to time <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> declare out of funds legally available.&nbsp;&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Liquidation Rights</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> --</div> In the event of any liquidation, dissolution or winding-up of affairs of Parent, after payment of all of our debts and liabilities and subject to the rights and preferences of the holders of any outstanding shares of any series of our preferred stock, the holders of Parent common stock will be entitled to share ratably in the distribution of any of our remaining assets.&nbsp;&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Other Matters</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> --</div> Holders of Parent common stock have no conversion, preemptive or other subscription rights, and there are no redemption rights or sinking fund provisions with respect to the common stock. All of the issued and outstanding shares of common stock on the date of this report are validly issued, fully paid and non-assessable.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic;">Preferred Stock</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;--</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"> Our Board of Directors has the authority to issue Parent preferred stock in <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">one</div> or more classes or series and to fix the designations, powers, preferences and rights,&nbsp;the qualifications, limitations or restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series, without further vote or action by the stockholders. The issuance of Parent preferred stock <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> have the effect of delaying, deferring or preventing a change in control of us without further action by the stockholders and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> may</div> adversely affect the voting and other rights of the holders of common stock.</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman,Times,serif; font-size: 10pt;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Common Stock Cancelation</div></div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company canceled <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2,696,521</div> common shares <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">two</div>-<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">thirds</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(2/3)</div> of the previously issued common shares held in escrow issued in connection with the Company through its subsidiary, LiqTech Int. DK, acquisition of all of the issued and outstanding capital stock of Provital Solutions A/S, as Provital Solutions A/S failed to meet the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> catchup gross revenue and EBITDA thresholds for release from escrow.</div> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">&nbsp;</div> <div style=" margin: 0pt 15.2pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Common Stock Issuanc</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">e</div></div></div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">14,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company issued an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,253</div> shares of restricted stock valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$20,167</div> for services provided and to be provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">27,253</div> shares vested on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div></div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> April</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">13,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company issued an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div> shares of restricted stock valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$75,000</div> for services provided and to be provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,333</div> shares vested on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,333</div> shares will vest on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,334</div> shares will vest on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> January</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div></div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">During the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">third</div> quarter <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47,500</div> shares of common stock in connection with the exercise of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">47,500</div> stock options with an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.50</div> each.</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">29,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the &#x201c;Shares&#x201d;) of LiqTech Systems and as part of the consideration for the LiqTech Systems Shares, the Company issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,044,782</div> of Parent<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s common shares.&nbsp;</div></div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> July</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">28,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> Parent completed a registered public offering of its common stock.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;As part of the closing, Parent issued <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8,000,000</div> shares of common stock at a per share price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.50</div> and generated net proceeds of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$10,736,278</div> net of offering costs of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1,263,722.</div>&nbsp;&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">During <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> the Company issued an additional <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div> shares of restricted stock valued at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$158,000</div> for services provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,333</div> shares vested on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2014,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,333</div> shares will vest on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,334</div> shares will vest on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016.</div> <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 7.7pt 0pt 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">As of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company has recorded non-cash compensation expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$77,667</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$204,500</div> relating to the awards, respectively.&nbsp;&nbsp;&nbsp;</div></div> <div style=" margin: 0pt 15.2pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15.2pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Common Stock Purchase Warrants</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">A summary of the status of the warrants outstanding at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> is presented below:</div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="10" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Warrants Outstanding</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Warrants Exercisable</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise Prices</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual Life</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">(years)</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average </div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercisable</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.81</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">133,333</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.00</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.65</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.57</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.65</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.65</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.06</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">125,575</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.18</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.06</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">125,575</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4.06</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">825,575</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.64</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.76</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">758,908</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 9%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.82</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt 19.8pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">At <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">66,667</div> non-vested warrants. We have recorded non-cash compensation expense&nbsp;of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$50,634</div> for the year ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> related to the warrants issued.</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The exercise price of the warrants and the number of shares underlying the warrants are subject to adjustment for stock dividends, subdivisions of the outstanding shares of common stock and combinations of the outstanding shares of common stock. For so long as the warrants remain outstanding, we are required to keep reserved from our authorized and unissued shares of common stock a sufficient number of shares to provide for the issuance of the shares underlying the warrants.</div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> February</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">15,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company issued to <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">a consultant a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div> shares at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.81</div> per share. The warrants are exercisable immediately and will remain exercisable until <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 60.5pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">On <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> the Company issued to Wolfe Axelrod Weinberger Associates, LLC a warrant to purchase <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">200,000</div> shares at an exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$1.00</div> per share. The warrants<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;vested <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1/3</div> upon issuance, <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1/3</div> on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">4,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1/3</div> will vest&nbsp;on <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> June</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017,</div> and will remain exercisable until <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div>&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt 15.2pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Stock Options</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">In <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> August</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2011,</div> Parent<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s Board of Directors adopted a Stock Option Plan (the &#x201c;Plan&#x201d;). Under the terms and conditions of the Plan, the Board of Directors is empowered to grant stock options to employees, officers, and directors of the Company.&nbsp;At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div></div> options were granted and outstanding under the Plan.&nbsp;</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company recognizes compensation costs for stock option awards to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average assumptions used to estimate the fair values of the stock options granted using the Black-Scholes option-pricing model are as follows:</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="3" style="width: 55%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">LiqTech</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">International, Inc.</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expected term (in years)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;5</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">10</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Volatility</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;74.65%</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">to</div></td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">76.87%</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Risk free interest rate</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;1.38%</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2.24%</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 83%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Dividend yield</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 5%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 5%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0%</div></td> <td style="width: 5%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">&nbsp;</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"></div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company recognized stock based compensation expense<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;related to the options of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$307,493</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$154,745</div> for the years ended <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015,</div> respectively. At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> the Company had approximately <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$105,927</div> of unrecognized compensation cost related to non-vested options expected to be recognized through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2018.</div></div></div> <div style=" margin: 0pt 22.7pt 0pt 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">A summary of the status of the options outstanding under the Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s stock option plans at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2015</div> is presented below:&nbsp;</div></div> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table style="; text-indent: 0px; font-family: Times New Roman, Times, serif; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 13%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">&nbsp;</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="10" style="width: 21474836.47%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Outstanding</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="6" style="width: 114111%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Options Exercisable</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td colspan="2" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Prices</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Outstanding</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Contractual</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Life (years)</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Number</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercisable</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.74</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">400,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.62</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.74</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">133,334</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.74</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.75</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">100,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.29</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.75</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">33,333</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.75</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.01</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">130,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">8.97</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.01</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">130,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.01</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">$</td> <td style="width: 13%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.90</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238,000</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0.08</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.90</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238,000</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.90</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td colspan="2" style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> </div><div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Total</div> </td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.41</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,10</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,667</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.32</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">A summary of the status of the options at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016,</div> and changes during the period is presented below:</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div> <table style="margin: 0pt; text-indent: 0px; font-size: 10pt;" cellspacing="0" cellpadding="0" border="0"> <tr style="vertical-align: bottom;"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="14" style="width: 21474836.47%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">December</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"> </div><div style="display: inline; font-weight: bold;">3</div><div style="display: inline; font-weight: bold;">1</div><div style="display: inline; font-weight: bold;">, 2016</div></div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Shares</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Exercise</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Price</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 1%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Remaining</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Life</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td colspan="2" style="width: 2%; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Weighted</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Average</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Intrinsic</div></div></div> <div style=" margin: 0pt; text-align: center; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-weight: bold;">Value</div></div></div> </td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> </tr> <tr style="vertical-align: bottom;"> <td style="width: 32%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> <td style="width: 2%;">&nbsp;</td> <td style="width: 14%;">&nbsp;</td> <td style="width: 1%;">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at beginning of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1,071,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.19</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.93</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Granted</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercised</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Forfeited</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">(203,000</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap"> <div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">)</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.59</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Expired</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">-</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Outstanding at end of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.10</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.41</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Vested and expected to vest</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">868,000</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.10</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.41</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1px; border-bottom-style: solid;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td style="width: 1%; padding-bottom: 1px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="width: 32%; font-family: Times New Roman, Times, serif; font-size: 10pt;"> <div style=" font-family: Times New Roman, Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Exercisable end of period</div> </td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">534,667</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.32</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">&nbsp;</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">3.32</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> <td style="width: 1%; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</td> <td style="width: 2%; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;">$</td> <td style="width: 14%; text-align: right; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 3px; border-bottom-style: double;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">0</div></td> <td style="width: 1%; padding-bottom: 3px; font-family: Times New Roman, Times, serif; font-size: 10pt; margin-left: 0pt;" nowrap="nowrap">&nbsp;</td> </tr> </table> </div> <div style=" margin: 0pt 7.7pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">At <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">201</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">6,</div> the Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">333,333</div> non-vested options with a weighted average exercise price of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.74</div> and with a weighted average grant date fair value of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.46,</div> resulting in unrecognized compensation expense of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$105,927,</div> which is expected to be expensed over a weighted-average period of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">1.2</div> years.</div></div> <div style=" margin: 0pt 7.7pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 50.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The total intrinsic value of options at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> was <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">$0.</div>&nbsp;Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> December</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">31,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2016</div> (for outstanding options), less the applicable exercise price.&nbsp;</div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">16</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;-&nbsp;SUBSEQUENT EVENT</div></div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company had <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">238,000</div> options and <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">125,575</div> warrants expire unexercised during the <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">first</div> quarter of <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The Company<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&#x2019;s management reviewed material events through <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;"> March</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">30,</div> <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2017.</div>&nbsp;</div></div></div> <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">NOTE <div style="display: inline; font-style: italic; font-weight: inherit; font-style: normal;">2</div> - GOING CONCERN</div></div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div> <div style=" margin: 0pt; text-align: left; text-indent: 49.6pt; font-family: Times New Roman, Times, serif; font-size: 10pt;">The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has limited cash and incurred significant recent losses. These factors raise substantial doubt about the ability of the Company to continue as a going concern. There is no assurance that the Company will be successful in raising additional cash through the issuance of debt or equity instruments or return to achieving profitable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.<div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;</div></div></div> -16556 <div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" margin: 0pt; text-align: left; text-indent: 48.4pt; font-family: Times New Roman, Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Accounting Estimates</div><div style="display: inline; font-family: Times New Roman, Times, serif; font-size: 10pt;">&nbsp;<div style="display: inline; font-weight: bold;">--</div>&nbsp;The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets allowance for doubtful accounts receivable, cost in excess of billings, reserve for obsolete inventory, depreciation and impairment of property plant and equipment and impairment of goodwill and liabilities billings in excess of cost commitment and contingencies, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.</div></div></div></div></div> 3542000 1095000 4000 12000 0 0 118000 109000 606504 1421345 1087871 2128452 1694375 3549797 449098 1654290 2103388 824958 1437949 2262907 174143 -80729 93414 -10117 -397368 -407485 -16737 -485690 -502427 0 36835514 36790420 36835514 36790420 Includes write-offs, the impact of foreign currency exchange rates and the effect of the acquisition of LiqTech Systems A/S. xbrli:shares xbrli:pure iso4217:USD iso4217:DKK iso4217:USD xbrli:shares iso4217:EUR 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember liqt:VestingOnDecember312014Member 2014-01-01 2014-12-31 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember liqt:VestingOnDecember312015Member 2014-01-01 2014-12-31 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember liqt:VestingOnDecember312016Member 2014-01-01 2014-12-31 0001307579 us-gaap:AccountsPayableAndAccruedLiabilitiesMember liqt:AdvanceFromRelatedPartyMember us-gaap:OfficerMember 2014-01-01 2014-12-31 0001307579 us-gaap:DirectorMember 2014-01-01 2014-12-31 0001307579 2014-07-01 2014-09-30 0001307579 2014-07-28 2014-07-28 0001307579 liqt:ProvitalAcquisitionMember 2014-07-29 2014-07-29 0001307579 liqt:LiqTechItalyMember us-gaap:ChiefExecutiveOfficerMember 2014-09-09 2014-09-09 0001307579 us-gaap:AccountsPayableAndAccruedLiabilitiesMember liqt:AdvanceFromRelatedPartyMember us-gaap:OfficerMember 2014-10-01 2014-10-31 0001307579 us-gaap:AccountsPayableAndAccruedLiabilitiesMember liqt:AdvanceFromRelatedPartyMember us-gaap:OfficerMember 2014-12-01 2014-12-31 0001307579 2015-01-01 2015-12-31 0001307579 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-12-31 0001307579 us-gaap:WarrantMember 2015-01-01 2015-12-31 0001307579 us-gaap:EmployeeStockOptionMember 2015-01-01 2015-12-31 0001307579 us-gaap:EmployeeStockOptionMember liqt:TwoThousandElevenStockOptionsPlanMember 2015-01-01 2015-12-31 0001307579 us-gaap:RestrictedStockMember 2015-01-01 2015-12-31 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2015-01-01 2015-12-31 0001307579 liqt:WarrantsIssuedForServicesMember 2015-01-01 2015-12-31 0001307579 us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember country:DK 2015-01-01 2015-12-31 0001307579 us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember country:US 2015-01-01 2015-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2015-01-01 2015-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer1Member 2015-01-01 2015-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer2Member 2015-01-01 2015-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer3Member 2015-01-01 2015-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer4Member 2015-01-01 2015-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember country:AU 2015-01-01 2015-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember us-gaap:AsiaMember 2015-01-01 2015-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember us-gaap:EuropeMember 2015-01-01 2015-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember us-gaap:SouthAmericaMember 2015-01-01 2015-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember liqt:USAndCanadaMember 2015-01-01 2015-12-31 0001307579 us-gaap:PatentsMember 2015-01-01 2015-12-31 0001307579 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2015-01-01 2015-12-31 0001307579 us-gaap:ForeignCountryMember liqt:DanishMinistryOfTaxationMember 2015-01-01 2015-12-31 0001307579 us-gaap:ForeignCountryMember liqt:GermanMinistryOfTaxationMember 2015-01-01 2015-12-31 0001307579 us-gaap:ForeignCountryMember liqt:SingaporeMinistryOfTaxationMember 2015-01-01 2015-12-31 0001307579 liqt:DanishMinistryOfTaxationMember 2015-01-01 2015-12-31 0001307579 liqt:CeramicDieselParticulateMember 2015-01-01 2015-12-31 0001307579 liqt:KilnFurnitureMember 2015-01-01 2015-12-31 0001307579 liqt:LiquidFiltersMember 2015-01-01 2015-12-31 0001307579 us-gaap:AssetsHeldUnderCapitalLeasesMember 2015-01-01 2015-12-31 0001307579 liqt:PriceRange1Member 2015-01-01 2015-12-31 0001307579 liqt:PriceRange2Member 2015-01-01 2015-12-31 0001307579 liqt:PriceRange3Member 2015-01-01 2015-12-31 0001307579 liqt:PriceRange4Member 2015-01-01 2015-12-31 0001307579 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-01-01 2015-12-31 0001307579 us-gaap:AccumulatedOtherComprehensiveIncomeMember liqt:IssuedForServicesProvidedAndToBeProvided1Member 2015-01-01 2015-12-31 0001307579 us-gaap:AccumulatedOtherComprehensiveIncomeMember liqt:IssuedForServicesProvidedAndToBeProvided2Member 2015-01-01 2015-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember 2015-01-01 2015-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember liqt:IssuedForServicesProvidedAndToBeProvided1Member 2015-01-01 2015-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember liqt:IssuedForServicesProvidedAndToBeProvided2Member 2015-01-01 2015-12-31 0001307579 us-gaap:CommonStockMember 2015-01-01 2015-12-31 0001307579 us-gaap:CommonStockMember liqt:IssuedForServicesProvidedAndToBeProvided1Member 2015-01-01 2015-12-31 0001307579 us-gaap:CommonStockMember liqt:IssuedForServicesProvidedAndToBeProvided2Member 2015-01-01 2015-12-31 0001307579 us-gaap:DeferredCompensationShareBasedPaymentsMember 2015-01-01 2015-12-31 0001307579 us-gaap:DeferredCompensationShareBasedPaymentsMember liqt:IssuedForServicesProvidedAndToBeProvided1Member 2015-01-01 2015-12-31 0001307579 us-gaap:DeferredCompensationShareBasedPaymentsMember liqt:IssuedForServicesProvidedAndToBeProvided2Member 2015-01-01 2015-12-31 0001307579 us-gaap:NoncontrollingInterestMember 2015-01-01 2015-12-31 0001307579 us-gaap:NoncontrollingInterestMember liqt:IssuedForServicesProvidedAndToBeProvided1Member 2015-01-01 2015-12-31 0001307579 us-gaap:NoncontrollingInterestMember liqt:IssuedForServicesProvidedAndToBeProvided2Member 2015-01-01 2015-12-31 0001307579 us-gaap:RetainedEarningsMember 2015-01-01 2015-12-31 0001307579 us-gaap:RetainedEarningsMember liqt:IssuedForServicesProvidedAndToBeProvided1Member 2015-01-01 2015-12-31 0001307579 us-gaap:RetainedEarningsMember liqt:IssuedForServicesProvidedAndToBeProvided2Member 2015-01-01 2015-12-31 0001307579 us-gaap:AllowanceForDoubtfulAccountsMember 2015-01-01 2015-12-31 0001307579 us-gaap:InventoryValuationReserveMember 2015-01-01 2015-12-31 0001307579 us-gaap:AccountsPayableAndAccruedLiabilitiesMember liqt:AdvanceFromRelatedPartyMember us-gaap:OfficerMember 2015-03-01 2015-03-31 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember liqt:VestingOnJanuary12016Member 2015-04-13 2015-04-13 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember liqt:VestingOnJanuary12017Member 2015-04-13 2015-04-13 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember liqt:VestingOnJanuary12018Member 2015-04-13 2015-04-13 0001307579 us-gaap:DirectorMember 2015-04-13 2015-04-13 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember liqt:VestingOnJanuary12016Member 2015-04-14 2015-04-14 0001307579 us-gaap:DirectorMember 2015-08-14 2015-08-14 0001307579 2016-01-01 2016-12-12 0001307579 us-gaap:WarrantMember 2016-01-01 2016-12-30 0001307579 2016-01-01 2016-12-31 0001307579 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001307579 us-gaap:WarrantMember 2016-01-01 2016-12-31 0001307579 us-gaap:EmployeeStockOptionMember 2016-01-01 2016-12-31 0001307579 us-gaap:EmployeeStockOptionMember liqt:TwoThousandElevenStockOptionsPlanMember 2016-01-01 2016-12-31 0001307579 us-gaap:RestrictedStockMember 2016-01-01 2016-12-31 0001307579 us-gaap:RestrictedStockMember us-gaap:DirectorMember 2016-01-01 2016-12-31 0001307579 liqt:WarrantsIssuedForServicesMember 2016-01-01 2016-12-31 0001307579 liqt:Warrant1Member 2016-01-01 2016-12-31 0001307579 liqt:Warrant2Member 2016-01-01 2016-12-31 0001307579 liqt:Warrants3Member 2016-01-01 2016-12-31 0001307579 liqt:Warrants4Member 2016-01-01 2016-12-31 0001307579 us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember country:DK 2016-01-01 2016-12-31 0001307579 us-gaap:AssetsTotalMember us-gaap:GeographicConcentrationRiskMember country:US 2016-01-01 2016-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2016-01-01 2016-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer1Member 2016-01-01 2016-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer2Member 2016-01-01 2016-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer3Member 2016-01-01 2016-12-31 0001307579 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember liqt:MajorCustomer4Member 2016-01-01 2016-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember country:AU 2016-01-01 2016-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember us-gaap:AsiaMember 2016-01-01 2016-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember us-gaap:EuropeMember 2016-01-01 2016-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember us-gaap:SouthAmericaMember 2016-01-01 2016-12-31 0001307579 us-gaap:ReportableGeographicalComponentsMember liqt:USAndCanadaMember 2016-01-01 2016-12-31 0001307579 us-gaap:PatentsMember 2016-01-01 2016-12-31 0001307579 us-gaap:PatentsMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0001307579 us-gaap:PatentsMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0001307579 us-gaap:DomesticCountryMember us-gaap:InternalRevenueServiceIRSMember 2016-01-01 2016-12-31 0001307579 us-gaap:ForeignCountryMember liqt:DanishMinistryOfTaxationMember 2016-01-01 2016-12-31 0001307579 us-gaap:ForeignCountryMember liqt:GermanMinistryOfTaxationMember 2016-01-01 2016-12-31 0001307579 us-gaap:ForeignCountryMember liqt:SingaporeMinistryOfTaxationMember 2016-01-01 2016-12-31 0001307579 liqt:DanishMinistryOfTaxationMember 2016-01-01 2016-12-31 0001307579 liqt:CapitalLease1Member us-gaap:CapitalLeaseObligationsMember 2016-01-01 2016-12-31 0001307579 liqt:CapitalLease2Member us-gaap:CapitalLeaseObligationsMember 2016-01-01 2016-12-31 0001307579 liqt:CapitalLease3Member us-gaap:CapitalLeaseObligationsMember 2016-01-01 2016-12-31 0001307579 liqt:TwoThousandElevenStockOptionsPlanMember 2016-01-01 2016-12-31 0001307579 liqt:CeramicDieselParticulateMember 2016-01-01 2016-12-31 0001307579 liqt:KilnFurnitureMember 2016-01-01 2016-12-31 0001307579 liqt:LiquidFiltersMember 2016-01-01 2016-12-31 0001307579 us-gaap:AssetsHeldUnderCapitalLeasesMember 2016-01-01 2016-12-31 0001307579 us-gaap:ComputerEquipmentMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0001307579 us-gaap:ComputerEquipmentMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0001307579 us-gaap:FurnitureAndFixturesMember 2016-01-01 2016-12-31 0001307579 liqt:LabEquipmentMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0001307579 liqt:LabEquipmentMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0001307579 us-gaap:LeaseholdImprovementsMember 2016-01-01 2016-12-31 0001307579 liqt:ProductionEquipmentMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0001307579 liqt:ProductionEquipmentMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0001307579 us-gaap:VehiclesMember us-gaap:MaximumMember 2016-01-01 2016-12-31 0001307579 us-gaap:VehiclesMember us-gaap:MinimumMember 2016-01-01 2016-12-31 0001307579 us-gaap:MaximumMember 2016-01-01 2016-12-31 0001307579 us-gaap:MinimumMember 2016-01-01 2016-12-31 0001307579 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-01-01 2016-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember 2016-01-01 2016-12-31 0001307579 us-gaap:CommonStockMember 2016-01-01 2016-12-31 0001307579 us-gaap:DeferredCompensationShareBasedPaymentsMember 2016-01-01 2016-12-31 0001307579 us-gaap:NoncontrollingInterestMember 2016-01-01 2016-12-31 0001307579 us-gaap:RetainedEarningsMember 2016-01-01 2016-12-31 0001307579 us-gaap:WarrantMember 2016-01-01 2016-12-31 0001307579 country:DK 2016-01-01 2016-12-31 0001307579 us-gaap:AllowanceForDoubtfulAccountsMember 2016-01-01 2016-12-31 0001307579 us-gaap:InventoryValuationReserveMember 2016-01-01 2016-12-31 0001307579 us-gaap:ScenarioForecastMember 2017-01-01 2017-03-31 0001307579 2014-07-28 0001307579 liqt:LiqTechItalyMember us-gaap:ChiefExecutiveOfficerMember 2014-09-09 0001307579 2014-12-31 0001307579 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2014-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember 2014-12-31 0001307579 us-gaap:CommonStockMember 2014-12-31 0001307579 us-gaap:DeferredCompensationShareBasedPaymentsMember 2014-12-31 0001307579 us-gaap:NoncontrollingInterestMember 2014-12-31 0001307579 us-gaap:RetainedEarningsMember 2014-12-31 0001307579 us-gaap:AllowanceForDoubtfulAccountsMember 2014-12-31 0001307579 us-gaap:InventoryValuationReserveMember 2014-12-31 0001307579 liqt:WolfeAxelrodWeinbergerAssociatesLlcMember 2015-06-04 0001307579 liqt:WolfeAxelrodWeinbergerAssociatesLlcMember liqt:VestingOnJune42016Member 2015-06-04 0001307579 liqt:WolfeAxelrodWeinbergerAssociatesLlcMember liqt:VestingOnJune42017Member 2015-06-04 0001307579 liqt:WolfeAxelrodWeinbergerAssociatesLlcMember liqt:VestingUponIssuanceMember 2015-06-04 0001307579 2015-12-31 0001307579 us-gaap:FairValueInputsLevel1Member 2015-12-31 0001307579 us-gaap:FairValueInputsLevel2Member 2015-12-31 0001307579 us-gaap:FairValueInputsLevel3Member 2015-12-31 0001307579 liqt:LEATechnologyMember 2015-12-31 0001307579 liqt:LiqTechItalyMember 2015-12-31 0001307579 liqt:LiqTechGermanyMember 2015-12-31 0001307579 liqt:LiqTechInternationalASAndLiqTechSystemsASMember 2015-12-31 0001307579 liqt:LiqTechInternationalAndLiqTechNAMember 2015-12-31 0001307579 liqt:LiqTechSingaporeMember 2015-12-31 0001307579 us-gaap:ComputerEquipmentMember 2015-12-31 0001307579 us-gaap:FurnitureAndFixturesMember 2015-12-31 0001307579 liqt:LabEquipmentMember 2015-12-31 0001307579 us-gaap:LeaseholdImprovementsMember 2015-12-31 0001307579 liqt:ProductionEquipmentMember 2015-12-31 0001307579 us-gaap:VehiclesMember 2015-12-31 0001307579 us-gaap:MaximumMember 2015-12-31 0001307579 us-gaap:MinimumMember 2015-12-31 0001307579 liqt:PriceRange1Member 2015-12-31 0001307579 liqt:PriceRange2Member 2015-12-31 0001307579 liqt:PriceRange3Member 2015-12-31 0001307579 liqt:PriceRange4Member 2015-12-31 0001307579 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2015-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember 2015-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember liqt:IssuedForServicesProvidedAndToBeProvided1Member 2015-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember liqt:IssuedForServicesProvidedAndToBeProvided2Member 2015-12-31 0001307579 us-gaap:CommonStockMember 2015-12-31 0001307579 us-gaap:DeferredCompensationShareBasedPaymentsMember 2015-12-31 0001307579 us-gaap:NoncontrollingInterestMember 2015-12-31 0001307579 us-gaap:RetainedEarningsMember 2015-12-31 0001307579 us-gaap:AllowanceForDoubtfulAccountsMember 2015-12-31 0001307579 us-gaap:InventoryValuationReserveMember 2015-12-31 0001307579 liqt:LCLFinanceLimitedMember 2016-02-15 0001307579 2016-06-30 0001307579 2016-12-31 0001307579 liqt:LiqTechSystemsASMember 2016-12-31 0001307579 liqt:Warrant1Member 2016-12-31 0001307579 liqt:Warrant2Member 2016-12-31 0001307579 liqt:Warrants3Member 2016-12-31 0001307579 liqt:Warrants4Member 2016-12-31 0001307579 liqt:LiqTechAsiaMember liqt:LiqTechInternationalDKMember 2016-12-31 0001307579 liqt:LiqTechGermanyMember liqt:LiqTechInternationalDKMember 2016-12-31 0001307579 liqt:LiqTechInternationalDKMember liqt:LiqTechUSAMember 2016-12-31 0001307579 liqt:LiqTechNAMember liqt:LiqTechUSAMember 2016-12-31 0001307579 liqt:LiqTechPTEMember liqt:LiqTechInternationalDKMember 2016-12-31 0001307579 us-gaap:FairValueInputsLevel1Member 2016-12-31 0001307579 us-gaap:FairValueInputsLevel2Member 2016-12-31 0001307579 us-gaap:FairValueInputsLevel3Member 2016-12-31 0001307579 us-gaap:FederalMinistryOfFinanceGermanyMember country:DE 2016-12-31 0001307579 us-gaap:FederalMinistryOfFinanceGermanyMember liqt:DanishMinistryOfTaxationMember 2016-12-31 0001307579 us-gaap:FederalMinistryOfFinanceGermanyMember country:SG 2016-12-31 0001307579 liqt:LEATechnologyMember 2016-12-31 0001307579 liqt:LiqTechGermanyMember 2016-12-31 0001307579 liqt:LiqTechInternationalASAndLiqTechSystemsASMember 2016-12-31 0001307579 liqt:LiqTechInternationalAndLiqTechNAMember 2016-12-31 0001307579 liqt:LiqTechSingaporeMember 2016-12-31 0001307579 liqt:TwoThousandElevenStockOptionsPlanMember 2016-12-31 0001307579 us-gaap:ComputerEquipmentMember 2016-12-31 0001307579 us-gaap:FurnitureAndFixturesMember 2016-12-31 0001307579 liqt:LabEquipmentMember 2016-12-31 0001307579 us-gaap:LeaseholdImprovementsMember 2016-12-31 0001307579 liqt:ProductionEquipmentMember 2016-12-31 0001307579 us-gaap:VehiclesMember 2016-12-31 0001307579 us-gaap:MaximumMember 2016-12-31 0001307579 us-gaap:MinimumMember 2016-12-31 0001307579 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2016-12-31 0001307579 us-gaap:AdditionalPaidInCapitalMember 2016-12-31 0001307579 us-gaap:CommonStockMember 2016-12-31 0001307579 us-gaap:DeferredCompensationShareBasedPaymentsMember 2016-12-31 0001307579 us-gaap:NoncontrollingInterestMember 2016-12-31 0001307579 us-gaap:RetainedEarningsMember 2016-12-31 0001307579 us-gaap:AllowanceForDoubtfulAccountsMember 2016-12-31 0001307579 us-gaap:InventoryValuationReserveMember 2016-12-31 0001307579 2017-03-23 EX-101.SCH 8 liqt-20161231.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Consolidated Balance Sheets link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Consolidated Balance Sheets (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Consolidated Statements of Operations link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Consolidated Statements of Other Comprehensive Income link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Consolidated Statement of Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 006 - Statement - Consolidated Statement of Stockholders' Equity (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 007 - Statement - Consolidated Statements of Cash Flows link:calculationLink link:definitionLink link:presentationLink 008 - Statement - Consolidated Statements of Cash Flows (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 1 - Summary of Significant Accounting Policies link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 2 - Going Concern link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 3 - Related Party Transactions link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 4 - Inventory link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 5 - Property and Equipment link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 6 - Investments at Costs link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 7 - Definite-life Intangible Assets link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 8 - Goodwill link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 9 - Lines of Credit link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 10 - Leases link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 11 - Agreements and Commitments link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 12 - Income Taxes link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 13 - Earnings Per Share link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Note 14 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 15 - Significant Customers / Concentration link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 16 - Subsequent Event link:calculationLink link:definitionLink link:presentationLink 025 - Document - Schedule II - Valuation and Qualifying Accounts link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 4 - Inventory (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 5 - Property and Equipment (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 6 - Investments at Costs (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 7 - Definite-life Intangible Assets (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 8 - Goodwill (Tables) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 10 - Leases (Tables) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 12 - Income Taxes (Tables) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 13 - Earnings Per Share (Tables) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 14 - Stockholders' Equity (Tables) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 15 - Significant Customers / Concentration (Tables) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Rollforward for Allowance for Doubtful Accounts (Details) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 3 - Related Party Transactions (Details Textual) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 4 - Inventory - Schedule of Inventory (Details) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 5 - Property and Equipment (Details Textual) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 5 - Property and Equipment - Schedule of Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 6 - Investments at Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 6 - Investments at Costs - Summary of Financial Assets and Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 7 - Definite-life Intangible Assets (Details Textual) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 7 - Definite-life Intangible Assets - Expected Future Amortization Expense (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 8 - Goodwill (Details Textual) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 8 - Goodwill - Summary of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 8 - Goodwill - Components of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 9 - Lines of Credit (Details Textual) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 10 - Leases (Details Textual) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 10 - Leases - Future Minimum Lease Payments for Non-cancelable Operating Leases (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 10 - Leases - Future Minimum Capital Lease Payments (Details) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 11 - Agreements and Commitments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 12 - Income Taxes (Details Textual) link:calculationLink link:definitionLink link:presentationLink 058 - Disclosure - Note 12 - Income Taxes - Deferred Tax Asset (Liabilities) (Details) link:calculationLink link:definitionLink link:presentationLink 059 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Tax Expense (Details) link:calculationLink link:definitionLink link:presentationLink 060 - Disclosure - Note 12 - Income Taxes - Components of Income Tax Expense (Benefit) from Continuing Operations (Details) link:calculationLink link:definitionLink link:presentationLink 061 - Disclosure - Note 13 - Earnings Per Share (Details Textual) link:calculationLink link:definitionLink link:presentationLink 062 - Disclosure - Note 13 - Earnings Per Share - Amounts Used in Computing Earnings Per Share (Details) link:calculationLink link:definitionLink link:presentationLink 063 - Disclosure - Note 14 - Stockholders' Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 064 - Disclosure - Note 14 - Stockholders' Equity - Warrants Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 065 - Disclosure - Note 14 - Stockholders' Equity - Assumptions Used to Calculate the Fair Values of Stock Options (Details) link:calculationLink link:definitionLink link:presentationLink 066 - Disclosure - Note 14 - Stockholders' Equity - Options Outstanding (Details) link:calculationLink link:definitionLink link:presentationLink 067 - Disclosure - Note 14 - Stockholders' Equity - Status of Options Granted and Changes During the Year (Details) link:calculationLink link:definitionLink link:presentationLink 068 - Disclosure - Note 15 - Significant Customers / Concentration (Details Textual) link:calculationLink link:definitionLink link:presentationLink 069 - Disclosure - Note 15 - Significant Customers / Concentration - Net Sales by Geographical Region (Details) link:calculationLink link:definitionLink link:presentationLink 070 - Disclosure - Note 15 - Significant Customers / Concentration - Sales by Product Line (Details) link:calculationLink link:definitionLink link:presentationLink 071 - Disclosure - Note 16 - Subsequent Event (Details Textual) link:calculationLink link:definitionLink link:presentationLink 072 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) link:calculationLink link:definitionLink link:presentationLink 073 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Rollforward for Allowance for Doubtful Accounts (Details) link:calculationLink link:definitionLink link:presentationLink EX-101.CAL 9 liqt-20161231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 10 liqt-20161231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 11 liqt-20161231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information Note To Financial Statement Details Textual us-gaap_InterestExpense Interest expense Property, Plant and Equipment Disclosure [Text Block] statementsignificantaccountingpoliciespolicies us-gaap_InterestExpenseLesseeAssetsUnderCapitalLease Interest Expense, Lessee, Assets under Capital Lease statementnote1summaryofsignificantaccountingpoliciestables Property, Plant and Equipment [Table Text Block] statementnote4inventorytables statementnote5propertyandequipmenttables statementnote6investmentsatcoststables statementnote7definitelifeintangibleassetstables Segment Reporting Disclosure [Text Block] statementnote8goodwilltables Consolidation, Policy [Policy Text Block] statementnote10leasestables statementnote12incometaxestables statementnote13earningspersharetables us-gaap_ValuationAllowancesAndReservesBalance Balance Beginning of Year Balance End of Year statementnote14stockholdersequitytables statementnote15significantcustomersconcentrationtables Inventory Disclosure [Text Block] statementscheduleiivaluationandqualifyingaccountstables Schedule of Inventory, Current [Table Text Block] statementnote1summaryofsignificantaccountingpoliciesrollforwardforallowancefordoubtfulaccountsdetails Deductions statementnote4inventoryscheduleofinventorydetails statementnote5propertyandequipmentscheduleofpropertyandequipmentdetails Charges to Costs and Expenses statementnote6investmentsatcostssummaryoffinancialassetsandliabilitiesdetails statementnote7definitelifeintangibleassetsexpectedfutureamortizationexpensedetails statementnote8goodwillsummaryofgoodwilldetails Increase (decrease) in accrued expenses statementnote8goodwillcomponentsofgoodwilldetails statementnote10leasesfutureminimumleasepaymentsfornoncancelableoperatingleasesdetails statementnote10leasesfutureminimumcapitalleasepaymentsdetails Inventory Valuation Reserve [Member] statementnote12incometaxesdeferredtaxassetliabilitiesdetails statementnote12incometaxesreconciliationofincometaxexpensedetails statementnote12incometaxescomponentsofincometaxexpensebenefitfromcontinuingoperationsdetails statementnote13earningspershareamountsusedincomputingearningspersharedetails Vesting On January 1, 2018 [Member] Refers to information regarding the vesting date January 1, 2018. statementnote14stockholdersequitywarrantsoutstandingdetails Vesting on January 1, 2016 [Member] Refers to information regarding vesting date January 1, 2016. statementnote14stockholdersequityassumptionsusedtocalculatethefairvaluesofstockoptionsdetails statementnote14stockholdersequityoptionsoutstandingdetails Vesting On January 1, 2017 [Member] Refers to information regarding the vesting date January 1, 2017. statementnote14stockholdersequitystatusofoptionsgrantedandchangesduringtheyeardetails statementnote15significantcustomersconcentrationnetsalesbygeographicalregiondetails Vehicle Purchased on Note Payable statementnote15significantcustomersconcentrationsalesbyproductlinedetails us-gaap_PolicyTextBlockAbstract Accounting Policies us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo 2018 statementscheduleiivaluationandqualifyingaccountsvaluationandqualifyingaccountsdetails Valuation Allowances and Reserves [Domain] us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree 2019 statementscheduleiivaluationandqualifyingaccountsrollforwardforallowancefordoubtfulaccountsdetails Notes To Financial Statements us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths 2017 Valuation Allowances and Reserves Type [Axis] Increase (decrease) in accounts payable Notes To Financial Statements [Abstract] Schedule of Valuation and Qualifying Accounts Disclosure [Text Block] Investments at costs Other Long-term Investments Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage us-gaap_FiniteLivedIntangibleAssetUsefulLife Finite-Lived Intangible Asset, Useful Life us-gaap_ComprehensiveIncomeNetOfTax Comprehensive Loss Attributable To LiqTech International Inc. Operating Expenses: Sales Revenue, Net [Member] Increase (decrease) long-term contracts Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Assets, Total [Member] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Axis] us-gaap_CashAndCashEquivalentsAtCarryingValue Cash Cash and Cash Equivalents at Beginning of Period Cash and Cash Equivalents at End of Period Intangible Assets Disclosure [Text Block] us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount us-gaap_DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance Non-cash compensation expenses Allocated Share-based Compensation Expense us-gaap_DeferredTaxAssetsValuationAllowanceNoncurrent Valuation Allowance us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets (Increase) decrease in prepaid expenses/deposits us-gaap_DeferredTaxAssetsValuationAllowanceCurrent Valuation Allowance Other Assets: us-gaap_IncreaseDecreaseInDeferredIncomeTaxes Change in deferred tax asset / liability Allowance for Credit Losses on Financing Receivables [Table Text Block] Customer Concentration Risk [Member] Geographic Concentration Risk [Member] Allowance for Doubtful Accounts [Member] us-gaap_AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition Deferred compensation on shares issued to the board of directors, employees and services Concentration Risk Type [Axis] Concentration Risk Type [Domain] Effect of currency translation Effect of currency translation us-gaap_DeferredTaxAssetsInventory Reserve for obsolete inventory Interest and other Income us-gaap_IncreaseDecreaseInReceivables (Increase) decrease in accounts receivable Warrants issued for services Allowance for doubtful Accounts Deferred compensation Vacation accrual us-gaap_StockIssuedDuringPeriodSharesAcquisitions Stock Issued During Period, Shares, Acquisitions LiqTech NA [Member] LiqTech NA LiqTech Asia [Member] LiqTech Asia LiqTech Germany [Member] Represents information about LiqTech Germany. LiqTech PTE [Member] LiqTech PTE liqt_ValueAddedTaxOfInvoicePercentage Value Added Tax Of Invoice, Percentage Value added tax of invoice, percentage. us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness Business tax credit carryover Production Equipment [Member] Production equipment us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGross Stock Issued During Period, Shares, Restricted Stock Award, Gross Fair Value, by Balance Sheet Grouping [Table Text Block] Lab Equipment [Member] Lab equipment Fair Value Measurement, Policy [Policy Text Block] LEA Technology [Member] LEA Technology liqt_ClassOfWarrantOrRightExpiredDuringPeriod Class of Warrant or Right, Expired During Period The number of warrants or rights expired during the period. Valuation Allowances and Reserves [Table Text Block] Tabular disclosure of a schedule of allowance and reserve accounts where the valuation and qualifying accounts are either netted against the cost of an asset (in order to value it at its carrying value) or that reflect a liability established to represent expected future costs. Net operating loss carryover us-gaap_AllowanceForDoubtfulAccountsReceivable Allowance for doubtful accounts at the beginning of the period Allowance for doubtful accounts at the end of the period us-gaap_StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross Cancelation of common share held in escrow in connection with acquisition of LiqTech Systems AS Represents the value of canceled common shares held in escrow in connection with acquisition of LiqTech Systems AS. Foreign Currency Transactions and Translations Policy [Policy Text Block] Canceled Common Shares Held in Escrow in Connection with an Acquisition (in shares) Canceled Common Shares Held in Escrow in Connection with an Acquisition, Shares Represents the number of canceled common shares held in escrow in connection with acquisition of LiqTech Systems AS. us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign LiqTech Singapore [Member] Represents information about LiqTech Singapore. Net operating loss carryover liqt_NetOperatingLossCarryover Net operating loss carryover. LiqTech International Inc and LiqTech NA [Member] Represents information about LiqTech International Inc and LiqTech NA. Allowance for doubtful accounts Amount of deferred income tax expense (benefit) pertaining to allowance for doubtful accounts. us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited Forfeiture of Stock Based Compensation LiqTech International AS and LiqTech Systems AS [Member] Represents information about LiqTech International AS and LiqTech Systems AS. liqt_DeferredTaxExpenseReserveForObsoleteInventory Reserve for obsolete inventory Deferred tax expense reserve for obsolete inventory. us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Shares forfeited (in shares) Earnings Per Share, Policy [Policy Text Block] us-gaap_IncreaseDecreaseInInventories (Increase) decrease in inventory us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Price Range 1 [Member] Price range 1 Price Range 2 [Member] Price range 2 Price Range 3 [Member] Price range 3 LiqTech USA [Member] Represents the legal entity of LiqTech USA. Income Tax, Policy [Policy Text Block] liqt_DeferredIncomeTaxExpenseValuationAllowance Valuation Allowance Amount of deferred income tax expense (benefit) pertaining for valuation allowance. Common shares issued (in shares) Stock Issued During Period, Shares, New Issues liqt_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. Major Customer 1 [Member] Major customer 1 us-gaap_StockIssuedDuringPeriodValueNewIssues Common shares issued Major Customer 2 [Member] Major customer 2 us-gaap_LiabilitiesAndStockholdersEquity Total Liabilities and Stockholders' Equity Research, Development, and Computer Software, Policy [Policy Text Block] Major Customer 3 [Member] Major customer 3 Major Customer 4 [Member] Major customer 4 US And Canada [Member] US and Canada Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Ceramic Diesel Particulate [Member] Ceramic diesel particulate Liquid Filters [Member] Liquid filters Kiln Furniture [Member] Kiln furniture Accumulated deficit Other comprehensive income, net Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Chief Executive Officer [Member] Singapore Ministry of Taxation [Member] Represents information about Singapore ministry of taxation. German Ministry of Taxation [Member] Represents information about German ministry of taxation. us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment Excess of book over tax depreciation Advertising Costs, Policy [Policy Text Block] Advance from Related Party [Member] The amount of the advance from the related party. AUSTRALIA Class of Warrant or Right [Domain] Class of Warrant or Right [Axis] us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights State us-gaap_ClassOfWarrantOrRightOutstanding Warrants Outstanding Number Outstanding (in shares) Changes in assets and liabilities: Foreign current income tax expense (benefit) us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights us-gaap_AssetsFairValueDisclosure Total Net sales Federal us-gaap_CurrentIncomeTaxExpenseBenefit Current tax (benefit) Long term deferred tax asset Statement of Comprehensive Income [Abstract] Current income tax expense: us-gaap_DeferredIncomeTaxExpenseBenefit Deferred tax expense (benefit) us-gaap_DepositsAssetsNoncurrent Deposits Gain (Loss) on currency transactions GERMANY Investments DENMARK Non-cash compensation Capital Lease 2 [Member] The second capital lease owned by the company. Capital Lease 1 [Member] The first capital lease owned by the company. Capital Lease 3 [Member] The third capital lease owned by the company. Danish Ministry of Taxation [Member] Information for the Danish Ministry of Taxation. LCL Finance Limited [Member] Represents LCL Finance Limited. Revenue Recognition, Policy [Policy Text Block] Common stock; par value $0,001, 100,000,000 shares authorized, 36,835,514 and 39,532,035 shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively us-gaap_TableTextBlock Notes Tables Common stock, shares issued (in shares) Common Stock, Shares, Issued Common stock, shares authorized (in shares) Common Stock, Shares Authorized Amendment Flag Depreciation and amortization us-gaap_Depreciation Depreciation Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Federal Ministry of Finance, Germany [Member] us-gaap_AssetsCurrent Total Current Assets Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Internal Revenue Service (IRS) [Member] Cost in excess of billing Goodwill and Intangible Assets, Policy [Policy Text Block] us-gaap_NonoperatingIncomeExpense Total Other Income (Expense) Income Tax Authority, Name [Axis] Income Tax Authority, Name [Domain] Foreign Tax Authority [Member] us-gaap_DeferredTaxAssetsLiabilitiesNetCurrent Net current tax assets Income Tax Authority [Domain] Current Fiscal Year End Date Domestic Tax Authority [Member] Adjustments to reconcile net (loss) to net cash provided (used) by operations: Income Tax Authority [Axis] us-gaap_CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation Statement of Financial Position [Abstract] Document Fiscal Period Focus Document Fiscal Year Focus Document Period End Date Document Type Statement of Cash Flows [Abstract] us-gaap_OperatingIncomeLoss Loss from Operations us-gaap_GrossProfit Gross Profit Statement of Stockholders' Equity [Abstract] Document Information [Line Items] Document Information [Table] Interest Income Taxes Entity Public Float Entity Filer Category Useful Life (Year) Property, Plant and Equipment, Useful Life Entity Current Reporting Status us-gaap_OperatingLeasesFutureMinimumPaymentsDue Total Minimum Lease Payments Entity Voluntary Filers Entity Well-known Seasoned Issuer us-gaap_MinorityInterestOwnershipPercentageByNoncontrollingOwners Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners Reserve for obsolete inventory us-gaap_OperatingLeasesFutureMinimumPaymentsDueThereafter Thereafter Assets Held under Capital Leases [Member] Prepaid expenses us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears 2018 us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears 2019 Furniture and Fixtures [Member] us-gaap_OperatingLeasesFutureMinimumPaymentsDueCurrent 2017 Inventories Net Inventory Entity Central Index Key Entity Registrant Name us-gaap_InventoryValuationReserves Reserve for obsolescence Entity [Domain] liqt_ClassOfWarrantOrRightVestingPercentage Class of Warrant or Right Vesting Percentage Vesting percentage of class of warrant or right. Work in process Legal Entity [Axis] Business Acquisition, Acquiree [Domain] Leasehold Improvements [Member] Finished goods and filtration systems liqt_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsNonvestedWeightedAverageExercisePrice Share Based Compensation Arrangements by Share Based Payment Award Options, Nonvested Weighted Average Exercise Price Weighted average per share amount at which grantees can acquire shares of common stock by exercise of non-vested options. Business Acquisition [Axis] Property, Plant and Equipment, Type [Axis] Vesting on December 31, 2015 [Member] Represents vesting date. Property, Plant and Equipment, Type [Domain] us-gaap_DeferredCompensationEquity Deferred compensation Property, Plant and Equipment, Policy [Policy Text Block] Additional paid-in capital Vesting on December 31, 2016 [Member] Represents vesting date. Vesting on December 31, 2014 [Member] Represents vesting date. Provital Acquisition [Member] Represents acquisition of Provital Solutions A/S, a Danish company. Stockholders' Equity: Entity Common Stock, Shares Outstanding (in shares) Vesting Upon Issuance [Member] Represents vesting date. Cash Flows from Operating Activities: Inventory, Policy [Policy Text Block] Wolfe Axelrod Weinberger Associates, LLC [Member] Represents Wolfe Axelrod Weinberger Associates, LLC. Furnace parts and supplies Vesting on June 4, 2017 [Member] Represents vesting date. Vesting on June 4, 2016 [Member] Represents vesting date. Raw materials Two Thousand Eleven Stock Options Plan [Member] Represents Stock Option Plan adopted in 2011. Statement [Line Items] Price Range 4 [Member] Represents price range 4. Trading Symbol AOCI Attributable to Parent [Member] Accounts receivable, net us-gaap_Liabilities Total Liabilities Commitment and Contingencies See Note 11 SINGAPORE Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Hierarchy [Axis] Restricted cash balances Current Assets: us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease Net Increase (Decrease) in Cash and Cash Equivalents Loss on Currency Translation Investment, Policy [Policy Text Block] us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Used by Financing Activities us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided (Used) by Operating Activities us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Used by Investing Activities us-gaap_PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs UNITED STATES Other items Noncontrolling Interest [Member] Valuation Allowance Effect of changes in tax rates us-gaap_StockholdersEquity Balance Balance Cost of Goods Sold us-gaap_IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary Non-deductible loss of subsidiaries Retained Earnings [Member] us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions Options Number Exercisable (in shares) us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 Options Exercisable Weighted Average Exercise Price (in dollars per share) Deferred Compensation, Share-based Payments [Member] us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 Options Weighted Average Exercise Price (in dollars per share) Additional Paid-in Capital [Member] us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2 Options Weighted Average Remaining Contractual Life (Year) us-gaap_ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions Options Number Outstanding (in shares) us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit Options Exercise Prices (in dollars per share) Common Stock [Member] Equity Components [Axis] Exercise Price Range [Axis] Equity Component [Domain] Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Domain] Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block] Dividend yield Risk free interest rate Non-deductible expenses Accounts Payable and Accrued Liabilities [Member] Non-deductible deferred compensation Volatility Non-deductible impairment of goodwill Expected term (in years) (Year) Currency Translation, Net of Taxes Currency translation, net Loans and Leases Receivable, Allowance for Loan Losses Policy [Policy Text Block] Book in excess of tax depreciation Non-US income taxed at different rates Computed tax at expected statutory rate State and local income taxes, net of federal benefits Cash and Cash Equivalents, Policy [Policy Text Block] Significant Accounting Policies [Text Block] us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Total Stockholders' Equity Basis of Accounting, Policy [Policy Text Block] Income Tax Disclosure [Text Block] Vehicles [Member] Accounting Policies [Abstract] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period liqt_ClassOfWarrantOrRightWeightedAverageRemainingContractualLife Warrants Outstanding Weighted Average Remaining Contractual Life (Year) Weighted average remaining contractual term for a class of warrant or right. us-gaap_GuaranteeObligationsCurrentCarryingValue Guarantor Obligations, Current Carrying Value liqt_ClassOfWarrantOrRightExercisable Warrants Exercisable Number Exercisable (in shares) Number of warrants or rights exercisable. liqt_ClassOfWarrantOrRightOutstandingWeightedAverageExercisePrice Warrants Outstanding Weighted Average Exercise Price (in dollars per share) The weighted average exercise price per share or per unit of warrants or rights outstanding. Warrant 1 [Member] Refers to information regarding the first set of warrants' exercise price range. Vested and expected to vest, average remaining life (Year) liqt_ClassOfWarrantOrRightExercisableWeightedAverageExercisePrice Warrants Exercisable Weighted Average Exercise Price (in dollars per share) The weighted average exercise price per share or per unit of warrants or rights exercisable. Computer Equipment [Member] Warrants 3 [Member] Refers to information regarding the third set of warrants' exercise price range. us-gaap_RepaymentsOfLongTermCapitalLeaseObligations Net payments proceeds on capital lease obligation Vested and expected to vest, weighted average exercise price (in dollars per share) Warrant 2 [Member] Refers to information regarding the second set of warrants' exercise price range. Vested and expected to vest, weighted average intrinsic value Warrants 4 [Member] Refers to information regarding the fourth set of warrants' exercise price range. us-gaap_RepaymentsOfLongTermDebt Payments on loans payable Shares vested and expected to vest (in shares) Exercisable end of period, weighted average intrinsic value Balance Sheet Location [Domain] Exercisable end of period, weighted average exercise price (in dollars per share) Exercisable end of period, average remaining life (Year) Balance Sheet Location [Axis] Warrants exercisable (in shares) Outstanding, weighted average intrinsic value Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Outstanding, average remaining life (Year) us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value us-gaap_AllowanceForDoubtfulAccountsReceivableWriteOffs Amount of receivables written off Other receivables us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, weighted average exercise price (in dollars per share) Outstanding, weighted average exercise price (in dollars per share) Forfeited, weighted average exercise price (in dollars per share) us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Maximum [Member] Minimum [Member] Range [Axis] Range [Domain] Customer [Axis] Customer [Domain] us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Shares outstanding (in shares) Shares outstanding (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Lease Arrangement, Type [Domain] Lease Arrangement, Type [Axis] Schedule of Goodwill [Table Text Block] Goodwill Disclosure [Text Block] us-gaap_EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage us-gaap_LossContingencyDamagesSoughtValue Loss Contingency, Damages Sought, Value Products and Services [Domain] Patents [Member] Products and Services [Axis] South America [Member] Vesting [Axis] Vesting [Domain] Plan Name [Axis] us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment Effect of dilutive securities, stock options and warrants (in shares) Europe [Member] Plan Name [Domain] us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Weighted Average Common Shares Outstanding Assuming Dilution (in shares) Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share (in shares) us-gaap_SharePrice Share Price us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options Asia [Member] Geographical [Axis] Award Type [Axis] Geographical [Domain] Equity Award [Domain] us-gaap_RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Employee Service Share-based Compensation, Tax Benefit from Compensation Expense Related Party Transaction [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Related Party Transaction [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Diluted Loss Per Share (in dollars per share) Scenario, Forecast [Member] Scenario, Unspecified [Domain] Weighted Average Common Shares Outstanding (in shares) Weighted average number of common shares used in basic earnings per share (in shares) Related Party [Domain] Scenario [Axis] Related Party [Axis] Basic Loss Per Share (in dollars per share) Related Party Transactions Disclosure [Text Block] Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block] Statement [Table] Commitments and Contingencies Disclosure [Text Block] Reportable Geographical Components [Member] us-gaap_LiabilitiesNoncurrent Total Long-Term Liabilities: us-gaap_GoodwillForeignCurrencyTranslationGainLoss Effect of currency translation us-gaap_NetIncomeLossAttributableToNoncontrollingInterest Less Net Loss Attributable To Non-Controlled Interests in Subsidiaries Consolidation Items [Axis] Income Statement [Abstract] Consolidation Items [Domain] Cash Flows from Financing Activities: us-gaap_IncreaseDecreaseInRestrictedCash (Increase) decrease in restricted cash Comprehensive Income (Loss) Attributable To Non-controlled Interest in Subsidiaries Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block] LiqTech Italy [Member] Information pertaining to LiqTech Italy. Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block] Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] LiqTech Systems A/S [Member] Information pertaining to LiqTech Systems A/S. Schedule of Effective Income Tax Rate Reconciliation [Table Text Block] Officer [Member] Schedule of Components of Income Tax Expense (Benefit) [Table Text Block] Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Director [Member] Capital Lease Obligations [Member] Title of Individual [Axis] Relationship to Entity [Domain] Investment Type [Axis] Investments [Domain] Schedule of Intangible Assets and Goodwill [Table Text Block] us-gaap_CapitalLeasesFutureMinimumPaymentsDueThereafter Thereafter us-gaap_ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest Other Comprehensive Loss us-gaap_CapitalLeasesFutureMinimumPaymentsDue Total minimum lease payments Net Loss Net Loss Long-term capital lease obligations, less current portion us-gaap_CapitalLeasesFutureMinimumPaymentsDueInTwoYears 2018 us-gaap_CapitalLeasesFutureMinimumPaymentsDueCurrent 2017 Long-term notes payable, less current portion Business tax credit carryover Amount of deferred income tax expense (benefit) pertaining to business tax credit carryover. Deferred Compensation Amount of deferred income tax expense (benefit) pertaining to deferred compensation. us-gaap_CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments Less amount representing interest Income Tax Expense (Benefit) Total tax expense (benefit) Accrued Vacation Amount of deferred income tax expense (benefit) pertaining to accrued vacation. us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Loss Before Income Taxes us-gaap_CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments Present value of minimum lease payments us-gaap_LiabilitiesCurrent Total Current Liabilities Issued for Services Provided and to be Provided 1 [Member] Information about the first set of shares issued for services provided and to be provided. Gain (Loss) on investments Class of Stock [Axis] Issued for Services Provided and to be Provided 2 [Member] Information about the second set of shares issued for services provided and to be provided. Schedule of Weighted Average Number of Shares [Table Text Block] Billing in excess of cost us-gaap_UnrealizedGainLossOnInvestments Loss on Investments Deferred revenue / customers deposits Leases of Lessee Disclosure [Text Block] Warrants Issued for Services [Member] Represents warrants issued for services. Current portion of capital lease obligations Less Current Portion Counterparty Name [Domain] us-gaap_PaymentsToAcquireInvestments Purchase of Long-term investments Counterparty Name [Axis] Total The total value of significant noncash (or part noncash) investing and financing activities. Current portion of notes payable us-gaap_DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] liqt_PercentageOfSubsidiaryOwned Percentage of Subsidiary Owned Represents the percentage of subsidiary owned by the parent company. us-gaap_DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost Recognized us-gaap_OperatingExpenses Total Operating Expense General and administrative expenses LiqTech International DK [Member] Represents the legal entity of LiqTech International DK. Accrued income taxes payable Substantial Doubt about Going Concern [Text Block] Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block] Accrued expenses us-gaap_LeaseAndRentalExpense Operating Leases, Rent Expense Supplemental Disclosures of Non-Cash Investing and Financing Activities: Subsequent Events [Text Block] us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Purchase of property and equipment Accounts payable Current Liabilities: us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions Stock based compensation expenses recognized for the year ended us-gaap_Assets Total Assets Impairment of goodwill Goodwill, Impairment Loss Impairment write down us-gaap_SharesIssued Balance (in shares) Balance (in shares) us-gaap_SharesIssuedPricePerShare Common shares issued, per share (in dollars per share) Stockholders' Equity Note Disclosure [Text Block] us-gaap_OtherAssets Total Other Assets us-gaap_CashUninsuredAmount Cash, Uninsured Amount us-gaap_AmortizationOfIntangibleAssets Amortization of Intangible Assets us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity Line of Credit Facility, Maximum Borrowing Capacity us-gaap_RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents Other intangible assets Intangible Assets, Net (Excluding Goodwill) us-gaap_FiniteLivedIntangibleAssetsNet us-gaap_NetIncomeLoss Net Income for the year ended Net Loss Attributable To LiqTech us-gaap_AdvertisingExpense Advertising Expense Goodwill LiqTech Systems A/S (Formerly Provital Solutions A/S) Goodwill at beginning of period Goodwill at end of period Warrant [Member] us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Less Accumulated Depreciation Restricted Stock [Member] Property and Equipment, net accumulated depreciation: Net Property and Equipment Employee Stock Option [Member] Property and equipment, gross us-gaap_CapitalLeasedAssetsGross Capital Leased Assets, Gross Antidilutive Securities, Name [Domain] Antidilutive Securities [Axis] Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block] Debt Disclosure [Text Block] Bad debt expense us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Reconciliation of Revenue from Segments to Consolidated [Table Text Block] Selling expenses Other Income (Expense) Use of Estimates, Policy [Policy Text Block] Cash Flows from Investing Activities: New Accounting Pronouncements, Policy [Policy Text Block] Earnings Per Share [Text Block] Research and development expenses Research and Development Expense us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Total Adjustments EX-101.PRE 12 liqt-20161231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 13 liqt20161231_10kimg001.jpg begin 644 liqt20161231_10kimg001.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# 4$! 0$ P4$! 0&!04&" T(" <' M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_ MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @("#_P 1" !\ ?4# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#[+HHHH ** M** "BBB@ HHHH **** "BBB@ HKD_'7Q!\-_#W0SJGB"ZVL^5@MH_FEN&]%' M\ST%?)7BCX[_ !*^(&KKHOA=9]*@N&V06>G9:XE_WGZ_7&!6AAQ]G:GXBT'15)U?6K*PXSBXG5#^1.:Y&X^-?PJM)3%/XXTY7'8,S?R% M>*>#?V7K[4]FJ_$C6IA(_P YL;>3>^3_ 'Y#D ^P_.O;=&^#/PRT.%8[/P?8 M2,/^6ERGGO\ F^323F^EBJE+"4O=YW)^6B_$CA^-WPHN)1%#XXTXN>@)8?J1 M77Z7XBT'6U#:/K5E?Y&<6\ZN1^ .16/J'PU\ ZI"T5]X/TF92,9^RJ"/H0,B MO#?B)^S5%96LNO?#&XN+2[@_>-IIF;Y\<_NWZAO8YSZTVY+IUFT\/>)_-URQDN$MC]H.+FW)8+]X_>P3T;\Q7VG M3A-36A&+P=3"R49]=F%%%%6<04444 %%%% !1110 4444 %%%% !1110 444 M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M 4444 %%%% :*0T4 +1110 4444 %%%% !1110 4444 %87B[Q3IG@SPE?^ M)-6?%M9Q[MH/S2-T5![DX%;M?(O[57C*2Z\0Z;X(M9O]'LD%Y=*#]Z5ON _1 M>?\ @7M43ERQN=N!PWUFO>Z^AXEXK\4>(/B)XSDU;46DN;V\D$5M;)R(E) MPD:#_.3S7VG\'?A'IWPY\/QW-W%'<>([M UU/V9?" M4>O?$Z37+N$26VAP^C?$+1;81QW%[#%J"QKPLN\;)<>_0^^/6OJ:,E MH48]2H-)-;P7,1BN(4FCR#LD4,,CD<&I*A1LV^YU5<3*K3A3E]FX44459RA1 M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%% M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (:*#10 M%%% !11 M10 4444 %%%% !1110 5^=/Q;U"35/C+XJNI&)Q?/$F>RIA0/TK]%J_.;XK6 M;6'QC\5VSJ1C4)'7/<-A@?UKFQ'PH^DR"WMI>GZGTM^RCID=O\-=5U7'[R]U M%D)]HU '\S7T'7B'[+\R2_!58U 5HM0G5L=_NG/ZU[?6M/X4>3F#;Q51ON<5 MJGQ7^'&BZMH> ]*NDC98DMU@ M13*[' 4'''&3^%-N2U)IQHS:C:5WZ&Y_PNKX4_\ 0]Z5_P!_O_K5-#\8/AA< M!O)\<:4V.O[_ !7SOH_Q'^!FI:E9V=Q\';6T6>5(I)O*C=(0S!0QXZ9(KWN\ M^!_PHOX2K>#+"(,/O6ZF,CZ%34J3EM8Z:V&HT&E54E?T-/\ X6Q\-O\ H==* M_P# @5V$$\-S;QW%O(LD,JAT=3D,I&017Y^?&KP'IOP]^(DNBZ0TK:?-;K

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end XML 14 R1.htm IDEA: XBRL DOCUMENT v3.7.0.1
Document And Entity Information - USD ($)
12 Months Ended
Dec. 31, 2016
Mar. 23, 2017
Jun. 30, 2016
Document Information [Line Items]      
Entity Registrant Name LIQTECH INTERNATIONAL INC    
Entity Central Index Key 0001307579    
Trading Symbol liqt    
Current Fiscal Year End Date --12-31    
Entity Filer Category Smaller Reporting Company    
Entity Current Reporting Status Yes    
Entity Voluntary Filers No    
Entity Well-known Seasoned Issuer No    
Entity Common Stock, Shares Outstanding (in shares)   36,835,514  
Entity Public Float     $ 14,711,188
Document Type 10-K    
Document Period End Date Dec. 31, 2016    
Document Fiscal Year Focus 2016    
Document Fiscal Period Focus FY    
Amendment Flag false    

XML 15 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Current Assets:    
Cash $ 1,208,650 $ 1,370,591
Restricted cash balances 292,826
Accounts receivable, net 1,111,759 3,191,858
Other receivables 306,177 505,945
Cost in excess of billing 642,700 2,519,321
Inventories 5,174,874 4,916,671
Prepaid expenses 62,161 13,670
Net current tax assets 172,122
Total Current Assets 8,506,321 12,983,004
Property and Equipment, net accumulated depreciation: 2,633,558 3,538,694
Other Assets:    
Investments at costs 5,282 21,838
Long term deferred tax asset 3,684,497
Goodwill 7,582,749
Other intangible assets 5,614 10,386
Deposits 261,553 252,378
Total Other Assets 272,449 11,551,848
Total Assets 11,412,328 28,073,546
Current Liabilities:    
Current portion of notes payable 15,034
Current portion of capital lease obligations 45,883 150,157
Accounts payable 2,262,688 3,455,085
Accrued expenses 2,385,586 1,441,840
Billing in excess of cost 106,375 175,338
Accrued income taxes payable 580 570
Deferred revenue / customers deposits 192,597 117,700
Total Current Liabilities 5,008,743 5,340,690
Long-term notes payable, less current portion 39,895
Long-term capital lease obligations, less current portion 93,942 165,572
Total Long-Term Liabilities: 133,837 165,572
Total Liabilities 5,142,580 5,506,262
Commitment and Contingencies See Note 11
Stockholders' Equity:    
Common stock; par value $0,001, 100,000,000 shares authorized, 36,835,514 and 39,532,035 shares issued and outstanding at December 31, 2016 and December 31, 2015, respectively 36,836 39,532
Additional paid-in capital 36,084,117 36,087,808
Accumulated deficit (24,011,343) (7,592,709)
Deferred compensation (148,561) (590,742)
Other comprehensive income, net (5,691,301) (5,376,605)
Total Stockholders' Equity 6,269,748 22,567,284
Total Liabilities and Stockholders' Equity $ 11,412,328 $ 28,073,546
XML 16 R3.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Balance Sheets (Parentheticals) - $ / shares
Dec. 31, 2016
Dec. 31, 2015
Common stock, par value (in dollars per share) $ 0.001 $ 0.001
Common stock, shares authorized (in shares) 100,000,000 100,000,000
Common stock, shares issued (in shares) 36,835,514 39,532,035
Common stock, shares outstanding (in shares) 36,835,514 39,532,035
XML 17 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Net sales $ 13,906,394 $ 15,812,587
Cost of Goods Sold 12,473,965 12,598,163
Gross Profit 1,432,429 3,214,424
Operating Expenses:    
Selling expenses 2,164,780 2,721,781
General and administrative expenses 3,997,304 2,814,747
Non-cash compensation expenses 435,794 369,531
Research and development expenses 626,147 707,844
Impairment of goodwill 7,343,208 0
Total Operating Expense 14,567,233 6,613,903
Loss from Operations (13,134,804) (3,399,479)
Other Income (Expense)    
Interest and other Income 968 98,171
Interest expense (38,945) (51,232)
Gain (Loss) on investments (16,621) 7,253
Gain (Loss) on currency transactions (9,555) 459,279
Total Other Income (Expense) (64,153) 513,471
Loss Before Income Taxes (13,198,957) (2,886,008)
Income Tax Expense (Benefit) 3,219,677 (697,786)
Net Loss (16,418,634) (2,188,222)
Less Net Loss Attributable To Non-Controlled Interests in Subsidiaries (21,635)
Net Loss Attributable To LiqTech $ (16,418,634) $ (2,209,857)
Basic Loss Per Share (in dollars per share) $ (0.45) $ (0.06)
Weighted Average Common Shares Outstanding (in shares) 36,835,514 36,790,420
Diluted Loss Per Share (in dollars per share) $ (0.45) $ (0.06)
Weighted Average Common Shares Outstanding Assuming Dilution (in shares) 36,835,514 36,790,420
XML 18 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Other Comprehensive Income - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Net Loss $ (16,418,634) $ (2,188,222)
Currency Translation, Net of Taxes (314,696) (2,540,688)
Other Comprehensive Loss (16,733,330) (4,728,910)
Comprehensive Income (Loss) Attributable To Non-controlled Interest in Subsidiaries
Comprehensive Loss Attributable To LiqTech International Inc. $ (16,733,330) $ (4,728,910)
XML 19 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statement of Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Deferred Compensation, Share-based Payments [Member]
Noncontrolling Interest [Member]
Total
Balance (in shares) at Dec. 31, 2014 39,404,782            
Balance at Dec. 31, 2014 $ 39,405 $ 35,632,410 $ (5,382,852) $ (2,835,917) $ (504,748) $ 16,717  
Common shares issued (in shares) | Issued for Services Provided and to be Provided 1 [Member] 100,000            
Common shares issued (in shares) | Issued for Services Provided and to be Provided 2 [Member] 27,253            
Common shares issued | Issued for Services Provided and to be Provided 1 [Member] $ 100 74,900 (75,000)  
Common shares issued | Issued for Services Provided and to be Provided 2 [Member] $ 27 20,140 (20,167)  
Stock Issued During Period, Shares, New Issues | Issued for Services Provided and to be Provided 1 [Member] 100,000            
Stock Issued During Period, Shares, New Issues | Issued for Services Provided and to be Provided 2 [Member] 27,253            
Deferred compensation on shares issued to the board of directors, employees and services 391,546 (391,546)  
Forfeiture of Stock Based Compensation (31,188) 31,188  
Stock based compensation expenses recognized for the year ended 369,531  
Currency translation, net (2,540,688) (16,717) $ (2,540,688)
Net Income for the year ended (2,209,857) (2,209,857)
Balance (in shares) at Dec. 31, 2015 39,532,035            
Balance at Dec. 31, 2015 $ 39,532 36,087,808 (7,592,709) (5,376,605) (590,742) 0  
Forfeiture of Stock Based Compensation (39,387) 39,387  
Stock based compensation expenses recognized for the year ended 435,794  
Currency translation, net (314,696) (314,696)
Net Income for the year ended (16,418,634) $ (16,418,634)
Balance (in shares) at Dec. 31, 2016 36,835,514            
Balance at Dec. 31, 2016 $ 36,836 36,084,117 (24,011,343) (5,691,301) (148,561) 0  
Warrants issued for services 33,000 (33,000)  
Canceled Common Shares Held in Escrow in Connection with an Acquisition (in shares) (2,696,521)           2,696,521
Cancelation of common share held in escrow in connection with acquisition of LiqTech Systems AS $ (2,696) $ 2,696  
XML 20 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statement of Stockholders' Equity (Parentheticals) - Additional Paid-in Capital [Member]
Dec. 31, 2015
$ / shares
Issued for Services Provided and to be Provided 1 [Member]  
Common shares issued, per share (in dollars per share) $ 0.75
Issued for Services Provided and to be Provided 2 [Member]  
Common shares issued, per share (in dollars per share) $ 0.74
XML 21 R8.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash Flows from Operating Activities:    
Net Loss $ (16,418,634) $ (2,188,222)
Adjustments to reconcile net (loss) to net cash provided (used) by operations:    
Depreciation and amortization 1,378,277 1,444,109
Non-cash compensation 435,794 369,531
Bad debt expense 1,437,949 80,729
Reserve for obsolete inventory 802,966 174,143
Change in deferred tax asset / liability 3,856,619 (250,523)
Impairment of goodwill 7,343,208 0
Loss on Investments 16,556
Changes in assets and liabilities:    
(Increase) decrease in restricted cash 292,826 (73,947)
(Increase) decrease in accounts receivable 841,918 (1,280,537)
(Increase) decrease in inventory (1,147,934) (175,948)
(Increase) decrease in prepaid expenses/deposits (57,666) 49,012
Increase (decrease) in accounts payable (1,192,386) 1,118,143
Increase (decrease) in accrued expenses 1,018,643 (24,671)
Increase (decrease) long-term contracts 1,807,658 (1,171,325)
Total Adjustments 16,834,428 97,258
Net Cash Provided (Used) by Operating Activities 415,794 (2,090,964)
Cash Flows from Investing Activities:    
Purchase of property and equipment (373,740) (576,278)
Purchase of Long-term investments (16,378)
Net Cash Used by Investing Activities (373,740) (592,656)
Cash Flows from Financing Activities:    
Payments on loans payable (26,714)
Net payments proceeds on capital lease obligation (175,905) (223,072)
Net Cash Used by Financing Activities (202,619) (223,072)
Loss on Currency Translation (1,376) (1,576,469)
Net Increase (Decrease) in Cash and Cash Equivalents (161,941) (4,483,161)
Cash and Cash Equivalents at Beginning of Period 1,370,591 5,853,752
Cash and Cash Equivalents at End of Period 1,208,650 1,370,591
Interest 38,945 51,232
Income Taxes 590 570
Supplemental Disclosures of Non-Cash Investing and Financing Activities:    
Non-cash compensation 435,794 369,531
Total 435,794 369,531
Employee Stock Option [Member]    
Adjustments to reconcile net (loss) to net cash provided (used) by operations:    
Non-cash compensation 307,493 154,745
Supplemental Disclosures of Non-Cash Investing and Financing Activities:    
Non-cash compensation 307,493 154,745
Restricted Stock [Member]    
Adjustments to reconcile net (loss) to net cash provided (used) by operations:    
Non-cash compensation 77,667 204,500
Supplemental Disclosures of Non-Cash Investing and Financing Activities:    
Non-cash compensation 77,667 204,500
Warrants Issued for Services [Member]    
Adjustments to reconcile net (loss) to net cash provided (used) by operations:    
Non-cash compensation 50,634 10,286
Supplemental Disclosures of Non-Cash Investing and Financing Activities:    
Non-cash compensation $ 50,634 $ 10,286
XML 22 R9.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Parentheticals)
12 Months Ended
Dec. 31, 2016
USD ($)
shares
Canceled Common Shares Held in Escrow in Connection with an Acquisition (in shares) | shares 2,696,521
Vehicle Purchased on Note Payable | $ $ 81,643
XML 23 R10.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Summary of Significant Accounting Policies
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Significant Accounting Policies [Text Block]
NOTE
1
- SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 
Business and Basis of Presentation
 
The consolidated financial statements include the accounts of LiqTech International, Inc. (“Parent”) and its subsidiaries.
 The terms "Company", “us", "we" and "our" as used in this report refer to Parent and its subsidiaries, which are set forth below. The Company engages in the development, design, production, marketing and sale of automated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America. Set forth below is a description of Parent and each of its subsidiaries:
 
LiqTech International, Inc., a Nevada corporation organized in
July
2004,
formerly known as Blue Moose Media, Inc.
 
LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in
May
2011.
 
LiqTech International AS, a Danish corporation, incorporated on
January
15,
2000
(“LiqTech Int. DK”), a
100%
owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.
 
LiqTech NA, Inc. (“LiqTech NA”), incorporated in Delaware on
July
1,
2005,
a
100%
owned subsidiary of LiqTech USA. LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.
 
LiqTech Asia (“LiqTech Asia”) a
60%
owned subsidiary of LiqTech Int. DK, incorporated in South Korea on
July
20,
2006,
was a dormant subsidiary. The company was closed on
March
6,
2015.
 
LiqTech Germany (“LiqTech Germany”) a
100%
owned subsidiary of LiqTech Int. DK, incorporated in Germany on
December
9,
2011,
engages in marketing and sale of liquid filters in Germany. The Company is in the process of closing operations, which is expected to be completed during
2017.
 
LiqTech PTE Ltd, (“LiqTech Sing”) a
95%
owned subsidiary of LiqTech Int. DK, incorporated in Singapore on
January
19,
2012,
engages in marketing and sale of liquid filters in Singapore and other countries in the area. The Company is in the process of closing operations, which is expected to be completed during
2017.
 
LiqTech Systems AS, a Danish Corporation ("LiqTech Systems") (Formerly Provital Solutions A/S) was incorporated on
September
1,
2009
and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of LiqTech Systems from the date of acquisition on
July
31,
2014.
 
  
Consolidation
 
--
 The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.
 
Functional Currency / Foreign currency translation
 -- 
The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar. The Functional Currency of LiqTech Int. DK and LiqTech Systems AS is the Danish Krone (“DKK”), the functional currency of LiqTech Germany is the Euro, the functional currency of LiqTech Singapore is the Singapore Dollar and the functional Currency of LiqTech Asia is South Korean Won. The Company’s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the years ended
December
31,
2016
and
2015.
Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders’ equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.
 
Cash, Cash Equivalents and Restricted Cash
 
--
 The Company considers all highly liquid debt instruments purchased with a maturity of
three
months or less to be cash equivalents. The Company had
no
balances held in a financial institution in the United States in excess of federally insured amounts at
December
31,
2016
and
December
31,
2015.
At
December
31,
2016
and
2015,
the Company had cash balances of
$0
and
$292,826
that are restricted to secure guarantees issued by the Company. The cash is restricted until the underlying guarantees are released. 
 
Accounts Receivable
 
--
 Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence. 
 
The roll forward of the allowance for doubtful accounts for the year ended
December
31,
2016
and
December
31,
2015
is as follows:
 
   
201
6
   
201
5
 
Allowance for doubtful accounts at the beginning of the period
  $
1,087,871
    $
1,654,290
 
Bad debt expense
   
1,437,949
     
80,729
 
Amount of receivables written off
   
(252,792
)
   
(398,083
)
Effect of currency translation
   
(144,576
)
   
(249,065
)
Allowance for doubtful accounts at the end of the period
  $
2,128,452
    $
1,087,871
 
 
 
Inventory
 
--
 Inventory is carried at the lower of cost or market, as determined on the
first
-in,
first
-out method.
 
Property and Equipment
 
--
 Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets, which range from
three
to
ten
years (See Note
5).
 
Long-Term Investments
 
--
 Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information
may
be more limited,
may
not be as timely as and
may
be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.
 
Intangible Assets
 
--
 Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (“FASB”) Accounting Standards Codification, (“ASC”) Topic
350,
“Goodwill and Other Intangible Assets” and amortized the patents on a straight line basis over the estimated useful life of
two
to
ten
years. 
 
Goodwill
-- Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill
may
not be recoverable. Triggering events that
may
indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.
 
Revenue Recognition and Sales Incentives
 
--
 The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No.
101,
“Revenue Recognition in Financial Statements” (SAB
101),
FASB ASC
605
Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collections of resulting receivable is reasonably assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.
 
The Company has received long-term contracts for the installation of various water filtrations systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long-term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long-term contract or grant multiplied by the long-term contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.
 
Project costs of the long-term contracts and grants include
 all direct material and labor costs and those indirect costs related to the project. Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.
 
In Denmark, Value Added Tax (“VAT”) of
25%
of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.
 
 
Advertising Cost
 
--
 Costs incurred in connection with advertising of the Company’s products is expensed as incurred. Such costs amounted to
$14,504
and
$34,442,
for the years ended
December
31,
2016
and
2015,
respectively.
 
Research and Development Cost
 
--
 The Company expenses research and development costs for the development of new products as incurred. Included in operating expense for the years ended
December
31,
2016
and
2015
were
$626,147,
and
$707,844,
respectively, of research and development costs.
 
Income Taxes
 
--
 The Company accounts for income taxes in accordance with FASB ASC Topic
740
Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.
 
Income (Loss) Per Share
 
--
 The Company calculates earnings (loss) per share in accordance with FASB ASC
260
Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options and warrants that have been granted but have not been exercised.
 
Stock Options and Awards
 
--
 The Companies have granted stock options to certain key employees. See Note
14.
During the years presented in the accompanying consolidated financial statements, the Company has granted stock options and awards. The Company accounts for options in accordance with the provisions of FASB ASC Topic
718,
Compensation – Stock Compensation. Non-cash compensation costs of
$435,794
and
$369,531
have been recognized for the vesting of options and stock awards granted to employees with an associated recognized tax benefit of
$35,045
and
$157,080
for the years ended
December
31,
2016
and
2015,
respectively.
 
Fair Value of Financial Instruments
 
--
 The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic
820.
The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a
three
-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
 
 
Level
1.
Observable inputs such as quoted prices in active markets for identical assets or
 liabilities;
 
  
 
Level
2.
Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
 
 
Level
3.
Unobservable inputs in which there is little or no market data, which require the
 reporting entity to develop its own assumptions.
 
Unless otherwise disclosed, the fair value of the Company
’s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.
 
 
Accounting Estimates
 
--
 The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets allowance for doubtful accounts receivable, cost in excess of billings, reserve for obsolete inventory, depreciation and impairment of property plant and equipment and impairment of goodwill and liabilities billings in excess of cost commitment and contingencies, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.
 
Recent Accounting Pronouncements
 
--
 In
May
2014,
the Financial Accounting Standards Board (FASB) issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On
July
9
2015,
the FASB agreed to delay the effective date by
one
year; accordingly, the new standard is effective for us beginning in the
first
quarter of
2018
and we expect to adopt it at that time. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method, nor have we determined the impact of the new standard on our consolidated financial statements.
 
In
2015,
the FASB issued an amended standard requiring that we classify all deferred tax assets and liabilities as non-current on the balance sheet instead of separating deferred taxes into current and non-current. The amended standard is effective for us beginning in the
first
quarter of
2017;
early adoption is permitted and we are evaluating whether we will early adopt. The amended standard
may
be adopted on either a prospective or retrospective basis. We do not expect that the adoption of this standard will have a significant impact on our financial position or results of operations.
 
In
February
2016,
the FASB issued changes to the accounting for leases that primarily affect presentation and disclosure requirements. The new standard will require the recognition of a right to use asset and underlying lease liability for operating leases with an initial life in excess of
one
year. This standard is effective for us beginning in the
first
quarter of
2019.
We have not yet determined the impact of the new standard on our consolidated financial statements.
 
In
August
2014,
the FASB issued ASU
2014
-
15,
Disclosure of Uncertainties About an Entity
’s Ability to Continue as a Going Concern, that will require management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. In connection with each annual and interim period, management will assess if there is substantial doubt about an entity’s ability to continue as a going concern within
one
year after the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within
one
year after the issuance date. The new standard defines substantial doubt and provides example indicators. Disclosures will be required if conditions give rise to substantial doubt. However, management will need to assess if its plans will alleviate substantial doubt to determine the specific disclosures. This standard is effective for public entities for annual periods ending after
December
15,
2016.
Earlier application of this standard is permitted. This standard is not expected to have a material effect on the Company’s financial position, results of operations and cash flows.
 
In
March
2016,
the FASB issued ASU
2016
-
09,
Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which changes how companies account for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled, allows an employer to repurchase more of an employee
’s shares than previously allowed for tax withholding purposes without triggering liability accounting, allows a company to make a policy election to account for forfeitures as they occur, and eliminates the requirement that excess tax benefits be realized before companies can recognize them. The new guidance also requires excess tax benefits and tax shortfalls to be presented on the cash flow statement as an operating activity rather than as a financing activity, and clarifies that cash paid to a tax authority when shares are withheld to satisfy its statutory income tax withholding obligation are to be presented as a financing activity. The standard is effective for financial statements issued for fiscal years beginning after
December
15,
2016,
and interim periods within those fiscal years. Early adoption is permitted. This standard is not expected to have a material effect on the Company’s financial position, results of operations and cash flows.
 
Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company
’s present or future financial statements. 
XML 24 R11.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 2 - Going Concern
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Substantial Doubt about Going Concern [Text Block]
NOTE
2
- GOING CONCERN
 
The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles of the United States of America, which contemplate continuation of the Company as a going concern. However, the Company has limited cash and incurred significant recent losses. These factors raise substantial doubt about the ability of the Company to continue as a going concern. There is no assurance that the Company will be successful in raising additional cash through the issuance of debt or equity instruments or return to achieving profitable operations. The financial statements do not include any adjustments that might result from the outcome of these uncertainties.
 
XML 25 R12.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Related Party Transactions
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]
NOTE
3
 
- RELATED PARTY TRANSACTIONS
 
 
During
October
and
December
of
2014,
an officer of LiqTech NA provided
$25,000
and
$35,000
in non-interest bearing advances to the Company totaling
$60,000.
These advances have been included in accounts payable at
December
31,
and were repaid in
January
2015.
 
During
March
2015,
an officer of LiqTech NA provided
$25,000
in non-interest bearing advances to the Company. These advances were repaid in
May
2015.
XML 26 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Inventory
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Inventory Disclosure [Text Block]
NOTE
4
- INVENTORY
 
Inventory consisted of the following at
December
31,
2016
and
December
31,
2015:
 
   
201
6
   
201
5
 
Furnace parts and supplies
  $
336,799
    $
466,538
 
Raw materials
   
1,216,098
     
1,498,406
 
Work in process
   
2,499,242
     
1,770,070
 
Finished goods and filtration systems
   
2,544,080
     
1,788,161
 
Reserve for obsolescence
   
(1,421,345
)
   
(606,504
)
Net Inventory
  $
5,174,874
    $
4,916,671
 
 
 
The inventory is held as collateral on a lines and credit and guarantees with financial institutions. See Note
9.
XML 27 R14.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Property and Equipment
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]
NOTE
5
 
- PROPERTY AND EQUIPMENT
 
Property and equipment consisted of the following at
December
31,
2016
and
December
31,
2015:
 
   
Useful Life
   
201
6
   
201
5
 
Production equipment
 
 3
-
10
    $
10,370,462
    $
10,536,377
 
Lab equipment
 
 3
-
10
     
76,658
     
143,783
 
Computer equipment
 
 3
-
5
     
185,652
     
269,526
 
Vehicles
 
 3
-
5
     
39,090
     
40,365
 
Furniture and fixture
 
 
5
 
     
146,453
     
141,502
 
Leasehold improvements
 
 
10
 
     
955,563
     
972,023
 
   
 
 
 
     
11,773,878
     
12,103,576
 
Less Accumulated Depreciation
 
 
 
 
     
(9,140,320
)    
(8,564,882
)
Net Property and Equipment
 
 
 
 
    $
2,633,558
    $
3,538,694
 
 
Depreciation expense amounted to $
1,373,505
and
$1,437,787,
for the year ended
December
31,
2016
and
2015,
respectively. The property and equipment is held as collateral on a lines of credit and guarantees with financial institutions. See Note
9.
XML 28 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Investments at Costs
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]
NOTE
6
– INVESTMENTS AT COST
 
The following tables summarize Level
1,
2
and
3
financial assets and financial (liabilities) by their classification in the Statement of Financial Position:
 
As of
December 31, 2016
 
Level 1
   
Level 2
   
Level 3
 
                         
Investments
   
-
     
-
     
5,282
 
                         
Total
   
-
     
-
     
5,282
 
 
   
As of December 31, 201
5
 
Level 1
   
Level 2
   
Level 3
 
                         
Investments
   
-
     
-
     
21,838
 
                         
Total
   
-
     
-
     
21,838
 
 
At
December
31,
2016,
our total investments of
$5,282
consisted of an investment of
$5,282
in LEA Technology in France to strengthen our sales channels in the French market.
 
At
December
31,
2015,
our total investments of
$21,838
consisted of an investment of
$5,460
in LEA Technology in France to strengthen our sales channels in the French market and an investment of
$16,378
in LiqTech Italy, a newly organized Italian Company, to strengthen our sales channels in the Italian market.
XML 29 R16.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Definite-life Intangible Assets
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Intangible Assets Disclosure [Text Block]
NOTE
7
 
- DEFINITE-LIFE INTANGIBLE ASSETS
 
At
December
31,
2016
and
December
31,
2015,
definite-life intangible assets, net of accumulated amortization, consisted of patents on the Company’s products of
$5,614
and
$10,386,
respectively. The patents are recorded at cost and amortized over
two
to
ten
years. Amortization expense for the years ended
December
31,
2016
and
2015
was
$4,772
and
$6,322,
respectively. Expected future amortization expense for the years ended are as follows:
 
Year ending December 31,
 
Amortization
Expenses
 
2017
   
2,699
 
2018
   
2,270
 
2019
   
645
 
Thereafter
 
 
-
 
    $
5,614
 
XML 30 R17.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Goodwill
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Goodwill Disclosure [Text Block]
NOTE
8
- GOODWILL
 
The following is a summary of goodwill:
 
   
December 31,
201
6
 
         
Goodwill at beginning of period
  $
7,582,749
 
Effect of currency translation
   
(239,541
)
Impairment write down
   
(7,343,208
)
Goodwill at end of period
  $
-
 
 
Goodwill consists of:
 
December 31,
201
6
 
         
LiqTech Systems A/S (Formerly Provital Solutions A/S)
  $
-
 
 
 
Goodwill is evaluated for impairment annually in the
fourth
quarter of the Company
’s fiscal year, and whenever events or changes in circumstances indicate the carrying value of goodwill
may
not be recoverable. Triggering events that
may
indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows. Key variables included in evaluating goodwill for impairment include the pipeline of proposed potential customer sales, budgeted reoccurring sales, risk free interest rate and risk premium rate and future budgeted operating results. The Company recorded an impairment charge of
$7,343,208
and
$0
on goodwill, during the year ended
December
31,
2016
and
2015,
as management's estimated fair value of the reporting unit did not exceeded the carrying value during
2016
fourth
quarter testing. 
XML 31 R18.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Lines of Credit
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Debt Disclosure [Text Block]
NOTE
9
- LINES OF CREDIT
 
In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a guarantee line of DKK
94,620
(approximately
$13,416
at
December
31,
2016)
with a bank, subject to certain base limitations. As of
December
31,
2016,
we had DKK
94,620
(approximately
$13,416)
 in working guarantee against the line. This line of credit is guaranteed by Vækstfonden (the Danish State's investments fund) and is secured by certain assets of LiqTech Systems such as receivables, inventory and equipment. The Company has no other available lines of credit.
XML 32 R19.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Leases
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Leases of Lessee Disclosure [Text Block]
NOTE
10
 - LEASES
 
Operating Leases
 
--
The Company leases office and production facilities under operating lease agreements expiring in
March
2021,
August
2018,
May
2018,
and
June
2017.
In some of these lease agreements, the Company has the right to extend.
 
The future minimum lease payments for non-cancelable operating leases having remaining terms in excess of
one
year as of
December
31,
2016
are as follows:
 
Year ending December 31,
 
Lease
Payments
 
2017
   
559,058
 
2018
   
457,735
 
2019
   
179,094
 
Thereafter
   
395,898
 
Total Minimum Lease Payments
  $
1,591,785
 
 
Lease expense charged to operations was
$645,817
and
$697,736,
for the year ended
December
31,
2016,
and
2015.
 
Capital Leases
 
--
 The Company leases equipment on various variable rate capital leases currently calling for monthly payments of approximately
$9,319,
$591
and
$532
expiring through
July
2018.
Included in property and equipment, at
December
31,
2016
and
December
31,
2015,
the Company had recorded equipment on capital lease at
$1,240,358
and
$1,302,005,
respectively, with related accumulated depreciation of
$1,126,550
and
$1,033,062,
respectively. 
 
During the years ended
December
31,
2016
and
2015,
depreciation expense for equipment on capital lease amounted to
$130,025,
and
$141,050,
respectively, and has been included in depreciation expense. During the years ended
December
31,
2016
and
2015,
interest expense on a capital lease obligation amounted to
$16,758
and
$26,840,
respectively.
 
Future minimum capital lease payments are as follows for the years ended
December
31:
 
Year ending December 31,
 
Lease
Payments
 
2017
  $
121,636
 
2018
   
23,720
 
Thereafter
 
 
-
 
Total minimum lease payments
   
145,356
 
Less amount representing interest
   
(5,531
)
Present value of minimum lease payments
   
139,825
 
Less Current Portion
   
(45,883
)
    $
93,942
 
XML 33 R20.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Agreements and Commitments
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]
NOTE
11
 
- AGREEMENTS, COMMITMENTS AND CONTINGENCIES
 
401(K)
Profit Sharing Plan
 -- LiqTech NA has a
401(k)
profit sharing plan and trust covering certain eligible employees. The amount LiqTech NA contributes is discretionary. For the year ending
December
31,
2016
and
2015,
matching contributions were expensed and totaled
$11,347
and
$14,610,
respectively.
 
Contingencies --
From time to time, we
may
be involved in litigation relating to claims arising out of our operations in the normal course of business.
 
On
September
9,
2014,
Mr. Raffaele Bruno Tronchetti Provera (“Plaintiff”), the
60%
owner of LiqTech Italy s.r.l. (the “Venture”), sued LiqTech International A/S, the
40%
owner of the Venture (“Defendant”),
750,000
Euros before the Court of Como, Italy alleging, among other things, that certain products provided by Defendant to the Venture were defective.
  As of
March
23,
2017,
the case is in the preliminary stages where the court has appointed an expert in order to verify the quality of the products in order to determine whether there is sufficient evidence to proceed.  An evaluation of the outcome will only be possible after the results of the court appointment expert are known. This outcome of the court appointment expert is expected to be reported in
second
quarter of
2017.
Defendant believes that the claims are without merit and intends to vigorously defend any litigation.
 
In connection with certain orders, we have to give the customer a working guarantee or a prepayment guarantee or security bond. For that purpose, we have a guarantee line of DKK
94,620
(approximately
$13,416
at
December
31,
2016)
with a bank, subject to certain base limitations. As of
December
31,
2016,
we had DKK
94,620
(approximately
$13,416)
 in working guarantee against the line. At
December
31,
2016,
the Company had a cash balance of
$292,826
that is restricted to secure work issued by the Company that is not part of the above line of credit
.
XML 34 R21.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
NOTE
12
 
- INCOME TAXES
 
The Company accounts for income taxes in accordance with FASB ASC Topic
740,
Accounting for Income Taxes; which requires the Company to provide a net deferred tax asset or liability equal to the expected future tax benefit or expense of temporary reporting differences between book and tax accounting and any available operating loss or tax credit carry forwards. The amount of and ultimate realization of the benefits from the deferred tax assets for income tax purposes is dependent, in part, upon the tax laws in effect, the Company
’s future earnings, and other future events, the effects of which cannot be determined. In accordance with prevailing accounting guidance, the Company is required to recognize and disclose any income tax uncertainties. The guidance provides a
two
-step approach to recognizing and measuring tax benefits and liabilities when realization of the tax position is uncertain. The
first
step is to determine whether the tax position meets the more-likely-than-not condition for recognition and the
second
step is to determine the amount to be recognized based on the cumulative probability that exceeds
50%,
Actual results could differ from these estimates.
 
As of
December
31,
2016,
the Company had net operating loss carryovers of approximately
$11,128,000
for U.S. Federal purposes expiring through
2036;
approximately
$6,486,000
 for Danish tax purposes, which do not expire; approximately
$437,000
for German tax purposes, which do not expire and approximately
$571,000
for Singapore tax purposes which do not expire. 
 
As of
December
31,
2016
and
2015,
the Company established a valuation allowance of
$3,542,000
and
$0
for the tax components of LiqTech International Inc and Liqtech NA,
$1,095,000
and
$0
for the tax components of LiqTech International AS and LiqTech Systems AS,
$122,000
and
$118,000
for the tax component of LiqTech Germany and
$97,000
 and
$109,000
 for the tax component of LiqTech Singapore as management could not determine that it was more than likely not that sufficient income could be generated by these components to realize the resulting net operating loss carry forwards and other deferred tax assets of these components.  The change in the valuation allowance for the year ended
December
31,
2016
was
$3,542,000,
$1,095,000,
$4,000
and
$12,000
for the US, Danish, German and Singapore components. The change in the valuation allowance for the year ended
December
31,
2015
was
$0,
$0,
$118,000
and
$109,000
for the US, Danish, German and Singapore components.
 
The Company is not relying on the reversal of deferred tax liabilities to realize the deferred tax assets. The same variable used by the Company in evaluating goodwill for impairment were used in assessing the realization of deferred tax assets (See Note
8).
 
The Company further considered the following positive and negative evidence:
 
Positive Evidence
 
1
) The Company had profitable
2015
third
and
fourth
quarter results. The Company noted a significant increase in proposed sales pipeline from
December
31,
2014
to
2015.
 
2
) The Company executed in
June
2015
a Diesel Particular Filtration supplier contract in China.
 
3
) For Danish tax purposes the Company is able to obtain tax refunds for research and development expenditures
 
Negative Evidence
 
 
1)
The Company has noted a longer than anticipated sales cycle from proposals to signing filtration systems order.
 
2)
The Company has a net loss from operations for the year ended
December
31,
2016
and
2015.
 
3)
The Company has experienced a decrease in l
iquid filter sales.
 
4)
The Company has experienced delays in requested shipment date of large DPF sales orders and collection of receivables from large water treatment systems.
 
The temporary differences, tax credits and carry forwards gave rise to the following deferred tax asset (liabilities) at
December
31,
2016
and
December
31,
2015:
 
 
 
   
201
6
   
201
5
 
Vacation accrual
  $
5,450
    $
3,933
 
Allowance for doubtful Accounts
   
1,202
     
14,089
 
Reserve for obsolete inventory
   
200,118
     
154,100
 
Valuation Allowance
   
(206,770
)
   
 
 
Net current tax assets
  $
-
    $
172,122
 
                 
Business tax credit carryover
   
30,935
     
30,935
 
Deferred compensation
   
8,500
     
-
 
Net operating loss carryover
   
4,906,974
     
4,333,820
 
Excess of book over tax depreciation
   
(296,227
)
   
(452,088
)
Valuation Allowance
   
(4,650,182
)
   
(228,170
)
Long term deferred tax asset
  $
-
    $
3,684,497
 
 
 
A reconciliation of income tax expense at the federal statutory rate to income tax expense at the Company
’s effective rate is as follows for the years ended 
December
31,
2016
and
2015:
 
 
   
201
6
   
201
5
 
Computed tax at expected statutory rate
  $
(4,487,649
)
  $
(991,139
)
State and local income taxes, net of federal benefits
   
(3,721
)
   
(20,476
)
Non-deductible expenses
   
4,242
     
5,291
 
Non-US income taxed at different rates
   
1,325,180
     
47,837
 
Non-deductible deferred compensation
   
148,170
     
140,175
 
Effect of changes in tax rates
   
(21,489
)    
(31,748
)
Non-deductible impairment of goodwill
   
1,615,506
     
-
 
Non-deductible loss of subsidiaries
   
-
     
50,579
 
Valuation Allowance
   
4,739,806
     
109,842
 
Other items
   
(100,368
)
   
(8,147
)
Income tax expense (benefit)
  $
3,219,677
    $
(697,786
)
 
 
The components of income tax expense (benefit) from continuing operations for the years ended
December
31,
2016
and
2015
consisted of the following:
 
   
2016
   
201
5
 
Current income tax expense:
               
Danish
  $
(329,816
)
  $
(266,107
)
Federal
   
-
     
-
 
State
   
580
     
570
 
Current tax (benefit)
  $
(329,236
)
  $
(265,537
)
                 
                 
Book in excess of tax depreciation
  $
(158,684
)
  $
(136,572
)
Business tax credit carryover
   
-
     
(5,226
)
Net operating loss carryover
   
(1,000,650
)
   
(517,153
)
Allowance for doubtful accounts
   
12,705
     
156,036
 
Valuation Allowance
   
4,756,013
     
-
 
Accrued Vacation
   
(1,517
)
   
1,143
 
Deferred Compensation
   
(8,500
)
   
171,615
 
Reserve for obsolete inventory
   
(50,452
)
   
(102,092
)
Deferred tax expense (benefit)
  $
3,548,913
    $
(432,249
)
Total tax expense (benefit)
  $
3,219,677
    $
(697,786
)
 
Deferred income tax expense / (benefit) results primarily from the reversal of temporary timing differences between tax and financial statement income.
 
 
 
The Company files Danish and U.S. federal and
 Minnesota state income tax returns. LiqTech International AS is generally no longer subject to tax examinations for years prior to
2010
for their Danish tax returns. LiqTech NA is generally no longer subject to tax examinations for years prior to
2012
for U.S. federal and U.S. states tax returns. 
XML 35 R22.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Earnings Per Share
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Earnings Per Share [Text Block]
NOTE
13
 
- EARNINGS PER SHARE
 
The following data shows the amounts used in computing earnings per share and the effect on income and the weighted average number of shares of potential dilutive common stock for the year ended
December
31,
2016
and
2015:
 
   
For the Year Ended
December 31
 
   
201
6
   
201
5
 
Net Loss attributable to LiqTech International Inc.
  $
(16,418,634
)
  $
(2,209,857
)
Weighted average number of common shares used in basic earnings per share
   
36,835,514
     
36,790,420
 
Effect of dilutive securities, stock options and warrants
   
-
     
-
 
Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share
   
36,835,514
     
36,790,420
 
 
For the year ended
December
31,
2016,
Parent had
868,000
options outstanding to purchase common stock of Parent at
$0.74
to
$1.90
per share and Parent had
825,575
 warrants outstanding to purchase common stock of Parent at
$0.81
to
$4.06
per share, which were not included in the loss per share computation because their effect would be anti-dilutive.
 
For the year ended
December
31,
2015,
Parent had
1,071,000
options outstanding to purchase common stock of Parent at
$0.74
to
$1.90
per share and Parent had
7,225,575
 warrants outstanding to purchase common stock of Parent at
$1.00
to
$4.06
per share, which were not included in the loss per share computation because their effect would be anti-dilutive. The basic and diluted weighted average shares was restated to reflect the cancelation of
2,696,521
shares held in escrow. See Note
14.
XML 36 R23.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Stockholders' Equity
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
NOTE
14
- STOCKHOLDERS' EQUITY
 
Common Stock --
Parent has
100,000,000
authorized shares of common stock,
$0.001
par value. As of
December
31,
2016
and
2015,
respectively, there were
36,835,514
and
39,532,035
common shares issued and outstanding.
  
  
 
Voting
--
Holders of Parent common stock are entitled to
one
vote for each share held of record on each matter submitted to a vote of stockholders, including the election of directors, and do not have any right to cumulate votes in the election of directors. 
 
Dividends
--
Subject to the rights and preferences of the holders of any series of preferred stock which
may
at the time be outstanding, holders of Parent common stock are entitled to receive ratably such dividends as our Board of Directors from time to time
may
declare out of funds legally available.  
 
Liquidation Rights
--
In the event of any liquidation, dissolution or winding-up of affairs of Parent, after payment of all of our debts and liabilities and subject to the rights and preferences of the holders of any outstanding shares of any series of our preferred stock, the holders of Parent common stock will be entitled to share ratably in the distribution of any of our remaining assets.  
 
 
Other Matters
--
Holders of Parent common stock have no conversion, preemptive or other subscription rights, and there are no redemption rights or sinking fund provisions with respect to the common stock. All of the issued and outstanding shares of common stock on the date of this report are validly issued, fully paid and non-assessable.
 
Preferred Stock
 --
Our Board of Directors has the authority to issue Parent preferred stock in
one
or more classes or series and to fix the designations, powers, preferences and rights, the qualifications, limitations or restrictions thereof, including dividend rights, dividend rates, conversion rights, voting rights, terms of redemption, redemption prices, liquidation preferences and the number of shares constituting any class or series, without further vote or action by the stockholders. The issuance of Parent preferred stock
may
have the effect of delaying, deferring or preventing a change in control of us without further action by the stockholders and
may
adversely affect the voting and other rights of the holders of common stock.
 
Common Stock Cancelation
 
 
On
December
31,
2016,
the Company canceled
2,696,521
common shares
two
-
thirds
(2/3)
of the previously issued common shares held in escrow issued in connection with the Company through its subsidiary, LiqTech Int. DK, acquisition of all of the issued and outstanding capital stock of Provital Solutions A/S, as Provital Solutions A/S failed to meet the
2014,
2015
and
2016
catchup gross revenue and EBITDA thresholds for release from escrow.
 
Common Stock Issuanc
e
 
On
August
14,
2015,
the Company issued an additional
27,253
shares of restricted stock valued at
$20,167
for services provided and to be provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which
27,253
shares vested on
January
1,
2016.
 
On
April
13,
2015,
the Company issued an additional
100,000
shares of restricted stock valued at
$75,000
for services provided and to be provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which
33,333
shares vested on
January
 
1,
2016,
33,333
shares will vest on
January
1,
2017
and
33,334
shares will vest on
January
1,
2018.
 
During the
third
quarter
2014,
the Company issued
47,500
shares of common stock in connection with the exercise of
47,500
stock options with an exercise price of
$1.50
each.
 
On the
July
29,
2014,
the Company, through its subsidiary, LiqTech Int. DK, completed the acquisition of all of the issued and outstanding capital stock (the “Shares”) of LiqTech Systems and as part of the consideration for the LiqTech Systems Shares, the Company issued
4,044,782
of Parent
’s common shares. 
 
On
July
28,
2014,
Parent completed a registered public offering of its common stock.
 As part of the closing, Parent issued
8,000,000
shares of common stock at a per share price of
$1.50
and generated net proceeds of
$10,736,278
net of offering costs of
$1,263,722.
  
 
During
2014,
the Company issued an additional
100,000
shares of restricted stock valued at
$158,000
for services provided by the board of directors. The Company will recognize the non-cash compensation of the award over the requisite service period, of which
33,333
shares vested on
December
31,
2014,
33,333
shares will vest on
December
31,
2015
and
33,334
shares will vest on
December
31,
2016.
 
 
As of
December
31,
2016
and
2015,
the Company has recorded non-cash compensation expense of
$77,667
and
$204,500
relating to the awards, respectively.   
 
Common Stock Purchase Warrants
 
A summary of the status of the warrants outstanding at
December
31,
2016
is presented below:
 
 
 
 
 
Warrants Outstanding
   
Warrants Exercisable
 
Exercise Prices
   
Number
Outstanding
   
Weighted
Average
Remaining
Contractual Life
(years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
 
$
0.81
     
100,000
     
1.00
    $
0.81
     
100,000
    $
0.81
 
$
1.00
     
200,000
     
1.00
    $
1.00
     
133,333
    $
1.00
 
$
1.65
     
400,000
     
2.57
    $
1.65
     
400,000
    $
1.65
 
$
4.06
     
125,575
     
0.18
    $
4.06
     
125,575
    $
4.06
 
Total
     
825,575
     
1.64
    $
1.76
     
758,908
    $
1.82
 
 
   
At
December
30,
2016,
the Company had
66,667
non-vested warrants. We have recorded non-cash compensation expense of
$50,634
for the year ended
December
31,
2016
related to the warrants issued.
 
The exercise price of the warrants and the number of shares underlying the warrants are subject to adjustment for stock dividends, subdivisions of the outstanding shares of common stock and combinations of the outstanding shares of common stock. For so long as the warrants remain outstanding, we are required to keep reserved from our authorized and unissued shares of common stock a sufficient number of shares to provide for the issuance of the shares underlying the warrants.
 
On
February
15,
2016,
the Company issued to
a consultant a warrant to purchase
100,000
shares at an exercise price of
$0.81
per share. The warrants are exercisable immediately and will remain exercisable until
December
31,
2017.
 
On
June
4,
2015,
the Company issued to Wolfe Axelrod Weinberger Associates, LLC a warrant to purchase
200,000
shares at an exercise price of
$1.00
per share. The warrants
 vested
1/3
upon issuance,
1/3
on
June
4,
2016,
1/3
will vest on
June
2017,
and will remain exercisable until
December
31,
2017.
 
 
Stock Options
  
 
In
August
2011,
Parent
’s Board of Directors adopted a Stock Option Plan (the “Plan”). Under the terms and conditions of the Plan, the Board of Directors is empowered to grant stock options to employees, officers, and directors of the Company. At
December
31,
2016,
868,000
options were granted and outstanding under the Plan. 
 
The Company recognizes compensation costs for stock option awards to employees based on their grant-date fair value. The value of each stock option is estimated on the date of grant using the Black-Scholes option-pricing model. The weighted-average assumptions used to estimate the fair values of the stock options granted using the Black-Scholes option-pricing model are as follows:
 
   
LiqTech
International, Inc.
 
Expected term (in years)
 
 5
-
10
 
Volatility
 
 74.65%
to
76.87%
 
Risk free interest rate
 
 1.38%
-
2.24%
 
Dividend yield
 
 
0%
 
 
 
The Company recognized stock based compensation expense
 related to the options of
$307,493
and
$154,745
for the years ended
December
31,
2016
and
2015,
respectively. At
December
31,
2016,
the Company had approximately
$105,927
of unrecognized compensation cost related to non-vested options expected to be recognized through
December
31,
2018.
 
A summary of the status of the options outstanding under the Company
’s stock option plans at
December
31,
2015
is presented below: 
 
 
 
 
 
Options Outstanding
   
Options Exercisable
 
Exercise
Prices
   
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life (years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
 
$
0.74
     
400,000
     
3.62
    $
0.74
     
133,334
    $
0.74
 
$
0.75
     
100,000
     
3.29
    $
0.75
     
33,333
    $
0.75
 
$
1.01
     
130,000
     
8.97
    $
1.01
     
130,000
    $
1.01
 
$
1.90
     
238,000
     
0.08
    $
1.90
     
238,000
    $
1.90
 
Total
     
868,000
     
3.41
    $
1,10
     
534,667
    $
3.32
 
 
A summary of the status of the options at
December
31,
2016,
and changes during the period is presented below:
 
   
December
3
1
, 2016
 
   
Shares
   
Weighted
Average
Exercise
Price
   
Average
Remaining
Life
   
Weighted
Average
Intrinsic
Value
 
                                 
Outstanding at beginning of period
   
1,071,000
    $
1.19
     
3.93
    $
-
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Forfeited
   
(203,000
)
   
1.59
     
-
     
-
 
Expired
   
-
     
-
     
-
     
-
 
Outstanding at end of period
   
868,000
    $
1.10
     
3.41
    $
0
 
Vested and expected to vest
   
868,000
    $
1.10
     
3.41
    $
0
 
Exercisable end of period
   
534,667
    $
1.32
     
3.32
    $
0
 
 
At
December
31,
201
6,
the Company had
333,333
non-vested options with a weighted average exercise price of
$0.74
and with a weighted average grant date fair value of
$0.46,
resulting in unrecognized compensation expense of
$105,927,
which is expected to be expensed over a weighted-average period of
1.2
years.
 
The total intrinsic value of options at
December
31,
2016
was
$0.
 Intrinsic value is measured using the fair market value at the date of exercise (for shares exercised) or at
December
31,
2016
(for outstanding options), less the applicable exercise price. 
XML 37 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Significant Customers / Concentration
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
NOTE
15
 
- SIGNIFICANT CUSTOMERS / CONCENTRATION
 
For the year ended
December
31,
2016,
our
four
largest customers accounted for approximately
33%,
25%,
5%
and
4%,
respectively, of our net sales (approximately
67
% in total). For the year ended
December
31,
2015,
our
four
largest customers accounted for approximately
24%,
15%,
11%
and
6%,
respectively, of our net sales (approximately
56%
in total).
 
The Company sells products
 throughout the world; sales by geographical region are as follows for the year ended
December
31,
2016
and
2015:
 
   
For the Year Ended December 31
 
   
201
6
   
201
5
 
United States and Canada
  $
689,766
    $
1,521,718
 
Australia
   
387,807
     
382,883
 
South America
   
115,675
     
2,400,000
 
Asia
   
1,105,272
     
1,139,090
 
Europe
   
11,607,874
     
10,368,896
 
    $
13,906,394
    $
15,812,587
 
 
 
The Company
’s sales by product line are as follows for the year ended
December
31,
2016
and
2015:
 
   
For the Year Ended
December 31
 
   
201
6
   
201
5
 
Ceramic diesel particulate
  $
5,820,793
    $
5,081,304
 
Liquid filters
   
7,731,079
     
10,347,010
 
Kiln furniture
   
354,522
     
384,273
 
    $
13,906,394
    $
15,812,587
 
 
As of
December
31,
2016,
approximately
85%
and
15%
of the Company’
s assets were located in Denmark and the United States, respectively. As of
December
31,
2015,
approximately
89%
and
11%
of the Company’s assets were located in Denmark and the United States, respectively
XML 38 R25.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 16 - Subsequent Event
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Subsequent Events [Text Block]
NOTE
16
 - SUBSEQUENT EVENT
 
The Company had
238,000
options and
125,575
warrants expire unexercised during the
first
quarter of
2017.
 
The Company
’s management reviewed material events through
March
30,
2017.
 
XML 39 R26.htm IDEA: XBRL DOCUMENT v3.7.0.1
Schedule II - Valuation and Qualifying Accounts
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
The financial statements are set forth under Item
 
8
of this Annual Report. The following financial statement schedule for the years ended
December
31,
2016
and
December
31,
2015
is included in this Annual Report on Form
10
-K:
 
a.
         Valuation and Qualifying Accounts for the years ended
December
31,
2016
and
December
31,
2015.
 
   
Balance
Beginning
of Year
   
Charges to
Costs and
Expenses
   
Deductions
(1)
   
Balance
End of
Year
 
Year Ended
December 31, 2016
                               
Allowance for inventory obsolescence
  $
606,504
    $
824,958
    $
(10,117
)
  $
1,421,345
 
Allowance for doubtful accounts
   
1,087,871
     
1,437,949
     
(397,368
)
   
2,128,452
 
Totals
  $
1,694,375
    $
2,262,907
    $
(407,485
)
  $
3,549,797
 
 
   
Balance
Beginning
of Year
   
Charges to
Costs and
Expenses
   
Deductions
(1)
   
Balance
End of
Year
 
Year Ended December 31,
2015
                               
Allowance for inventory obsolescence
  $
449,098
    $
174,143
    $
(16,737
)
  $
606,504
 
Allowance for doubtful accounts
   
1,654,290
     
(80,729
)
   
(485,690
)
   
1,087,871
 
Totals
  $
2,103,388
    $
93,414
    $
(502,427
)
  $
1,694,375
 
 
 
   
201
6
   
201
5
 
Allowance for doubtful accounts at the beginning of the period
  $
1,087,871
    $
1,654,290
 
Bad debt expense
   
1,437,949
     
80,729
 
Amount of receivables written off
   
(252,792
)
   
(398,083
)
Effect of currency translation
   
(144,576
)
   
(249,065
)
Allowance for doubtful accounts at the end of the period
  $
2,128,452
    $
1,087,871
 
 
(1)
Includes write-offs, the impact of foreign currency exchange rates and the effect of the acquisition of LiqTech Systems A/S. 
 
Schedules other than that listed above are omitted because the conditions requiring their filing do not exist or because the required information is provided in the Consolidated Financial Statements, including the Notes thereto. Financial statement schedules have been omitted since they are either not required, not applicable, or the information is otherwise included.
XML 40 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Significant Accounting Policies (Policies)
12 Months Ended
Dec. 31, 2016
Accounting Policies [Abstract]  
Basis of Accounting, Policy [Policy Text Block]
Business and Basis of Presentation
 
The consolidated financial statements include the accounts of LiqTech International, Inc. (“Parent”) and its subsidiaries.
 The terms "Company", “us", "we" and "our" as used in this report refer to Parent and its subsidiaries, which are set forth below. The Company engages in the development, design, production, marketing and sale of automated filtering systems, liquid filters, diesel particulate air filters and kiln furniture in United States, Canada, Europe, Asia and South America. Set forth below is a description of Parent and each of its subsidiaries:
 
LiqTech International, Inc., a Nevada corporation organized in
July
2004,
formerly known as Blue Moose Media, Inc.
 
LiqTech USA, a Delaware corporation and a wholly-owned subsidiary of Parent formed in
May
2011.
 
LiqTech International AS, a Danish corporation, incorporated on
January
15,
2000
(“LiqTech Int. DK”), a
100%
owned subsidiary of LiqTech USA, engages in development, design, application, marketing and sales of membranes on ceramic diesel particulate and liquid filters and catalytic converters in Europe, Asia and South America.
 
LiqTech NA, Inc. (“LiqTech NA”), incorporated in Delaware on
July
1,
2005,
a
100%
owned subsidiary of LiqTech USA. LiqTech NA, Inc. engages in the production, marketing and sale of ceramic diesel particulate and liquid filters and kiln furniture in United States and Canada.
 
LiqTech Asia (“LiqTech Asia”) a
60%
owned subsidiary of LiqTech Int. DK, incorporated in South Korea on
July
20,
2006,
was a dormant subsidiary. The company was closed on
March
6,
2015.
 
LiqTech Germany (“LiqTech Germany”) a
100%
owned subsidiary of LiqTech Int. DK, incorporated in Germany on
December
9,
2011,
engages in marketing and sale of liquid filters in Germany. The Company is in the process of closing operations, which is expected to be completed during
2017.
 
LiqTech PTE Ltd, (“LiqTech Sing”) a
95%
owned subsidiary of LiqTech Int. DK, incorporated in Singapore on
January
19,
2012,
engages in marketing and sale of liquid filters in Singapore and other countries in the area. The Company is in the process of closing operations, which is expected to be completed during
2017.
 
LiqTech Systems AS, a Danish Corporation ("LiqTech Systems") (Formerly Provital Solutions A/S) was incorporated on
September
1,
2009
and engages in the manufacture of fully automated filtering systems for application within the pool and spa markets, marine applications, and a number of industrial applications within Denmark and international markets. The financial statements include the accounts of LiqTech Systems from the date of acquisition on
July
31,
2014.
Consolidation, Policy [Policy Text Block]
Consolidation
 
--
 The consolidated financial statements include the accounts and operations of the Company. The non-controlling interests in the net assets of the subsidiaries are recorded in equity. The non-controlling interests of the results of operations of the subsidiaries are included in the results of operations and recorded as the non-controlling interest in subsidiaries. All material inter-company transactions and accounts have been eliminated in the consolidation.
Foreign Currency Transactions and Translations Policy [Policy Text Block]
Functional Currency / Foreign currency translation
 -- 
The functional currency of LiqTech International, Inc., LiqTech USA, Inc. and LiqTech NA is the U.S. Dollar. The Functional Currency of LiqTech Int. DK and LiqTech Systems AS is the Danish Krone (“DKK”), the functional currency of LiqTech Germany is the Euro, the functional currency of LiqTech Singapore is the Singapore Dollar and the functional Currency of LiqTech Asia is South Korean Won. The Company’s reporting currency is U.S. Dollar for the purpose of these financial statements. The foreign subsidiaries balance sheet accounts are translated into U.S. Dollars at the period-end exchange rates and all revenue and expenses are translated into U.S. Dollars at the average exchange rates prevailing during the years ended
December
31,
2016
and
2015.
Translation gains and losses are deferred and accumulated as a component of other comprehensive income in stockholders’ equity. Transaction gains and losses that arose from exchange rate fluctuations from transactions denominated in a currency other than the functional currency are included in the statement of operations as incurred.
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash, Cash Equivalents and Restricted Cash
 
--
 The Company considers all highly liquid debt instruments purchased with a maturity of
three
months or less to be cash equivalents. The Company had
no
balances held in a financial institution in the United States in excess of federally insured amounts at
December
31,
2016
and
December
31,
2015.
At
December
31,
2016
and
2015,
the Company had cash balances of
$0
and
$292,826
that are restricted to secure guarantees issued by the Company. The cash is restricted until the underlying guarantees are released. 
Loans and Leases Receivable, Allowance for Loan Losses Policy [Policy Text Block]
Accounts Receivable
 
--
 Accounts receivables consist of trade receivables arising in the normal course of business. The Company establishes an allowance for doubtful accounts which reflects the Company’s best estimate of probable losses inherent in the accounts receivable balance. The Company determines the allowance based on known troubled accounts, historical experience, and other currently available evidence. 
 
The roll forward of the allowance for doubtful accounts for the year ended
December
31,
2016
and
December
31,
2015
is as follows:
 
   
201
6
   
201
5
 
Allowance for doubtful accounts at the beginning of the period
  $
1,087,871
    $
1,654,290
 
Bad debt expense
   
1,437,949
     
80,729
 
Amount of receivables written off
   
(252,792
)
   
(398,083
)
Effect of currency translation
   
(144,576
)
   
(249,065
)
Allowance for doubtful accounts at the end of the period
  $
2,128,452
    $
1,087,871
 
Inventory, Policy [Policy Text Block]
Inventory
 
--
 Inventory is carried at the lower of cost or market, as determined on the
first
-in,
first
-out method.
Property, Plant and Equipment, Policy [Policy Text Block]
Property and Equipment
 
--
 Property and equipment are stated at cost. Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized, upon being placed in service. Expenditures for maintenance and repairs are charged to expense as incurred. Depreciation is computed for financial statement purposes on a straight-line basis over the estimated useful lives of the assets, which range from
three
to
ten
years (See Note
5).
Investment, Policy [Policy Text Block]
Long-Term Investments
 
--
 Investments in non-consolidated companies are included in long-term investments in the consolidated balance sheet and are accounted for under the cost method and equity method. For these non-quoted investments, we regularly review the assumptions underlying the operating performance and cash flow forecasts based on information requested from these privately held companies. Generally, this information
may
be more limited,
may
not be as timely as and
may
be less accurate than information available from publicly traded companies. Assessing each investment's carrying value requires significant judgment by management. If it is determined that there is an-other-than-temporary decline in the fair value of a non-public equity security, we write-down the investment to its fair value and record the related write-down as an investment loss in the consolidated statement of operations.
Goodwill and Intangible Assets, Policy [Policy Text Block]
Intangible Assets
 
--
 Definite life intangible assets include patents. The Company accounts for definite life intangible assets in accordance with Financial Accounting Standards Board, (“FASB”) Accounting Standards Codification, (“ASC”) Topic
350,
“Goodwill and Other Intangible Assets” and amortized the patents on a straight line basis over the estimated useful life of
two
to
ten
years. 
Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]
Goodwill
-- Goodwill is evaluated for impairment annually, and whenever events or changes in circumstances indicate the carrying value of goodwill
may
not be recoverable. Triggering events that
may
indicate impairment include, but are not limited to, a significant adverse change in customer demand or business climate that could affect the value of goodwill or a significant decrease in expected cash flows.
Revenue Recognition, Policy [Policy Text Block]
Revenue Recognition and Sales Incentives
 
--
 The Company accounts for revenue recognition in accordance with the Securities and Exchange Commission Staff Accounting Bulletin No.
101,
“Revenue Recognition in Financial Statements” (SAB
101),
FASB ASC
605
Revenue Recognition. The Company recognizes revenue when rights and risk of ownership have passed to the customer, when there is persuasive evidence of an arrangement, product has been shipped or delivered to the customer, the price and terms are finalized, and collections of resulting receivable is reasonably assured. Products are primarily shipped FOB shipping point at which time title passes to the customer. In some instances the Company uses common carriers for the delivery of products. In these arrangements, sales are recognized upon delivery to the customer. The Company's revenue arrangements with its customers often include early payment discounts and such sales incentives are recorded against sales.
 
The Company has received long-term contracts for the installation of various water filtrations systems and grants from government entities for development and use of silicon carbide membranes in various water filtration and treatment applications. Revenues from long-term contracts and grants are recognized on the percentage-of-completion method, measured by the percentage of project costs incurred to date to estimated total project costs for each long-term contract or grant multiplied by the long-term contract or grant income on a project by project basis. This method is used because management considers costs incurred to be the best available measure of progress on contracts in process.
 
Project costs of the long-term contracts and grants include
 all direct material and labor costs and those indirect costs related to the project. Project costs are capitalized and accreted into cost of sales based on the percentage of the project completed. Should a loss be estimated on an incomplete project it would be recorded in the period in which such a loss is determined. Changes in estimated profitability of a project are recognized in the period in which the revisions are determined. The aggregate of costs incurred and income recognized on incomplete projects are recorded as costs in excess of billings and are shown as a current asset. The aggregate of billings in excess of related costs incurred and income recognized on projects is shown as a current liability.
 
In Denmark, Value Added Tax (“VAT”) of
25%
of the invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The VAT collected is not revenue of the Company; instead, the amount is recorded as a liability on the balance sheet until such VAT is paid to the authorities.
 
Advertising Costs, Policy [Policy Text Block]
Advertising Cost
 
--
 Costs incurred in connection with advertising of the Company’s products is expensed as incurred. Such costs amounted to
$14,504
and
$34,442,
for the years ended
December
31,
2016
and
2015,
respectively.
Research, Development, and Computer Software, Policy [Policy Text Block]
Research and Development Cost
 
--
 The Company expenses research and development costs for the development of new products as incurred. Included in operating expense for the years ended
December
31,
2016
and
2015
were
$626,147,
and
$707,844,
respectively, of research and development costs.
Income Tax, Policy [Policy Text Block]
Income Taxes
 
--
 The Company accounts for income taxes in accordance with FASB ASC Topic
740
Accounting for Income Taxes. This statement requires an asset and liability approach for accounting for income taxes.
Earnings Per Share, Policy [Policy Text Block]
Income (Loss) Per Share
 
--
 The Company calculates earnings (loss) per share in accordance with FASB ASC
260
Earnings Per Share. Basic earnings per common share (EPS) are based on the weighted average number of common shares outstanding during each period. Diluted earnings per common share are based on shares outstanding (computed as under basic EPS) and potentially dilutive common shares. Potential common shares included in the diluted earnings per share calculation include in-the-money stock options and warrants that have been granted but have not been exercised.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]
Stock Options and Awards
 
--
 The Companies have granted stock options to certain key employees. See Note
14.
During the years presented in the accompanying consolidated financial statements, the Company has granted stock options and awards. The Company accounts for options in accordance with the provisions of FASB ASC Topic
718,
Compensation – Stock Compensation. Non-cash compensation costs of
$435,794
and
$369,531
have been recognized for the vesting of options and stock awards granted to employees with an associated recognized tax benefit of
$35,045
and
$157,080
for the years ended
December
31,
2016
and
2015,
respectively.
Fair Value Measurement, Policy [Policy Text Block]
Fair Value of Financial Instruments
 
--
 The Company accounts for fair value measurements for financial assets and financial liabilities in accordance with FASB ASC Topic
820.
The authoritative guidance, which, among other things, defines fair value, establishes a consistent framework for measuring fair value and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as the exit price, representing the amount that would either be received to sell an asset or be paid to transfer a liability in an orderly transaction between market participants. As such, fair value is a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability. As a basis for considering such assumptions, the guidance establishes a
three
-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value as follows:
 
 
Level
1.
Observable inputs such as quoted prices in active markets for identical assets or
 liabilities;
 
  
 
Level
2.
Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
 
 
Level
3.
Unobservable inputs in which there is little or no market data, which require the
 reporting entity to develop its own assumptions.
 
Unless otherwise disclosed, the fair value of the Company
’s financial instruments including cash, accounts receivable, prepaid expenses, investments, accounts payable, accrued expenses, capital lease obligations and notes payable approximates their recorded values due to their short-term maturities.
Use of Estimates, Policy [Policy Text Block]
Accounting Estimates
 
--
 The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets allowance for doubtful accounts receivable, cost in excess of billings, reserve for obsolete inventory, depreciation and impairment of property plant and equipment and impairment of goodwill and liabilities billings in excess of cost commitment and contingencies, the disclosures of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimated.
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Pronouncements
 
--
 In
May
2014,
the Financial Accounting Standards Board (FASB) issued a new standard to achieve a consistent application of revenue recognition within the U.S., resulting in a single revenue model to be applied by reporting companies under U.S. generally accepted accounting principles. Under the new model, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. In addition, the new standard requires that reporting companies disclose the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. On
July
9
2015,
the FASB agreed to delay the effective date by
one
year; accordingly, the new standard is effective for us beginning in the
first
quarter of
2018
and we expect to adopt it at that time. The new standard is required to be applied retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying it recognized at the date of initial application. We have not yet selected a transition method, nor have we determined the impact of the new standard on our consolidated financial statements.
 
In
2015,
the FASB issued an amended standard requiring that we classify all deferred tax assets and liabilities as non-current on the balance sheet instead of separating deferred taxes into current and non-current. The amended standard is effective for us beginning in the
first
quarter of
2017;
early adoption is permitted and we are evaluating whether we will early adopt. The amended standard
may
be adopted on either a prospective or retrospective basis. We do not expect that the adoption of this standard will have a significant impact on our financial position or results of operations.
 
In
February
2016,
the FASB issued changes to the accounting for leases that primarily affect presentation and disclosure requirements. The new standard will require the recognition of a right to use asset and underlying lease liability for operating leases with an initial life in excess of
one
year. This standard is effective for us beginning in the
first
quarter of
2019.
We have not yet determined the impact of the new standard on our consolidated financial statements.
 
In
August
2014,
the FASB issued ASU
2014
-
15,
Disclosure of Uncertainties About an Entity
’s Ability to Continue as a Going Concern, that will require management to assess an entity’s ability to continue as a going concern, and to provide related footnote disclosures in certain circumstances. In connection with each annual and interim period, management will assess if there is substantial doubt about an entity’s ability to continue as a going concern within
one
year after the issuance date. Substantial doubt exists if it is probable that the entity will be unable to meet its obligations within
one
year after the issuance date. The new standard defines substantial doubt and provides example indicators. Disclosures will be required if conditions give rise to substantial doubt. However, management will need to assess if its plans will alleviate substantial doubt to determine the specific disclosures. This standard is effective for public entities for annual periods ending after
December
15,
2016.
Earlier application of this standard is permitted. This standard is not expected to have a material effect on the Company’s financial position, results of operations and cash flows.
 
In
March
2016,
the FASB issued ASU
2016
-
09,
Compensation - Stock Compensation: Improvements to Employee Share-Based Payment Accounting, which changes how companies account for certain aspects of share-based payments to employees. The new guidance requires all income tax effects of awards to be recognized in the income statement when the awards vest or are settled, allows an employer to repurchase more of an employee
’s shares than previously allowed for tax withholding purposes without triggering liability accounting, allows a company to make a policy election to account for forfeitures as they occur, and eliminates the requirement that excess tax benefits be realized before companies can recognize them. The new guidance also requires excess tax benefits and tax shortfalls to be presented on the cash flow statement as an operating activity rather than as a financing activity, and clarifies that cash paid to a tax authority when shares are withheld to satisfy its statutory income tax withholding obligation are to be presented as a financing activity. The standard is effective for financial statements issued for fiscal years beginning after
December
15,
2016,
and interim periods within those fiscal years. Early adoption is permitted. This standard is not expected to have a material effect on the Company’s financial position, results of operations and cash flows.
 
Other recent accounting pronouncements issued by the FASB did not or are not believed by management to have a material impact on the Company
’s present or future financial statements. 
XML 41 R28.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Allowance for Credit Losses on Financing Receivables [Table Text Block]
   
201
6
   
201
5
 
Allowance for doubtful accounts at the beginning of the period
  $
1,087,871
    $
1,654,290
 
Bad debt expense
   
1,437,949
     
80,729
 
Amount of receivables written off
   
(252,792
)
   
(398,083
)
Effect of currency translation
   
(144,576
)
   
(249,065
)
Allowance for doubtful accounts at the end of the period
  $
2,128,452
    $
1,087,871
 
XML 42 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Inventory (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
   
201
6
   
201
5
 
Furnace parts and supplies
  $
336,799
    $
466,538
 
Raw materials
   
1,216,098
     
1,498,406
 
Work in process
   
2,499,242
     
1,770,070
 
Finished goods and filtration systems
   
2,544,080
     
1,788,161
 
Reserve for obsolescence
   
(1,421,345
)
   
(606,504
)
Net Inventory
  $
5,174,874
    $
4,916,671
 
XML 43 R30.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Property and Equipment (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Property, Plant and Equipment [Table Text Block]
   
Useful Life
   
201
6
   
201
5
 
Production equipment
 
 3
-
10
    $
10,370,462
    $
10,536,377
 
Lab equipment
 
 3
-
10
     
76,658
     
143,783
 
Computer equipment
 
 3
-
5
     
185,652
     
269,526
 
Vehicles
 
 3
-
5
     
39,090
     
40,365
 
Furniture and fixture
 
 
5
 
     
146,453
     
141,502
 
Leasehold improvements
 
 
10
 
     
955,563
     
972,023
 
   
 
 
 
     
11,773,878
     
12,103,576
 
Less Accumulated Depreciation
 
 
 
 
     
(9,140,320
)    
(8,564,882
)
Net Property and Equipment
 
 
 
 
    $
2,633,558
    $
3,538,694
 
XML 44 R31.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Investments at Costs (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Fair Value, by Balance Sheet Grouping [Table Text Block]
As of
December 31, 2016
 
Level 1
   
Level 2
   
Level 3
 
                         
Investments
   
-
     
-
     
5,282
 
                         
Total
   
-
     
-
     
5,282
 
As of December 31, 201
5
 
Level 1
   
Level 2
   
Level 3
 
                         
Investments
   
-
     
-
     
21,838
 
                         
Total
   
-
     
-
     
21,838
 
XML 45 R32.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Definite-life Intangible Assets (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Year ending December 31,
 
Amortization
Expenses
 
2017
   
2,699
 
2018
   
2,270
 
2019
   
645
 
Thereafter
 
 
-
 
    $
5,614
 
XML 46 R33.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Goodwill (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Goodwill [Table Text Block]
   
December 31,
201
6
 
         
Goodwill at beginning of period
  $
7,582,749
 
Effect of currency translation
   
(239,541
)
Impairment write down
   
(7,343,208
)
Goodwill at end of period
  $
-
 
Schedule of Intangible Assets and Goodwill [Table Text Block]
Goodwill consists of:
 
December 31,
201
6
 
         
LiqTech Systems A/S (Formerly Provital Solutions A/S)
  $
-
 
XML 47 R34.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Leases (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Future Minimum Rental Payments for Operating Leases [Table Text Block]
Year ending December 31,
 
Lease
Payments
 
2017
   
559,058
 
2018
   
457,735
 
2019
   
179,094
 
Thereafter
   
395,898
 
Total Minimum Lease Payments
  $
1,591,785
 
Schedule of Future Minimum Lease Payments for Capital Leases [Table Text Block]
Year ending December 31,
 
Lease
Payments
 
2017
  $
121,636
 
2018
   
23,720
 
Thereafter
 
 
-
 
Total minimum lease payments
   
145,356
 
Less amount representing interest
   
(5,531
)
Present value of minimum lease payments
   
139,825
 
Less Current Portion
   
(45,883
)
    $
93,942
 
XML 48 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   
201
6
   
201
5
 
Vacation accrual
  $
5,450
    $
3,933
 
Allowance for doubtful Accounts
   
1,202
     
14,089
 
Reserve for obsolete inventory
   
200,118
     
154,100
 
Valuation Allowance
   
(206,770
)
   
 
 
Net current tax assets
  $
-
    $
172,122
 
                 
Business tax credit carryover
   
30,935
     
30,935
 
Deferred compensation
   
8,500
     
-
 
Net operating loss carryover
   
4,906,974
     
4,333,820
 
Excess of book over tax depreciation
   
(296,227
)
   
(452,088
)
Valuation Allowance
   
(4,650,182
)
   
(228,170
)
Long term deferred tax asset
  $
-
    $
3,684,497
 
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
   
201
6
   
201
5
 
Computed tax at expected statutory rate
  $
(4,487,649
)
  $
(991,139
)
State and local income taxes, net of federal benefits
   
(3,721
)
   
(20,476
)
Non-deductible expenses
   
4,242
     
5,291
 
Non-US income taxed at different rates
   
1,325,180
     
47,837
 
Non-deductible deferred compensation
   
148,170
     
140,175
 
Effect of changes in tax rates
   
(21,489
)    
(31,748
)
Non-deductible impairment of goodwill
   
1,615,506
     
-
 
Non-deductible loss of subsidiaries
   
-
     
50,579
 
Valuation Allowance
   
4,739,806
     
109,842
 
Other items
   
(100,368
)
   
(8,147
)
Income tax expense (benefit)
  $
3,219,677
    $
(697,786
)
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
   
2016
   
201
5
 
Current income tax expense:
               
Danish
  $
(329,816
)
  $
(266,107
)
Federal
   
-
     
-
 
State
   
580
     
570
 
Current tax (benefit)
  $
(329,236
)
  $
(265,537
)
                 
                 
Book in excess of tax depreciation
  $
(158,684
)
  $
(136,572
)
Business tax credit carryover
   
-
     
(5,226
)
Net operating loss carryover
   
(1,000,650
)
   
(517,153
)
Allowance for doubtful accounts
   
12,705
     
156,036
 
Valuation Allowance
   
4,756,013
     
-
 
Accrued Vacation
   
(1,517
)
   
1,143
 
Deferred Compensation
   
(8,500
)
   
171,615
 
Reserve for obsolete inventory
   
(50,452
)
   
(102,092
)
Deferred tax expense (benefit)
  $
3,548,913
    $
(432,249
)
Total tax expense (benefit)
  $
3,219,677
    $
(697,786
)
XML 49 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Weighted Average Number of Shares [Table Text Block]
   
For the Year Ended
December 31
 
   
201
6
   
201
5
 
Net Loss attributable to LiqTech International Inc.
  $
(16,418,634
)
  $
(2,209,857
)
Weighted average number of common shares used in basic earnings per share
   
36,835,514
     
36,790,420
 
Effect of dilutive securities, stock options and warrants
   
-
     
-
 
Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share
   
36,835,514
     
36,790,420
 
XML 50 R37.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Stockholders' Equity (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]
 
 
 
 
Warrants Outstanding
   
Warrants Exercisable
 
Exercise Prices
   
Number
Outstanding
   
Weighted
Average
Remaining
Contractual Life
(years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
 
$
0.81
     
100,000
     
1.00
    $
0.81
     
100,000
    $
0.81
 
$
1.00
     
200,000
     
1.00
    $
1.00
     
133,333
    $
1.00
 
$
1.65
     
400,000
     
2.57
    $
1.65
     
400,000
    $
1.65
 
$
4.06
     
125,575
     
0.18
    $
4.06
     
125,575
    $
4.06
 
Total
     
825,575
     
1.64
    $
1.76
     
758,908
    $
1.82
 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
LiqTech
International, Inc.
 
Expected term (in years)
 
 5
-
10
 
Volatility
 
 74.65%
to
76.87%
 
Risk free interest rate
 
 1.38%
-
2.24%
 
Dividend yield
 
 
0%
 
 
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]
 
 
 
 
Options Outstanding
   
Options Exercisable
 
Exercise
Prices
   
Number
Outstanding
   
Weighted
Average
Remaining
Contractual
Life (years)
   
Weighted
Average
Exercise
Price
   
Number
Exercisable
   
Weighted
Average
Exercise
Price
 
$
0.74
     
400,000
     
3.62
    $
0.74
     
133,334
    $
0.74
 
$
0.75
     
100,000
     
3.29
    $
0.75
     
33,333
    $
0.75
 
$
1.01
     
130,000
     
8.97
    $
1.01
     
130,000
    $
1.01
 
$
1.90
     
238,000
     
0.08
    $
1.90
     
238,000
    $
1.90
 
Total
     
868,000
     
3.41
    $
1,10
     
534,667
    $
3.32
 
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding and Exercisable [Table Text Block]
   
December
3
1
, 2016
 
   
Shares
   
Weighted
Average
Exercise
Price
   
Average
Remaining
Life
   
Weighted
Average
Intrinsic
Value
 
                                 
Outstanding at beginning of period
   
1,071,000
    $
1.19
     
3.93
    $
-
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
-
     
-
     
-
     
-
 
Forfeited
   
(203,000
)
   
1.59
     
-
     
-
 
Expired
   
-
     
-
     
-
     
-
 
Outstanding at end of period
   
868,000
    $
1.10
     
3.41
    $
0
 
Vested and expected to vest
   
868,000
    $
1.10
     
3.41
    $
0
 
Exercisable end of period
   
534,667
    $
1.32
     
3.32
    $
0
 
XML 51 R38.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Significant Customers / Concentration (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Schedule of Revenue from External Customers Attributed to Foreign Countries by Geographic Area [Table Text Block]
   
For the Year Ended December 31
 
   
201
6
   
201
5
 
United States and Canada
  $
689,766
    $
1,521,718
 
Australia
   
387,807
     
382,883
 
South America
   
115,675
     
2,400,000
 
Asia
   
1,105,272
     
1,139,090
 
Europe
   
11,607,874
     
10,368,896
 
    $
13,906,394
    $
15,812,587
 
Reconciliation of Revenue from Segments to Consolidated [Table Text Block]
   
For the Year Ended
December 31
 
   
201
6
   
201
5
 
Ceramic diesel particulate
  $
5,820,793
    $
5,081,304
 
Liquid filters
   
7,731,079
     
10,347,010
 
Kiln furniture
   
354,522
     
384,273
 
    $
13,906,394
    $
15,812,587
 
XML 52 R39.htm IDEA: XBRL DOCUMENT v3.7.0.1
Schedule II - Valuation and Qualifying Accounts (Tables)
12 Months Ended
Dec. 31, 2016
Notes Tables  
Valuation Allowances and Reserves [Table Text Block]
   
Balance
Beginning
of Year
   
Charges to
Costs and
Expenses
   
Deductions
(1)
   
Balance
End of
Year
 
Year Ended
December 31, 2016
                               
Allowance for inventory obsolescence
  $
606,504
    $
824,958
    $
(10,117
)
  $
1,421,345
 
Allowance for doubtful accounts
   
1,087,871
     
1,437,949
     
(397,368
)
   
2,128,452
 
Totals
  $
1,694,375
    $
2,262,907
    $
(407,485
)
  $
3,549,797
 
   
Balance
Beginning
of Year
   
Charges to
Costs and
Expenses
   
Deductions
(1)
   
Balance
End of
Year
 
Year Ended December 31,
2015
                               
Allowance for inventory obsolescence
  $
449,098
    $
174,143
    $
(16,737
)
  $
606,504
 
Allowance for doubtful accounts
   
1,654,290
     
(80,729
)
   
(485,690
)
   
1,087,871
 
Totals
  $
2,103,388
    $
93,414
    $
(502,427
)
  $
1,694,375
 
Allowance for Credit Losses on Financing Receivables [Table Text Block]
   
201
6
   
201
5
 
Allowance for doubtful accounts at the beginning of the period
  $
1,087,871
    $
1,654,290
 
Bad debt expense
   
1,437,949
     
80,729
 
Amount of receivables written off
   
(252,792
)
   
(398,083
)
Effect of currency translation
   
(144,576
)
   
(249,065
)
Allowance for doubtful accounts at the end of the period
  $
2,128,452
    $
1,087,871
 
XML 53 R40.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Summary of Significant Accounting Policies (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash, Uninsured Amount $ 0 $ 0
Restricted Cash and Cash Equivalents 0 292,826
Advertising Expense 14,504 34,442
Research and Development Expense 626,147 707,844
Allocated Share-based Compensation Expense 435,794 369,531
Employee Stock Option [Member]    
Allocated Share-based Compensation Expense 435,794 369,531
Employee Service Share-based Compensation, Tax Benefit from Compensation Expense $ 35,045 $ 157,080
DENMARK    
Value Added Tax Of Invoice, Percentage 25.00%  
Minimum [Member]    
Property, Plant and Equipment, Useful Life 3 years  
Finite-Lived Intangible Asset, Useful Life 2 years  
Maximum [Member]    
Property, Plant and Equipment, Useful Life 10 years  
Finite-Lived Intangible Asset, Useful Life 10 years  
LiqTech USA [Member] | LiqTech International DK [Member]    
Percentage of Subsidiary Owned 100.00%  
LiqTech USA [Member] | LiqTech NA [Member]    
Percentage of Subsidiary Owned 100.00%  
LiqTech International DK [Member] | LiqTech Asia [Member]    
Percentage of Subsidiary Owned 60.00%  
LiqTech International DK [Member] | LiqTech Germany [Member]    
Percentage of Subsidiary Owned 100.00%  
LiqTech International DK [Member] | LiqTech PTE [Member]    
Percentage of Subsidiary Owned 95.00%  
XML 54 R41.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 1 - Summary of Significant Accounting Policies - Rollforward for Allowance for Doubtful Accounts (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Allowance for doubtful accounts at the beginning of the period $ 1,087,871 $ 1,654,290
Bad debt expense 1,437,949 80,729
Amount of receivables written off (252,792) (398,083)
Effect of currency translation (144,576) (249,065)
Allowance for doubtful accounts at the end of the period $ 2,128,452 $ 1,087,871
XML 55 R42.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 3 - Related Party Transactions (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Mar. 31, 2015
Dec. 31, 2014
Oct. 31, 2014
Dec. 31, 2014
Accounts Payable and Accrued Liabilities [Member] | Officer [Member] | Advance from Related Party [Member]        
Related Party Transaction, Amounts of Transaction $ 25,000 $ 35,000 $ 25,000 $ 60,000
XML 56 R43.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 4 - Inventory - Schedule of Inventory (Details) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Furnace parts and supplies $ 336,799 $ 466,538
Raw materials 1,216,098 1,498,406
Work in process 2,499,242 1,770,070
Finished goods and filtration systems 2,544,080 1,788,161
Reserve for obsolescence (1,421,345) (606,504)
Net Inventory $ 5,174,874 $ 4,916,671
XML 57 R44.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Property and Equipment (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Depreciation $ 1,373,505 $ 1,437,787
XML 58 R45.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 5 - Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Property and equipment, gross $ 11,773,878 $ 12,103,576
Less Accumulated Depreciation (9,140,320) (8,564,882)
Net Property and Equipment 2,633,558 3,538,694
Production Equipment [Member]    
Property and equipment, gross 10,370,462 10,536,377
Lab Equipment [Member]    
Property and equipment, gross 76,658 143,783
Computer Equipment [Member]    
Property and equipment, gross 185,652 269,526
Vehicles [Member]    
Property and equipment, gross $ 39,090 40,365
Furniture and Fixtures [Member]    
Useful Life (Year) 5 years  
Property and equipment, gross $ 146,453 141,502
Leasehold Improvements [Member]    
Useful Life (Year) 10 years  
Property and equipment, gross $ 955,563 $ 972,023
Minimum [Member]    
Useful Life (Year) 3 years  
Minimum [Member] | Production Equipment [Member]    
Useful Life (Year) 3 years  
Minimum [Member] | Lab Equipment [Member]    
Useful Life (Year) 3 years  
Minimum [Member] | Computer Equipment [Member]    
Useful Life (Year) 3 years  
Minimum [Member] | Vehicles [Member]    
Useful Life (Year) 3 years  
Maximum [Member]    
Useful Life (Year) 10 years  
Maximum [Member] | Production Equipment [Member]    
Useful Life (Year) 10 years  
Maximum [Member] | Lab Equipment [Member]    
Useful Life (Year) 10 years  
Maximum [Member] | Computer Equipment [Member]    
Useful Life (Year) 5 years  
Maximum [Member] | Vehicles [Member]    
Useful Life (Year) 5 years  
XML 59 R46.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Investments at Costs (Details Textual) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Other Long-term Investments $ 5,282 $ 21,838
LEA Technology [Member]    
Other Long-term Investments $ 5,282 5,460
LiqTech Italy [Member]    
Other Long-term Investments   $ 16,378
XML 60 R47.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 6 - Investments at Costs - Summary of Financial Assets and Liabilities (Details) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Fair Value, Inputs, Level 1 [Member]    
Investments $ 0 $ 0
Total 0 0
Fair Value, Inputs, Level 2 [Member]    
Investments 0 0
Total 0 0
Fair Value, Inputs, Level 3 [Member]    
Investments 5,282 21,838
Total $ 5,282 $ 21,838
XML 61 R48.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Definite-life Intangible Assets (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Intangible Assets, Net (Excluding Goodwill) $ 5,614 $ 10,386
Minimum [Member]    
Finite-Lived Intangible Asset, Useful Life 2 years  
Maximum [Member]    
Finite-Lived Intangible Asset, Useful Life 10 years  
Patents [Member]    
Amortization of Intangible Assets $ 4,772 $ 6,322
Patents [Member] | Minimum [Member]    
Finite-Lived Intangible Asset, Useful Life 2 years  
Patents [Member] | Maximum [Member]    
Finite-Lived Intangible Asset, Useful Life 10 years  
XML 62 R49.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Definite-life Intangible Assets - Expected Future Amortization Expense (Details)
Dec. 31, 2016
USD ($)
2017 $ 2,699
2018 2,270
2019 645
$ 5,614
XML 63 R50.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Goodwill (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Goodwill, Impairment Loss $ 7,343,208 $ 0
XML 64 R51.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Goodwill - Summary of Goodwill (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Goodwill at beginning of period $ 7,582,749  
Effect of currency translation (239,541)  
Impairment write down (7,343,208) $ 0
Goodwill at end of period $ 7,582,749
XML 65 R52.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 8 - Goodwill - Components of Goodwill (Details) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
LiqTech Systems A/S (Formerly Provital Solutions A/S) $ 7,582,749
LiqTech Systems A/S [Member]    
LiqTech Systems A/S (Formerly Provital Solutions A/S)  
XML 66 R53.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 9 - Lines of Credit (Details Textual) - Dec. 31, 2016
USD ($)
DKK
Line of Credit Facility, Maximum Borrowing Capacity $ 13,416 DKK 94,620
Guarantor Obligations, Current Carrying Value $ 13,416 DKK 94,620
XML 67 R54.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Leases (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Operating Leases, Rent Expense $ 645,817 $ 697,736
Capital Leased Assets, Gross 1,240,358 1,302,005
Capital Leases, Lessee Balance Sheet, Assets by Major Class, Accumulated Depreciation 1,126,550 1,033,062
Depreciation 1,373,505 1,437,787
Interest Expense, Lessee, Assets under Capital Lease 16,758 26,840
Assets Held under Capital Leases [Member]    
Depreciation 130,025 $ 141,050
Capital Lease Obligations [Member] | Capital Lease 1 [Member]    
Debt Instrument, Periodic Payment 9,319  
Capital Lease Obligations [Member] | Capital Lease 2 [Member]    
Debt Instrument, Periodic Payment 591  
Capital Lease Obligations [Member] | Capital Lease 3 [Member]    
Debt Instrument, Periodic Payment $ 532  
XML 68 R55.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Leases - Future Minimum Lease Payments for Non-cancelable Operating Leases (Details)
Dec. 31, 2016
USD ($)
2017 $ 559,058
2018 457,735
2019 179,094
Thereafter 395,898
Total Minimum Lease Payments $ 1,591,785
XML 69 R56.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 10 - Leases - Future Minimum Capital Lease Payments (Details) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
2017 $ 121,636  
2018 23,720  
Thereafter 0  
Total minimum lease payments 145,356  
Less amount representing interest (5,531)  
Present value of minimum lease payments 139,825  
Less Current Portion (45,883) $ (150,157)
$ 93,942 $ 165,572
XML 70 R57.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 11 - Agreements and Commitments (Details Textual)
12 Months Ended
Sep. 09, 2014
EUR (€)
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2016
DKK
Defined Contribution Plan, Cost Recognized   $ 11,347 $ 14,610  
Line of Credit Facility, Maximum Borrowing Capacity   13,416   DKK 94,620
Guarantor Obligations, Current Carrying Value   13,416   DKK 94,620
Restricted Cash and Cash Equivalents   $ 0 $ 292,826  
Chief Executive Officer [Member] | LiqTech Italy [Member]        
Equity Method Investment, Ownership Percentage 60.00%      
Noncontrolling Interest, Ownership Percentage by Noncontrolling Owners 40.00%      
Loss Contingency, Damages Sought, Value | € € 750,000      
XML 71 R58.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes (Details Textual) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Deferred Tax Assets, Operating Loss Carryforwards, Domestic $ 11,128,000  
LiqTech International Inc and LiqTech NA [Member]    
Deferred Tax Assets, Valuation Allowance 3,542,000 $ 0
LiqTech International AS and LiqTech Systems AS [Member]    
Deferred Tax Assets, Valuation Allowance 1,095,000 0
LiqTech Germany [Member]    
Deferred Tax Assets, Valuation Allowance 122,000 118,000
LiqTech Singapore [Member]    
Deferred Tax Assets, Valuation Allowance 97,000 109,000
Federal Ministry of Finance, Germany [Member] | Danish Ministry of Taxation [Member]    
Deferred Tax Assets, Operating Loss Carryforwards, Foreign 6,486,000  
Federal Ministry of Finance, Germany [Member] | GERMANY    
Deferred Tax Assets, Operating Loss Carryforwards, Foreign 437,000  
Federal Ministry of Finance, Germany [Member] | SINGAPORE    
Deferred Tax Assets, Operating Loss Carryforwards, Foreign 571,000  
Internal Revenue Service (IRS) [Member] | Domestic Tax Authority [Member]    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 3,542,000 0
Danish Ministry of Taxation [Member] | Foreign Tax Authority [Member]    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 1,095,000 0
German Ministry of Taxation [Member] | Foreign Tax Authority [Member]    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 4,000 118,000
Singapore Ministry of Taxation [Member] | Foreign Tax Authority [Member]    
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount $ 12,000 $ 109,000
XML 72 R59.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes - Deferred Tax Asset (Liabilities) (Details) - USD ($)
Dec. 31, 2016
Dec. 31, 2015
Vacation accrual $ 5,450 $ 3,933
Allowance for doubtful Accounts 1,202 14,089
Reserve for obsolete inventory 200,118 154,100
Valuation Allowance (206,770)
Net current tax assets 172,122
Business tax credit carryover 30,935 30,935
Deferred compensation 8,500
Net operating loss carryover 4,906,974 4,333,820
Excess of book over tax depreciation (296,227) (452,088)
Valuation Allowance (4,650,182) (228,170)
Long term deferred tax asset $ 3,684,497
XML 73 R60.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes - Reconciliation of Income Tax Expense (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Computed tax at expected statutory rate $ (4,487,649) $ (991,139)
State and local income taxes, net of federal benefits (3,721) (20,476)
Non-deductible expenses 4,242 5,291
Non-US income taxed at different rates 1,325,180 47,837
Non-deductible deferred compensation 148,170 140,175
Effect of changes in tax rates (21,489) (31,748)
Non-deductible impairment of goodwill 1,615,506
Non-deductible loss of subsidiaries 50,579
Valuation Allowance 4,739,806 109,842
Other items (100,368) (8,147)
Total tax expense (benefit) $ 3,219,677 $ (697,786)
XML 74 R61.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 12 - Income Taxes - Components of Income Tax Expense (Benefit) from Continuing Operations (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Current income tax expense:    
Federal $ 0 $ 0
State 580 570
Current tax (benefit) (329,236) (265,537)
Book in excess of tax depreciation (158,684) (136,572)
Business tax credit carryover (5,226)
Net operating loss carryover (1,000,650) (517,153)
Allowance for doubtful accounts 12,705 156,036
Valuation Allowance 4,756,013
Accrued Vacation (1,517) 1,143
Deferred Compensation (8,500) 171,615
Reserve for obsolete inventory (50,452) (102,092)
Deferred tax expense (benefit) 3,548,913 (432,249)
Total tax expense (benefit) 3,219,677 (697,786)
Danish Ministry of Taxation [Member]    
Current income tax expense:    
Foreign current income tax expense (benefit) $ (329,816) $ (266,107)
XML 75 R62.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Earnings Per Share (Details Textual) - $ / shares
11 Months Ended 12 Months Ended
Dec. 12, 2016
Dec. 31, 2016
Dec. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price   $ 1.10 $ 1.19
Canceled Common Shares Held in Escrow in Connection with an Acquisition, Shares 2,696,521 2,696,521  
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price   $ 0.74 0.74
Class of Warrant or Right, Exercise Price of Warrants or Rights   0.81 1
Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price   1.90 1.90
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 4.06 $ 4.06
Employee Stock Option [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   868,000 1,071,000
Warrant [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   825,575 7,225,575
XML 76 R63.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 13 - Earnings Per Share - Amounts Used in Computing Earnings Per Share (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Net Income for the year ended $ (16,418,634) $ (2,209,857)
Weighted average number of common shares used in basic earnings per share (in shares) 36,835,514 36,790,420
Effect of dilutive securities, stock options and warrants (in shares) 0
Weighted average number of common shares and potential dilutive common shares outstanding used in dilutive earnings per share (in shares) 36,835,514 36,790,420
XML 77 R64.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Stockholders' Equity (Details Textual) - USD ($)
3 Months Ended 11 Months Ended 12 Months Ended
Aug. 14, 2015
Apr. 14, 2015
Apr. 13, 2015
Jul. 29, 2014
Jul. 28, 2014
Sep. 30, 2014
Dec. 12, 2016
Dec. 31, 2016
Dec. 30, 2016
Dec. 31, 2015
Dec. 31, 2014
Feb. 15, 2016
Jun. 04, 2015
Common Stock, Shares Authorized               100,000,000   100,000,000      
Common Stock, Par or Stated Value Per Share               $ 0.001   $ 0.001      
Common Stock, Shares, Issued               36,835,514   39,532,035      
Canceled Common Shares Held in Escrow in Connection with an Acquisition, Shares             2,696,521 2,696,521          
Stock Issued During Period, Shares, New Issues         8,000,000 47,500              
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period           47,500              
Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price           $ 1.50              
Share Price         $ 1.50                
Proceeds from Issuance of Common Stock         $ 10,736,278                
Payments of Stock Issuance Costs         $ 1,263,722                
Allocated Share-based Compensation Expense               $ 435,794   $ 369,531      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number               868,000   1,071,000      
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options               $ 105,927          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares               333,333          
Share Based Compensation Arrangements by Share Based Payment Award Options, Nonvested Weighted Average Exercise Price               $ 0.74          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Weighted Average Grant Date Fair Value               $ 0.46          
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition               1 year 73 days          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value               $ 0          
Common Stock, Shares, Outstanding               36,835,514   39,532,035      
Two Thousand Eleven Stock Options Plan [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number               868,000          
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options               $ 105,927          
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross               868,000          
LCL Finance Limited [Member]                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                       100,000  
Class of Warrant or Right, Exercise Price of Warrants or Rights                       $ 0.81  
Wolfe Axelrod Weinberger Associates, LLC [Member]                          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                         200,000
Class of Warrant or Right, Exercise Price of Warrants or Rights                         $ 1
Warrant [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period                 66,667        
Allocated Share-based Compensation Expense               $ 50,634          
Provital Acquisition [Member]                          
Stock Issued During Period, Shares, Acquisitions       4,044,782                  
Vesting Upon Issuance [Member] | Wolfe Axelrod Weinberger Associates, LLC [Member]                          
Class of Warrant or Right Vesting Percentage                         33.30%
Vesting on June 4, 2016 [Member] | Wolfe Axelrod Weinberger Associates, LLC [Member]                          
Class of Warrant or Right Vesting Percentage                         33.30%
Vesting on June 4, 2017 [Member] | Wolfe Axelrod Weinberger Associates, LLC [Member]                          
Class of Warrant or Right Vesting Percentage                         33.30%
Employee Stock Option [Member]                          
Allocated Share-based Compensation Expense               435,794   $ 369,531      
Employee Stock Option [Member] | Two Thousand Eleven Stock Options Plan [Member]                          
Allocated Share-based Compensation Expense               307,493   154,745      
Director [Member]                          
Stock Issued During Period, Shares, Restricted Stock Award, Gross 27,253   100,000               100,000    
Stock Issued During Period, Value, Restricted Stock Award, Gross $ 20,167   $ 75,000               $ 158,000    
Director [Member] | Restricted Stock [Member]                          
Allocated Share-based Compensation Expense               $ 77,667   $ 204,500      
Director [Member] | Restricted Stock [Member] | Vesting on January 1, 2016 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period   27,253 33,333                    
Director [Member] | Restricted Stock [Member] | Vesting On January 1, 2017 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     33,333                    
Director [Member] | Restricted Stock [Member] | Vesting On January 1, 2018 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period     33,334                    
Director [Member] | Restricted Stock [Member] | Vesting on December 31, 2014 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period                     33,333    
Director [Member] | Restricted Stock [Member] | Vesting on December 31, 2015 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period                     33,333    
Director [Member] | Restricted Stock [Member] | Vesting on December 31, 2016 [Member]                          
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period                     33,334    
XML 78 R65.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Stockholders' Equity - Warrants Outstanding (Details)
12 Months Ended
Dec. 31, 2016
$ / shares
shares
Warrants Outstanding Number Outstanding (in shares) | shares 825,575
Warrants Outstanding Weighted Average Remaining Contractual Life (Year) 1 year 233 days
Warrants Outstanding Weighted Average Exercise Price (in dollars per share) $ 1.76
Warrants Exercisable Number Exercisable (in shares) | shares 758,908
Warrants Exercisable Weighted Average Exercise Price (in dollars per share) $ 1.82
Warrant 1 [Member]  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 0.81
Warrants Outstanding Number Outstanding (in shares) | shares 100,000
Warrants Outstanding Weighted Average Remaining Contractual Life (Year) 1 year
Warrants Outstanding Weighted Average Exercise Price (in dollars per share) $ 0.81
Warrants Exercisable Number Exercisable (in shares) | shares 100,000
Warrants Exercisable Weighted Average Exercise Price (in dollars per share) $ 0.81
Warrant 2 [Member]  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 1
Warrants Outstanding Number Outstanding (in shares) | shares 200,000
Warrants Outstanding Weighted Average Remaining Contractual Life (Year) 1 year
Warrants Outstanding Weighted Average Exercise Price (in dollars per share) $ 1
Warrants Exercisable Number Exercisable (in shares) | shares 133,333
Warrants Exercisable Weighted Average Exercise Price (in dollars per share) $ 1
Warrants 3 [Member]  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 1.65
Warrants Outstanding Number Outstanding (in shares) | shares 400,000
Warrants Outstanding Weighted Average Remaining Contractual Life (Year) 2 years 208 days
Warrants Outstanding Weighted Average Exercise Price (in dollars per share) $ 1.65
Warrants Exercisable Number Exercisable (in shares) | shares 400,000
Warrants Exercisable Weighted Average Exercise Price (in dollars per share) $ 1.65
Warrants 4 [Member]  
Class of Warrant or Right, Exercise Price of Warrants or Rights $ 4.06
Warrants Outstanding Number Outstanding (in shares) | shares 125,575
Warrants Outstanding Weighted Average Remaining Contractual Life (Year) 65 days
Warrants Outstanding Weighted Average Exercise Price (in dollars per share) $ 4.06
Warrants Exercisable Number Exercisable (in shares) | shares 125,575
Warrants Exercisable Weighted Average Exercise Price (in dollars per share) $ 4.06
XML 79 R66.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Stockholders' Equity - Assumptions Used to Calculate the Fair Values of Stock Options (Details)
12 Months Ended
Dec. 31, 2016
Dividend yield 0.00%
Minimum [Member]  
Expected term (in years) (Year) 5 years
Volatility 74.65%
Risk free interest rate 1.38%
Maximum [Member]  
Expected term (in years) (Year) 10 years
Volatility 76.87%
Risk free interest rate 2.24%
XML 80 R67.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Stockholders' Equity - Options Outstanding (Details)
12 Months Ended
Dec. 31, 2015
$ / shares
shares
Options Number Outstanding (in shares) | shares 868,000
Options Weighted Average Remaining Contractual Life (Year) 3 years 149 days
Options Weighted Average Exercise Price (in dollars per share) $ 110
Options Number Exercisable (in shares) | shares 534,667
Options Exercisable Weighted Average Exercise Price (in dollars per share) $ 3.32
Price Range 1 [Member]  
Options Exercise Prices (in dollars per share) $ 0.74
Options Number Outstanding (in shares) | shares 400,000
Options Weighted Average Remaining Contractual Life (Year) 3 years 226 days
Options Weighted Average Exercise Price (in dollars per share) $ 0.74
Options Number Exercisable (in shares) | shares 133,334
Options Exercisable Weighted Average Exercise Price (in dollars per share) $ 0.74
Price Range 2 [Member]  
Options Exercise Prices (in dollars per share) $ 0.75
Options Number Outstanding (in shares) | shares 100,000
Options Weighted Average Remaining Contractual Life (Year) 3 years 105 days
Options Weighted Average Exercise Price (in dollars per share) $ 0.75
Options Number Exercisable (in shares) | shares 33,333
Options Exercisable Weighted Average Exercise Price (in dollars per share) $ 0.75
Price Range 3 [Member]  
Options Exercise Prices (in dollars per share) $ 1.01
Options Number Outstanding (in shares) | shares 130,000
Options Weighted Average Remaining Contractual Life (Year) 8 years 354 days
Options Weighted Average Exercise Price (in dollars per share) $ 1.01
Options Number Exercisable (in shares) | shares 130,000
Options Exercisable Weighted Average Exercise Price (in dollars per share) $ 1.01
Price Range 4 [Member]  
Options Exercise Prices (in dollars per share) $ 1.90
Options Number Outstanding (in shares) | shares 238,000
Options Weighted Average Remaining Contractual Life (Year) 29 days
Options Weighted Average Exercise Price (in dollars per share) $ 1.90
Options Number Exercisable (in shares) | shares 238,000
Options Exercisable Weighted Average Exercise Price (in dollars per share) $ 1.90
XML 81 R68.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 14 - Stockholders' Equity - Status of Options Granted and Changes During the Year (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Shares outstanding (in shares) 1,071,000  
Outstanding, weighted average exercise price (in dollars per share) $ 1.19  
Outstanding, average remaining life (Year) 3 years 149 days 3 years 339 days
Shares forfeited (in shares) (203,000)  
Forfeited, weighted average exercise price (in dollars per share) $ 1.59  
Shares outstanding (in shares) 868,000 1,071,000
Outstanding, weighted average exercise price (in dollars per share) $ 1.10 $ 1.19
Outstanding, weighted average intrinsic value $ 0  
Shares vested and expected to vest (in shares) 868,000  
Vested and expected to vest, weighted average exercise price (in dollars per share) $ 1.10  
Vested and expected to vest, average remaining life (Year) 3 years 149 days  
Vested and expected to vest, weighted average intrinsic value $ 0  
Warrants exercisable (in shares) 534,667  
Exercisable end of period, weighted average exercise price (in dollars per share) $ 1.32  
Exercisable end of period, average remaining life (Year) 3 years 116 days  
Exercisable end of period, weighted average intrinsic value $ 0  
XML 82 R69.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Significant Customers / Concentration (Details Textual)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Customer Concentration Risk [Member] | Sales Revenue, Net [Member]    
Number of Major Customers 4 4
Concentration Risk, Percentage 67.00% 56.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Major Customer 1 [Member]    
Concentration Risk, Percentage 33.00% 24.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Major Customer 2 [Member]    
Concentration Risk, Percentage 25.00% 15.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Major Customer 3 [Member]    
Concentration Risk, Percentage 5.00% 11.00%
Customer Concentration Risk [Member] | Sales Revenue, Net [Member] | Major Customer 4 [Member]    
Concentration Risk, Percentage 4.00% 6.00%
Geographic Concentration Risk [Member] | Assets, Total [Member] | DENMARK    
Concentration Risk, Percentage 85.00% 89.00%
Geographic Concentration Risk [Member] | Assets, Total [Member] | UNITED STATES    
Concentration Risk, Percentage 15.00% 11.00%
XML 83 R70.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Significant Customers / Concentration - Net Sales by Geographical Region (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Net sales $ 13,906,394 $ 15,812,587
Reportable Geographical Components [Member] | US And Canada [Member]    
Net sales 689,766 1,521,718
Reportable Geographical Components [Member] | AUSTRALIA    
Net sales 387,807 382,883
Reportable Geographical Components [Member] | South America [Member]    
Net sales 115,675 2,400,000
Reportable Geographical Components [Member] | Asia [Member]    
Net sales 1,105,272 1,139,090
Reportable Geographical Components [Member] | Europe [Member]    
Net sales $ 11,607,874 $ 10,368,896
XML 84 R71.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 15 - Significant Customers / Concentration - Sales by Product Line (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Net sales $ 13,906,394 $ 15,812,587
Ceramic Diesel Particulate [Member]    
Net sales 5,820,793 5,081,304
Liquid Filters [Member]    
Net sales 7,731,079 10,347,010
Kiln Furniture [Member]    
Net sales $ 354,522 $ 384,273
XML 85 R72.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 16 - Subsequent Event (Details Textual) - Scenario, Forecast [Member]
3 Months Ended
Mar. 31, 2017
shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 238,000
Class of Warrant or Right, Expired During Period 125,575
XML 86 R73.htm IDEA: XBRL DOCUMENT v3.7.0.1
Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Balance Beginning of Year $ 1,694,375 $ 2,103,388
Charges to Costs and Expenses 2,262,907 93,414
Deductions [1] (407,485) (502,427)
Balance End of Year 3,549,797 1,694,375
Inventory Valuation Reserve [Member]    
Balance Beginning of Year 606,504 449,098
Charges to Costs and Expenses 824,958 174,143
Deductions [1] (10,117) (16,737)
Balance End of Year 1,421,345 606,504
Allowance for Doubtful Accounts [Member]    
Balance Beginning of Year 1,087,871 1,654,290
Charges to Costs and Expenses 1,437,949 (80,729)
Deductions [1] (397,368) (485,690)
Balance End of Year $ 2,128,452 $ 1,087,871
[1] Includes write-offs, the impact of foreign currency exchange rates and the effect of the acquisition of LiqTech Systems A/S.
XML 87 R74.htm IDEA: XBRL DOCUMENT v3.7.0.1
Schedule II - Valuation and Qualifying Accounts - Rollforward for Allowance for Doubtful Accounts (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Allowance for doubtful accounts at the beginning of the period $ 1,087,871 $ 1,654,290
Bad debt expense 1,437,949 80,729
Amount of receivables written off (252,792) (398,083)
Effect of currency translation (144,576) (249,065)
Allowance for doubtful accounts at the end of the period $ 2,128,452 $ 1,087,871
EXCEL 88 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( #R"?DH?(\\#P !," + 7W)E;',O+G)E;'.MDD^+ MPD ,Q;]*F?L:5\'#8CUYZ6U9_ )Q)OU#.Y,A$[%^>X>];+=44/ 87O+>CT?V M/S2@=AQ2V\54C'X(J32M:OP"2+8ECVG%D4)6:A:/FD=I(*+ML2'8K-<[D*F' M.>RGGD7E2B.5^S3%":4A+,*P).B0\5?UX^8 TBTH_0(:+L A#&^NQT:E8(C M-R."?S]PN -02P,$% @ /()^2F;S"V"" L0 ! !D;V-0&UL38Y-"\(P$$3_2NG=;BGB06) L$?!D_>0;FP@R8;-"OGYIH(? MMWF\81AU8\K(XK%T-8943OTJDH\ Q:X831F:3LTXXFBD(3^ G/,6+V2?$9/ M-(X'P"J8%EQV^3O8:W7..7AKQ%/25V^9"CGIYFHQ*/B76_..7+8\#?NW_+"" MWTG] E!+ P04 " \@GY*&A-9YN\ K @ $0 &1O8U!R;W!S+V-O M&ULS9+/2L0P$(=?17)O)]GB*J';B^))07!!\1:2V=U@\X=DI-VW-ZV[ M740?0,@E,[]\\PVDU5'JD/ YA8B)+.:KT?4^2QTW[$ 4)4#6!W0JUR7A2W,7 MDE-4KFD/4>D/M4=8<;X&AZ2,(@43L(H+D76MT5(G5!32"6_T@H^?J9]A1@/V MZ-!3!E$+8-TT,1['OH4+8((1)I>_"V@6XES]$SMW@)V28[9+:AB&>FCF7-E! MP-O3X\N\;F5])N4UEE?92CI&W+#SY-?F[G[[P+H5%S<5;ZJ&;\5:EG-]^SZY M_O"["+M@[,[^8^.S8-?"KW_1?0%02P,$% @ /()^2IE&UL[5I;<]HX%'[OK]!X9_9M"\8V@;:T M$W-I=MNTF83M3A^%$5B-;'EDD81_OTV23;J;/ 0LZ?O.14?GZ#AY M\^XN8NB&B)3R> +]O6N[!3+UES@6QHO(];JM-O=5H1I;*$81V1@?5XL:$#05%%:;U\@M.4? M,_@5RU2-9:,!$U=!)KF(M/+Y;,7\VMX^9<_I.ATR@6XP&U@@?\YOI^1.6HCA M5,+$P&IG/U9KQ]'22(""R7V4!;I)]J/3%0@R#3LZG5C.=GSVQ.V?C,K:=#1M M&N#C\7@XMLO2BW A(5M>5 TR 6'!VULS2 Y9>*?IUE!K9';O=05SP6.XYB1'^QL4$UFG2&98T M1G*=D 4. #?$T4Q0?*]!MHK@PI+27)#6SRFU4!H(FLB!]4>"(<7K;YH]5Z%82=J$^!!&&N*<<^9ST6S[!Z5&T?95O-RCEU@5 9<8WS2J M-2S%UGB5P/&MG#P=$Q+-E L&08:7)"82J3E^34@3_BNEVOZKR2. MFJW"$2M"/F(9-AIRM1:!MG&IA&!:$L;1>$[2M!'\6:PUDSY@R.S-D77.UI$. M$9)>-T(^8LZ+D!&_'H8X2IKMHG%8!/V>7L-)P>B"RV;]N'Z&U3-L+([W1]07 M2N0/)J<_Z3(T!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL! M_]':-\*K^(+ .7\N?<^E[[GT/:'2MSAD M6R4)RU3393>*$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W MF)&Y"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>( M\J(A[J&&F,_#0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R M4E5@,5O& RN0HGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K> M9;'!51W/55ORL+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4X MOT4SMA*7&+SCYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5 MYYN MTB42%(JP# 4A%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+ MA=OB5,V[&KXF8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'YA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> , M?-2K6J5D*Q$_2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H: M,]6+K#F-"F]!U4#E/]O4#6CV#30,9FV-J/D3@H\W/[O#;#"Q([A[8N_ M 5!+ P04 " \@GY*>L<1#*L" '"@ & 'AL+W=OY9DQ%;VU32=7\5FI_AXAN3^SELH[WK-. M_SERT5*EA^*$9"\8/5A2VR"2) 5J:=W%ZZ6=>Q3K);^HIN[8HXCDI6VI^+MA M#;^M8AR_3SS5I[,R$VB][.F)_63J5_\H] B-5@YURSI9\RX2[+B*'_#]#E>& M8!'/-;O)23\RKKQP_FH&WPZK.#$K8@W;*V."ZN;*MJQIC"6]CC_.:#QJ&N*T M_V[]BW5>._-")=ORYG=]4.=57,71@1WII5%/_/:5.8?R.'+>?V=7UFBX68G6 MV/-&VF^TOTC%6V=%+Z6E;T-;=[:]#7]RXF@P@3@"&0FD^)20.D(Z$G#V*2%S MA,PCH,$5NS<[JNAZ*?@M$L/Q]M1$$;[/].[OS:3=;/M/;X_4L]=ULD178\8A M-@."3!!X1"!M>Q0@D,"&!'3R46 ;(M*/B%V(R. EI*"/J:6G$WH.TS.0GEEZ M-J$7WA:%B!(6R$&!/*!7GL" R"VB&\X@3@*EF M5&:2&X<6_#.',',J8(8_8!)8(-XELG68:02G197F^=S18#B5<1IJ>2&V9 MGA%)9N,:O@%PF-\DB&L ,WN1<,;V4Y$YOZ5E79>.@84=E MNJ7NBZ$T&0:*]Z[L0F/MM_X'4$L#!!0 ( #R"?DH;5>%D'P4 @9 8 M >&PO=V]R:W-H965T&UL?9EO;^,V#,:_2I#W=Q%)49*+ MML"28=B #3C<<-MK7^NVP25Q9KOM[=M/=MPL):GKB_I/'DH/;?DG6KY^;;MO M_5/3#(OO^]VAOUD^#LB'W>.J/W9-?3\% M[7K6YSS'P MOOS9S0KQ0^[MI=/_U?W#WW0[N?6\E6]O7WTW9[F+:O<_MO878 S@%X#@#_PP": M T@$K$[.IE1_KH?Z]KIK7Q?=Z6X=ZW%0P!7EBWDWGIRNW?1;SK;/9U]N":Y7 M+V,[LV1]DN"%!-\K-EI!_TM6N?^S"31-X!1/E_%DQY,93U.\OXSW(HF3)$R2 MPR0!="FP$ZD8.HJ.*[#]>-./UWY8^#$D05@Y2?C""E:8,-A.V'3"NILHG+#J M!O)?Y$K8T3J""A(GVT\P_03M)PD_0??C D1A>Z-EG&^39]M---U$[49DO8ZJ MF^ Q.CELM P9*L+"L$FFG:3L>-'/.NFL(?H4Q7#?:)VO((18\%.9?BKM1[*A MTI<'(0C51JN 0G2V%W VJ)QV@Y)46J.>JEGSSDQ$P *PH(!-T&Y(N@'54V(7 M+@?%;$D+ :M$SOF"*1NC@-J4Y."L>3=2 Q%SDJ:TD)A2J$J>;#0#*;:7GE&P M80H:E3[(K#0K.:-2IF00%1(5 8V44$CU4ND&AH]#@V>AN1]%0MV;*"")JJ7 M1#4TVH[F:>2$T5<%.S9102/52Z2"AB4'D 0S5.#R^"O8L8D*&JERQE^#9B4& M8"9IR- Q4BP-'YNIH*'*JN#2O,2(7E[(C:&#;!R2+WA"&ZVHLHL8*!-6-3TE)/E&C4](<_TD:4E0Q>92E,0VI!% M#5E9K:_1@&R25:LE*I5E:!,6-6&#)"QJI2I4<0D93)1*1#5;2M6N0M2OI MDK2B2A;<&T,&@3D6BFFR.4T:KD&]OQN@= BF66-'*%T15J?+(!2QJP40*6-#<_@$^LE@8L(5->^60>UJWU 6JOW5Q9+T^(W@C[I[W![ZQ==V&-K]M ;]T+9#DUMU M'W.63TU]?S[8-0_#N!OS?G=:FS\=#.UQ_NZP.G_\N/T/4$L#!!0 ( #R" M?DHS("H4[ $ $D% 8 >&PO=V]R:W-H965T&ULC93= MCILP$(5?!?D!8OZ<9"- ZJ:J6JF5HJVZO79@"&AM3&TG;-^^MF$I =1N+K#' M/F?F&V*<=$*^J I >Z^<-2I%E=;M 6.55\"IVH@6&K-3"LFI-J&\8-5*H(4S M<89#W]]B3NL&98E;.\DL$5?-Z@9.TE-7SJG\_0A,="D*T-O"4WVIM%W 6=+2 M"WP'_:,]21/A,4M1"9YKZ-1D[ME.SD*\V.!+D2+? M @-L,U PW. )C-I'!^#7D1&-):YS.W[)_+[MVY M/=.M,JNW;$<2?+-Y!LEC+PDGDO!><5PJHK\2;.J/$.$J1.C\\11B.X/H)3LG M:9S$W_A^, /YG^J.)5IEB98LNQE++R&3*H$__&8\[U'>,<6K3/&2:3]CBA>5 MHNT^(B2(9T@KP@<2A7Y$UHG(*A%9$CW,B,A[B5:$ZT1X[,7/9?=Q]HT0X7%QYOS^P/4$L#!!0 M ( #R"?DJ)?4DV(@0 -41 8 >&PO=V]R:W-H965T&ULC9C;;N,V$(9?Q?!](L[P'#@&8A=%"[3 8HNVUXK-Q,;*EBLI\?;M2QW6 MJW"&;6]LB?Z'\P]-?J*XNM;-E_800K?X>JK.[>/RT'67AZ)H=X=P*MO[^A+. M\9>7NCF57;QM7HOVTH1R/P2=J@*%,,6I/)Z7Z]70]JE9K^JWKCJ>PZ=FT;Z= M3F7S]R94]?5Q"N;RC6JTOY&GX+W>^73TV\*VZ][(^G<&Z/]7G1 MA)?'Y1,\;-'U 8/BCV.XMK/K15_*\H5&'7]5V4\>L];$-5 M]3U%'W]-G2YO.?O ^?6WWG\KF8JO\EO(NKMKA<[%[:[OZ-/42K9S*K^/W\3Q\7\=?K)S" M^ "< O 6 .9? ^04(+\'J*'XT=E0Z@]E5ZY737U=-.._=2G[20$/,@[FKF\< MQF[X+5;;QM;WM1.KXKWO9Y)L1@G.)'!3%+'S6P;D,FR0A./'!%NJD,AGD&P- M*%$6H'J)WE'2G6D:*.DJ(WHT3/$Z&RTAN= M..*$VCLPDG>D64>:.I*)(TT3*8D*?6*(ZB2"4JAX/X;U8X9.Y-Q/)MZR\9;6 MDPSM:/ MIWYLXL>3/$IJ2U8$E4GCM,X+Z<2EG!,EDT(!*?&\9G176JKJ (.WSF>0$\#('2T* @]7H'3U*5V!8O,.C$%('5&= M19V;B#Q<@=+5IW0%BLT[KS49("I3VF-V"O)T!8I7G^(5*#COC )-%BO5Z;A^ M< B!:Q/ 8L4G/U:]<[KE+&<%)TS8H:^C[9XRB*EK$\IBQ2><4/AC26F MJ/#.>&MG3]J/GGC6(F4MB!2V2!$:I[<"9V3*-4Z*X!QB9M4ACUNDN 61\I81 M29,:8D ;MSY29^SPF$6ZB061[F(GD?D_P\1($85W.K.Q01[>2.$-(J7W)'+S M9.*>X)*7B=Q\XOF-E-^0/OPV2,$LC9-: QDG3FF]4)C94B /<:00!Y%2?!+] MYSBQLNPX\11'2G$0*<:1V25GQHE3LN-4S%Z&3Z%Y'R>3V>V\5SW<57]>&%^J6NNQ"-BOMH\1#* M_>VF"B]=?VGC=3,>-(PW77V9#E&*VTG.^A]02P,$% @ /()^2LH-.;@X M @ ;08 !@ !X;"]W;W)K3(!2-*+\4ID)T SN6_FH.JUG_O> 8[D3-4S M[[_"6$_B>V/QW^$"5,L-B=I>)LC*)1&'D;QJ:U8S_&O[JY'?#H M@"<'E'[H$(T.T;M#;(L?R&RIGXDB92%X[XGAL#IBW@FTBO1F5L9H]\X^T]5* M;;V4*,R*X&("C9K-H,%SS:0(=/0I!7:EV. [=WR;8'NOB+ [0^0L(K+^\4T1 MX:*(09-:36LUGU :HSR-X@6-0XE1GF/\'Z;8R10[F/(%TZ!)YIDB%*>/Z8+( MH<-)'*9Y[B9*G$2)@^AQ093<9T)I%NG?8C^W#F6> M^83-+5_8-[J7#JWO/VYTCW$WO0CYPHT9_B@3Z_6O7]:4#@J M,\WT7 P=<%@HWHW-/9B^,.4_4$L#!!0 ( #R"?DHB&":3 4 !$; 8 M >&PO=V]R:W-H965T&ULE9E1E[K]"3ARCXW7N:TT ?<7XNJY_U M3NMF\NM0'.O[Z:YI3G>>5S_M]"&OOY0G?32?/)?5(6_,9O7BU:=*Y]NNZ%!X MW/>5=\CWQ^EBWNU[J!;S\K4I]D?]4$WJU\,AK_Y;ZJ(\WT_9]'W'M_W+KFEW M>(OY*7_1WW7S]^FA,EO>ME\>)Y5^OI]^97<;+MN"COAGK\_UI_>3 M]E >R_)GN_'']G[JMR/2A7YJVA:Y>7G3*UT4;2',PCWFM5V7Q8[]M=O?3:#K9ZN?\M6B^E>>-[@](3B?]T?^IWW1A\'8D1N.I M+.KN_^3IM6[*0]_%#.60_[J\[H_=Z[GO_UY&%_"^@%\+.!\L$'V!N!8(-5@0 M] 7!AT(X6"#[ OFA,%R@^@)U+9!BL"#L"\(/A>&"J"^(K@6L*_ NT]'-;Y(W M^6)>E>=)=3E%3WE[);"[R)Q!3^W.[H3I/C-37)N];PO&^-Q[:QOUS/+"<(L1 M-K.BF,!F$HJ1-K.F&&4S*<6$-I-13&0S&XJ)KXQG?+N:QTGS>-<@^-R ^\"\ M"R,[YM@Q(@[\((PXK21()4$H,:!T8110 @:O"$HJP0,&!IY@<"9%Q",)3H\U M ?)(R!C.24IU-$X$8%XRS#$5?NIF^160?@6$7_"T#M#,,+_]HW4DJ2,)'7!I M+"72X2&7@I91I(PB9,#5M538-1_,Z4JAH81!#*D$JPEP":['D11KS4+I0[%L ML)-E34A:$Q+6@'-^&2)K.#@W5R&>))\%T!DLAIP91U*L-3-B"M["!CM9SD2D M,Q'A#!C*,OJM:R F=6)"!QS+,OZ=:X#Y]%+E$T+@WK$D(.C_JF?L>S*3 > 2 MAUYK!R8E]&:48#;,&+-90B/HT7BOM0.3$GJ$7#;< MRG:(7K,9L6@+N&@3$'9HG$DQEVT,'#48D#2BS)"!L MSSB3.##KGK'OEC+P%3PW4H=N&=7-#A=]-*1"#5"U[:1S""."B$#Y&D/8SG$F M83C1S#CWXTB&T-3Q;JD#DSDP&Y=1V5;248L164O K,5PV!+F.N&^D#?$Z,#% MB,0E8.)B.')U8G#J.W!$+9GG$D,-<.[1+'9C, M@=GTC!H4D ,31X5&OTH M0 _+$H*<\%T9N549H7?0 D( M.X;3H1#HD47BT&KMP*2$W(S0RX9[V0[1,913,11^=>944#.W'@F?-&X($H+V MJ.A$QZE$!P-##RDX*CAU&,-40BCBF1MG4@2R;ICQTS^6?R[+1II__Q?3;Z7Q[W2CT<].^#]5>P MQ?]02P,$% @ /()^2MN<3S2O 0 @0 !@ !X;"]W;W)K$V'8 R>Q&CZ#\ M2:^-9,Z'YD3L:(!UL4@*0K/LCDC&%6ZJF#N8IM)G)[B"@T'V+"4S__8@]%3C M'%\33_PTN) @336R$SR#^ST>C(_(RM)Q"+N_LG^+O?M>CLS" MHQ9_>>>&&C]@U$'/SL(]Z>D[+/V4&"W-_X0+" \/3KQ&JX6-7]2>K=-R8?%6 M)'N;5Z[B.BW\U[)T 5T*Z%I B]C++!2=?V6.-971$S+SW8\L/'&^H_YNVI", M5Q'/O'GKLY[\W\V\Y!TZ/R\21=>R;=U!+ P04 M" \@GY*\3I\"XH% "T' & 'AL+W=OW3[&;=U]:O9Q ME_ZY;]IMW:?+]F'>[=M8WXV%MILY*>7FVWJ]FUXMQGN?VZM%\]1OUKOXN9UT M3]MMW?ZWC)OFY7*JIS]N?%D_//;#C?G58E\_Q+]B_W7_N4U7\U,M=^MMW'7K M9C=IX_WE]%I?K*P9"HR*O]?QI3O[/1E"N6F:;\/%[W>74S4XBIMXVP]5U.GK M.:[B9C/4E'S\>ZQT>GKF4/#\]X_:?QV#3\'/,BP]57>Q%+&KK)<>"\#M!.D'9MW>@!Q<[*3V5Y)75">"JU303L5L*,S M.Q5X#%7.96ZD3'N3C&,[6F$R*&"(=V2/:&LS;O,U 7%QBF,04UP* UA2HP M!S4 H17#@1$!446!1$12-_-&5V+ @$IOJS-"88 G:F4+@QA M&B-6(\:*?)7P3.U4$0?A">!8ZU F&R:M!JAU.?DU@*A*H[WAW)04SL@X7YHC M8=H2H*W+\4\2HCJ-,R[OY!40IB;UFLD67&']'TI+LQ) IQT.2<)<)(29\0[+2LKS20( Y( ('T.2 +<&P8M97,_ M")#$:7Y<6.-A0C(@I,\)R6B:J4C.1Z'P+5,8D P Z7- LL3>+"VS\A2!LI2S MQA76$8P!R0"0/@8]>X1&+DU]6L'F>Y9 1LI850H*P\*$#_0V3FX#DEL& M)9,6!B5E;P5E<6Y;D-NA@ >+<]M^(+MDGON0*85A<*\U^+, MMA_(;(LSV[XGLZT\(8 Q21F*:7YVUK.-[<-X+-9-;ING73^$ [6&PO=V]R:W-H965T&UL=5/M;ILP%'T5RP]0 M!X?0+ *DIM.T2JT4==KVVX'+A^H/9IO0OOUL0QC+V!_L>SGWG'/MZW10^LTT M !:]"RY-AAMKNP,AIFA ,'.G.I#N3Z6T8-:%NB:FT\#*4"0XH9M-0@1K)<[3 MD#OI/%6]Y:V$DT:F%X+ICR-P-60XPM?$:ULWUB=(GG:LAF]@OW$8>WP _&AA,(L]\IVO:O@*4S\[C*;F MG^$"W,&]$Z=1*&["%Q6]L4I,+,Z*8._CVLJP#A/_M6R]@$X%="Z@]Z&742@X M_\PLRU.M!J3'L^^8O^+H0-W9%#X9CB+\<^:-RU[R:$]3FZU8:=%;6 M34&XJTHI"\[,YLXUW+C'. <<*NNW]VZOQY$< ZNZZ;61^&UL;5/;;MLP#/T501]0)4K:9H%MH.DP;, &!!VV/2LV;0O5Q9/DN/O[4;+K MN9U?))'B.3RDJ&RP[MFW (&\:&5\3ML0NB-COFQ!"W]C.S!X4UNG14#3-J)!:5H\3+NTJ1]&&]N M^01;!_ )P&? (>5A8Z*D_*,(HLB<'8@;>]^)^,3;(\?>E-&96I'N4+Q'[[78 M'NXR=HU$4\QIC.'+F#F"(?N<@J^E./'_X'P=OEM5N$OPW1N%]^L$^U6"?2+8 MOR$XO"MQ+>;#NR1LT5,-KDG3Y$EI>Y,F>>&=!_8A/2+[%SY.^S?A&FD\N=B M+YOZ7UL; *5L;G"$6OQ@LZ&@#O%XCV?2=39GCX*30<#;$#DIQ\^<$$L>"IO35\23:S@4'*_.> MM_ =W(_^;+S%%I9:*-!6H"8&FH+>I\?3/L3'@)\"1KLZDU#)!?$Y&%_J@B9! M$$BH7&#@?KO" T@9B+R,WS,G75(&X/K\ROXIUNYKN7 +#RA_B=IU!3U04D/# M!^F>E/@<%4H;5U(-UJ&:6;P4Q5^F7>BXC]/-;3K# MM@'9#,@6P"'F85.BJ/R1.U[F!D=BIM[W/#QQ>LQ\;ZK@C*V(=UZ\]=YKF7Y, MP?/MN&[386["-^MLQ_NM@GVFP3[2+#_ MK\3T38E;,6]5LE5/%9@V3I,E%0XZ3O+*NPSL?1;?Y%_X-.W?N&F%MN2"SK]L M['^#Z,!+26[\"'7^@RV&A,:%XYT_FVG,)L-A/_\@MGSC\B]02P,$% @ M/()^2@1%S6"W 0 T@, !D !X;"]W;W)K&UL M;5/;CILP$/T5RQ^P#H1TTPB0-EM5K=1*T59MGQT8P%I?J&W"]N\[-BRE6UYL MS_B<,Q>/\]'89]/*BI'8%[;SO3XRYJ@/%W9WI0>--8ZSB'DW;,M=;X'4D M*X=4UQH6N;1=[%E;@8OA8:+)6Y0BMO?9Y!F+&A"7QU/HNU\<+ R[WD+ MW\!_[R\6+;:HU$*!=L)H8J$IZ$-R.FH?5?0(R4U-'R0 M_LF,GV"NYT#)7/P7N(%$>,@$8U1&NKB2:G#>J%D%4U'\9=J%COLXW1R2F;9- M2&="NA".,0Z; L7,/W#/R]R:D=BI]ST/3YR<4NQ-%9RQ%?$.DW?HO97)^WW. M;D%HQIPG3+K&+ B&ZDN(="O$.?V/GF[3]YL9[B-]OXY^O-\6R#8%LBB0_5-B M]J;$+%XCV<[C=ED>-///X@MW[C\ U!+ P04 " \ M@GY*)E"8OK;$] MXW/.7#S.!F.?70O@R8N2VN6T];X[,N;*%A1W-Z8#C3>UL8I[-&W#7&>!5Y&D M)$LVFUNFN-"TR*+O;(O,]%X*#6=+7*\4MZ\GD&;(Z9:^.YY$T_K@8$76\09^ M@/_9G2U:;%:IA +MA-'$0IW3^^WQE 9\!/P2,+C%F81*+L8\!^-;E=--2 @D ME#XH<-RN\ !2!B%,X\^D2>>0@;@\OZM_B;5C+1?NX,'(WZ+R;4X/E%10\U[Z M)S-\A:F>3Y1,Q7^'*TB$ATPP1FFDBRLI>^>-FE0P%<5?QEWHN _CS2Z=:.N$ M9"(D,^$0X[ Q4,S\,_>\R*P9B!U[W_'PQ-MC@KTI@S.V(MYA\@Z]UV)[=YNQ M:Q":,*<1DRPQ,X*A^APB60MQ2OZC)^OTW6J&NTC?+:,?]NL"Z:I &@72?TK< M?RAQ#7/X$(0M>JK -G&:'"E-K^,D+[SSP-XG\4W^PL=I?^2V$=J1B_'XLK'_ MM3$>,)7-#8Y0BQ]L-B34/ASW>+;CF(V&-]WT@]C\C8LW4$L#!!0 ( #R" M?DJ295RSM@$ -(# 9 >&PO=V]R:W-H965T]T?&7-6!XN[&]*#QIC%6<8^F;9GK+? ZDI1D M:9)\8HH+3PG?P M/_JS18LM*K50H)TPFEAH"OJP.YZR@(^ GP)&MSJ34,G%F-=@?*D+FH2$0$+E M@P+'[0J/(&40PC1^SYIT"1F(Z_.[^G.L'6NY< >/1OX2M>\*>J"DAH8/TK^8 M\3/,]=Q2,A?_%:X@$1XRP1B5D2ZNI!J<-VI6P504?YMVH>,^3C>WV4S;)J0S M(5T(AQB'38%BYD_<\S*W9B1VZGW/PQ/OCBGVI@K.V(IXA\D[]%[+W?U]SJY! M:,:<)DRZQBP(ANI+B'0KQ"G]CYYNT_>;&>XC?;^.?KC;%L@V!;(HD*WC)\F' M$KV$ *S:FMEG2O^_8L)1N><$SPSEG M+AYGH[%OK@7PY%VKSN6T];X_,.;*%K1P=Z:'#O_4QFKAT;4-<[T%44625HPG MR0>FA>QHD<78R1:9&;R2'9PL<8/6POX^@C)C3G?T&GB53>M#@!59+QKX!OY[ M?[+HL46EDAHZ)TU'+-0Y?=H=CFG 1\ /":-;V21TV#^8"VG=9L&UL;5/;;MP@$/T5 MQ <$+^LDJY5M*9LH:J566J5J^\S:8QL%/"[@=?KW!>RX;NH78(9SSEP8LA'- MJVT!''G3JK,Y;9WKCXS9L@4M[ WVT/F;&HT6SINF8;8W(*I(THKQ)+EC6LB. M%EGTG4V1X>"4[.!LB!VT%N;W"12..=W1=\>+;%H7'*S(>M' -W#?^[/Q%EM4 M*JFALQ([8J#.Z$H#/@)^2!CMZDQ")1?$UV!\KG*:A(1 0>F"@O#;%1Y! MJ2#DT_@U:](E9""NS^_JS[%V7\M%6'A$]5-6KLWI@9(*:C$H]X+C)YCKN:5D M+OX+7$%Y>,C$QRA1V;B2]\\M9[KP5/;C-V#4(SYC1A^ JS M6Q#,JR\A^%:($_^/SK?I^\T,]Y&^7T<_W&\+I)L":11(_RGQ[D.)6YB/0=BJ MIQI,$Z?)DA*'+D[RRKL,[$-\1/87/DW[5V$:V5ER0>=?-O:_1G3@4TEN_ BU M_H,MAH+:A>.]/YMIS";#83__(+9\X^(/4$L#!!0 ( #R"?DKUCFY&PO=V]R:W-H965TI%"VP)US_8$06W4@F;W2/2A_TV@CF?.F:8GM#; ZDJ0@-$F^$,FXPF4> M?2=3YGIP@BLX&60'*9GY9TV\A S$]?E=_5NLW==R9A;NM'CFM>L*O,>HAH8-PCWJ\0'F>JXQFHO_ M 1<0'AXR\3$J+6Q<4358I^6LXE.1[&W:N8K[.-UDV4S;)M"90!?"/L8A4Z"8 M^3USK,R-'I&9>M^S\,3I@?K>5,$96Q'O?/+6>R\E3?8YN02A&7.<,'2%21<$ M\>I+"+H5XDC_H]-M>K:981;IV3KZ_F9;8+3*CU#G M/]AB"&A<.-[XLYG&;#*<[N&PO=V]R:W-H965T-JN5;2F;JFJE5EJE:O/,VF,;!8P+>)W^?0?L==S4+\ ,YYRY,&2CL2^N M!?#D5:O.Y;3UOC\RYLH6M'!WIH<.;VICM?!HVH:YWH*H(DDKQG>[CTP+V=$B MB[ZS+3(S>"4[.%OB!JV%_7,"9<:<)O3F>))-ZX.#%5DO&O@!_F=_MFBQ1:62 M&CHG34,L$8I5$NKJ0E,$96Q'O,'F'WFO!DR1CUR T8TX3AJ\P;PB& MZDL(OA7BQ/^C\VUZNIEA&NGI.OKA?EM@ORFPCP+[?TKD[TK&PO=V]R:W-H965T)W^?0?LN&[J%V"&<\Y<&++1V%?7 GCR MIE7G7;G!XHJ: 6@_(O9OP$53 5+=ZF779Q'Z>;-)EIVP0^$_A".,0X; H4,W\2 M7A29-2.Q4^][$9XX.7+L31FW#\1[/=AJSR?"FGW\06[YQ\0=02P,$% @ /()^2N/_94>X 0 T@, M !D !X;"]W;W)K&UL;5/MCIP@%'T5P@,L(^-V MIA,UV=FF:9,VF6S3]C>C5R4+7@LX;M^^@*ZU6_\ ]W+.N1]X=TT)VM,BB[V** M# >G9 <70^R@M3"_SZ!PS&E"7QU/LFE=<+ BZT4#W\!][R_&6VQ1J:2&SDKL MB($ZIP_)Z9P&? 3\D##:U9F$2JZ(S\'X7.5T%Q("!:4+"L)O-W@$I8*03^/7 MK$F7D(&X/K^J?XRU^UJNPL(CJI^ROPG"5CW58)HX M39:4.'1QDE?>96 ?>'R3O_!IVK\*T\C.DBLZ_[*Q_S6B Y_*[LZ/4.L_V&(H MJ%TX'OS93&,V&0[[^0>QY1L7?P!02P,$% @ /()^2L)-?Q2V 0 T@, M !D !X;"]W;W)K&UL;5-A;]P@#/TKB!]0$NZZ MGDY)I%ZGJI,VZ=1IVVFAPYO:F.U\&C:AKG>@J@B2"O&D^03TT)VM,BB[VR+ MS Q>R0[.EKA!:V'_G$"9,: GQ)&MSJ34,G%F)=@?*ERF@1!H*#T@4'@=H4'4"H0H8S? M,R==4@;@^OS&_AAKQUHNPL]DY=N<'BBIH!:#\L]F?(*YGEM*YN*_PA44 MA@4$IR@R/4X@=;# 6U M#\<[/-MIS";#FW[^06SYQL5?4$L#!!0 ( #R"?DJ*E*K;MP$ -(# 9 M >&PO=V]R:W-H965T)W^?0?L.&[J%V"&<\Y<&++1V!?7 GCRJE7G M-/ =_(_^;-%BBTHE-71.FHY8 MJ'-ZOS^>TH"/@)\21K M,L$8I5$NKJ0%%D MUHS$3KWO17CB_9%C;\K@C*V(=YB\0^^UX#S)V#4(S9C3A.$KS'Y!,%1?0O"M M$"?^'YUOTY/-#)-(3];1#W?; NFF0!H%TG]*3#^4N(6Y_1"$K7JJP39QFAPI MS=#%25YYEX&]CX_(WN'3M'\3MI&=(Q?C\65C_VMC/& JNQL&UL;5/;;N,@$/T5Q >4A*1-%-F6 MFE;5KK25HE:[^TSL\47EX@4;]U2 M6GO?'AAS>0U*N!O3@L:;TE@E/)JV8JZU((I(4I+QU>J.*=%HFB71=[)98CHO M&PTG2URGE+ ?1Y"F3^F:7ATO357[X&!9THH*7L'_;$\6+3:I%(T"[1JCB84R MI??KPW$;\!'PJX'>SFXI&8O_ 1>0" ^9 M8(S<2!=7DG?.&S6J8"I*O ][H^/>#S>W5]HR@8\$/A'VD<"&0#'S1^%%EEC3 M$SOTOA7AB=<'CKW)@S.V(MYA\@Z]EXSSNX1=@M"(.0X8/L.L)P1#]2D$7PIQ MY/_1^3)]LYCA)M(W\^C[W;+ =E%@&P6V_Y2X^U+B$F;_)0B;]52!K>(T.9*; M3L=)GGFG@;WG\4W^PH=I?Q:V:K0C9^/Q96/_2V,\8"JK&QRA&C_89$@H?3CN M\&R',1L,;]KQ!['I&V>?4$L#!!0 ( #R"?DJEHJ ZMP$ -(# 9 M>&PO=V]R:W-H965T)W^?0;LN%;J%V"&<\Y<&++1V!?7 GCRJE7GV168&KV0' M9TODZ8B%.J?W MN^,I#?@(^"5A=*LS"9553 5+5ZG779Q'Z>;]##3M@E\)O"%<(AQV!0H9OY%>%%DUHS$ M3KWO17CBW9%C;\K@C*V(=YB\0^^UX/PN8]<@-&-.$X:O,+L%P5!]"<&W0ISX M?W2^3=]O9KB/]/TZ^N%V6R#=%$BC0+J.OT\^E+B%^5@D6_54@VWB-#E2FJ&+ MD[SR+@-[S^.;_(-/T_Y3V$9VCER,QY>-_:^-\8"I)#&UL;5/MCIP@%'T5P@,L(]KN9*(F.]LT M;=(FDVW:_F;TJF3!:P''[=L7T+5VZQ_@7LXY]X-+/J%YMAV (R]:];:@G7/# MB3%;=:"%O<,!>G_3H-'">=.TS X&1!U)6C%^.+QG6LB>EGGT74R9X^B4[.%B MB!VU%N;W&11.!4WHJ^-)MIT+#E;F@VCA&[COP\5XBZTJM=306XD],= 4]"$Y MG;. CX ?$B:[.9-0R17Q.1B?ZX(>0D*@H')!0?CM!H^@5!#R:?Q:-.D:,A"W MYU?UC[%V7\M56'A$]5/6KBOHD9(:&C$J]X33)UCJ>4?)4OP7N('R\)")CU&A MLG$EU6@=ZD7%IZ+%R[S+/N[3?),F"VV?P!<"7PG'&(?-@6+F'X0396YP(F;N M_2#"$R.]/YMY MS&;#X;#\(+9^X_(/4$L#!!0 ( #R"?DI")RV.M@$ -(# 9 >&PO M=V]R:W-H965T(%'+=_WP$[7F_7+\ ,YYRY,"2]L6^N!O#D74GM4EI[WQX8 MR66(Z+QL-)TM< MIY2P'T>0ID_IFEX=+TU5^^!@6=**"E[!_VQ/%BTVJ12- NT:HXF%,J7WZ\-Q M&_ 1\*N!WLW.)%1R-N8M&-^+E*Y"0B A]T%!X':!!Y R"&$:?T9-.H4,Q/GY MJOX4:\=:SL+!@Y&_F\+7*=U34D I.NE?3/\-QGIN*1F+_P$7D @/F6",W$@7 M5Y)WSALUJF J2KP/>Z/CW@\WNRMMFM^* M\,3K \?>Y,$96Q'O,'F'WDO&-[<)NP2A$7,<,'R&64\(ANI3"+X4XLC_H_-E M^F8QPTVD;^;1][ME@>VBP#8*;/\I\>Y+B4N8KT'8K*<*;!6GR9'<=#I.\LP[ M#>P]CV_R%SY,^[.P5:,=.1N/+QO[7QKC 5-9W> (U?C!)D-"Z<-QAV<[C-E@ M>-../XA-WSC[!%!+ P04 " \@GY*4>RET: " 4"P &0 'AL+W=O MNS#PQ$E\2I;>#Z][6=D%)G_$)L9W9VG9U==GF5ZEV?A##)1UTU>I6>C&D? M"=&[DZBY?I"M:.R;@U0U-W:KCD2W2O"]-ZHKPK(L)S4OFW2]]&=;M5[*LZG* M1FQ5HL]US=6?C:CD=972]';P4AY/QAV0];+E1_%#F)_M5MD=&5CV92T:7*P2I_HXX8Q9^ 1KZ6XZKMUXJ[R)N6[VWS=K]+,120JL3..@MO'13R+JG), M-H[?/6DZ^'2&]^L;^V=_>7N9-Z[%LZQ^E7MS6J7S--F+ S]7YD5>OXC^0K,T MZ6__35Q$9>$N$NMC)ROM?Y/=61M9]RPVE)I_=,^R\<]KSW\SPP:L-V"! >D< M^<@_<H^?LM=CNDCL]]FYP[]I_#O;/#:GE[6;#)?DHLCZC&;#L/N M,'1 $,L^N&#(Q8:-S!DVG\ ()]Y\\E^$"TPPA0133S"])YAFP141)G+)&70R M P0L<((P$^PDATYR0# -G"#,##LIH),"$.2!$X0IL),Y=#('!*'L$":2^ 5T MLA@3S,+$(TPD\33#%90!BC#U$!3)/8U4*@448?8A*))^"LOUB3) $0H @B(* MH+BNZ010C%H/ D5$0''Y4U#;>2@#"(KI '< "LH['^D @6(ZP$V @@K/1SI MH)@.A#J H% 'Y&XHJ84Z^G%,)SMY;OPL M>'&UL;5-A;]L@$/TKB!]0')(U661; M:CI5F[1)4:>UGXE]ME'!>(#C[M_OP*[K=?X"W''OW;OC2 =C7UP#X,FK5JW+ M:.-]=V3,%0UHX6Y,!RW>5,9JX=&T-7.=!5%&D%:,)\DMTT*V-$^C[VSSU/1> MR1;.EKA>:V'_G$"9(:,;^N9XE'7C@X/E:2=J^ G^5W>V:+&9I90:6B=-2RQ4 M&;W;'$^[$!\#GB0,;G$FH9*+,2_!^%9F- F"0$'A X/ [0KWH%0@0AF_)TXZ MIPS Y?F-_2'6CK5Y*DU M [%C[SL1GGASY-B;(CAC*^(=BG?HO>9\?TC9-1!-,:+_P?DZ?+NJ>&=!_8N/B)[#Q^G_8>PM6P=N1B/+QO[7QGC :4D-SA"#7ZPV5!0^7#< MX]F.8S8:WG33#V+S-\[_ E!+ P04 " \@GY*L(F+>K8! #2 P &0 M 'AL+W=O.;S2>FA6QIGD;?R>0I]D[) M%DZ&V%YK8=Z/H'#(Z)9>'2^R;EQPL#SM1 W?P?WH3L9;;%8II8;62FR)@2JC M]]O#,0GX"/@I8;"+,PF5G!%?@_%89G03$@(%A0L*PF\7> "E@I!/X_>D2>>0 M@;@\7]6_QMI]+6=AX0'5+UFZ)J-[2DJH1*_<"P[?8*KGEI*I^">X@/+PD(F/ M4:"R<25%;QWJ2<6GHL7;N,LV[L-X^"^-T5PQE;$.Y^\]=Y+SO<\99<@-&&.(X8O,-L9P;SZ'(*OA3CR M_^A\G;Y;S7 7Z;LE_>[SND"R*I!$@>2?$GQ[?Y"]\G/9G86K96G)&YU\V]K]"=.!3V=SX$6K\!YL-!94+QSM_ M-N.8C8;#;OI!;/[&^1]02P,$% @ /()^2D!*F NX 0 T@, !D !X M;"]W;W)K&UL;5/M;ML@%'T5Q .4A+A-&MF6FE;3 M)FU2U&G;;V)?VZC@ZP&.N[9=VXX&!YVHD:OH/[T9V-M]BL4DH-K978$@-51A^V MQU,2\!'P4\)@%V<2*KD@O@3C2YG134@(%!0N* B_7>$1E I"/HW?DR:=0P;B M\ORF_BG6[FNY" N/J'[)TC49/5!20B5ZY9YQ^ Q3/;>43,5_A2LH#P^9^!@% M*AM74O36H9Y4?"I:O(Z[;.,^C#?)_41;)_")P&?"(<9A8Z"8^9-P(D\-#L2, MO>]$>.+MD?O>%,$96Q'O?/+6>Z\Y/]RF[!J$)LQIQ/ %9CLCF%>?0_"U$"?^ M@<[7Z;O5#'>1OEO2]_?K LFJ0!(%DO]*O'M7XAIF_RX(6_14@ZGC-%E28-_& M25YXYX%]X/%-_L'':?\F3"U;2R[H_,O&_E>(#GPJFQL_0HW_8+.AH'+AN/=G M,X[9:#CLIA_$YF^<_P502P,$% @ /()^2K3H>-2X 0 T@, !D !X M;"]W;W)K&UL;5/;;MP@$/T5Q <$+[OI7F1;RJ:J M6JF55JF:/K/VV$8!XP)>IW_? 3NNF_H%F.&<,Q>&=##VQ34 GKQJU;J,-MYW M)\9FMXKV<+% M$M=K+>SO,R@S9'1#WQQ/LFY\<+ \[40-W\'_Z"X6+3:KE%)#ZZ1IB84JHP^; MTWD7\!'P+&%PBS,)E5R->0G&ES*C24@(%!0^* C<;O (2@4A3./7I$GGD(&X M/+^I?XJU8RU7X>#1J)^R]$U&#Y244(E>^2]^)\,2;$\?>%,$96Q'O,'F'WEO.#X>4W8+0A#F/&+[ ;&8$0_4Y!%\+<>;_ MT?DZ?;N:X3;2MTOZ_K@NL%L5V$6!W3\E'M^5N((Y)N^"L$5/-=@Z3I,CA>G; M.,D+[SRP#SR^R5_X..W?A*UEZ\C5>'S9V/_*& ^82G*'(]3@!YL-!94/QSV> M[3AFH^%--_T@-G_C_ ]02P,$% @ /()^2J">OG.S 0 T@, !D !X M;"]W;W)K&UL;5/;CILP$/T5RQ^P3IRTVXT :;-5 MU4JM%&W5]MF! :RU/=0V8?OWM0UA:M] M=V#,E2UHX>ZP Q/^U&BU\,&U#7.=!5$EDE:,;S;OF1;2T")+L9,M,NR]D@9. MEKA>:V'_'$'AD-,MO0:>9=/Z&&!%UHD&OH/_T9UL\-BL4DD-QDDTQ$*=T\?M MX;B/^ 3X*6%P"YO$3LZ(+]'Y4N5T$PL"!:6/"B(<%W@"I:)0*./WI$GGE)&X MM*_JGU+OH9>SL?)O3#Y144(M>^6<;3?.O$3V$4C9W887:\,!F1T'MHWD?;#NNV>AX M[*87Q.9G7/P%4$L#!!0 ( #R"?DHZ[4X'Q0$ #<$ 9 >&PO=V]R M:W-H965TE7TP#8-&KX-)DN+&V.Q)BB@8$ M,W>J ^EV*J4%LVZI:V(Z#:P,),$)7:UV1+!6XCP-L;/.4]5;WDHX:V1Z(9A^ M.P%70X;7^"/PU-:-]0&2IQVKX1?8W]U9NQ695&']?&4>'P M_&EA,(LY\I5!06*_ W'"%1^#<"[DT_DZ:>+;TQ.7\0_UK MJ-W5A>(F?%'1 M&ZO$I.)2$>QU'%L9QF'2-RYZS>G]-B57+S1A3B.&+C#K&4&<^FQ!8Q8G^A^=QNF; M:(:;0-\LZ?O[N, V*K - MM/)28W)<8PN[A)$C5)(@+[&Y,8YG!C0A87)T#7 MXAG991.>N> @OA?R#CRWUD^FZE09=E'7/)UQRI90%E\KJSN72N"Z> M%QPJZZ=[-]?C6QX75G53FY+Y7Y&_ U!+ P04 " \@GY*Z%B\ L,! W M! &0 'AL+W=OXR4:EWTT+ M8-&'X-+DN+6V/Q!BRA8$,W>J!^F^U$H+9EVH&V)Z#:P*),$)39)/1+!.XB(+ MN9,N,C58WDDX:60&(9C^?02NQAQO\#7QUC6M]0E29#UKX!O8[_U)NX@L*E4G M0)I.2:2ASO'CYG#<>7P _.A@-*L]\IVC5-R$7U0.QBHQJS@K@GU,:R?#.L[Z5UJ<0&<"O2&0J5!P_IE9 M5F1:C4A/9]\S?\6; W5G4_ID.(KPS9DW+GLIZ'Z?D8L7FC''"4-7F,V"($Y] M*4%C)8[T'SJ-T].HPS30TS7]?A\7V$8%MD%@NQ)(D^2FQ1CF/TWNHD5V$0%Z M4R2&26^*D-7%"=!->+(&E6J085Q6V64J'FFX^+_P::1>F6XZ:=!96?=\PB77 M2EEP5I([YZ5U4[P$'&KKM_=NKZ>W/ 56]?.8DN6_HO@#4$L#!!0 ( #R" M?DKL@#ZWT@$ )P$ 9 >&PO=V]R:W-H965TGW[ GK6;ODBS/#[ M,X- /DGUJCL @]X$[W6!.V.&$R&ZZD!0_2 'Z.U*(Y6@QH:J)7I00&M/$IPD M490105F/R]SG+JK,Y6@XZ^&BD!Z%H.KW&;B<"ASC]\0+:SOC$J3,!]K"-S#? MAXNR$5E5:B:@UTSV2$%3X*?X=,X/7HHE72T?;2]7JN%9\I^L-EV!CQC5T-"1FQS]0]XOC4V+WIG))OQ5^S1:O;?96[J(T)ST;]26JD-&!+B1YLPYU]*M: 0V/<]&#G M:KXP&UL;5/;;MP@$/T5Q >$-=Y; O@R*N2VN:T=:X_ M,&;+%I2P5]B#]C[D!!(*%U0$'Z[P -(&81\&K]G3;J$#,3U M^4W]*=;N:SD+"P\H?W65:W-Z1TD%M1BD>\;Q,\SU7%,R%_\5+B ]/&3B8Y0H M;5Q).5B':E;QJ2CQ.NV=COLXW=Q8=P3SZDL(OA7BR/^C M\VUZNIEA&NGIFG[[:5M@ORFPCP+[?TKD'TKRN_ BU_H,MAH3:A>.M/YMI MS";#83__(+9\X^(O4$L#!!0 ( #R"?DI#"-0#VP$ $% 9 >&PO M=V]R:W-H965T.KM22268L:&JB>X5L-*3!">IS%Y6G"BD!Z$ M8.KW&;@<,QSC>^*UK1OC$B1/>U;#-S#?^XNR$5E4RE9 IUO9(055AI_CTSEQ M> _XT<*H5W/D.KE*^>:"SV6&(U<0<"B,4V!VN,$+<.Z$;!F_9DV\6#KB>GY7 M_^A[M[U8^SE@-#?_!6[ +=Q58CT*R;7_ MHF+01HI9Q98BV/LTMIT?QUG_3@L3Z$R@&P*9C'SE'YAA>:KDB-2T]SUSOS@^ M4;LWA4OZK?!KMGAML[=\%^]3@*$R\(8M47"QJR.-/_Z#1,WP4K MW'GZ;DU/GL("^Z# W@OL_VGQL&DQA#F&30Y!DT- (-F8A#"/89-CT.08$'C: MF 0P- J;)$&3)" 0;TQ"F.U/):LC*$#5_O)I5,BA\Q=_E5WN]S/U1_@O?'H< MOC)5MYU&5VGL1?#'M9+2@"TE>K"[VMCW: DX5,9-$SM7TZV< B/[^<$ARZN7 M_P%02P,$% @ /()^2F)Z>3?" 0 -P0 !D !X;"]W;W)K&UL;51A;]L@$/TKB!]0$APW761;:CI-F[1)4:>MGXE]ME'! M>(#C]M\/L..Y&5\"=W[OW3O@DHU*OYH6P*(W*3J3X];:_D"(*5N0S-RI'CKW MI59:,NM"W1#3:V!5($E!Z&9S3R3C'2ZRD#OI(E.#%;R#DT9FD)+I]R,(->9X MBZ^)9]ZTUB=(D?6L@9]@?_4G[2*RJ%1<0F>XZI"&.L>/V\,Q]?@ ^,UA-*L] M\IVSLS MDQ(OO+)MCA\PJJ!F@[#/:OP*C5,*$7U0.QBHYJS@K MDKU-*^_".L[Z5UJ<0&<"O2&0J5!P_IE95F1:C4A/9]\S?\7; W5G4_ID.(KP MS9DW+GLI$IIDY.*%9LQQPM 59KL@B%-?2M!8B2/]CT[C]"3J, GT9$W??XH+ M[*("NR"P^]#B[J;%&":-%TFC1=*(P/U-D1AF?U.$K"Y.@F["DS6H5$,7QF65 M7:;BD8:+_P>?1NH'TPWO##HKZYY/N.1:*0O.RN;.>6G=%"^!@-KZ[=[M]?26 MI\"J?AY3LOQ7%'\!4$L#!!0 ( #R"?DK;Z%\=R $ #<$ 9 >&PO M=V]R:W-H965T)3P@XE-8K,+=N)Z M_Z[^'&IWM5R8@4?%?W65;7-\P*B"F@W3[CD6BD++I7D MSN72NBE># ZU]=N]V^OI+4^&5?T\IF3Y5Q1_ 5!+ P04 " \@GY*X9?D M4"T# #=#0 &0 'AL+W=O1*O_V=KNH/W2B MW Q&31W1.$ZCIJS:<#$;UAZZQ4P>55VUXJ$+^F/3E-V_I:CE>1Z2\'7AL=KM ME5F(%K-#N1,_A?IU>.CT++IXV52-:/M*MD$GMO/PGMRM:&X,!L3O2IS[JW%@ M4GF2\ME,OFWF86P8B5JLE7%1ZL=)K$1=&T^:Q]_):7B):0ROQZ_>OPS)ZV2> MREZL9/VGVJC]/,S#8".VY;%6C_+\54P)\3"8LO\N3J+6<,-$QUC+NA]^@_6Q M5[*9O&@J3?DR/JMV>)XG_Z]FV(!.!O1B0-*;!LEDD+P9L"'YD=F0ZN=2E8M9 M)\]!-[ZM0VD.!;E+]&:NS>*P=\-_.MM>KYX624)FTO4O"BK$<,>F :0=,;+&XA7A'@D$2#)!( M+!(CAM\@X2)H07.:8B8<,N& ";.8<"<.83RV4"L7E3#&/.\FA6120(9;9%(G M3$I3PC*+C0O+XBQG#-/)()T,T$DM.ID3AR4\*^S-<6%)6O#$HXT%[""W1,*7!1V4@#$?%1Q'2.@D#'?_N,J1$ 98G8MA*#$$P?7& **#+.+ M# 1Q3QQ)@R1.@>>8YT!2K ME *5,OM (Q#W'&B*M4>!]KCO\H"U1Y&L'*H Y*6*M4>!]KCG2T>Q]BB2E4,5 M@+A'>Q1KCP)9<<]7D&)9420KARH >7<5:X\"67%/!:!85A0IQJ$*0-PN$]'5 MI;@1W6[H'_I@+8^M,M?/J]5+CW)/S:7:6E_JWF7L--[MR-#<&UL?571CILP$/P5Q'L/,!A#1)".5%4KM=+IJFN?'>($= 93VPG7OZ]M M",<9JR_!7F9V9Q9[4XR,OXJ&$.F]=;07>[^1%NPJ:=N3)^Z):]=A_K?VTD@=",IBP!?RD\B7X8FK7;!D.;4=Z47+>H^3\]Y_C'8'I/$&\*LEHUBM M/>WDR-BKWGP[[?U0"R*4U%)GP.IQ(P="J4ZD9/R9<_I+24USWSO1,[X2N4S&[^2V0_TO=G\=W(C5,&U$E6C9E287Z^^"LFZ M.8N2TN&WZ=GVYCG.^>\T-P',!+ 0HO2_A'@FQ.^$Q)B?E!FKG['$9<'9Z/'I M8PU8GXEH%ZMFUCIH>F?>*;="16]E#%$1W'2B&5--&+#"1 LB4-F7$L!5H@(; M.OA8X+!%Q,!=(7::B T_^6 BLTQ,F-1@^LE$F*$,1986!RZ%"ZMNPBBX3\Q'H.V[%*S5)I\'WGF8:PS\P MO[2]\(Y,J@EB[OF9,4F4S/!!M:Q1DW_94'*6>HG4FD_S;]I(-LRC/5C^7\I_ M4$L#!!0 ( #R"?DJ5@PC& P( (,% 9 >&PO=V]R:W-H965TK64G9KA$1> \7BB770JCU'+& M+2-_FD+6J?OB.@64^$3D&^N_@JTG_P81PZK*=NM8[4Y\JUTWP=\T[U4RCO.0MB/T%G+60QFP'CSS#! M'+._QZQ&!%(9C&GX2VEL_(40X3S$=@D3S3&[)4Q\D^ICG5FRP6+/ B,0S@2> MEP7"18%P0>#EIND#)C:8UF#\R/.\FY[P_4$L#!!0 ( #R"?DH, MS$-F-@( &L& 9 >&PO=V]R:W-H965TN(^+/@3(^[D,0ODT\M==&F8FH*@=R MI3^H>AX>A1Y%2Y1SV]%>MKP/!+WLPX]@5V=&;P4_6SK*53\PE1PY?S&#K^=] M&!L@RNA)F0A$-W=:4\9,((WQ>XX9+BF-<=U_B_[9UJYK.1)):\Y^M6?5[,,\ M#,[T0FY,/?'Q"YWK2<-@+OX;O5.FY89$YSAQ)NTS.-VDXMT<1:-TY'5JV]ZV MX[2"X6SS&Y+9D"P&@/YK@+,!.H9H(K.E?B**5*7@8R"FPQJ(>2? #NK-/)E) MNW=V35R]@K@HH[L)-&L.DR99:9+WBGJK@/\DD098*!(O16+]:.W/8H=B MTF"KZ2<-Q%GAP-9;&<(XA;D?!WIQH <'.#B3)EWE 0G <9$[/!X=*G(48S\0 M\@(A#Y!S!@>T292@HDB0>U9;'H"@ Y1N@5*$XMPYV'JK M UF> PS\0-@+A#U R '"FT0? $H 1*E#Y!'B&*UE<.1*WR#V.[]PKJB.&3_H^AI]\R\# M1B_*=#/=%]/]-PT4'^:K/5K^+]5?4$L#!!0 ( #R"?DKS&3^7U $ "D$ M 9 >&PO=V]R:W-H965TTP^"?FB.@ = MO#+*51%V6@\'A%35 2/J00S S4XC)"/:+&6+U""!U([$*$JB*$6,]#PLIC4:AY8)QGY3_^R\&R\7HN DZ.^^UET1/H9!#0T9J7X6TQ>8_>S#8#;_ M#:Y #=Q68G)4@BKW#:I1:<%F%5,*(Z]^[+D;)[^3WFC;A&0F) LA3O]+P#,! MOQ%VSKROS%G]1#0IV]JV<#MC-IC=E<06ITP ]FZ9E1!)4:NK9=5=.GWI\3>T%W\:-Z!;]LW M&?^(OA/9]EP%%Z'-_;M;:H308,J,'DQG=N;=+@L*C;;3S,RE[UZ_T&*8'R9: M_@[E/U!+ P04 " \@GY*.D7L:J$# "O$0 &0 'AL+W=OM/[977SUG_C>7AVR2]%^T=/:S6.>MN"G9'IIF[;K#O7?^? MJ;8QH\\;BI-5\-PE&C$/ X9/,.R&"$SVVQ0<3?' K7#^>H*MC2".9R!8!/7Q MT:LBTED1 T;VF&HH@L4Q)?-JMP#(64@BEIA2!"E%-J4DG%$:,&(RTYN412'Q M&7 +@(F049(XNB0@)0$HL1DE8L37WN)BO$L!QF0KN$">#EG3/.*A*.%)@SV%+ M3(?99D)IF,[U/<*F11D;D"Y"V'$8LAQ76[!#,&01\;PF!$H<\V#A,Z!\NW?2 M-N)(1H+FS9/@/FZ!T"1PV$8=@BVQ")&T+1[ MJ1!"6MT#N)B'W.$2'+L$!RX1N5X2L$MPX!)6]Q HQHOD212.0DRI6- >*3AT*Y%B!'"G0H@I 3JI8IAPH M,'6EP KD0($V50!R424L*T*R(M?(BL$ MSEK"L:(FL$,A)%MA"&"Y:?1ZW1X+;'LWF+U!+ M P04 " \@GY*B^;K =X! &!0 &0 'AL+W=O)?W[ MVH90LNLF><$^QS/#C#'.)RX>90>@O"=&!UF@3JEQA[&L.V!$WO 1!KW259J>P2![/G@"V@)]"'95:O 6\+.'26[FGDER MX/S1%%^: OG&$%"HE5$@>CA#!90:(6WC]Z*)UE<:XG;^K/[)9M=9#D1"Q>FO MOE%=@3+D-="2$U4/?/H,2YX$>4OXKW &JN'&B7Y'S:FT3Z\^2<79HJ*M,/(T MC_U@QVE>2;*%YB:$"R%<"4'\*B%:"-$% <_.;-2/1)$R%WSRQ/RQ1F+.1+"+ M]&;6IFGWSJ[IM%)WSV5TE^7X;(06S/V,"3>8\"6BND9$_R!8&UA=A$X7H>7' M+US<7;B8,:G%#!:3A-FED6M0&&11YO82.;U$5UYBWW<+Q$Z!^!UAXO>$F4') M%A2G_[&2.*TDCBR!6R!U"J1O9ZG2JRQ!&MU>[CG>G$AS0WPCXM@/TCMPI0^W M/8(MYPJTHG^C?7?Z4EH+"JTRTUL]%_.O.1>*C\NM@]>KK_P+4$L#!!0 ( M #R"?DI ?#-/% ( /H& 9 >&PO=V]R:W-H965TWJF*KP=7]V_Z/ RS!%SV%/RNRY$ ME=JQ;150XC,1+[3_"F.@T+;&]-_A D3*%8E\1DX)U[]6?N:"-J.+1&GP^W"M M6WWM1_]KF;G &PN\J< -5@O\L--Z-9J'8WRO\_Q(D 28*STCAZ?I@1N&; M#7RC@6\P"!8Q!DVD-:W6.(L8:XH91&"$".X@7'>[@!@TX0K$FF(&$1HA0D,G M0K-!9#2('FAE]&&*-<4,8F.$V#S0RLV'$&N*&41LA(@-G8C,!ENCP?:!5F[O M&$,O7GY?]R+/C?W8S")W5>.7[CS0TU$4K>,85"8>=+,)J5/A!V:GNN76D0JY MG^E=IZ14@+1TGF2X2AY$TX1 *=1P(\=LV(V'B:#=>-*@Z;C+_@%02P,$% M @ /()^2A$.#PY/ @ DP< !D !X;"]W;W)K&ULC55A;YLP$/TKB!]0,!!((H*49*HV:9.B3ML^.^024 VFMA.Z?S_;4)K" M,?4+ML_OWKTS]EW:Y[,"ZBH?. -U'KGS$5%E5Z* MBR<; ?1DG2KF!;X?>Q4M:S=+K>T@LI1?%2MK. A'7JN*BK\[8+S=N,1],SR5 MET(9@Y>E#;W 3U"_FH/0*V]@.945U++DM2/@O'&W9+TGH7&PB-\EM/)N[IA4 MCIP_F\6WT\;UC2)@D"M#0?5P@STP9IBTCI>>U!UB&L?[^1O[HTU>)W.D$O:< M_2E/JMBX2]F7KB[5?H$UJX3I_]=[@!TW"C1,?(.9/VZ^17J7C5LV@I M%7WMQK*V8]OMQ*O>#7<(>H=@<"#Q?QW"WB%\=XAL\ITRF^H7JFB6"MXZHOM; M#367@JQ#?9BY,=JSLWLZ6ZFMMRSRD]2[&:(>L^LPP1V&# A/LP\A BS$+IBX M!Q\#[*>(,, CA&@2H?6//B2Q'"7186*+J2UF$9-H)&0*(GZXC'$M$:HEFF@) MHYGC6J $"X1@I'.'819XD!@-$B,$,VDF*$'R"948)L&#+-$@2^2_KG""%4JP MFA(0?Z1R-?GG49*,;^@4%(?!S!TE/O[2?$3,S,T@,X^5?.+44=#,Y2#HB]V2 M )$ZERW^),GT32)2,=#XAGAWI:P"<;%57SHYO];*%(T[Z]!9MH$IA2/[SG0< M6R+?:;IV]8.*2UE+Y\B5+K2V')XY5Z U^@_ZK16Z0PX+!F=EIHF>BZY-= O% MF[X%>D,?SOX!4$L#!!0 ( #R"?DIKU=#BO0$ "H$ 9 >&PO=V]R M:W-H965TS $:S:F-E.:/]];4-0FO@+OCN_>^_N;%.,4KWI#L!$[X+WND2=,<,68UUW M(*A^D /T=J>52E!C777$>E! &Y\D."9QG&-!68^JPL?VJBKDR7#6PUY%^B0$ M51\[X'(L48(N@6=V[(P+X*H8Z!'^@ODW[)7U\,+2, &]9K*/%+0E^I9L=YG# M>\ +@U%?V9'KY"#EFW-^-26*74' H3:.@=KE#$_ N2.R9?R?.=$BZ1*O[0O[ M#]^[[>5 -3Q)_LH:TY7H$44-M/3$S;,$$,B>0)8%,O4Q"OO+OU-"J4'*,U#3[@;HC M3K;$SJ9V03\*OV>+US9ZKM)D5>"S(YHQNPE#OF#2!8,M_R)"@B+$$V2>H/<$ M)$[6-RH3*+\&Y9M-6&85E%F%9!YO9 (@LH[#,FE0)@W);&YD[D%YFH55LI#* M+KL;1Y;?31U?';-[17^H.K)>1P=I[(WQY]I*:< 2Q@^6L;,/=W$XM,:9:VNK MZ?I.CI'#_#+Q\GNH/@%02P,$% @ /()^2OC,<#?2 0 (P0 !D !X M;"]W;W)K&UL?51M;YLP$/XKEG] #8:F501(3:9I MDS8IZK3MLP-'0/4+LTWH_OW\0BE-HGW!OO/SW-UCWU%,2K^8#L"B5\&E*7%G M[; EQ-0="&;NU #2G;1*"V:=J4_$#!I8$TB"$YHD&R)8+W%5!-]!5X4:+>\E M'#0RHQ!,_]T!5U.)4_SF>.Y/G?4.4A4#.\$/L#^'@W866:(TO0!I>B61AK;$ M3^EVGWE\ /SJ83*K/?)*CDJ]>.-K4^+$%P0<:NLC,+><80^<^T"NC#]S3+RD M],3U_BWZYZ#=:3DR WO%?_>-[4K\B%$#+1NY?5;3%YCUW&,TB_\&9^ .[BMQ M.6K%3?BB>C16B3F**T6PU[CV,JQ3/,DW,^TV@D6G'Q/LKQ$9O9TANRDB"_S\@XC-A8B(V02,#)B'+,]H\GA1 MRS4NN2B%K.Y6@#Z%-C2H5J.T7L7*NW3Z$_5O<^'?N0F(#?L>)H[/=Z9/O33H MJ*Q[^? ^K5(67(')G>O)SDWL8G!HK=\^N+V.?1L-JX9Y),GR7ZC^ 5!+ P04 M " \@GY*#NFIC!$" ""!0 &0 'AL+W=O]=@+KD(D#:IJE9JI6BK;9\=,@EH;4QM)VS_OKX0 ME@5:]07;XW/FS#'V9!T7+[("4-XKHXW,_4JI=HN0+"M@1#[P%AJ]<^:"$:67 MXH)D*X"<+(E1A(,@18S4C5]D-G801<:OBM8-'(0GKXP1\7L'E'>Y'_KWP%-] MJ90)H")KR06^@WIN#T*OT)#E5#-H9,T;3\ Y]Q_#[3XU> OX44,G1W//.#ER M_F(67TZY'YB"@$*I3 :BAQOL@5*32)?QJ\_I#Y*&.)[?LW^RWK67(Y&PY_1G M?5)5[J]][P1G?H?>3^%YO_BO<@&JXJ41KE)Q*^_7*JU2<]5ET*8R\ MNK%N[-BYG?1.6R;@GH '0IC^DQ#UA.B-$%OSKC)K]2-1I,@$[SSA?E9+S)T( MMY$^S-($[=G9/>U6ZNBMB,-5AFXF48_9.0P>8<(!@73V00(O2>SPC([?"^SG MB @O*T2+)B++C]^96$],.$QJ,8W%K)(U7L6;9:%X42B>"45I,!%RF&0D] %' MFR3^RYDEBT+)@J/-1"B9"ZVB.,+!Q/H^F5D/EFM)%VM)Y[7@J>DY)DHG5:3_ M^0/0Z.HR$!?[RJ57\FNCS"4918=&\HC-U9_$=[K!N'[PEL9UIV]$7.I&>D>N M],.RU__,N0)=9O"@3ZO2#7%84#@K,UWIN7!MP2T4;_N.AX:V6_P!4$L#!!0 M ( #R"?DH??LKIP0$ #<$ 9 >&PO=V]R:W-H965T0'J,-'DRX"I";3M$F;%'7:]MN!2T#U![.=T+W]KHW+ M:(*F_HE]K\\Y/@?;R0>EGTT+8*,7P:4I2&MMOZ745"T(9NY4#Q)7&J4%LUCJ M$S6]!E9[DN T6:W65+!.DC+WO8,N@9=ZS$WP'^Z,_:*SHI%)W J3IE(PT- 5YC+?[S.$]X&<'@YG-(Y?DJ-2S M*[[4!5DY0\"ALDZ!X7"!/7#NA-#&[Z!)IBT=<3Y_5?_DLV.6(S.P5_Q75]NV M( \DJJ%A9VZ?U/ 90IY[$H7P7^$"'.'.">Y1*6[\;U2=C54BJ* 5P5[&L9-^ M',:5=1IHRX0D$)*)$&?_):2!D%X1Z.C,1_W(+"MSK89(CX?5,W\I,L"V:) ]HXPMYA9F'$/.CM" M]Z2^,7WJI(F.RN)M\&?6*&4!Y59W>$];?,53P:&Q;KK!N1[O\EA8U8=G2J?_ MBO(O4$L#!!0 ( #R"?DH'E\NTP $ ",$ 9 >&PO=V]R:W-H965T M0'J $3VD2 U*::-JF5HD[;?CMP"5;] MP6PGM&]?VU"61&CJ'WSO]3G'Y_J#8E#ZU70 -GH37)H2==;V&XQ-W8&@YD;U M(-U,J[2@UJ7Z@$VO@3:!)#A.XSC'@C*)JB+4=KHJU-%R)F&G(W,4@NKW!^!J M*%&"/@LO[-!97\!5T=,#_ 3[J]]IE^%9I6$"I&%*1AK:$MTGFRWQ^ #XS6 P M9W'D.]DK]>J3'TV)8F\(.-36*U WG& +G'LA9^/OI(GF)3WQ//Y4_Q9Z=[WL MJ8&MXG]88[L2W:&H@98>N7U1PW>8^EFA:&K^"4[ '=P[<6O4BIOPC>JCL4I, M*LZ*H&_CR&08AW%FM9YHRX1T(J0S(8G_2R 3@?PCI*'YT5EH]9%:6A5:#9$> M#ZNG_DXD&^(VL_;%L'=ASG5K7/5496E6X),7FC /(R:]P*PN,=LE3#YCL/,P M&TD7C:1!(+L0N+TR,F+R@)$!DY LR:^LC*CU&6J=Y6F\;(8LFB$+9NZNS) O MF2%?,H//CLL_GV>J#TR::*^L._EP/JU2%IQB?./N9.=>[)QP:*T/;UVLQWL[ M)E;UTY/$\W^A^@!02P,$% @ /()^2K&#&&RM @ .@D !D !X;"]W M;W)K&ULC5;M;ML@%'T5RP]0\V'\4261FDS3)FU2 MU6G;;YJ0Q*IM/"!)]_8#[+J>N9[VQP9\[KGG +ZPNDGUHL]"F.BUJ5N]CL_& M=/=)HO=GT7!])SO1VB]'J1IN;%>=$MTIP0\^J*D3@E"6-+QJX\W*CSVJS4I> M3%VUXE%%^M(T7/W>BEK>UC&.WP:>JM/9N(%DL^KX27P3YGOWJ&PO&5D.52-: M7^,HN'U=Q4[4 MM6.R.GX-I/&8TP5.VV_L'[UY:^:9:[&3]<_J8,[KN(BC@SCR2VV>Y.V3& RQ M.!K#?JY\]^L6VU'KYN4 ME*ODZH@&S+;'D D&CXC$LH\I")1B2X)P\G>"78B@!,Y 01/4QZ=3$Q3-3/28 MS&-:C\E25N!\)@6 E7E.,UA."LI) 3EX)J?'L$D>3%)$63'3 ^ HLG\I@P4Q M4! #!,W68,O"1)ADC,WF<0?@$*4H6UBP#!24!8)H/EN);08XSRF;..\% ;C4 MLA4Y+"@'!>7 #-&9H#Q,E.7!@H4HDA4I@L44H)@"$)/"!"5(4/[']);0QD)D M/KME\#_@%".VX S MCO;RTAI7VR>CXP7@@;@3:S:^=1<#?Y*]T_2WBJ]$! # ! &0 'AL+W=O#J)P6RG' T*B:J$GXHF-,*@W#>,]D6K)+TB,'$AM@GJ* M L^+44^ZP2USLW?B9-UZ[2ROU!BKSD5S@ M%\C?XXFK%5I=ZJZ'071L<#@TA?O%/QQCK3>"/QU,8C-W="5GQM[TXGM=N)Y. M""A44CL0-=S@&2C51BJ-]\7379$Z<#N_N[^8VE4M9R+@F=&_72W;PDU=IX:& M7*E\9=,W6.K!KK,4_P-N0)5<9Z(8%:/"/)WJ*B3K%Q>52D\^YK$;S#@M_O

T"P! 1K0##7,H-,YE^))&7.V>3PN?-*TP[U3R0NW>RBC, M3NV@T H* M;:!T!WH413A)0FP'15909 /M^_8H\I/,RSYI';:"L/&(MKV/O!T'/W#"#*?9 M)YV+K9S8PO%WG/CA"_DX\Y-TWSFT.7SZW_Y)^*4;A'-F4IUC<]H:QB0H3^]) MI=VJZV1=4&BDGB9JSN>?:EY(-B[W!5HOK?(_4$L#!!0 ( #R"?DJF&PO=V]R:W-H965T]SSG&&S* MD8L7V5"J@M>.]7(;-DH-&P#DL:$=D8]\H+U>.7/1$:6'X@+D("@Y65/'0!Q% M*>A(VX=5:>?VHBKY5;&VIWL1R&O7$?%[1QD?MR$,WR:>VDNCS 2HRH%J MGH>]T".P1#FU'>UER_M T/,V_ W=6'T5O"CI:.\ZP>FD@/G+V;PY;0-(Y,0 M9?2H3 2BFQNM*6,FD$[CUQPS7)#&>-]_B_[)UJYK.1!):\Y^MB?5;,,\#$[T M3*Y,/?'Q,YWKP6$P%_^5WBC3Q#( M0> 5 B88X7>V+/5R4@\G<3CIBO. ,8)^3.;%9!X,=C#9NAQ4Y#'V3K\M)<)X[NUOGJP_R >((XLR?3^'+9U>L@A2H<(]@O5;!%./,/63@[MB; M:_@;$9>VE\&!*WV#V'-^YEQ1'3)ZU/4U^N9?!HR>E>EFNB^F^V\:*#[,5SM8 M_B_5'U!+ P04 " \@GY* YB[W48" !8!P &0 'AL+W=OEGYH# &#O3(*5#<76 -C1DC;^#UH^F-(0YSV MW]4_V]QU+CLJ8?8$AG]CWAN2_P068AALG.L:> M,VG_O?U9*EX/*MI*3=_ZMFILV_4K*1IH;@(>"'@DX'\3HH$0W4L@ X'<2X@' M0CP24&JWM\_=;N:&*EKD@G>>Z(]#2\VI0X^Q+M?>3-KJV#6]GU+/7@I"TCRX M&*$!L^HQ^ JSN,:L'1A$KC$;ETYVC7ER8.)PQ 0ZES$A[$P(6P%R)8!F9GM, M8C&-Q2 4S=/>.% D01^8B9QFHELS>!9FW6/B:9B(H&2V+STJFZ RDN /S!"G M&>(P,R\CN3Q'%@L%L@ M=0JD#H%9*JM;3#3!7 59.(,L'$%FW]?*A8G=03)GD,PA,*O]JL>@<++G:1SJ MWRQ0,+F!S)OSG8I3U4AOQY6^S.R5<^1<@=8,'W0=2_W,C0,&1V6ZJ>Z+_K+O M!XJWPSL6C(]I\1=02P,$% @ /()^2A2S[^OR @ F P !D !X;"]W M;W)K&ULC5=M;YLP&/PKB!]0L'FODDA-IFF3-JGJ MM.ZSFS@)*F!FG*3[][.!4AJ?JWX)V+GG? ><>5A\:TR%$P?SGS# MJ\HP:1U_1U)_6M,4SL]?V;_VYK69)];QC:C^E#MU7/JY[^WXGITJ]2 NW_AH M*/&]T?T/?N:5AALE>HVMJ+K^U]N>.B7JD45+J=G+<"R;_G@9^5_+< $="^A4 M0-(/"Z*Q('HKB'OS@[+>ZA>FV&HAQ<63P]UJF7DHR&VD+^;63/;7KO]/N^WT M['D5)]DB.!NB$;,>,'2&(1,BT.S3$A0ML:96.7V_P,9&1!2O$$$345\?OS.1 M7YD8,&F/:083A- \#$.\4@Q7BL%*!29(($%B$Z3AE=0!D\RD1DE,YTJ'RY98 MEAQ>4B@E!5(<-S:#!-DGO&26%Q(6B>W%QCF\Y%!*#J0X'J$"$A2?\%+87BBX M+0!&W,\9"7$N0R HT)P/1]=)N".\$=H4!1[*# 42<@ MZVER;2JRU*9QGKKEXK 3D/8T=5#@N!.4=TNN'?@XRMQJ<9P)RG/FH,"!)BC1 MEEH[JDE&W&IQ8 E*;.Z@P)$E*+/%M5H[C7@S!4"'(XH32T%B,Q<%3BQ%B;UV M1&$4P98*@"XY.*X4Q#5SO?IQ7"F*J^7(CFL,[-BHC_95BC--0:8SQYN"XDQ3 ME&G+D_UR)N"I0S"TKP:S?J[F\M"WOIVW%:=&F<"^$XEIF>*-E'O5GPC2H^%Z9TTR?RZ%7'@9* MM.-W0#!]C*S^ U!+ P04 " \@GY*%."4%Y\" C"0 &0 'AL+W=O MZ:OI%?#"F MG25)OSFH6O8/NE6-_;/372V-;7;[I&\[);>#45TE!*$LJ679Q,OYT/?8+>?Z M:*JR48]=U!_K6G:_5JK2YT6,X[>.IW)_,*XC6MF6M MFK[43=2IW2)^CV<%)LY@4'POU;F_^HY<*FNM7USC\W81(T>D*K4QSH6TKY,J M5%4Y3Y;CY^0TOL1TAM??;]X_#LG;9-:R5X6N?I1;/E7G2YT]J M2BB-HRG[+^JD*BMW)#;&1E?]\(PVQ][H>O)B46KY.K[+9GB?QS]<3&:P 9D, MR,4 L[\:T,F >@;)2#:D^D$:N9QW^AQUXVRUTBT*/*-V,#>N] MIR7C=)ZLBK^I;J!$2","&"XOV!$$$6DR)^>T,^] MZ&"J[&&"K'/E2H"787!JIQ M)AC+N8>37)U6[OKP57;[LNFCM3;VX!N.IYW61EFGZ,%F=[ WEDNC4COC/KG] M[L9C>VP8W4Y7DN1R+UK^!E!+ P04 " \@GY*E.6^-M$" #'"0 &0 M 'AL+W=OG^J;49MKODZ'K9;EU1DV=$(2RI"FK-EXM MW-ICOUJHHZZK5C[VT7!LFK+_NY:U.B]C'+\O/%7[@[8+R6K1E7OY4^KG[K$W MLV3VLJT:V0Z5:J->[I;Q [XO,+4&3O&KDN?A8AS95%Z4>K63;]MEC"R1K.5& M6Q>E>9QD(>O:>C(W&^T.0Y:-9,7@]*4;^.S:MWS//E_ M-X,-R&1 9@.<_=> 3@;TPX"YY$K1:_.43^^K:ZT18'OJ=G,C5UT M>^?^,]D.9O6T8@(MDI-U-&G6HX9<:/"L2(SW.02!0JQ)8$ZN Q2A@A(X @63 MH,Z>726!O21&3>8TK=-\8DSPC.4>#"#,7%?1I(AC!/81P!X@@ )_-P!% 0!L@O8T!&,6<" MQLE!G!S X1Y.'J:=X31%'G81^J(W:A@CN%,A@$;XK2H449]DTEQ5,4KYC>\; MW^B;.*3A_JN:1-<52G,1; X@Q"@7[$87Q&"C?< $V*'<9R)A86"$:"9\)D H M,+OQ>6&X,V.@->?!^1*V7$IPGG'N(P&].FMK^TMQ1VK'V[&*\Z/LM]7[1"]*&T.9W>$[I32TG"B.[-I M!W.KFB>UW&D[Y&;+<:)5-UV;DOGNMOH'4$L#!!0 ( #R"?DKEL8JA M+P, $,, 9 >&PO=V]R:W-H965T[[4^W"5)O][+INQOU4&VYLM6=4VIS;+;)?VAD^7& M&35U0@D125-6;;R8N;V';C%31UU7K7SHHO[8-&7W=REK=9K'$+]M/%:[O;8; MR6)V*'?RA]0_#P^=625G+YNJD6U?J3;JY'8>W\/="@IKX!"_*GGJ+]XCF\J3 M4L]V\74SCXEE)&NYUM9%:1XOK?U4;OYW$>1QNY+8^U?E2G+W),B,?1F/TW^2)K [=,3(RUJGOW&ZV/O5;- MZ,50:H M&T[K4-JF@#MFBKFVFZYV[IO)MC>[+XNT@%GR8AV-F.6 H1>8=T1BO)]#4"S$ MD@;F]#K *D0PBD=@:!+,V;.K)"82YZ$[ZD=W;S]I9V0W4CW[F88K[^7W:YJ^^A) M:3,8NO%MJY26AB>Y-8>W-Q/]>5'+K;:OF7GOAK%V6&AU&$?VY/R_8?$/4$L# M!!0 ( #R"?DH$7Q&PO=V]R:W-H965TWYE_%6<*)7>6UTU8N&?I&P?@D#L3K0F8L9:VJ@O M!\9K(M60'P/1^)J)8#EOR9'^I/)7N^5J% Q>]F5-&U&RQN/TL/ ?T<,&Q=K M*)Y+>A6COJ=#>6'L50^^[1=^J(EH17=2NR"JN= UK2KM27'\Z9WZPYK:<-Q_ M]_[%!*^">2&"KEGUN]S+T\+/?6]/#^1%4I.WKBT;TUY[_^]FL 'N#?!@@-+_&D2]072O0=P;Q!\& M)OU!%XK)S89(LIQS=O5XM[TMT:<(/<0J^SL]:9)MOJGT"#5[629A- \NVE&O M674:/-'$4\W:U:!!$2B" 0-#&"L,+)%82[@:/%5L7$6$88H(3$9D[.,)16I1 M=)K<:)HNT!FR.$!- 9/$($D,D&36MG2:9+0*3HLTP1;-^G/=!"@!@1('*(IO M.$A!!^D=N4V=O(6SS#IIFTZ$T"W5A"4#63* );=8,FB9'(7CG[WOF9/I&RG* M0:PSVSDS6>J*%(/I6%0T8/4W4SU M>?=:Z :2M?U+*!B>8\M_4$L#!!0 ( #R"?DHF^MC#'0( -@% 9 M>&PO=V]R:W-H965T/@R7LAWU0-H(-WSEJU M#6NMNTT4J:H&3M6#Z* U;XY"4=/\!WT:_R'>[.;+81O&%@@85-HZ4/.XP X8LT8& MX]?H&4XE;>)\?77_Y'HWO>RI@IU@/YN#KK?A.@P.<*1GIE]$_QG&?K(P&)O_ M"A=@1FY)3(U*,.5^@^JLM."CBT'A]'UX-JU[]J/_-$S MMX34-3^0N58_4DV+7(H^D,.?U5'[320;; ZSLD%W=NZ=Z5:9Z*7(DB2/+M9H MU)2#!LTT-T5DW*<2R%>B1'?IZ.\"NWL%1OX*V-L$=OGI'! O:I2#ACA-ZS0? M$I(F:X+3!8U'B5#\N,Y6?J;4RY3>,67)DFG09+-*F*QQEB5+))]P]1BG*/8C M95ZDS(.$%TC97:5XP7+O@HF?@G@IB(=BT6])_O=@?$+OP42S"\%!GMSL4$$E MSJVVG]XL.HVG)V0OU")>FK$U3)F;S3#SOE%Y:EH5[(4VU]5=JJ,0&@QG_& 0 M:S-FIPV#H[;+E5G+8=@,&RVZ<8Y&TS O_@!02P,$% @ /()^2EW>Y0BF M!0 ^1\ !D !X;"]W;W)K&ULE5G1W=TSB978M=CX@,1[?W^ L==(/0[KA]B0'DV+ M4;<&F&SSXD>YL+8:_5QEZ_)BO*BJS7D0E"\+NTK+LWQCU_5_7O-BE5;U8?$6 ME)O"IO,V:)4%,@Q-L$J7Z_%TTIY[*J:3_+W*EFO[5(S*]]4J+?Z[M%F^O1B+ M\?[$]^7;HFI.!-/))GVS?]KJK\U341\%AU'FRY5=E\M\/2KLZ\7X#W'^:&03 MT"+^7MIM>?1[U$SE.<]_- >S^<4X;!C9S+Y4S1!I_?5AKVR6-2/5//[M!AT? MBA :8+,$,#HBX@&AH0=P'QT("D"TA^!>B3 2+<5RX< MFD,#-V59A[3]K393UV8^I%GH2?#0C=9C+'4;V,*:/N4*8J(^Y1IBXC_F" M,$D?)CW5QQM0[P5D2D,6IXTTR/$NS+<(=(@1YI&O).Y#IR3Q2 M1D8QDXW;CP3(IMQLPL\FC8J.?+>?C'$ZX5N=4JZI=*#C9*1TE+@J!CAEDN.2 M]#DQ/B> T2ER.2E?-2;VS1?@ZK((UGL%8W<"^)WRMDH":T G1[[8S\78F ^ MYA?%-RC5?IAD_-B_$(" MOR"NEHP/2. #Y'C.-^FW(.)$'RL9)Y# "<+8S86<(#YTSNV'V5@DXPL229ZK M*R-YB23O7*?'#M1K'D_U^XSN%="]>YT>%>@[F#2,C!60L>"H,C)60,;D4/VJ M?!F;^L-40'&W0;Z*_99%^2K6H5',EJ48$2LDXH09@Q&G N+43I?R1?F;.85$ M4CB)AU2XS,:(C,R.^NX9T!^7(\=6= W#,' MH$?--(?$Z)%\/8)Y@>8ZC"A1[KQ\G*BW%&[S)4:VA&3+V"(QLB6D2,>!+\F_ MMY>1U,ZTK@%,@"<2#Y_C^M09(R!D!(E+/?:6D R%<9^P ECS\,)C[L.$YCLO M8NR'@+,89@S-.(OVG<5?D-K?Y:/(N+._!S 9$OOP1C-&I8$'&4:KFO$@/: C MN-)^1X#6(X"=N-75C*-IT/X;9H/5C -IU!'$+EWP./,$7>YA)F@<##<&8RP: M=?4>7;^K;]@R.[%F_$<#_S'<&(P1:-2@.W0?.M#0J\LH5R/E,K9M&.4:=%_N MTC7@;ING:QA%&J1(9NNUYJ7XM[1X6Z[+T7->5?FJ M?9WVFN>5K8<,S^K!%C:='PXR^UHU/Z/Z=[%[&;T[J/)-]Z(].+SMG_X/4$L# M!!0 ( #R"?DJ* +JS:0, #P0 9 >&PO=V]R:W-H965TN-;?CC*[D:P7M;9@7_G\D?]V*BK8(BRRTM>M;FHO(;O5_X] MN=NPJ!N@$3]S?FE'YUXWE2?PV M0?V!LQLX/G^-_E%/7DWF*6OY@RA^Y3MY7/FI[^WX/CL5\INX?.)F0I'OF=E_ MX6=>*'B7B>+8BJ+5?[WMJ96B-%%4*F7VTA_S2A\O_9,D-L/P &H&T&$ TSQ! M3Z0S_Y#);+ULQ,5K^N+76;?&Y(ZJVFR[F[H4^IE*OE5WS^LH3I;!N0MD,)L> M0T<8,B "%7V@H(AB0ZWA49SB SFR'2 ^9L BTF./2;2F$IC4AI%281YYI!G M;O,DX80'81S5B"!)! +0"4F/24>3(;,DQBPQ9(D!"YNPQ%;)DBA=A(ZE22!/ M GCF$YX$S":EF"6%+"E@<:SL @98V %&\^S37%AIAK.4A..?8Z%)B*T5WJ!; M QJO0L_IH'*XF-P@70ARJ(I *]\3>H-Z#>A=E<0-@( .8,F9V"W@:B5Q#R#( MX%-%&]"[9HB[ D%M(7&$P)8GP/.6R TH'A?)P8(-3X#C;5$GUE+0:TN!74^0 M[2U1(Y!+U+@Y$- =;%$O;BTL5/56M -]8..YZB=[PE7-OQ5VN''4^1F2WAIO\S)VQY"BR?.G)E MV,\,^-G2K@&-X8L/=4NL[_LP9R"T>:MY,U!;UM; M;RM.E=XSC^X.6^-[JC=__^#]OOIKUASRJO6>A%1;2+W1VPLAN4HFG*EDCFHK M/UP4?"^[TT2=-_U^MK^0HC9[]6#XA\'Z+U!+ P04 " \@GY*(G#!P@\" M !X!@ &0 'AL+W=OV.FS 0?!7$ M YSY#HD(TN6JJI5:*;JJU]\.V0 Z&U/;"=>WKVT(39.-E#^QO@ET[Y(X(U$09(33 MMO/+PL6VLBS$4;.V@ZWTU)%S*O]L@(EA[8?^.?#:UHVV 5(6/:WA!^B?_5:: M$YE9]BV'3K6B\R0LZ7LA'BWAZ_[M1]81\"@TI:" MFN4$+\"893(^?D^D_JQI$R_W9_;/KGA3S(XJ>!'L5[O7S=K/?6\/!WID^E4, M7V J*/6]J?IO< )FX-:)T:@$4^[7JXY*"SZQ&"N?\$]6T+*08/#DVOZ?V/PY7D>E-98.N%>Z9,:],]%2F>520DR6: M,)L1$UU@PAE!#/LL$6$2F^@F/<+38]1A[-*3_QS&5PXQ3(*+)*A(* M3%&"%'&07KF\Q<1YCHMDJ$B&B&17(AAF@8LL4)$%0I!?B6"8)2Z2HR(YTN\, M)UBB!,L'^GV+B9,[K0@#_'8$#W0< RV#.SIW;F'X0-,QT/+Z)247%Y^#K-W( M4UXECIV;MQ?1>:P^1VYP_(./,_D[E77;*6\GM!D_;D@11]'H)SO9UH72E^T^Z8ZM*+9F4%TE MC) LJ8NRB5<+<^^Q72WD255E(Q[;J#O5=='^68M*GI?M\N8]!6)2FQ4GZ+0AQ?Q(*JJSZ3K^&V3QA?-?N#X_"W[1S-Y/9FGHA,/ MLOI5;M5A&>=QM!6[XE2I;_+\2=@)I7%D9_]%O(A*A_>5:(V-K#KS/]J<.B5K MFT674A>OP[%LS/$\/)FE=A@>P.P =AG C4XR")G*/Q2J6"U:>8[:H?G'HO^, MZ1W3O=GT-TTKS#-=?*?OOJS2.5LD+WTB&[,>8M@HAEXB$IW](L&0Q)IYP],Y MQPDXK)&;!--W":9.C4-,:F(:$Y-G.2$$ZTRASA3HI(X.BLFP2 I%4I!@YH@, M,=EH,I0&9I)!D0R(Y(Y(YG4LY=,LFV&=&=29 9VYHS/$Y",=/N$,J^10)?=4 MLM '.X<)YB !=V62R6R*52C!+)$;C&J#QGV?$A)T*@U@2V_P*@C*2*#S M%+)[3]D-=K5!-_8.,TX1Y*YEJ4\YY?HO)(4QIXAAU[4VZ,8Y8=2ISWI& M]\ M%(-,?9)]Z]H@I]8T((1)I@AES[LSO__7O(MQIC[/P+L(^E#[,?74QQYX%W(? MZ!W#W#/$O>M=YG/?6S=@!X:Q9PA[U[HVZ,8I8>Z9SWU&0BDPTN#1K7 M2B M8>P9PMZS+L#^6N\P]@QA[WDW_Y\Y8>X9>MT'EC4<$\U]HGWOVJ#WM=2[W MJ;_:.DP]1]2[SK5!UZ>4C+9EM6CW9D/:11MY:LQN>'3WLNF]9V9;]R]\V#%_ M+=I]V731DU1Z+2NQ4?ZKWE%$[[%2'"R6/=A>> M7'X*6/T%4$L#!!0 ( #R"?DJU,"]'PP( (,* 9 >&PO=V]R:W-H M965TDP9G0?<&7G)DS,S;'4URX>)5'QE3P5E>-7(9'I=I%%,GM MD=54/O"6-?K+GHN:*KT4ATBV@M&=-:JKB""41C4MFW!5V+TGL2KX255EPYY$ M($]U3<6?-:OX91GB\+KQ7!Z.RFQ$JZ*E!_:=J1_MD]"KJ/>R*VO6R)(W@6#[ M9?B(%QN<&P.+^%FRBQS, Y/*"^>O9O%EMPR1B8A5;*N,"ZJ',]NPJC*>=!R_ MG=.PYS2&P_G5^R>;O$[FA4JVX=6O.RS /@QW;TU.EGOGE,W,))6'@LO_* MSJS2>PH"4:S)R)S<$FS&B)C ##&81&SM9\,D,/*2Z#")Q31=$BC# M""&8: 82S0 B[!%UF'Q(](#G,$L"LB0 BU>R]1B3S%.OK)"?& XD!0-) 09H/L^E*.X;=O4US M,)[Y.V[3'+I-7C @9J(R&,$R@(!84E\'.E Z()K(%T^(#098,I\%_^\(;JE MT7G$!*#*?2IRM[JW/+#T8$A[1@(Z!@W_K;<\L/)@0'J(?WD=Z#T'!"L/!B2# M^%?2@88'E,2S-,TFJ&!MP8"X$%_E'.CV@*;>!@QK"P;$A<0^$02:3?# ZH(! M>2&^B#G0O1.*!D]WS<3!=CDRV/)3H\PC.=CM.ZE'8IY^;W]M.BS;$OQST[5G MWZ@XE(T,7KC2C85]_O><*Z8C1 _Z7(^Z(^P7%=LK,\WT7'1M4;=0O'4M7]3W MG:N_4$L#!!0 ( #R"?DI$O$8.B@( +P) 9 >&PO=V]R:W-H965T M< MD(2@XVJ&)!%(9)4)&R]K/4CNU$EO*S8F5-=\*3YZHB MXM^&,MZN?.1?!U[*4Z',0)"E#3G17U3];G9"]X*!Y5!6M)8EKSU!CRM_C9ZW M:&X"+.*UI*TU)_F-,$ MCMM7]J_6O#:S)Y)N.?M3'E2Q\A>^=Z!'>Z':K(>90H&>L%S,W@W;M['_:K=2CERR)DC2X&*(>L^DPT0B# M!D2@V8 8,FL(V/;TS,88(8)(@!@H6S"AUF9C&U MQ<2.C<\0-R)FH(@9(&+IB P.'1D0)B)#4M (0E ,+$?@V-W3P >G,!"4 A?U!"@F#CD:.*NHP?<0"#L MW(4M"%I.B &SPAI%]Q2C9;NE@*\]@N[]G1\ %"/7#P2:./((3B$(R"$QGJ" M$P!Z) - H-C-1"!HXN C. D@( O$4T<63@/HD3P @7#B^H% [GD+1F]>1<7) ME@?2R_FY5N9U&8T.)<@Z,F^F,[XQI8E]2S]HNKKF)Q&GLI;>GBO](MMW\\BY MHEIC^*37O-"EU-!A]*A,&PO=V]R:W-H965TY2U,!]4*QOW9*]T+:Q;ZD-B M6BW%+B3554(0HDDMRB9>+4+L0:\6ZF2KLI$/.C*GNA;ZSUI6ZK*,"P/ M1^L#R6K1BH/\+NV/]D&[53*P[,I:-J943:3E?AG?X[L-3GU"0/PLY<6,YI&W M\J34LU]\V2UCY!7)2FZMIQ!N.,N-K"K/Y'3\[DGC84^?.)Z_LG\*YIV9)V'D M1E6_RIT]+F,>1SNY%Z?*/JK+9]D;RN.H=_]5GF7EX%Z)VV.K*A.^H^W)6%7W M+$Y*+5ZZL6S">.GY7]/@!-(GD"$!TW\FI'U"^I:0!?.=LF#UH[!BM=#J$NGN MUVJ%?RGP7>H.<^N#X>S",^?6N.AY13.V2,Z>J,>L.PP98?" 2!S[L 6!MEB3 M63IYO\%FCD@)O$,*FDA#?C;*YWCBH8/0 &DZ#VF!:%ID$RT ,.>8Y)S!BC)0 M43931#,.$^0@07[;4@?)1THI+QBE$T-S&,X)9OB*' K*H8"? B9@( &[[8?- MA*:<<31Y&S<0C'">PFHXJ(;/[>0()BA @N*VG6)^[CBG+)_8F<-(AOP'EH,1 M?(T1X.C*+<57*@&^[:G'O#>%6\H!-5R:@"UU(?0K,RT5:=&NMKW2@Z-,1[XBOX)+[V MC3)4]C>:KLM^$_I0-B9Z4M;UAU#%]TI9Z82B#^[HCZZQ#XM*[JV?,C?777?K M%E:U?>=.AK\/J[]02P,$% @ /()^2I>1K94_ @ G 8 !D !X;"]W M;W)K&ULA57MCILP$'P5Q ,<8/,9$:1+JJJ56BFZ MJNUOAVP".H.I[83KV]P>4]5LW<.^!E_I221WPBKPC%_@&\GMWX&KE32RGNH%6U*QU.)RW M[G.PV6<:;P _:NC%;.YH)T?&7O7B\VGK^EH04"BE9B!JN,$>*-5$2L:OD=.= M2NK$^?S._M%X5UZ.1,">T9_U259;-W6=$YS)EL=_CPL3JBST2PP6HS2QTT>V?>*;="16]%'.'CO OLU B-[!6PU@4U^.,M/@X6' 1(;2#MXP)D?XRQ< M:+$ HS1 49K8%8561>%*41R%=H+(2A ]MC1 HIG2*$5^DBT^W]Z"\], ^__0 M$UOUQ!9#D9T@L1(DCPTE*Z%)@@/E:&%HC0M\'"9^X-L%I59!J<51;"?(K 39 M8T?9ZC#A*(S0\OQ;8&F($KQ0X\U^Z@;XQ?0_X93LVDK]^\RB4XM]1KHI+.([ MU7J'3OE.,_3MKX1?ZE8X1R95RS&-X!-UU(Q1]02P,$% @ /()^2BOA87O& 0 0 !D !X;"]W M;W)K&UL;5/;CILP$/T5RQ^P)@XD:01(FUVM6JF5 MHJVZ?79@N&A]H;8)V[^O;0BE*2_8,YPYYXP]3@>EWTT#8-&'X-)DN+&V.Q)B MB@8$,P^J ^G^5$H+9EVH:V(Z#:P,18(3&D4[(E@K<9Z&W%GGJ>HM;R6<-3*] M$$S_/@%70X8W^)9X;>O&^@3)TX[5\!WLC^ZL741FEK(5($VK)-)09?AQ@'-/Y&S\FCCQ+.D+E_L; M^TOHW?5R80:>%/_9EK;)\ &C$BK6<_NJAL\P]9-@-#7_%:[ '=P[<1J%XB9\ M4=$;J\3$XJP(]C&NK0SK,/'?RM8+Z%1 YP(:"L@H%)P_,\OR5*L!Z?'L.^:O M>'.D[FP*GPQ'$?XY\\9EK_DNV:?DZHDFS&G$T'\PAQE#'/\L0M=$3G2%X-,Z MP7;5Y380Q$N"773GD M<<]Q#CA4UF_W;J_'H1P#J[KIO9'YT>=_ %!+ P04 " \@GY*N"!#WR<# M !0# &0 'AL+W=O:8^!*P_=S=<\?Q<%E> M5?W2G*34P5M95,TJ/&E]7D11LSO),FONU5E6YN2@ZC+39ED?H^97O$GF.6OD1A6_ M\[T^K<(D#/;RD%T*_5U=/\LNH3@,NNR_RE=9&+AE8F+L5-&XWV!W:;0J.R^& M2IF]M=>\,]9[:+\(*9ZN_LIBNV.S/E:K:,.LVDQY :#>T1DO/D$G12DD\YHTG04)R$LC1./SAB&A>E1"M/!")8B-*-- M09#?IQUHT( 88>RW!8CC@D[T*9Z04#RC4SO0H$2,8,K\=P< >ATPY 1J[@,F M *=TP@4LJGB.JG:@05HH$8G ?EH D,?,Z-T$*5A8\1QEQ6/)-+TH4I;ZI,; MNP0),E4H6%WQ''D%0:.^!823IH)R_WV#@$:&^60U88G%U'W$=B M1RQO?V-'7V#_ 8O%QB0Y/C$$S8F;EJ./T.VL_2VKCWG5!,]*FZ'/C68'I;0T M>:%[\\!/9KSO%X4\:'LKS'W=SKCM0JMS-[]'_9^(]3]02P,$% @ /()^ M2A1(Q!]" @ :P8 !D !X;"]W;W)K&UL?55= MCYLP$/PKB/<>8# ?$4&ZI*I:J95.5[5]=L@FH#.8VDYR_?>U#2'46'V)[65F M=V;!F_+&^)MH *3WWM%>;/U&RF$3!*)NH"/BB0W0JRM'_GWP&M[;J0.!%4Y MD#-\!_EC>.'J%,Q9CFT'O6A9[W$X;?WG:+//--X ?K9P$XN]IYT<&'O3AR_' MK1]J04"AECH#4_*RX$(V#/ZJSW*9NOG MOG>$$[E0^1_7MC?K M;/CR]K(/J;B#:Q:F:M M@Z9WYIER*U3T6J595 97G6C"[$8,6F >B$!EGTL@5XD=6M'1OP7V:T2,W!5B MIXG8\),E'^>6B1&3&DP_F@CS++?-[AVX%">H"-V"$J>@9"4HPJ$E:,3@9:$D MSHJDL 2M<7F8H<(M!SOE8$=_K#([O"KS 6&4%?:[6(^(WW'K?A.3=)Q\#W2C&/X&^'GMA?>@4DU0K_,]O[M;K^^_>O#-7_Z4)W_YT_HOQ^ETLXQ7:S9:S=AXM4[63^QTQ?M,TA4[ M9)\GQVQ_[^!/[]9_^=,[;,0;^@'[E*[6=SFTFL6SZNOC>-IB'=]C0=OO55]^ MBK(6"SKTLE]]^=?-"EJV[2W5=/4Y_G*6K&)VNHZ7^?^K-A!+NHIODWR=1=#R M/%K&U:_.3O]V/3[Z@9V>7X^OSD?7IQ?GHS/X=>3H[@BFD$4+F,4L_L(^QD_5 M[ZZS:):L;MGD:7F3+JIO%\D_UM5G1YLLPX6=)/D4>OXYCC*$+#N.UL9T#P_] MX+#C.R9WDBSBC!U!N]LT,V8V648+?'\5WZ?9&N=XE"[OHY7QH5RJF%?Q_60= MK3=Y]?.?8^.1Z.''= %H%V5B9L9GYZFCX4_Q8G'XZRI]7+%)'.7I*IZQTSS? MQ)EKKNER"?@P6:?37STVN8NR.&<7FW6^CE:T'?O)BN7TV,!GT<7EYF:13-G) M(HV,+5+(=_UT;^R)WS[\Z&QP&6=).G/NISPL_^<__J,6Z77<.(&'!BBK7XIQ MK=^>_%Q],H*F,]Y\$=U6W\ZC16[,_"A=Y>DBF<&B9NQ]M(A6TQ@ #_0G=Y,. MG39T7>=@E.?0R7?&ZRB_JSZ[BN%H)U.LQL^C^J*D8Q^E]]'T_C/;X!. MYG'V$+_Y"S.@,)TBF6\4&-ERL[^ 8%1\9 #Y*@70#PL5? M8"XY2^?L)EDL VK'YZN'F#%:9:8?5QF\7V4S* /(/:Y^?X\7K.I@-@Z^L(B M@II!C=(U($,9LN9(P$\R. $1,H)_;))[Q 1:.8NF@%:;!6WR+ ;831.BO,;N M<)@XM@Z7F:^QUYQ%,&T CS&+LQ1.Z3K.EC#./(;YSHIE5;_]D*:S1X"H?1() MD)S5;0(;XP#*,1"T/'$!2U^)_0O[.PGDLR2"W4[6L* 1+G:VB7Y8A@-?MB@:\-APX)ATI0]0!8 M,/UI&9CNQDX0-^N(3Y>ZN\;NZA!"?.M>$C*VA(X.'4^@NLB)X]44O@7>&+-S M6"GS#8F ..%=NI@!8/^;3O7ZR41'SC5S_/9[@%;&'J(%;,I>VVNW@4K[;?R# M_A/,DT6;]1W0J_^)9Q[K]+Q!I^MU_9#FUAEZW4[@M3M=^7&"+'M&+U.-%P,) M $80+V_@G$E!D3ZJ/NUZ@"?Y?3Q=)P_QPI!31K-9@AL $$12>0B8*K;.@J(: M&9LGT\1D\1(S 8GQ0$2VK>6T ;_(XCOX"*8ET-[**/CNVK9B*QX0/)JTK./# M^Y<1(NI=O$Y )L@/@#'OP8GCNU.'#)Z&#"@YS=+%(H(3"GR"MS8X>[FU@2QU M\I>UJ4"=79NES42^$M!0JHTY/C%B32 MU2$)3SKB.[\&B0MDT.D=C3 #(KY(25QP-C@%%2/)Z!, S*V#/,L76K;9#^CIYP9[8N.C"T\70&I!Z&$$R>MB?/#V#ZE#Z!ELWV;*Y+O))C9_GO &\!( M*Z9CO\98R ?E2S9:@Q1^LUDCLV77*4.40DZ5 =E S4V ,$=98K*YR9-9$MED M7F>'9\D_KN.I(?Z_CW+0V*@%Z#M<[6M(KWZ*D]L[//VC!T"DVUAID#NICL?) M8H.=?.LI@,2Y6>(?-"">SV<2-T*DHQ+_$NC@)'9'$D^O$4\7=.@\VGOHT(I@ MME%L2&2=AS@@-I2:FBBU#:/,2;APBW>YBH1 ;-I-0,L@L'&J&L@JADKV"^? M2.0QS%>:<',IA)LC(9>ZFES%:R Q,+=QE*T 6W)WYQ='IV5 K%/&A05G&R4@ M'6E\0MA:#F] 4IY!#T\JK7H),P -_0'593=I ME,V0(LV2#-2F-(.)QV*= "$!D[R":V8L:P."81@C'03# M^5U-WX95U]&W\=U/489^"[7'N%+7]AUACPN^6YH0\4.\0,,,&^?3+'W$OX") MK6(2-MECLD8YGHVFP+#R9*M<04-$RA"EG7=V)\:)U3C3ZCC:(-!: M&S::?"6WM>BZSV"AI;UVZ\K?EFIZA=#84)1\23;A%![1 (_ND<<:S5C[1E?3 M4(1%(X[="#::_7TCS<,P4:08JVD"0@E:H/<7) _"<_Q%BNJ]7,;^!NC. ;MY M8JE2!XW>CS6S-=>+EVBW^Q\K/;,JP^;Y1=7WQJD27G$/ VU'>@/@C-0"SX7]AZZSL9VG8*C+]*0U;.H'E^/Z^XBQYYS(ER^9L7S8_*,W48;9V-ZLU MH=N:+0HS,TK"H/>[O S%J;!Q/SIIZD#O?Y8GP7;BMIU2CD);3NGE)IO>D4%\ MCB>P MIW0O/X9E3^-X1JU<3H*M:[+-SW6V;;JW0Q02B':LXR>-2VX#_ ,9Y4.TL!(* MUXK[/U?SS0M, M2%;3Q686D^ZC^)AXL'=UG/:YB%NO_ "<-,;S:H7BN]4F34*[R(77$27R_Z.X2B,W9 M&E3):G\30':MLV'W;0%"WE=0[:O0T;5-.=+V?_]-Y=,W!VS_!#<[@Z63D$J. M\)0[+Z"G=Y,#]ACEQFY.XOLU7Q>'^9!#3YIK6ZS@BQ2C>LA.-JNI0!HE+;UC M,'@,Q*#B9%NH5DA3YD5+]5D]_:R)$]^A<%"V+ M!WRAW-!0[LBV5CHW22YHWT?H &2(G])5B=+CDOS^]Y*+((56DX*V&GR5 ?!^ M YC$M0WX"7_8V"8?9"[00R>:,GB041!UP5*1$$CL(?H K$P;GD1<&I[DV\,8 MZ?*7*5?J$:\YBX@6"Q7S1*1;VD>;=A\))V&E;Y O'J*$O"DS;I>6MM"<&T,M MH3:<\* 8Z5D$=IB<)MK2>S@PZ[L,!.-5:NG.B-II.<;TV%Z;[07#P!L$/:;B MTZZ4=4">3/0/X1X]"F,VK7\!#)'V!_=[EFYNUO/-HM@FTPS<9*KX?XQFQ[IL MM&4(L1,WNCY4[#S; YK5'O2]0=^GOWO=T N&;58U%\&KL-/WAN&0#=I>/Q@" M_\'0:_>Z\&?#5<:KF;&^P/.#@1=V@]):91#K$V[?/,GRM?A_>V!I M@4VXN.Y!2PN5TP-%X;,E2 GRO],BJI/'7^('G2ZPU?5C2EW)J%!\H?X&6A%C M'!.7]F#!21&/$JV [X'(XM$$'^_B%1Q00)X'KFEE;%K8SZ9)-MTLT2$_I0@G[WA.C XZ6T*!@J8YR$V$NSN>5J M*EE1;E, Q8I']F!\/!)(PA%&X,DHJ&VZ<3=F,MCYE:&#@>L2:3';E%@@N MDM#-R2-RT=397S MJ$Z(=!ANPR.<(28]G6:QXL)3$ M#(1H@2Z$^WPWZ6O5/%FS1VIUPQ$ZFTF%6I%A^,65Y7R#&C/O/<'H:80KQG\ M;R\(5S'H/04="F\"J<%JV,KY<0R(ST#<2'*B'-A&'Q,)570+2'&+IT/$BFM8 M17H_Q]_R437!4!QH6G]48*B94B'$*S0V0[75"+PQ!5W/)6J5(S6.-;,N>[ W97B_H>7[8!VFM MWP8.#S)$*9P0F_;#=B5>JPA^@]=!KUVRH?(]&J$XQUD<*')]?P CA)TNB#6X MFAY&CX/@! _:("1I@?)<89/C%/ M][QXALO+,[Q9GCL1@O:SE&.!W#M+OQ"I(?4PR8H#3&L$"K6)!5%.T)$-P.2L M -J ZK(FHZ-F:AT+RD7[B$I"Q1(+6C#\/8W57@NC$N K&0V& E-06>8"*?P> MX%GDS]6S_O="PF0G\4U&IA!$M$K+(1WCT>9VPW^'W"1!AB>U7R-!76&9/%4# MU3TD"A]2?HAAOMD*MQ_$;!(1,W2?927&#(V1<)&-6.":&B J!IB6!KBE :9R M .'T%ZYR1=KF:;K&?9.H2&X3%&^!SD15,9<67(WC((F&2\Z",B)_7@IFX>GK MH/6)E22$X-QX@%HWC+!&M";] U:5;M;/7BU-+%G1=N%_BF1PFZ#?HX5PNQO? M6*(C[:&V<2( _:%O,D/*+ "#I'6*4.7@%CC2!AY@J,+>T-.#W'^H#/?WG)K MLJ+]\IS!0X_W1BQ"G'-8US+Z-49.C'Z%)Q8O!*P1!WA+&GNNHK-R! " $CCX M%#@-W^EXD0 7ED=/XA1')L0TP>-P!3<\TCOG$H80?FYXU#B?%HKZTVA5,#OL M<\FYZ"I^9+>;9,;CEQ9Y*L?*K6,0%L(#.NQS6'XNA,M[[N\H)"H*NIBCS5O9 M:FBG5S*T TWXW'7WA*8/C#"FS2)TF"OWGOR&PV6Z -5CGO"-E=$C2!01O#S, M@J>H0*>H_ZG$%0 &;36ZO^!;C /)YT_0^D@V@_:B6X/OSS!A P?N#?E0G97?2 Z*VD>%2_4:-9V?F= M !/V/=^0,\5NQ+-Z!P-V6*:SIN.X(#S'&N$I-7JF9R_@4N94'&U!GK;X\ @Z M-W$L(E@R+GM#._24$%(BR;WE23T+(B9H()^5-PSP$%3(6"E9)><3/A3^)>EE M0U**0:$H# NRJBP%^JZ8E+;%?@!R"$*I5_H0[1)(@50>MA"9N?R<:YY4@6^H MLP@7(]II(XI4A6.-0I*+.Y 1L%!>]/'KV0,-PSG/BCCK)B/R121![X;XU0W. M8(JD#*UB&/L4<0$\*J():8T@5*:;6ZX5X2FA/C'R%DU]J/KSN$1=;DOQP %6 M"_)^!V=&'#E2S- YJ>+8A*':AC6SE Z=4I9QJ_00.ES7$G-+,&YKLUAS$PK. M$^#(#0C21(X'G3@_E[ZLQZK#4/SB\L-EA/:\ZYJ,)?>76JA&W1GCQXD&'9^- MKL?'[')T=?TSN[X:G4]&1UBA8R)CL"\ <6YT^L;ELKV@2SFKI$S@OSW*8:W8 MI:7;2YBL>8]*2N@6W0BYLFLDA!!X0ICIJ2M>K;"-[K)XZO+\Q_'Y]<75SYI] ME2PV.7%-?@#F*4H4SIQ:P]S]7?0*8"*2,7-LB.!PC:Y!=[K%.IP>:V1#^ M"GL]4,T&["IZ5'0\9[X7 !MI#P=HSAX.O+#=8S^EV:^:#8@%\&;H!6$ W_3[ ML ?]-FIJ27X'2[BE'$D<5;,(2G-DX'5![T3]#UH.!I[?\YD95ID#,<'8:YA! MX'N=$,W;^[UVCQ3D \8CHR3P]EC7\_NA-^B'N"AO"-/O]7TZ9BK>$(D$,7VR M.: %E=(IR>"VP+@-+E8 64NX_?,64 B(52S$P(K"!A*;.,PJ57MHQZ(N;+G= M7FZ$KHFO/':YB(05MC"N[X)F-.;5Q>48C]?H_)B-__;Y]/(3H%UY*BK [R40 M\',>(V$]2^9Q"1DO5=2&-AY2 ;^-WH:VUP$$"GL!_]$%[.ST^^PLNC$_[\/& M=@$OPP[@3H?(^P:EH/*'7>8/NO!AP *T/00])N*2T.^6HHLU+/5R_%+^\//1\G%+01U0?0'R#T(!#([G"XH..F MUX'N 2APL/$P>[UA6.Y9.J3HPQ6X;#3+DM>H/^FZ3DP.W>X)" M:B5 CFPE0/1O* SCAF/W)PKB(?XH@OTG\518#-@^A1T*]5467^(>HH.=3D./ M2Z'^]T1Z)]=X#B9L=,V.+B;7PFLLD7W-/70YA:*AAB1L2@ -0)X1"5TFD,1' MTL0D+4MEKQ>BGA? EO(HX.*WO5? P*;= HD< !DO^A4/1I:3"\R/CRK^L7Q# M#)+W !^%/3BF/A[*@14'^@P-CD =04@\7.#A-QQZEM#0BL>OV7;6".DTB_') MZ?GI]?CP[/1DC'6_1NX(5UFU1!. M.\ 30!0$'J_D%//LWE*+D9:=H.H D)4*3_%PR(U8@1< +T6K%.N%72[@-!'7IMMSEV%"'%Q?'/YV>G55."46OY46XIG2+?F=B<:_P MV$;KLH==>9_[7G<0>/UPN-7O'6 IDM 'JJA5'T!W>@RR\R-\T =AH>,%[0%\ MH@\LG-YJ2,V1+%@?'D+K_(VHG7>3!C%0I2&:^*JE;V:>;C!,4#,4*_7_V[NS M]PKX[;DM]/0GGZ<5%8>P]C.2J3"HF40J,W[Y9C>1AOH\/1]/V,4).[H:'Y]> MVXR8TMR)YFF,\7R,N2H./.\6#2X$!U&7"",;0:Y%B"AACVP?7&>GU(#RFYQS MIR=VDZYF+8Q%XSJ9,!@6PT5:.Y0NBZ&,N*)<,JL/ M/*EO#=".OXI%,"*/V".A"\N:+#=+X990V1EX8E:4OT5YBIHZC099/BR '7]E M,1;'3$3%L8H;L&1"5CCM)-BTH"+UG2AUMPNR(TA;1*O#+HA-G2ZGUGX?I\;ILHKK#?)<_J@4PR* B[JVM@GX.@R[N69= _G]TZ=3*OYA?'YT"I0I;/O['P\0X;4HWCNR(N*K M7RVT5F$5VASZY)'O@118F3/&)I/=+5ERMV>RY*0?.>B%'NK,PZY#CZ+%0_BO MW^4UU[C(+^BD*)KK(7L!OB+(XO^?S,VJL,C 4KL2Z@>DA38JB[03NE&_YX!D M8W8]^K^ 47K$7BD\M50@462=9MR51AM'WI71Y @._GTRQ2 +S4$I>%\L2KMX M6N$J^>J!>_8I>I,D9$(?8?,' 9(<-:68G5-S$EI L>9DD#Z_LMV?DGS(_3>3 MB=O<84C%P42P ]FG-5=9Q>2,T%(>1>&NQL.'ZA3WO0M\[[;?>B[5FA]&#$[% M8Q.T.[WO4=,*02\C^R]:+NB/;M_73I;S9'= ?0AX"\ZDAMWB5R#>^#X?;F\H M.O?;0_K#[+;HT-.ZP_@7T3*P-NQB)4;^GQI,#G)=W@?D. NG&L8;I[E M:+V03;AX&<)%=M\L(GJ":QDMH+(8S4&2IZ MS"-Z8F2:&(\-D%R?ST-YHBQ38?O*C#HX*">&S5'-H-J,/*@QGE7LDY0/CN2/ M0E9]!_Q-O!^+1PQ99CGZ=J:[:FA_UG=)-I/*6'7[0B%;!96. MXB] 0]70R8I-Z0T1>OPTB^>;U8S3F:RV1M], MA!&<2Q@4"SY@@8O=M5CG@.F9<3PLLL7" Y$HN,0T'E#T9PG0'E3*,8((I\:M MY<)RCLJE#.W/V2TRB@R]?B)8L]@O2S&$?0UQ#Y[E\?@QF@K'/,8ZP=% 6TF( M@B@#4:;3<07'JUP%D&C; 7GLPM#@D]#H/F+[DP;%E?C?T?#BQ/_+# :,7 MH^P'[1ZZ1H0!URSH3!8"D!7[&'L?%-FC!6 Y3#%<&VOG#T'1$/_8*P<-O&X; M%3,JX%:H1QA$6G04>D.8U[ ?PE\=$- 'P'O'1>1EFO[*Z#N(X,A$(+>[C1&A4$1E4.,DWT%%T,Y3&2^%BT(LE1]4 M2K^I3'4/P18.^EXO')($OC\$G1#D=?A![GX>)9U.R?]42!N\F#< 1X) 1>CL MH][ATQ:TO9!R13"%'B:.SABD,RI3*21/7M<+0!_$;SY/]#%F.&]Y]M@+MM_!!/R*F)=?MB8PX(S0/0OWM]U!7W28,?] 0G07"E M*UD0P(*]13_D^Q?1$20<%#:"YMBJ_D)<%33*'/4[R;M@OIT 8.#W.)(&O1Y0 M0%SRB< _=#]PA.T"(JD"X*=?L6"?!=ASMPF$=PCR1-'4"(!%X$+GE8D?$5H-9\/F=U@$/:L%8 ML02];XNG(KY%%WD+B62=4.U433 !^K=^Q+ KHK)1 M%M65^;*K#9$S).6B1/@<=(%U+ +,J)[N0ZRJV5'60J-<4L[%3\2G\M:>\J5PJON"K1$M4"/!>6OUQ%4#,X8\I#>4,5D"V"U M6OX4^ /$ &4^Q7D5H'+E>O<$M%(MQ^-1UKI! M]X=MBR9D_,TNYR.>K3QBLZ M:;"U'AOTA+;=;F&TD-\:MMD ))EN'U7RUL 'S;T%G+Y!;U@UPFL+LX/>7Q]8 M#.]1 4U?(@;OR_I9)>342H"LL2NR;^!DT#T,# ZD.3]TV,!"8KO;+Q6P5EBD M+G8RC=%PUQ=''W^X.#L>7TW^FR*,KG\N7=>$AE*Q(#2[ZG=. +C:<'1<9AI] MAXN[)WY,B7A K^3(24B[G97RB<](D>5\\@IQE-YR<>T3G$[,B<1999(CJ8E> M;#*0/$1:^K&LL4H3)UJFHLE1J<#0:;FT>]47WT61KB!G5 *(7FCSPA)0X&E; M35$':(1 .?@=Z.@J,T4(;:6>3WF<*HNQ7^%SDY_#_P-*@@"S!YJ W^O+GZHZ MB,REP*; :T!\[B@,EQO6YW8R4!E!;:PV]>S/^_QQ6'D\:.DN(6YHX8L#70)% M&_$/' $0P"ZXS8N[J)1!'?3T$$0IT#&5_E8B*K08WF8@VXQR"HB4$6Z([92\ M(392!,0/"B2E\3$,!#UL09^<74$/]:I +8%WK<"$8JD&)\-PY+G>="6L#*1H M;;-I]D%KA%V%W0T);B7$4*7Z5+&RD1ZYL>:I">N-BC&WTBRK24;UJ!>T5P_' M7^)LFN0\N(O_C75*J3;:.6<7I7;5FOE7RI-[)!**-Y&(+MPGL>C ;%,>1PZC MSV1;DSU&3$#N)R?"Y6?BYQY_&92_I']\L<=[Q=->EX7BRZ#5[5>?B9][C.B] M+]A'N^4/JL_$3RZ'2\X%C4/J ]3\/F#@$.,WX&(K*=US\F=)U)JN[AI_B+YR2+ MP76<+*2^$A5<^%<)&,5L^>1!7HWY!'C^"#3M3'3 M=Q9S"/-X$HY=*YXPHG +VW 'FF5@#/X"A?4Q%AC""SZ4)6PL.2&+N7M8%P8. M7"9<@:K@>R4YIN6([Y0BKJ[=*@=>7C;(%?4L]/FPB!OQ]5F5RB0DHFS%(=7+ M*+*=N4JMHA HH[34,<)"KY5 GBF1NL_ALE%>H_>+:/KKX61ZEU(&%'5PB*0( M/UBFLWC!AY.*X:%41K14;:Y/: 4]*NG9><$#]>V@J<2SG293"2JIK=1'X9]D M!B9[.);6%"RMRP/=?TQ12J2,J'X(G.$MKJ'?:PWZ;T&NS4&1Q;QW%0A")F2_ MU1F\Q>#?5A"^5>(Q>THPZZ']UHX/4FIU%_JO5MV0, + [77:?2\<=E#L 6$L M[#IE%*M?M]WUAD'?> ?BX18114U!5QS5034,^R4,O%]@36"+/--55$472^2S M/ZXT@ZX>08$[+^$#?%3_JGJZA[IQ4,Y3,ES- ODFE &.KP#P>M8;_Z M3/S$?T ;#CJ<'('&-Z@^$S^%,"/H5J<5\C);< ZZG9 +*O"T$S3%"YNTJN,@ M\YG 3E$,=QLFLM+ M-"4*]HK_U.$#=F<^M1M7D"CK58./U,6F[WAN\4IDN1G6EOB6Y-OBHNV=K"PT M[NF'\].3TZ/1^34[^CRYOO@TOIK@N!?G1^/SZRNZV+RA\0NC&0"H;SVL0>,Q MX"HA_ /[\9;\;@C&@U9#TQ?U%6!['_OR_;>LAWWVRHPFC[$T@"CC],-?*\/.MEH@YW^2@/B*5&#]8DD*K[VOKDPNZ M0?U^?C\9_^TSIGR.,=_8"'B2/%@:%HJB.2T[5FGE'[",2HS54U3U!Y&+(E/G M>62KL#?T#9LUR-'Q; /LX?04IEJX21'6?P/!*)D_\8K^W*_J; XPW]JX*40)!SFL6R@$0"?)- MAZBX#+I,>KJ!Q(,<^Z^!9'7A3DB&6.EU2$)T/Z0 >Y$['K@V.[>\/3*MIA W%1!^;"K-.6UJ0( MSLC5PHL:.G*%><++N\1/M'#0?1 T/$*:S]BC7Z+@+!6_4X5S2RLI2O>)8BLS MDTEMN2=D7_YE9.19;Q49W>2D]QN,1UT5,M(*BEWRJF&_B']K^-;KM2.OUXZ\ M7COR>NW(Z[4CS[EVQ'T[%R%'KTG9_9J4QC<=[D0%_K57KYBW34:"N(CL_^)&%J^BMN"G%,0:[T!\ M[#4B7N]_^3?10YTU#W$$C5I8 MN\%VR]4YNPXMW^\RB=_O[3QF!5/CLIX=%FHG=J\7 +U> /1Z 9!U<:\7 +U> M /1Z 9#] B##9%RY$&@G,>!K;A.R7'Y.)28\_68A3Q9YXN5V)^E\C?:L7>;X M@I<6N>O[["8[&3LM4/^.MT!5=_DSES'5A5 [43W[A5)&2$S\Z+Y< MZ@7$_]?;JUYOKWJ]O>KU]JK7VZM>;Z]R%$RE,$^5M[ UKN2:K,36.L\YXR\- M7E@R_?*2V]*:#VLZ4=MZI9FA?Z&^=F9YKY;UE[>LF_<-.=% #W[5#/*RRM)+ M;.KK]4$]UQZY;_-Q;EC]M3[/W:_7VW9^-[?M['0UCA--"H770W8E@X@GY(S_ MD*6;>R2?ST67/]C--<^]::81U3SA/9R1K\7B!!,UY&WWM3P;_K^'6V$: 4=] M_-R5_G%N@*GGK%7,0EKPU<#Y#2Z=V78]2+,CPH^ O++B"CTBB^*> ^2TQL4? M+WXT?OO[-W8 2:47$KO+-VW\)O#XM[]LHEKV>BSB_MZIT36%4CHD29'I45-7D=3F,THXY&5,KB'9%^4//A>!KF;C?>YFX MIK%U;(3T4CB% 4UJSF1Q&HN":&.M(!H^]LHEUNB+8A.^WI[Z6K;N=U:V[BNK MQ342)V1^">5*C+\0T5YH?8Z$],@7J+*,49_@29U/[(.JJ@8('T>_A7#[AZVG M9H8M5V\A*VV(*/ G"@-I%39^ QC_WDJM?661+^=IL&C!*J,6H?9\6>BU6L%PD>.X[740)#XV& 0W8 S3]/CMG^GG&N>*XZ4.H5SY3C$566O(U2 MVKHM0[XN'T5L=>-T$,?WN#.\-*-3F'.T'(L*YD"KLX>$(BI<6@5:1H5!E)/W M)OT?C\\_C:X^VJB6G@MT0=%::8(W+5^J'+-JJZ +2JM1+5+Z''_Y1.COS'AV MI$YKH4+5EAVNX1FQ*'41$K4=!O8./T5?:E< ?,?:3BLWHMJR?SI,9,L'OT] ? 8OB $4R7P:'"Z.=0/,$ZR1? MD_:\09#O(;.&\S;!8'>0KC%Q/3ZW^K(2FFOC!%NCJMF^X5+-AKLLU6R]=:E;@K2;$Q<>U'&F MJE]H_1F(-QXQ%)Q6Z2*];2""@0[I_JI^ 24)J\B>=L3"-6$W6GCZZ0IV)O=4 ME+=KBC6@<'<7N.F#LTVG'DJ- L>;[[@E9!QI\/[XBTS;EF&^)A>(UK6TIA0- M;@M#WM8AH/Y6;='29(MZUAB*AX53I"Z*7N%;G5S8?.^* E=:^/B9 MA06;HY2.E#%V@S$=OA0#O6QQ[75]EIP53=91#@O;92G/"DMOTDDMYJ%CZ S# MLBBFC0=EV?:\A#V&N."0#3\:IAL<2AOI))J2S]M3Q^1]FF7\QO.CZ![>FM!X)E/I67Z!T=VL\AF= M;>&A.CX>-DB&P/#9*;_N&OF#D2WB9 %%[H+QIB:-8_OYMZ "-8E5%@U MN;J\"E-':Y1=81VGDF1AAPE:WT:W62QOM^&%G9;)NKQ^16L,MUY\WZ(:%6B= M&7^^HBI7G5[X?2TS[SI5)5]W3RX2B\3C+[Y+[&HL^G .JAY=263(F"9R],=+- M2@/^6;77T&X'QG!27M_E%FV*'CN.EG2]P01O95K+"F7_9&++[!ABIMSL8FHQ M,F\\_?#3#)'["7LNO#V&@?)U,FUFB8:)54N.NTFP92X6;W*S@4<35W'R;7I< M4Y-[44_XE3*$0WH$]T^O)@#5SKZ'+Q74C70.J4IM98K/INK)+#/[4()&N,6S->"=;UM!V^#9, M8#-PZ3DY:Q:6:\M7LWVV/65M2^?6A+4:;Y\E7VW+"/94M2V-;-EJ=L-E8G/@ MU&3I-,:D'7+/1*P%%5+CT=2Q+&+=!-7<:6<.5F+%.E>WI;0SXU!OS35K2%@B M!V&IIG@YN?51#?[5)VL]A_,8@"U=-V/;BVT8Y$KGLHB>>^R=R *J=N77NZ1) MV1#7$1GVH9<,$M=BEKUM4=JFZHY*,Y\$YCN)6&\R9P"FC?-IAA=Y88QON0(B M,/;1%'25/-%S)(SNT2!#27 \64CE(GG5Z/'B&RUAR1(,;G06%I;E2K(34OEV"'R37\ M6V.0YV?9U73ZKTV^JYG8MHR[YJKG:'/;8J+\J1%P,KK/MKWLV%_^=;-HL6!H MCT;A+P?VEV0I$7<@&R^YX:-MIT4G\4U+U40TQURU6-NQ%$DT$):6-*GZSR^C M#$\ZL<.9L!6H\]%D)-!PJ"ZCR6 19_D[=LRO:;H4A5EE2ZS32U^8USV_(&66 M-(Y$L$NKQZ3)_R;L4:>JV80P.81NR#V/O!4GY&P193F!\2%/<6ZE;"27?DM5ZKFYAGY MY?8=?M\0Y<2'I7$MPSX+S5Y^[<8L*$&,':.B5WCTOQT.D)G8A@C\-)(8KEW> M8XB4_-ZQ?H?-HJ??[F144O*:$5^M!T.C>TS9]5VZR2E ;($&L/))(*.ZV\;S M@NO\("^$4?30ZF\\.SJ39CYVEBPIG\SI[G(+M=K1*Z33HVBQX%6!MTNX/Z6+ M>Z#BZ+4=#4WU MTQ/=[&$3Q%\T:^-6 =>XZDV.[W3*=3JMC.E!D.[JG M=X7%5GC"UDO.VCY&_T7'**BGG@^OC?"5Y."8+F5*LZ]"'BVSB'\ND-U*#>HZ M%"%A._5GK " 8G30>/EUC2D8L=AR>35R!;->:HB+ZA#];S_$X%L JIKK%_X6 M@W1_BT'7=VNUQG^1>U]IRZ['0Z^*0J0^3C:.%2(:G"R*4HJ$IO9+5N0]0 MJ5I-]:TU!,-90L>.TD5%G>H;7F"G^M119V?SKJ8U(C04P#*U8Z1SI64>WLNQ=B8JM_M#+3$ROF.2F M*Y7Q5W%3LL".,UO/ M%9I>-T2B)$1E.1V*TQ/>X^/BHGNJCM# *QZCJ(Y2;?[X+@ M>I>RITP=RL7V@]CIV($JEC8OJ@JY%Z9*#WV391E=)LJ*\V"SXHB9/]04*ZI9 M2TV-HY=:7>T0.VWB;I/= C"4\T ST)UW[<3PET6L@6& M.]>JVA87+)M6VI'$HD?GT97+(@*/)TXYU2%ENA.Y!')RIC6T.F)=C8U>WR:X M=7NVIU^_*,JNTF=?PT4['=L<@O"WFIF;M_K6:@[?8@YNSFR=@N__5A-S,WOK M_EC12:O$5C\S&7?+ ['TR%1[M9F!%3B#X;>9Q.?ST^OQ,9M&OGFBB[O)<)8ZD&+0M,7,&&CHB:=N^##+GV./D^NKT9G MIZ.OZZ9<\.Z%IE974F:WKD19O7H+UBZ;KS9>))I3HE^CL#]1_NZ8E[^[U,K? MU03:8_F[$U'^SO495< KBA'4K[5'>:$W>?R/#27:/;AJ4TQ@V1'P:AXN/XUR M-^/K-"ZLTK>K@R\;,7&?R&A,IV>I-JJ,U_,L&>V-">]8*[!1/<'M..0L6V>L MKZZ*G6GOD$7MJF]^\8V]MI2\JWY2E(4I%BU+K#@3R;>42'*G[%/<'B]>%!^F M\WG.+S.7%Z3.L4,MUA,O!_["PYK%]1MTN2Z6(U)Q;/@KTER.\,B2 VQ<#KX[ M4KQHH:AW>;[^R_\"4$L#!!0 ( #R"?DH;:=N<: ( 'P, - >&PO M)>$T)N^ MA,[ODYZX[G9B$]P@G_PA^:^X-ZBG.ZC?7E]OV8XA\N"&G.X@_O[UVQ;B(?(@ M\9DA=MHCC8)4\.%DQ] "NC)B&"P0#>$EHF0NB49)QANYB=!;T] M"T8!ZNJ 7$ARK_E,J\0:P!*"!9:*Q*O(%XF*&:Y5UTYUNJ]F_P U/_8^9YAC MB>BJ:-W[3WF7_[/B\>G?2V[^538%/Z)&\V(] )&30Q Y/021!]&39T]?Y/C\ M'VMTVO?WRB5A[8K0HV!>$:H(;]7F)$FPU6/N:"'\:"Z'=.U%/=P4-+U"<_TI ML,:O5-P^-Z(?@!02P,$ M% @ /()^2DAJ_L4V!0 MS \ !X;"]W;W)K8F]O:RYX;6S%FUU3 MVS@40/^*)B_+/K");5D&!IAA [O#3+?-%J;OPE:(!EM*)1G*OZ^DP/:ZC>_L MBY6G)([MG-&'S[U7ROF+-D\/6C^1;UVK[,5LX]SV;#ZW]49TW/ZAMT+Y;];: M=-SYC^9Q;K=&\,9NA'!=.\\7"S;ON%2SR_/W>ZW,_/(\O/DBQ8O]<3Q\)+QV M\EG<\X>+V6+FSYN#$^--WU]W1&?F_S#I]5K6XEK7?2>4VT$9T7(GM;(;N;4S MHG@G+F;OIY KU9 ;Y:1[);=J=RM_[HS$G[YM+F:9?^^X\]<\2RL?6C$CYDSZ M+\QMDP7PZ2"7_K-N9>-_O2%_\I:K6I"[V#8 ,$< \X,!DJ,5!Y % EDDA+P+ M$.$"2_2:?-H* R I DD/!^DV D"6"&1Y",C >.=T_00@&0+)#@E9 <@*@:P. MUMU+;C< \@2!/#DDY"F /$4@3Z>%_*B=(!DY)G=]UW'S&CM:/BKIK^?*P0?Y M GN2+Q)@YA[S;RW5(_%-6PLST SJF8E%$^D*3_\6-%^*]XG)5L;?)K0=#W'%UUYNPY40$Y-, M-K%E(B9[:T#K=M.9.S\<[2"DR##)9!-;)D)6'O):K*623ARWB9@G<4;KYD6V+03#U))-[)8(=NK!/D@E=D]K(QHY&(285;*)M;)[ M8B\"H.!6#,8=)I(LB4F"2JX>C7AS79C&2]UU@^;+,9/D*4R2Y7$2U[H3Y)Y_ M&S1BCIDD3V&2+*CDAAOE56?)2AB?$W #@]@<35I2:"0+'HEAZT:WC3#VM_BX M=E I.::4/(52LN 4$,Z096^=[W0SZ'!,*7D*I60L!F /5GSM0[!]\SR47H[Y M))_8)W?^'DW?>H/<>LHOO.WC.7%J_]O#)#7'?))/[!/8RU=UK7OE0J2X\A%X M+8<3'+-+GL(N8_%V?@(Q,FB35&FCRZEEH MV??Y!3-:21BX[Z;$+%0FR87V8'X6M58UW-2" M68@=9-GGOV<\Q,0LQ ZX_N-'*,3$+,22+ &-8!Y#63+,0BR)A4:*,PSF0@RS M$$MBH3%,F LQS$(LB87&,*&%&+I_[9 5.08MQ# +L206&L.$N1##+,226&BD M<,A@+L0P"[$D%AK!K&!%KL(L5"6QT!@FK,A5F(6J)!;:MR@=HR2(B5FHFMA" M:+6X*B F9J%J8@OAF-!"%6:A*EIH'D^VE^=-J$V(YJ/_">N/U[RM5X:$E]T^ M0UJ&W4#KOFV7_M@G]4'S<#S>X_V/!)?? 5!+ P04 " \@GY*1'W]Q& " M !C+ &@ 'AL+U]R96QS+W=OQ)4%4D>3V5;VI"B3ZNC ^;6P8-F;>C1\( ME!Y?\KD>3FU3CJ>NK-XOYZ9LJN,P=-^<*]MCOM3EKNUR,WZS;_M+/8P?^X/K MZNUK?-//KK\/^O;_?ZTS=_;[:]+;H9/*OXNJ-SG03(?)/0@G0]2>E"8#PKT MH#@?%.E!-A]D]* T'Y3H0??S0??TH(?YH =ZD%\#&=?\)(0U7VL/N/9\KST MV_/%]H!LSS?; [0]7VT/V/9\MSV V_/E]H!NS[?; [P]7V\!>@M?;P%ZRP+7 MVNABFZ^W +V%K[< O86OMP"]A:^W +V%K[< O86OMP"]A:^W +V%K[<"O96O MMP*]E:^W KUU@;,2=%C"UUN!WLK76X'>RM=;@=[*UUN!WLK76X'>RM=;@=[* MUSL O0-?[P#T#GR] ] [\/4.0.^PP%DW.NSFZQV WH&O=P!Z![[> >@=^'H' MH'?@ZQV WH&O=P1Z1[[>$>@=^7I'H'?DZQV!WI&O=P1ZQP7N5:*;E7R](] [ M\O6.0._(USL"O2-?[PCTCGR]#>AM?+T-Z&U\O0WH;7R]#>AM?+T-Z&U\O0WH M;0L\:X(>-N'K;4!OX^MM0&_CZVU ;^/KG8#>B:]W GHGOMX)Z)WX>B>@=^+K MG8#>B:]WFNA=CG6?=S^&_M07!E&ULS=K-3N,P% 7@5ZFR18WKW\"(LAG8#D@S+V"2 MVR9J$ENV8?(4%_NA'^.Z:%/R/QB+ M=4N#C:7S-.;*QH7!IGP:MLS;>F>WQ,1J95CMQD1C6J:I1W%U>4T;^]"GQ<^7 MZU/K=6&][[O:ILZ-['%LWC5=OC8L _7SFMAV/I[E!<7B9I^[Q'QM7>1J+-@G M)KR_<3K/]]T^4@A=0U^*YC:;KJ;&U0]#OJ6,/I!M8DN4AKZ,K0W4_$ZA&[>O M>>]L2+_LD!NS?<_^6U">+D=ZZNEP@+ERS,DI;PLZ-&HNO'SR;PU\VPVU"[3T M(5=#Z@X\7HYTEZN130N/^8@T;9V&FD\-SZU/]\/^=6$W?S_TPO\5(YL/WWOK MQ\LA0')(D!P*)(<&R6% MYK/YC[57SU!+ 0(4 Q0 ( #R"?DH?(\\#P !," + M " 0 !?D !D;V-0&UL4$L! A0#% M @ /()^2AH36>;O *P( !$ ( !F0$ &1O8U!R;W!S M+V-O&UL4$L! A0#% @ /()^2IEL<1#*L" '"@ & @ 'X" >&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2AM5X60?!0 "!D !@ M ( !V0L 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0# M% @ /()^2LH-.;@X @ ;08 !@ ( !J!< 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2O$Z? N* M!0 M!P !@ ( !,2$ 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% M @ /()^2@1%S6"W 0 T@, !D ( !R2P 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2F_ DJ>U 0 T@, !D M ( !6#@ 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ /()^2L)-?Q2V 0 T@, !D ( !(3X M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M/()^2J6BH#JW 0 T@, !D ( !Z4, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2E'LI=&@ @ M% L !D ( !L4D 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2D!*F NX 0 T@, !D M ( !8U 'AL+W=O&PO=V]R:W-H M965T&UL4$L! M A0#% @ /()^2CKM3@?% 0 -P0 !D ( !*U8 'AL M+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ /()^ M2IE&L#BV 0 T@, !D ( !*EP 'AL+W=O&PO=V]R:W-H965TGDWP@$ #<$ 9 " 2E@ !X;"]W;W)K M&UL4$L! A0#% @ /()^2MOH7QW( 0 -P0 M !D ( !(F( 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2I6#",8# @ @P4 !D M ( !_VD 'AL+W=O&PO=V]R:W-H965T M&UL4$L! A0# M% @ /()^2CI%[&JA P KQ$ !D ( !L7 'AL+W=O M&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2A$. M#PY/ @ DP< !D ( !Z7@ 'AL+W=OP >&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2@[IJ8P1 @ @@4 !D M ( !;'\ 'AL+W=O&PO M=V]R:W-H965T&UL4$L! A0#% @ /()^2K&#&&RM @ .@D !D ( ! MHX4 'AL+W=O$! # ! &0 @ &'B >&PO=V]R:W-H965T&UL4$L! A0#% M @ /()^2@.8N]U& @ 6 < !D ( !_HP 'AL+W=O&PO=V]R:W-H965TB; !X;"]W;W)K&UL4$L! A0#% @ /()^2B;ZV,,= @ V 4 !D M ( !RIX 'AL+W=OH0 >&PO=V]R M:W-H965T&UL M4$L! A0#% @ /()^2B)PP<(/ @ > 8 !D ( !FZH M 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ M/()^2D2\1@Z* @ O D !D ( !?+, 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ /()^2F&UL4$L! A0#% @ /()^ M2AMIVYQH @ ? P T ( !TOP 'AL+W-T>6QE&PO=V]R:V)O;VLN>&UL4$L! A0#% @ /()^2D1]_<1@ @ 8RP !H M ( !R 0! 'AL+U]R96QS+W=O XML 89 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 90 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 92 FilingSummary.xml IDEA: XBRL DOCUMENT 3.7.0.1 html 226 320 1 true 104 0 false 6 false false R1.htm 000 - Document - Document And Entity Information Sheet http://liqtech.com/20161231/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Consolidated Balance Sheets Sheet http://liqtech.com/20161231/role/statement-consolidated-balance-sheets- Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Consolidated Balance Sheets (Parentheticals) Sheet http://liqtech.com/20161231/role/statement-consolidated-balance-sheets-parentheticals Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Consolidated Statements of Operations Sheet http://liqtech.com/20161231/role/statement-consolidated-statements-of-operations Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Consolidated Statements of Other Comprehensive Income Sheet http://liqtech.com/20161231/role/statement-consolidated-statements-of-other-comprehensive-income Consolidated Statements of Other Comprehensive Income Statements 5 false false R6.htm 005 - Statement - Consolidated Statement of Stockholders' Equity Sheet http://liqtech.com/20161231/role/statement-consolidated-statement-of-stockholders-equity Consolidated Statement of Stockholders' Equity Statements 6 false false R7.htm 006 - Statement - Consolidated Statement of Stockholders' Equity (Parentheticals) Sheet http://liqtech.com/20161231/role/statement-consolidated-statement-of-stockholders-equity-parentheticals Consolidated Statement of Stockholders' Equity (Parentheticals) Statements 7 false false R8.htm 007 - Statement - Consolidated Statements of Cash Flows Sheet http://liqtech.com/20161231/role/statement-consolidated-statements-of-cash-flows Consolidated Statements of Cash Flows Statements 8 false false R9.htm 008 - Statement - Consolidated Statements of Cash Flows (Parentheticals) Sheet http://liqtech.com/20161231/role/statement-consolidated-statements-of-cash-flows-parentheticals Consolidated Statements of Cash Flows (Parentheticals) Statements 9 false false R10.htm 009 - Disclosure - Note 1 - Summary of Significant Accounting Policies Sheet http://liqtech.com/20161231/role/statement-note-1-summary-of-significant-accounting-policies Note 1 - Summary of Significant Accounting Policies Notes 10 false false R11.htm 010 - Disclosure - Note 2 - Going Concern Sheet http://liqtech.com/20161231/role/statement-note-2-going-concern- Note 2 - Going Concern Notes 11 false false R12.htm 011 - Disclosure - Note 3 - Related Party Transactions Sheet http://liqtech.com/20161231/role/statement-note-3-related-party-transactions Note 3 - Related Party Transactions Notes 12 false false R13.htm 012 - Disclosure - Note 4 - Inventory Sheet http://liqtech.com/20161231/role/statement-note-4-inventory Note 4 - Inventory Notes 13 false false R14.htm 013 - Disclosure - Note 5 - Property and Equipment Sheet http://liqtech.com/20161231/role/statement-note-5-property-and-equipment Note 5 - Property and Equipment Notes 14 false false R15.htm 014 - Disclosure - Note 6 - Investments at Costs Sheet http://liqtech.com/20161231/role/statement-note-6-investments-at-costs Note 6 - Investments at Costs Notes 15 false false R16.htm 015 - Disclosure - Note 7 - Definite-life Intangible Assets Sheet http://liqtech.com/20161231/role/statement-note-7-definitelife-intangible-assets Note 7 - Definite-life Intangible Assets Notes 16 false false R17.htm 016 - Disclosure - Note 8 - Goodwill Sheet http://liqtech.com/20161231/role/statement-note-8-goodwill Note 8 - Goodwill Notes 17 false false R18.htm 017 - Disclosure - Note 9 - Lines of Credit Sheet http://liqtech.com/20161231/role/statement-note-9-lines-of-credit Note 9 - Lines of Credit Notes 18 false false R19.htm 018 - Disclosure - Note 10 - Leases Sheet http://liqtech.com/20161231/role/statement-note-10-leases Note 10 - Leases Notes 19 false false R20.htm 019 - Disclosure - Note 11 - Agreements and Commitments Sheet http://liqtech.com/20161231/role/statement-note-11-agreements-and-commitments Note 11 - Agreements and Commitments Notes 20 false false R21.htm 020 - Disclosure - Note 12 - Income Taxes Sheet http://liqtech.com/20161231/role/statement-note-12-income-taxes Note 12 - Income Taxes Notes 21 false false R22.htm 021 - Disclosure - Note 13 - Earnings Per Share Sheet http://liqtech.com/20161231/role/statement-note-13-earnings-per-share Note 13 - Earnings Per Share Notes 22 false false R23.htm 022 - Disclosure - Note 14 - Stockholders' Equity Sheet http://liqtech.com/20161231/role/statement-note-14-stockholders-equity Note 14 - Stockholders' Equity Notes 23 false false R24.htm 023 - Disclosure - Note 15 - Significant Customers / Concentration Sheet http://liqtech.com/20161231/role/statement-note-15-significant-customers-concentration Note 15 - Significant Customers / Concentration Notes 24 false false R25.htm 024 - Disclosure - Note 16 - Subsequent Event Sheet http://liqtech.com/20161231/role/statement-note-16-subsequent-event Note 16 - Subsequent Event Notes 25 false false R26.htm 025 - Document - Schedule II - Valuation and Qualifying Accounts Sheet http://liqtech.com/20161231/role/statement-schedule-ii-valuation-and-qualifying-accounts Schedule II - Valuation and Qualifying Accounts Uncategorized 26 false false R27.htm 026 - Disclosure - Significant Accounting Policies (Policies) Sheet http://liqtech.com/20161231/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Uncategorized 27 false false R28.htm 027 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Tables) Sheet http://liqtech.com/20161231/role/statement-note-1-summary-of-significant-accounting-policies-tables Note 1 - Summary of Significant Accounting Policies (Tables) Uncategorized 28 false false R29.htm 028 - Disclosure - Note 4 - Inventory (Tables) Sheet http://liqtech.com/20161231/role/statement-note-4-inventory-tables Note 4 - Inventory (Tables) Uncategorized 29 false false R30.htm 029 - Disclosure - Note 5 - Property and Equipment (Tables) Sheet http://liqtech.com/20161231/role/statement-note-5-property-and-equipment-tables Note 5 - Property and Equipment (Tables) Uncategorized 30 false false R31.htm 030 - Disclosure - Note 6 - Investments at Costs (Tables) Sheet http://liqtech.com/20161231/role/statement-note-6-investments-at-costs-tables Note 6 - Investments at Costs (Tables) Uncategorized 31 false false R32.htm 031 - Disclosure - Note 7 - Definite-life Intangible Assets (Tables) Sheet http://liqtech.com/20161231/role/statement-note-7-definitelife-intangible-assets-tables Note 7 - Definite-life Intangible Assets (Tables) Uncategorized 32 false false R33.htm 032 - Disclosure - Note 8 - Goodwill (Tables) Sheet http://liqtech.com/20161231/role/statement-note-8-goodwill-tables Note 8 - Goodwill (Tables) Uncategorized 33 false false R34.htm 033 - Disclosure - Note 10 - Leases (Tables) Sheet http://liqtech.com/20161231/role/statement-note-10-leases-tables Note 10 - Leases (Tables) Uncategorized 34 false false R35.htm 034 - Disclosure - Note 12 - Income Taxes (Tables) Sheet http://liqtech.com/20161231/role/statement-note-12-income-taxes-tables Note 12 - Income Taxes (Tables) Uncategorized 35 false false R36.htm 035 - Disclosure - Note 13 - Earnings Per Share (Tables) Sheet http://liqtech.com/20161231/role/statement-note-13-earnings-per-share-tables Note 13 - Earnings Per Share (Tables) Uncategorized 36 false false R37.htm 036 - Disclosure - Note 14 - Stockholders' Equity (Tables) Sheet http://liqtech.com/20161231/role/statement-note-14-stockholders-equity-tables Note 14 - Stockholders' Equity (Tables) Uncategorized 37 false false R38.htm 037 - Disclosure - Note 15 - Significant Customers / Concentration (Tables) Sheet http://liqtech.com/20161231/role/statement-note-15-significant-customers-concentration-tables Note 15 - Significant Customers / Concentration (Tables) Uncategorized 38 false false R39.htm 038 - Disclosure - Schedule II - Valuation and Qualifying Accounts (Tables) Sheet http://liqtech.com/20161231/role/statement-schedule-ii-valuation-and-qualifying-accounts-tables Schedule II - Valuation and Qualifying Accounts (Tables) Uncategorized 39 false false R40.htm 039 - Disclosure - Note 1 - Summary of Significant Accounting Policies (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-1-summary-of-significant-accounting-policies-details-textual Note 1 - Summary of Significant Accounting Policies (Details Textual) Uncategorized 40 false false R41.htm 040 - Disclosure - Note 1 - Summary of Significant Accounting Policies - Rollforward for Allowance for Doubtful Accounts (Details) Sheet http://liqtech.com/20161231/role/statement-note-1-summary-of-significant-accounting-policies-rollforward-for-allowance-for-doubtful-accounts-details Note 1 - Summary of Significant Accounting Policies - Rollforward for Allowance for Doubtful Accounts (Details) Uncategorized 41 false false R42.htm 041 - Disclosure - Note 3 - Related Party Transactions (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-3-related-party-transactions-details-textual Note 3 - Related Party Transactions (Details Textual) Uncategorized 42 false false R43.htm 042 - Disclosure - Note 4 - Inventory - Schedule of Inventory (Details) Sheet http://liqtech.com/20161231/role/statement-note-4-inventory-schedule-of-inventory-details Note 4 - Inventory - Schedule of Inventory (Details) Uncategorized 43 false false R44.htm 043 - Disclosure - Note 5 - Property and Equipment (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-5-property-and-equipment-details-textual Note 5 - Property and Equipment (Details Textual) Uncategorized 44 false false R45.htm 044 - Disclosure - Note 5 - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://liqtech.com/20161231/role/statement-note-5-property-and-equipment-schedule-of-property-and-equipment-details Note 5 - Property and Equipment - Schedule of Property and Equipment (Details) Uncategorized 45 false false R46.htm 045 - Disclosure - Note 6 - Investments at Costs (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-6-investments-at-costs-details-textual Note 6 - Investments at Costs (Details Textual) Uncategorized 46 false false R47.htm 046 - Disclosure - Note 6 - Investments at Costs - Summary of Financial Assets and Liabilities (Details) Sheet http://liqtech.com/20161231/role/statement-note-6-investments-at-costs-summary-of-financial-assets-and-liabilities-details Note 6 - Investments at Costs - Summary of Financial Assets and Liabilities (Details) Uncategorized 47 false false R48.htm 047 - Disclosure - Note 7 - Definite-life Intangible Assets (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-7-definitelife-intangible-assets-details-textual Note 7 - Definite-life Intangible Assets (Details Textual) Uncategorized 48 false false R49.htm 048 - Disclosure - Note 7 - Definite-life Intangible Assets - Expected Future Amortization Expense (Details) Sheet http://liqtech.com/20161231/role/statement-note-7-definitelife-intangible-assets-expected-future-amortization-expense-details Note 7 - Definite-life Intangible Assets - Expected Future Amortization Expense (Details) Uncategorized 49 false false R50.htm 049 - Disclosure - Note 8 - Goodwill (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-8-goodwill-details-textual Note 8 - Goodwill (Details Textual) Uncategorized 50 false false R51.htm 050 - Disclosure - Note 8 - Goodwill - Summary of Goodwill (Details) Sheet http://liqtech.com/20161231/role/statement-note-8-goodwill-summary-of-goodwill-details Note 8 - Goodwill - Summary of Goodwill (Details) Uncategorized 51 false false R52.htm 051 - Disclosure - Note 8 - Goodwill - Components of Goodwill (Details) Sheet http://liqtech.com/20161231/role/statement-note-8-goodwill-components-of-goodwill-details Note 8 - Goodwill - Components of Goodwill (Details) Uncategorized 52 false false R53.htm 052 - Disclosure - Note 9 - Lines of Credit (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-9-lines-of-credit-details-textual Note 9 - Lines of Credit (Details Textual) Uncategorized 53 false false R54.htm 053 - Disclosure - Note 10 - Leases (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-10-leases-details-textual Note 10 - Leases (Details Textual) Uncategorized 54 false false R55.htm 054 - Disclosure - Note 10 - Leases - Future Minimum Lease Payments for Non-cancelable Operating Leases (Details) Sheet http://liqtech.com/20161231/role/statement-note-10-leases-future-minimum-lease-payments-for-noncancelable-operating-leases-details Note 10 - Leases - Future Minimum Lease Payments for Non-cancelable Operating Leases (Details) Uncategorized 55 false false R56.htm 055 - Disclosure - Note 10 - Leases - Future Minimum Capital Lease Payments (Details) Sheet http://liqtech.com/20161231/role/statement-note-10-leases-future-minimum-capital-lease-payments-details Note 10 - Leases - Future Minimum Capital Lease Payments (Details) Uncategorized 56 false false R57.htm 056 - Disclosure - Note 11 - Agreements and Commitments (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-11-agreements-and-commitments-details-textual Note 11 - Agreements and Commitments (Details Textual) Uncategorized 57 false false R58.htm 057 - Disclosure - Note 12 - Income Taxes (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-12-income-taxes-details-textual Note 12 - Income Taxes (Details Textual) Uncategorized 58 false false R59.htm 058 - Disclosure - Note 12 - Income Taxes - Deferred Tax Asset (Liabilities) (Details) Sheet http://liqtech.com/20161231/role/statement-note-12-income-taxes-deferred-tax-asset-liabilities-details Note 12 - Income Taxes - Deferred Tax Asset (Liabilities) (Details) Uncategorized 59 false false R60.htm 059 - Disclosure - Note 12 - Income Taxes - Reconciliation of Income Tax Expense (Details) Sheet http://liqtech.com/20161231/role/statement-note-12-income-taxes-reconciliation-of-income-tax-expense-details Note 12 - Income Taxes - Reconciliation of Income Tax Expense (Details) Uncategorized 60 false false R61.htm 060 - Disclosure - Note 12 - Income Taxes - Components of Income Tax Expense (Benefit) from Continuing Operations (Details) Sheet http://liqtech.com/20161231/role/statement-note-12-income-taxes-components-of-income-tax-expense-benefit-from-continuing-operations-details Note 12 - Income Taxes - Components of Income Tax Expense (Benefit) from Continuing Operations (Details) Uncategorized 61 false false R62.htm 061 - Disclosure - Note 13 - Earnings Per Share (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-13-earnings-per-share-details-textual Note 13 - Earnings Per Share (Details Textual) Uncategorized 62 false false R63.htm 062 - Disclosure - Note 13 - Earnings Per Share - Amounts Used in Computing Earnings Per Share (Details) Sheet http://liqtech.com/20161231/role/statement-note-13-earnings-per-share-amounts-used-in-computing-earnings-per-share-details Note 13 - Earnings Per Share - Amounts Used in Computing Earnings Per Share (Details) Uncategorized 63 false false R64.htm 063 - Disclosure - Note 14 - Stockholders' Equity (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-14-stockholders-equity-details-textual Note 14 - Stockholders' Equity (Details Textual) Uncategorized 64 false false R65.htm 064 - Disclosure - Note 14 - Stockholders' Equity - Warrants Outstanding (Details) Sheet http://liqtech.com/20161231/role/statement-note-14-stockholders-equity-warrants-outstanding-details Note 14 - Stockholders' Equity - Warrants Outstanding (Details) Uncategorized 65 false false R66.htm 065 - Disclosure - Note 14 - Stockholders' Equity - Assumptions Used to Calculate the Fair Values of Stock Options (Details) Sheet http://liqtech.com/20161231/role/statement-note-14-stockholders-equity-assumptions-used-to-calculate-the-fair-values-of-stock-options-details Note 14 - Stockholders' Equity - Assumptions Used to Calculate the Fair Values of Stock Options (Details) Uncategorized 66 false false R67.htm 066 - Disclosure - Note 14 - Stockholders' Equity - Options Outstanding (Details) Sheet http://liqtech.com/20161231/role/statement-note-14-stockholders-equity-options-outstanding-details Note 14 - Stockholders' Equity - Options Outstanding (Details) Uncategorized 67 false false R68.htm 067 - Disclosure - Note 14 - Stockholders' Equity - Status of Options Granted and Changes During the Year (Details) Sheet http://liqtech.com/20161231/role/statement-note-14-stockholders-equity-status-of-options-granted-and-changes-during-the-year-details Note 14 - Stockholders' Equity - Status of Options Granted and Changes During the Year (Details) Uncategorized 68 false false R69.htm 068 - Disclosure - Note 15 - Significant Customers / Concentration (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-15-significant-customers-concentration-details-textual Note 15 - Significant Customers / Concentration (Details Textual) Uncategorized 69 false false R70.htm 069 - Disclosure - Note 15 - Significant Customers / Concentration - Net Sales by Geographical Region (Details) Sheet http://liqtech.com/20161231/role/statement-note-15-significant-customers-concentration-net-sales-by-geographical-region-details Note 15 - Significant Customers / Concentration - Net Sales by Geographical Region (Details) Uncategorized 70 false false R71.htm 070 - Disclosure - Note 15 - Significant Customers / Concentration - Sales by Product Line (Details) Sheet http://liqtech.com/20161231/role/statement-note-15-significant-customers-concentration-sales-by-product-line-details Note 15 - Significant Customers / Concentration - Sales by Product Line (Details) Uncategorized 71 false false R72.htm 071 - Disclosure - Note 16 - Subsequent Event (Details Textual) Sheet http://liqtech.com/20161231/role/statement-note-16-subsequent-event-details-textual Note 16 - Subsequent Event (Details Textual) Uncategorized 72 false false R73.htm 072 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) Sheet http://liqtech.com/20161231/role/statement-schedule-ii-valuation-and-qualifying-accounts-valuation-and-qualifying-accounts-details Schedule II - Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) Uncategorized 73 false false R74.htm 073 - Disclosure - Schedule II - Valuation and Qualifying Accounts - Rollforward for Allowance for Doubtful Accounts (Details) Sheet http://liqtech.com/20161231/role/statement-schedule-ii-valuation-and-qualifying-accounts-rollforward-for-allowance-for-doubtful-accounts-details Schedule II - Valuation and Qualifying Accounts - Rollforward for Allowance for Doubtful Accounts (Details) Uncategorized 74 false false All Reports Book All Reports liqt-20161231.xml liqt-20161231.xsd liqt-20161231_cal.xml liqt-20161231_def.xml liqt-20161231_lab.xml liqt-20161231_pre.xml true true ZIP 94 0001437749-17-005629-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-17-005629-xbrl.zip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�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end